
<html lang="en"     class="pb-page"  data-request-id="48ed95c8-21cb-410b-bb4a-48697a803ac3"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";issue:issue:10.1021/jmcmar.2014.57.issue-4;requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;article:article:10.1021/jm401321v;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Euodenine A: A Small-Molecule Agonist of Human TLR4" /></meta><meta name="dc.Creator" content="Juliette E.  Neve" /></meta><meta name="dc.Creator" content="Hasanthi P.  Wijesekera" /></meta><meta name="dc.Creator" content="Sandra  Duffy" /></meta><meta name="dc.Creator" content="Ian D.  Jenkins" /></meta><meta name="dc.Creator" content="Justin A.  Ripper" /></meta><meta name="dc.Creator" content="Simon J.  Teague" /></meta><meta name="dc.Creator" content="Marc  Campitelli" /></meta><meta name="dc.Creator" content="Agatha  Garavelas" /></meta><meta name="dc.Creator" content="George  Nikolakopoulos" /></meta><meta name="dc.Creator" content="Phuc V.  Le" /></meta><meta name="dc.Creator" content="Priscila  de A. Leone" /></meta><meta name="dc.Creator" content="Ngoc B.  Pham" /></meta><meta name="dc.Creator" content="Philip  Shelton" /></meta><meta name="dc.Creator" content="Neil  Fraser" /></meta><meta name="dc.Creator" content="Anthony R.  Carroll" /></meta><meta name="dc.Creator" content="Vicky M.  Avery" /></meta><meta name="dc.Creator" content="Christopher  McCrae" /></meta><meta name="dc.Creator" content="Nicola  Williams" /></meta><meta name="dc.Creator" content="Ronald J.  Quinn" /></meta><meta name="dc.Description" content="A small-molecule natural product, euodenine A (1), was identified as an agonist of the human TLR4 receptor. Euodenine A was isolated from the leaves of Euodia asteridula (Rutaceae) found in Papua N..." /></meta><meta name="Description" content="A small-molecule natural product, euodenine A (1), was identified as an agonist of the human TLR4 receptor. Euodenine A was isolated from the leaves of Euodia asteridula (Rutaceae) found in Papua N..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="February 7, 2014" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm401321v" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2014 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm401321v" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm401321v" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm401321v" /></link>
        
    
    

<title>Euodenine A: A Small-Molecule Agonist of Human TLR4 | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm401321v" /></meta><meta property="og:title" content="Euodenine A: A Small-Molecule Agonist of Human TLR4" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401321v/production/images/large/jm-2013-01321v_0018.jpeg" /></meta><meta property="og:description" content="A small-molecule natural product, euodenine A (1), was identified as an agonist of the human TLR4 receptor. Euodenine A was isolated from the leaves of Euodia asteridula (Rutaceae) found in Papua New Guinea and has an unusual U-shaped structure. It was synthesized along with a series of analogues that exhibit potent and selective agonism of the TLR4 receptor. SAR development around the cyclobutane ring resulted in a 10-fold increase in potency. The natural product demonstrated an extracellular site of action, which requires the extracellular domain of TLR4 to stimulate a NF-κB reporter response. 1 is a human-selective agonist that is CD14-independent, and it requires both TLR4 and MD-2 for full efficacy. Testing for immunomodulation in PBMC cells shows the induction of the cytokines IL-8, IL-10, TNF-α, and IL-12p40 as well as suppression of IL-5 from activated PBMCs, indicating that compounds like 1 could modulate the Th2 immune response without causing lung damage." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm401321v"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm401321v">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm401321v&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm401321v&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm401321v&amp;href=/doi/10.1021/jm401321v" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2014</span><span class="cit-fg-volume">, 57</span><span class="cit-fg-issue">, 4</span><span class="cit-fg-pageRange">, 1252-1275</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/57/4" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm401780b" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm401326j" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Euodenine A: A Small-Molecule Agonist of Human TLR4</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Juliette+E.++Neve">Juliette E. Neve</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Hasanthi+P.++Wijesekera">Hasanthi P. Wijesekera</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Sandra++Duffy">Sandra Duffy</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ian+D.++Jenkins">Ian D. Jenkins</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Justin+A.++Ripper">Justin A. Ripper</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Simon+J.++Teague">Simon J. Teague</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Marc++Campitelli">Marc Campitelli</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Agatha++Garavelas">Agatha Garavelas</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=George++Nikolakopoulos">George Nikolakopoulos</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Phuc+V.++Le">Phuc V. Le</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Priscila++de+A.+Leone">Priscila de A. Leone</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ngoc+B.++Pham">Ngoc B. Pham</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Philip++Shelton">Philip Shelton</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Neil++Fraser">Neil Fraser</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Anthony+R.++Carroll">Anthony R. Carroll</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Vicky+M.++Avery">Vicky M. Avery</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Christopher++McCrae">Christopher McCrae</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Nicola++Williams">Nicola Williams</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ronald+J.++Quinn">Ronald J. Quinn</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-symbol">†</span> <span class="aff-text">Eskitis Institute for Drug Discovery, Griffith University, Nathan, 4111 Queensland, Australia</span></div><div class="aff-info" id="aff2"><span class="aff-symbol">‡</span> <span class="aff-text">AstraZeneca R&D Charnwood, Bakewell Road, Loughborough, LE11 5RH Leicestershire, United Kingdom</span></div><div class="aff-info" id="aff3"><span class="aff-symbol">§</span> <span class="aff-text">AstraZeneca R&D Mölndal, Translational Science, Respiratory & Inflammation iMed, Pepperedsleden 1, SE-431 83 Mölndal, Sweden</span></div><div class="corresp-info"><strong>*</strong>Phone: +61 7 37356009. Fax: +61 7 37356001. E-mail: <a href="/cdn-cgi/l/email-protection#20720e7155494e4e6047524946464954480e4544550e4155"><span class="__cf_email__" data-cfemail="87d5a9d6f2eee9e9c7e0f5eee1e1eef3efa9e2e3f2a9e6f2">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm401321v&amp;href=/doi/10.1021%2Fjm401321v" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2014</span></span><span class="cit-volume">, 57</span><span class="cit-issue">, 4</span><span class="cit-pageRange">, 1252–1275</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">January 28, 2014</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>27 August 2013</li><li><span class="item_label"><b>Published</b> online</span>7 February 2014</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 27 February 2014</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm401321v" title="DOI URL">https://doi.org/10.1021/jm401321v</a></div><div class="article_header-article-copyright"><strong>Copyright © 2014 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D1252%26pageCount%3D24%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DJuliette%2BE.%2BNeve%252C%2BHasanthi%2BP.%2BWijesekera%252C%2BSandra%2BDuffy%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D57%26issueNum%3D4%26contentID%3Djm401321v%26title%3DEuodenine%2BA%253A%2BA%2BSmall-Molecule%2BAgonist%2Bof%2BHuman%2BTLR4%26numPages%3D24%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D1275%26publicationDate%3DFebruary%2B2014">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm401321v"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">2739</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">31</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm401321v" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Euodenine A: A Small-Molecule Agonist of Human TLR4&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Juliette&quot;,&quot;last_name&quot;:&quot;E. Neve&quot;},{&quot;first_name&quot;:&quot;Hasanthi&quot;,&quot;last_name&quot;:&quot;P. Wijesekera&quot;},{&quot;first_name&quot;:&quot;Sandra&quot;,&quot;last_name&quot;:&quot;Duffy&quot;},{&quot;first_name&quot;:&quot;Ian&quot;,&quot;last_name&quot;:&quot;D. Jenkins&quot;},{&quot;first_name&quot;:&quot;Justin&quot;,&quot;last_name&quot;:&quot;A. Ripper&quot;},{&quot;first_name&quot;:&quot;Simon&quot;,&quot;last_name&quot;:&quot;J. Teague&quot;},{&quot;first_name&quot;:&quot;Marc&quot;,&quot;last_name&quot;:&quot;Campitelli&quot;},{&quot;first_name&quot;:&quot;Agatha&quot;,&quot;last_name&quot;:&quot;Garavelas&quot;},{&quot;first_name&quot;:&quot;George&quot;,&quot;last_name&quot;:&quot;Nikolakopoulos&quot;},{&quot;first_name&quot;:&quot;Phuc&quot;,&quot;last_name&quot;:&quot;V. Le&quot;},{&quot;first_name&quot;:&quot;Priscila&quot;,&quot;last_name&quot;:&quot;de A. Leone&quot;},{&quot;first_name&quot;:&quot;Ngoc&quot;,&quot;last_name&quot;:&quot;B. Pham&quot;},{&quot;first_name&quot;:&quot;Philip&quot;,&quot;last_name&quot;:&quot;Shelton&quot;},{&quot;first_name&quot;:&quot;Neil&quot;,&quot;last_name&quot;:&quot;Fraser&quot;},{&quot;first_name&quot;:&quot;Anthony&quot;,&quot;last_name&quot;:&quot;R. Carroll&quot;},{&quot;first_name&quot;:&quot;Vicky&quot;,&quot;last_name&quot;:&quot;M. Avery&quot;},{&quot;first_name&quot;:&quot;Christopher&quot;,&quot;last_name&quot;:&quot;McCrae&quot;},{&quot;first_name&quot;:&quot;Nicola&quot;,&quot;last_name&quot;:&quot;Williams&quot;},{&quot;first_name&quot;:&quot;Ronald&quot;,&quot;last_name&quot;:&quot;J. Quinn&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2014&quot;,&quot;month&quot;:&quot;02&quot;,&quot;day&quot;:&quot;07&quot;,&quot;issue&quot;:&quot;4&quot;,&quot;volume&quot;:&quot;57&quot;,&quot;pages&quot;:&quot;1252-1275&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm401321v&quot;},&quot;abstract&quot;:&quot;A small-molecule natural product, euodenine A (1), was identified as an agonist of the human TLR4 receptor. Euodenine A was isolated from the leaves of Euodia asteridula (Rutaceae) found in Papua New Guinea and has an unusual U-shaped structure. It was synthesized along with a series of analogues that exhibit potent and selective agonism of the TLR4 receptor. SAR development around the cyclobutane ring resulted in a 10-fold increase in potency. The natural product demonstrated an extracellular site of action, which requires the extracellular domain of TLR4 to stimulate a NF-κB reporter response. 1 is a human-selective agonist that is CD14-independent, and it requires both TLR4 and MD-2 for full efficacy. Testing for immunomodulation in PBMC cells shows the induction of the cytokines IL-8, IL-10, TNF-α, and IL-12p40 as well as suppression of IL-5 from activated PBMCs, indicating that compounds like 1 could modulate the Th2 immune response without causing lung damage.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm401321v&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm401321v" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm401321v&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm401321v" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm401321v&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm401321v" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm401321v&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm401321v&amp;href=/doi/10.1021/jm401321v" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm401321v" /></input><a href="/doi/pdf/10.1021/jm401321v" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (2 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm401321v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm401321v%26sid%3Dliteratum%253Aachs%26pmid%3D24471857%26genre%3Darticle%26aulast%3DNeve%26date%3D2014%26atitle%3DEuodenine%2BA%253A%2BA%2BSmall-Molecule%2BAgonist%2Bof%2BHuman%2BTLR4%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D57%26issue%3D4%26spage%3D1252%26epage%3D1275%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291011" title="High-performance liquid chromatography">High-performance liquid chromatography</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=292234" title="Chromatography">Chromatography</a>,</li><li><a href="/action/doSearch?ConceptID=291316" title="Mixtures">Mixtures</a>,</li><li><a href="/action/doSearch?ConceptID=292349" title="Alkyls">Alkyls</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/57/4" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jmcmar.2014.57.issue-4/production/jmcmar.2014.57.issue-4.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401321v/production/images/medium/jm-2013-01321v_0018.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401321v/production/images/large/jm-2013-01321v_0018.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401321v&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">A small-molecule natural product, euodenine A (<b>1</b>), was identified as an agonist of the human TLR4 receptor. Euodenine A was isolated from the leaves of <i>Euodia asteridula</i> (Rutaceae) found in Papua New Guinea and has an unusual U-shaped structure. It was synthesized along with a series of analogues that exhibit potent and selective agonism of the TLR4 receptor. SAR development around the cyclobutane ring resulted in a 10-fold increase in potency. The natural product demonstrated an extracellular site of action, which requires the extracellular domain of TLR4 to stimulate a NF-κB reporter response. <b>1</b> is a human-selective agonist that is CD14-independent, and it requires both TLR4 and MD-2 for full efficacy. Testing for immunomodulation in PBMC cells shows the induction of the cytokines IL-8, IL-10, TNF-α, and IL-12p40 as well as suppression of IL-5 from activated PBMCs, indicating that compounds like <b>1</b> could modulate the Th2 immune response without causing lung damage.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_70074" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_70074" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Steroids and antibodies dominate the current anti-inflammatory treatment for allergy and asthma. Since the discovery of the Toll-like receptors (TLRs) in 1988<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> and the identification of their role in adaptive immunity,<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> the targeting of TLRs has opened up new therapeutic possibilities for the prevention and treatment of inflammatory diseases. TLRs are attractive targets for the prevention and treatment of cancer, infection, allergy, asthma, autoimmune disease, and chronic neuropathic pain.<a onclick="showRef(event, 'ref3 ref4 ref5 ref6 ref7 ref8 ref9 ref10'); return false;" href="javascript:void(0);" class="ref ref3 ref4 ref5 ref6 ref7 ref8 ref9 ref10">(3-10)</a> Activation of the innate immune system through mammalian TLRs has an instructive role for the responses of the acquired immune response and thus may influence allergic diseases, such as asthma. The allergic response usually features a strong Th2 response, which can be counterbalanced by TLR signaling induction; this would induce a cytokine response, activating antigen-presenting cells and a Th1 response.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> Agonists of Toll-like receptor 4 (TLR4) could be therapeutically useful for treating the acute phase of asthma.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> There is evidence that the acquired immune response in asthma is polarized to a response dominated by Th2 lymphocytes, which are involved in the orchestration of the allergic inflammatory response by secreting a variety of type-2 cytokines (interleukin (IL)-4, IL-5, and IL-13). These cytokines enhance the migration and survival of eosinophils and B cells and contribute to mucous cell hyperplasia and mast cell activation. Modulation of the type-2 acquired immune response is an attractive approach in controlling allergic disease because it offers the potential for disease normalization and contrasts with existing steroidal and antibody treatments on the market and in late-stage development, which offer only symptomatic relief. There are very few small-molecule inhibitors of the TLR4 receptor known, examples include TAK-242 and (+)-naloxone (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>). TAK-242 is a small-molecule inhibitor of protein–protein interactions of the Toll/interleukin-1 receptor (TIR) domain of TLR4;<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> however, this compound acts as a Michael acceptor, binding covalently to Cys<sup>747</sup> in the intracellular domain of TLR4.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> (+)-Naloxone is an opioid-inactive TLR4 signaling inhibitor that can reverse neuropathic pain in rats.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> Very recently, dimethyl 2-(2-nitrobenzylidene)malonate has been found to inhibit LPS-mediated nuclear factor-kappaB (NF-κB) activation, the cytokine production of IL-1β, tumor necrosis factor (TNF-α), and nitric oxide (NO) in the nanomolar to low micromolar range.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> However, as with TAK-242, dimethyl 2-(2-nitrobenzylidene)malonate is a Michael acceptor and almost certainly binds covalently to Cys<sup>747</sup> (the corresponding compound without the α,β-double bond is inactive with an IC<sub>50</sub> > 100 μM).<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> TAK-242, (+)-naloxone, and dimethyl 2-(2-nitrobenzylidene)malonate are all TLR4 antagonists. There is clearly an urgent need for small-molecule, druglike agonists of the TLR4 receptor.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401321v/production/images/medium/jm-2013-01321v_0020.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401321v/production/images/large/jm-2013-01321v_0020.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Small-molecule inhibitors of TLR4: Tak-242 (a), (+)-naloxone (b), and dimethyl 2-(2-nitrobenzylidene)malonate (c).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401321v/production/images/large/jm-2013-01321v_0020.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401321v&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Identification of a Novel Class of TLR-4 Agonists</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_22648" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_22648" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Screening a small library of 750 pure natural products against a panel of TLRs led to the identification of a potent and selective small-molecule agonist of the TLR4 receptor. Euodenine A (<b>1</b>) was originally isolated from the air-dried leaves of the tree <i>Euodia asteridula</i> (Rutaceae) collected in Papua New Guinea. The EL-Nino fires of 1997/8 destroyed the original tree from which <b>1</b> was isolated, and subsequent recollection of the plant from the same and different areas failed to provide further quantities of <b>1</b>, resulting in the need for total synthesis. The molecule (C<sub>26</sub>H<sub>29</sub>NO<sub>5</sub>, relative molecular mass 435.51) consists of two aromatic regions held together in a U-shape, as dictated by the relative stereochemistry about the central cyclobutane ring (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>). The relative stereochemistry was determined through ROESY correlations observed between the methyl at 8′ and H-7′ and among H-7′, H-4, and H-3, placing the methyl and trimethoxyphenyl groups trans and the pyranoquinoline and trimethoxyphenyl groups cis on the cyclobutane ring. The cis relationship of the two aromatic groups was further supported by the significant upfield shift (by ∼0.5 ppm) observed for trimethoxyaryl protons H-2′ and H-6′ because of shielding by the adjacent pyranoquinolinone.</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401321v/production/images/medium/jm-2013-01321v_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401321v/production/images/large/jm-2013-01321v_0001.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Structure and 3D shape of euodenine A (<b>1</b>) (relative stereochemistry and MacroModel/MMFF force field with H<sub>2</sub>O solvation of the lowest-energy conformer are shown).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401321v/production/images/large/jm-2013-01321v_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401321v&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Compound <b>1</b> is closely related to melicodenines C–F (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>) that have recently been isolated from the leaves of <i>Melicope denhamii</i>, a rutaceous shrub indigenous to regions from Borneo to the Solomon Islands.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a></div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401321v/production/images/medium/jm-2013-01321v_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401321v/production/images/large/jm-2013-01321v_0002.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Structures related to euodenine A, melicodenines C–F (relative stereochemistry shown).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401321v/production/images/large/jm-2013-01321v_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401321v&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Compound <b>1</b> appears to have full activity on the desired readout in peripheral blood mononuclear cells (PBMCs) (IL-5 suppression) while limiting the undesired proinflammatory effects of full/LPS-driven TLR4 agonism. Compound <b>1</b> was also selective for TLR4, exhibiting no activity against TLR2/6 and TLRs 3, 5, 7, 8, and 9 at 10 μM (higher concentrations would be required to determine if the level of selectivity is significant, see the <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a> for details of TLR4 selectivity). In addition, <b>1</b> showed minimal cytotoxicity against PBMCs at concentrations greater than 30 μM (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>). It is worth noting that closely related melicodenines C–F showed limited cytotoxicity against DLD-1 human colon cancer cells. For example, melicodenine D, the compound that most closely resembles <b>1</b>, resulted in a 30% reduction in cell viability at 50 μM but no reduction at 20 μM.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a></div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Activity Profiles and Toxicity of <b>1</b> and LPS</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="2" align="center">TLR receptor activity (EC<sub>50</sub>)</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">cell line</th><th class="colsep0 rowsep0" align="center"><b>1</b></th><th class="colsep0 rowsep0" align="center">LPS</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">TLR4</td><td class="colsep0 rowsep0" align="left">4 μM</td><td class="colsep0 rowsep0" align="left">3 ng/mL</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">TLR2/6</td><td class="colsep0 rowsep0" align="left">NA at 10 μM</td><td class="colsep0 rowsep0" align="left">NA at 1.5 μg/mL</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">TLR3</td><td class="colsep0 rowsep0" align="left">NA at 10 μM</td><td class="colsep0 rowsep0" align="left">NA at 1.5 μg/mL</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">TLR5</td><td class="colsep0 rowsep0" align="left">NA at 10 μM</td><td class="colsep0 rowsep0" align="left">NA at 1.5 μg/mL</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">TLR7</td><td class="colsep0 rowsep0" align="left">NA at 10 μM</td><td class="colsep0 rowsep0" align="left">NA at 1.5 μg/mL</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">TLR8</td><td class="colsep0 rowsep0" align="left">NA at 10 μM</td><td class="colsep0 rowsep0" align="left">NA at 1.5 μg/mL</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center">Toxicity (CC<sub>50</sub>)<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="center"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">PBMC</td><td class="colsep0 rowsep0" align="left">>33 μM</td><td class="colsep0 rowsep0" align="left">>1000 ng/mL</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>a</sup><p class="last">Toxicity data from IL-5-suppression experiments using PHA-stimulated PBMCs at a concentration of 20 μM showed no toxic effect for <b>1</b>. In PBMCs from 4 donors, <b>1</b> was tested up to 100 μM with a small effect at 33 μM and clear evidence of toxicity at 100 μM.</p></div></div></div><div class="NLM_p">In HEK cell line-secreted alkaline phosphatase (SEAP) reporter assays for human, mouse, and rat TLR4, <b>1</b> was found to be human-selective in comparison to LPS, which shows species crossover to both rat and mouse. Subsequent reporter assays using chimeric human/mouse TLR4 receptors were used to determine the receptor domains required for agonist function, with LPS used as a control. In the four possible combinations of chimeric human/mouse, intra/extracellular TLR reporter assays, <b>1</b> only stimulated the NF-κB reporter when the extracellular domain of human TLR4 was expressed as a fusion to either the mouse or human intracellular domain (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>). When the murine extracellular domain was fused to either the mouse or human intracellular domain, <b>1</b> was inactive. From these studies, and the lack of activity of <b>1</b> in the SEAP mouse assays, it can be concluded that <b>1</b> has an extracellular site of action, as there is a requirement for the extracellular domain of human TLR4 to stimulate a NF-κB reporter response.</div><figure id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401321v/production/images/medium/jm-2013-01321v_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401321v/production/images/large/jm-2013-01321v_0003.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Extracellular site of action of euodenine A (<b>1</b>). A HEK293/NFκB reporter cell line stably transfected with human MD-2 and CD14 was transiently transfected with a chimeric construct consisting of either the human or mouse TLR4 extracellular domain fused to either the human or mouse transmembrane and intracellular domains. Cells were subsequently treated with LPS or <b>1</b>, and reporter gene activity was measured 24 h later. Data are representative of at least two independent experiments and are expressed as the mean of triplicate determinations. (A) LPS is active in all human/mouse chimeric assays. (B) <b>1</b> is a human-selective agonist and only shows a response when the extracellular domain of human TLR4 is present.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401321v/production/images/large/jm-2013-01321v_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401321v&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">TLR4 is a multicomponent receptor composed of TLR4, myeloid differentiation factor 2 (MD-2), and cluster of differentiation 14 (CD14), each of which has their own costimulatory function (Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>).</div><figure id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401321v/production/images/medium/jm-2013-01321v_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401321v/production/images/large/jm-2013-01321v_0004.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. LPS activation of TLR4 via the CD14, TLR4, and MD-2 complex proceeds via MyD88 and the IRAK/TRAF6 pathway, leading to activation of proinflammatory cytokines.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401321v/production/images/large/jm-2013-01321v_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401321v&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Initial studies with <b>1</b> and LPS revealed that these agonists require both MD-2 and TLR4 to function and do not work with TLR4 alone, confirming the essential role of MD-2 in TLR4 signaling (Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>).</div><figure id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401321v/production/images/medium/jm-2013-01321v_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401321v/production/images/large/jm-2013-01321v_0005.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. LPS and <b>1</b> require MD-2 and TLR4 for agonism. A HEK293/NFκB reporter cell line stably transfected with human TLR4 was transiently transfected with constructs containing either human MD-2, human CD14, a combination of human MD-2 and CD14, or empty vector. Cells were subsequently treated with (A) LPS or <b>1</b>, and reporter gene activity was measured 24 h later. TNF-α was used as a control to stimulate maximal reporter gene activity, and results were calculated as the percent of the maximal TNF-α response. Data are representative of at least two independent experiments and are expressed as the mean of triplicate determinations. Signaling only occurs when both TLR4 and MD-2 are present.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401321v/production/images/large/jm-2013-01321v_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401321v&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Various rat, mouse, and human MD-2 and TLR4 combination reporter assays were used to determine the dependency of <b>1</b> on MD-2. LPS was active at both human and mouse TLR4 irrespective of the species of MD-2; however, reduced potency was observed when mouse MD-2 was combined with human TLR4 (Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a>a). Compound <b>1</b> showed activity only when human TLR4 was expressed with human MD-2 (Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a>b). Mouse MD-2 could not substitute. Therefore, <b>1</b> is human-selective for both human proteins.</div><figure id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401321v/production/images/medium/jm-2013-01321v_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401321v/production/images/large/jm-2013-01321v_0006.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. <b>1</b> is human-selective. A HEK293 NFκB reporter cell line was transiently transfected with a construct containing either human or mouse TLR4 together with a construct containing human or mouse MD-2 and CD14. Cells were subsequently treated with LPS or <b>1</b>, and reporter gene activity was measured 24 h later. Data are representative of at least two independent experiments and are expressed as the mean of triplicate determinations. (A) LPS is nonselective against human and mouse TLR4. (B) <b>1</b> is human selective for both TLR4 and MD-2, and mouse MD-2 cannot substitute.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401321v/production/images/large/jm-2013-01321v_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401321v&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Because <b>1</b> and LPS stimulate TLR4 by different mechanisms, cytokine profiling was undertaken. Compound <b>1</b> was compared to LPS, and as expected, LPS showed significant induction of IL-8, IL-12p40, IL-10, and TNF-α, with little effect on IL-2, IL-4, and IL-5. In comparison to LPS, <b>1</b> showed reduced induction of IL-12p40, IL-10, and TNF-α as well as induction of IL-8 from PBMCs and the suppression of IL-5 from activated PBMCs. In 8/8 donors tested, IL-8 induction was equal to that observed for LPS, whereas IL-10, TNF-α, and IL-12p40 induction were less than that observed for LPS. In 9/9 activated PBMCs tested, IL-5 was suppressed (Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a>). These results suggest that <b>1</b> would have the potential to prevent IL-5-mediated allergic inflammation while having a lower risk of inducing IL-12- and TNF-α-mediated proinflammatory responses compared to LPS.</div><figure id="fig8" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401321v/production/images/medium/jm-2013-01321v_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401321v/production/images/large/jm-2013-01321v_0007.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Cytokine induction time-course data: IL-8 (A), IL-12p40 (B), IL-10 (C), and TNF-α (D). (E) IL-5 suppression from activated PBMCs by <b>1</b> and (F) IL-5 suppression from activated PBMCs by LPS. In PBMC, <b>1</b> suppresses PHA-induced IL-5 release and, compared to LPS, stimulates lower levels of three out of four cytokines tested. (A–F) Human PBMCs were treated with LPS or <b>1</b> for 20 h. Levels of IL-8 (A), IL-12p40 (B), IL-10 (C), and TNF-α (D) were measured in the cell supernatants by ELISA. (E, F) Human PBMC were stimulated for 44 h with 1 μg/mL of phytohemeagglutinin (PHA) in the presence or absence of LPS or <b>1</b>. Levels of IL-5 were measured in the cell supernatants by ELISA. Data are from a representative experiment in PBMC from 1 of 8 donors (cytokine stimulation) or 9 donors (IL-5 suppression) and are expressed as the mean ± standard deviation of triplicate determinations.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401321v/production/images/large/jm-2013-01321v_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401321v&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i4">Synthesis of <b>1</b> and Analogues</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_46870" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_46870" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Compared to other known TLR4 agonists such as LPS, <b>1</b> is much simpler in structure. Compound <b>1</b> was at first synthesized via a photochemically induced [2 + 2] cycloaddition reaction from <i>O</i>-methyl flindersine (<b>3</b>) and (<i>E</i>)-1,2,3-trimethoxy-5-(prop-1-enyl)benzene followed by cleavage of the methyl ether with potassium iodide in acetic acid to afford the natural product (Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>).</div><figure id="sch1" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401321v/production/images/medium/jm-2013-01321v_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401321v/production/images/large/jm-2013-01321v_0008.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of <b>1</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401321v/production/images/large/jm-2013-01321v_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401321v&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Relative stereochemistry shown. Reagents and conditions: (i) UV light (hv), 125 W, neat 16 h; (ii) KI, HOAc, 50 °C, 4 h.</p></p></figure><div class="NLM_p">Initially, the photochemistry was carried out in dichloromethane, and the product was isolated by laborious preparative thin-layer chromatography.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> Improved yields resulted when the photoaddition was performed without solvent. Evaporation of a chloroform solution of <i>O</i>-methyl flindersine<a onclick="showRef(event, 'ref17 ref18'); return false;" href="javascript:void(0);" class="ref ref17 ref18">(17, 18)</a> and (<i>E</i>)-1,2,3-trimethoxy-5-(prop-1-enyl)benzene in a jacketed round-bottomed flask afforded a thin film of reagents on the walls of the flask. Irradiation of this thin film using a medium-pressure UV lamp (125 or 400 W) with water cooling for 16 h led to the desired intermolecular cycloaddition product in modest yield (36%) with excellent chemo- and regioselectivity, possibly as a result of a π-stacking interaction between the aryl group of the styrene and the quinolinone ring. Demethylation with potassium iodide in acetic acid afforded the desired natural product in 85% yield. Subsequent photoaddition of flindersine (<b>2a</b>) and (<i>E</i>)-1,2,3-trimethoxy-5-(prop-1-enyl)benzene afforded the natural product in one step. This method was used for the generation of 53 cyclobutane-based analogues of <b>1</b>. Closely related melicodenines C, D, and E (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>) have also been synthesized in our laboratory by this route.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a></div><figure id="sch2" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401321v/production/images/medium/jm-2013-01321v_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401321v/production/images/large/jm-2013-01321v_0009.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. General Synthetic Approach<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401321v/production/images/large/jm-2013-01321v_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401321v&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Relative stereochemistry shown. Reagents and conditions: (i) UV light (hv), 125 or 400 W, neat 16 h. Yields: 2–36% (generally, 5–10%).</p></p></figure><div class="NLM_p">Most of the analogues were synthesized directly from the corresponding flindersine analogue and functionalized styrene (Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>). This general synthetic approach enabled variation of the pyranoquinoline, the alkyl carbon group R at C8′, and the pendant aromatic attached at C7′. Because only a few of the required styrenes were commercially available, most were synthesized using one of four methods (Scheme <a class="ref internalNav" href="#sch3" aria-label="3">3</a>) depending on the availability of starting materials. The preferred method of synthesis of the styrenes was from the aldehyde by reaction with a Grignard reagent to afford the corresponding carbinol (method A). Subsequent dehydration using excess self-indicating silica gel in dioxane under microwave conditions<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> predominately gave the trans styrene, which was purified by flash chromatography prior to the photochemical cycloaddition. Cyclopentyl and cyclohexyl styrenes were accessed via the required benzylic alcohol, which had been treated with phosphorus tribromide followed by triethyl phosphite to afford the phosphonate ester (Michaelis–Arbuzov reaction). Reaction with cyclopentyl or cyclohexylcarbaldehyde gave the corresponding styrene (Horner–Wadsworth–Emmons procedure, method B). Nitrostyrenes produced via the Henry reaction provided substituted styrenes upon treatment with the corresponding alkyl iodide in the presence of triethylboron and oxygen (method C),<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> and the Suzuki coupling of cyclopropylvinylboronic acid pinacol ester with an aryl bromide afforded the cyclopropyl substituted styrenes (method D).</div><figure id="sch3" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401321v/production/images/medium/jm-2013-01321v_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401321v/production/images/large/jm-2013-01321v_0010.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Methods for Synthesis of Styrenes<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401321v/production/images/large/jm-2013-01321v_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401321v&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) RCH<sub>2</sub>MgX, MePh; (ii) 1,4-dioxan, silica, microwave, 160 °C, 30 min; (iii) PBr<sub>3</sub>, DCM; (iv) P(OEt)<sub>3</sub>, (Bu)<sub>4</sub>NI, 110 °C 16 h; (v) NaH, RCHO, THF, 0 °C to rt, O/N; (vi) CH<sub>3</sub>NO<sub>2</sub>, NH<sub>4</sub>OAc, 48 h, reflux; (vii) RI, B(Et)<sub>3</sub>, rt, 24 h; (viii) Pd(OAc)<sub>2</sub>, 2 M K<sub>2</sub>CO<sub>3</sub>, DME, 80 °C, 16 h. Overall yields for methods A–C were 40–60% and for D (Suzuki coupling), ∼80%.</p></p></figure><div class="NLM_p">Further functionalized styrenes were prepared to incorporate a solubilizing group onto the pendant aryl ring by the following methods (Scheme <a class="ref internalNav" href="#sch4" aria-label="4">4</a>).</div><figure id="sch4" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401321v/production/images/medium/jm-2013-01321v_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401321v/production/images/large/jm-2013-01321v_0011.jpeg" id="gr12" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of Functionalized Styrenes<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401321v/production/images/large/jm-2013-01321v_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401321v&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) DMAP, pyridine; (ii) K<sub>2</sub>CO<sub>3</sub>, acetone. Yields: <b>5a</b> (78%), <b>5b</b> (37%), <b>5c</b> (20%), and <b>5d</b> (96%).</p></p></figure><div class="NLM_p">Modifications to the pyranoquinoline were investigated by utilizing flindersine and further functionalized analogues. Flindersine (<b>2a</b>), <i>N</i>-methylfindersine (<b>2b</b>), and 9-methylflindersine (<b>2c</b>) were prepared by the method of Lee et al.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> utilizing a tandem Knoevenagel-electrocyclic reaction (Scheme <a class="ref internalNav" href="#sch5" aria-label="5">5</a>).</div><figure id="sch5" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401321v/production/images/medium/jm-2013-01321v_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401321v/production/images/large/jm-2013-01321v_0012.jpeg" id="gr13" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Synthesis of Flindersine Analogues<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401321v/production/images/large/jm-2013-01321v_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401321v&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) (a) Yb(OTf)<sub>3</sub>, MeCN, 80 °C, 12 h or (b) MgSO<sub>4</sub>, pyridine, reflux 16 h. Yields: <b>2a</b> (42%), <b>2b</b> (98%), <b>2c</b> (95%), and <b>2e</b>,<b>f</b> (18%).</p></p></figure><div class="NLM_p">9-Methoxyflindersine (<b>2d</b>) was purchased from Chembridge and afforded <b>57</b>–<b>58</b>. 9-Methylflindersine (<b>2c</b>) afforded <b>47</b>–<b>49</b>.</div><div class="NLM_p">Pruning of the pyranoquinoline core was also investigated. Analogues <b>55</b> and <b>56</b>, possessing a single methyl group at C-10, were prepared as a mixture from the corresponding flindersine analogues (<b>2e</b>,<b>f</b>). These were obtained using the same procedure as that employed for flindersine but by replacing 3-methyl-2-butenal with crotonaldeyde. Further modifications were made to the pyranoquinolinone by pruning the phenyl ring to afford a pyranopyridinone (<b>6</b>) scaffold, which was used to synthesize a few selected pyridinone analogues (<b>59</b>–<b>61</b>, Scheme <a class="ref internalNav" href="#sch6" aria-label="6">6</a>). The pyranopyridinone scaffold (<b>6</b>) was synthesized from 2,4-dihydroxypyridine. Unfortunately, these compounds (<b>59</b>–<b>61</b>) had no activity when tested in the TLR4 assay.</div><figure id="sch6" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401321v/production/images/medium/jm-2013-01321v_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401321v/production/images/large/jm-2013-01321v_0013.jpeg" id="gr14" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 6. Synthesis of Pyridinone Analogues<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401321v/production/images/large/jm-2013-01321v_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401321v&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) (a) Yb(OTf)<sub>3</sub>, MeCN, 80 °C, 12 h or (b) MgSO<sub>4</sub>, pyridine, reflux 16 h; (ii) UV light (hv), 125 or 400 W, neat 16 h. Yields: <b>6</b> (80%), <b>59</b> (6.6%), <b>60</b> (11%), and <b>61</b> (8.5%).</p></p></figure><div class="NLM_p">Relative to the styrene starting material, all of the analogues (<b>9</b>–<b>61</b>) of euodenine A exhibited a characteristic upfield shift of ortho aryl protons H-2′ and/or H-6′ by ∼0.5 ppm (range 0.2–0.75 ppm) in the <sup>1</sup>H NMR spectrum. Meta aryl protons H-3′ and/or H-5′ exhibited a smaller upfield shift of ∼0.3 ppm (range 0.1 – 0.6 ppm), but para aryl protons H-4′ displayed a negligible or very small (<0.2 ppm) upfield shift. This upfield shift of the ortho and meta protons is due to shielding by the adjacent pyranoquinolinone (or pyranopyridinone) and served as a diagnostic to confirm the cis relationship of the two aromatic groups. The cis relationship between the two aromatic rings was confirmed by ROESY for the majority of analogues. For example, using a combination of HSQC and ROESY, correlations were observed between the methyl group on the cyclobutane ring of <b>59</b> and H-3 and H-7′ and between H-7′ and H-3 and H-4.</div><div class="NLM_p">In an attempt to avoid the low-yielding photochemical addition step, the cyclobutane portion of <b>1</b> was replaced by an acetal. The acetals (<b>62</b>–<b>64</b>) were produced in good yield from the diol of flindersine (<b>7</b>) and the corresponding dimethyl acetal (<b>8a</b>–<b>c</b>) of a functionalized benzaldehyde (Scheme <a class="ref internalNav" href="#sch7" aria-label="7">7</a>). The relative cis stereochemistry of the two aromatic rings was established by NMR (ROESY correlations were observed between the methine H at 11a and the methine H at 3a, and between H-11a and the H-7′ and H-8′ methylene hydrogens of the butyl group). Interestingly, the significant upfield shift (by ∼0.5 ppm) observed for the ortho aryl protons in all of the cyclobutane analogues was not seen with the acetal analogues. For example, with compound <b>62</b>, the upfield shift was very small (0.03 ppm), but there was a significant upfield shift (0.4 ppm) for the para hydrogen. It was originally thought that these acetals could mimic the shape of the cyclobutane portion of <b>1</b>, thus providing a more synthetically tractable target and avoiding the photocycloaddition. However, the upfield shift for the para hydrogen rather than the ortho hydrogen probably reflects a slightly different shape or conformation for these acetal analogues.</div><figure id="sch7" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Scheme 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401321v/production/images/medium/jm-2013-01321v_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401321v/production/images/large/jm-2013-01321v_0014.jpeg" id="gr15" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 7. Synthesis of Acetal Analogues<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401321v/production/images/large/jm-2013-01321v_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401321v&amp;id=sch7"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) PropylMgBr, MePh, rt, 26 h; (ii) MnO<sub>2</sub>, DCM, rt, 24 h; (iii) H<sub>2</sub>SO<sub>4</sub>, MeOH, (MeO)<sub>3</sub>CH; (iv) DCM, PPTS, 18 h. Overall yields: <b>62</b> (50%), <b>63</b> (78%), and <b>64</b> (30%).</p></p></figure></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i12">Screening Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_41110" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_41110" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The cyclobutane series showed good SAR at the TLR4 receptor (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>). When the methyl group on the cyclobutane is removed (<b>9</b>),<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> activity is lost, whereas replacing the methyl group by larger groups results in an increase in activity up to R = cyclopentyl. For example, in the dimethoxyphenylcyclobutane series (<b>1</b> and <b>9</b>–<b>43</b>, R<sub>1</sub> and R<sub>4</sub> = H, R<sub>2</sub> and R<sub>3</sub> = OMe), there is a regular increase from R = Me (<b>10</b>, EC<sub>50</sub> 3.1 μM) to Et (<b>19</b>, EC<sub>50</sub> 1.2 μM) to Bu (<b>37</b>, EC<sub>50</sub> 1.2 μM) to <i>i</i>-Pr (<b>26</b>, EC<sub>50</sub> 1.0 μM) to cyclopropyl (<b>31</b>, EC<sub>50</sub> 0.63 μM) to cyclopentyl (<b>34</b>, EC<sub>50</sub> 0.39 μM). Cyclopentyl compound <b>34</b> was the most active analogue prepared. In the trimethoxphenylcyclobutane series (<b>1</b> and <b>9</b>–<b>43</b>, R<sub>1</sub> = H, R<sub>2</sub>–R<sub>4</sub> = OMe), there was a similar increase in activity with increasing size of R, but it was not as pronounced or as regular (<b>1</b>, Me, EC<sub>50</sub> 3.9 μM; <b>20</b>, Et, EC<sub>50</sub> 0.79 μM; <b>36</b>, Bu, EC<sub>50</sub> 2.0 μM; <b>22</b>, <i>i</i>-Pr, EC<sub>50</sub> 0.79 μM; <b>32</b>, cyclopropyl, EC<sub>50</sub> 0.63 μM; and <b>35</b>, cyclopentyl, EC<sub>50</sub> 0.63 μM). When R is larger than cyclopentyl or with any group other than alkyl, activity at TLR4 is reduced or lost altogether (e.g., <b>38</b>, COMe, EC<sub>50</sub> 10 μM; <b>42</b>, CH<sub>2</sub>O<i>i</i>Pr, not active at 300 μM). This indicates that the methyl group occupies a hydrophobic pocket of limited size.</div><div class="NLM_p">Comparing the activities of the trimethoxyphenylcyclobutane with the dimethoxyphenylcyclobutane series, the removal of one of the meta methoxy groups had little effect on TLR4 activity (e.g., <b>1</b>, EC<sub>50</sub> 3.9 μM and <b>10</b>, EC<sub>50</sub> 3.1 μM; <b>31</b>, EC<sub>50</sub> 0.63 μM and <b>32</b>, EC<sub>50</sub> 0.63 μM), whereas introduction of groups larger than OMe at the para position (R<sub>3</sub>) proved detrimental to TLR4 activity (<b>26</b>, OMe, EC<sub>50</sub> 1.0 μM and <b>28</b>, OEt, EC<sub>50</sub> 3.9 μM; <b>10</b>, OMe, EC<sub>50</sub> 3.1 μM and <b>17</b>, OBn, not active at 300 μM). Replacing the para OMe group of <b>1</b> by the smaller H did not affect the activity (<b>11</b>, EC<sub>50</sub> 3.1 μM), but replacing it by the polar OH resulted in a significant loss of activity (<b>18</b>, EC<sub>50</sub> >10 μM). Groups larger than OMe could, however, be introduced at the meta position (R<sub>2</sub>), allowing the introduction of solubilizing groups and resulting in analogues with improved solubility properties and sometimes improved activities (<b>26</b>, OMe, EC<sub>50</sub> 1.0 μM and <b>29</b>, O(CH<sub>2</sub>)<sub>2</sub>OH, EC<sub>50</sub> 0.5 μM; <b>31</b>, OMe, EC<sub>50</sub> 0.79 μM and <b>30</b>, O(CH<sub>2</sub>)<sub>3</sub>OH, EC<sub>50</sub> 0.79 μM), but the larger solubilizing group O(CH<sub>2</sub>)<sub>3</sub>morpholine, resulted in reduced activity (<b>31</b>, OMe, EC<sub>50</sub> 0.63 μM; <b>33</b>, O(CH<sub>2</sub>)<sub>3</sub>morpholine, EC<sub>50</sub> 3.9 μM). Replacing a meta methoxy group by an acyl group resulted in a significant reduction in activity (<b>26</b>, OMe, EC<sub>50</sub> 1.0 μM and <b>25</b>, OAc, EC<sub>50</sub> >10 μM; <b>27</b>, OCO(CH<sub>2</sub>)<sub>2</sub>CO<sub>2</sub>H, EC<sub>50</sub> 6.3 μM). Removal of both meta methoxy groups was detrimental to activity (<b>10</b>, R<sub>2</sub> and R<sub>3</sub> = OMe, EC<sub>50</sub> 3.1 μM and <b>15</b>, R<sub>2</sub> = H, R<sub>3</sub> = OMe, EC<sub>50</sub> >10 μM).</div><div class="NLM_p">Replacing a meta methoxy group in the dimethoxyphenylcyclobutane series by a halogen resulted in a modest decrease in activity, with the effect becoming more pronounced with increasing electronegativity (<b>10</b>, OMe, EC<sub>50</sub> 3.1 μM and <b>12</b>, Br, EC<sub>50</sub> 3.9 μM; <b>26</b>, OMe, EC<sub>50</sub> 1.0 μM and <b>23</b>, Cl, EC<sub>50</sub> 2.0 μM; <b>19</b>, OMe, EC<sub>50</sub> 1.2 μM and <b>21</b>, F, EC<sub>50</sub> 3.1 μM).</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Aryl and Alkyl Modifications</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401321v/production/images/medium/jm-2013-01321v_0015.gif" alt="" id="fx1" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center">EC<sub>50</sub> TLR4 (μM)<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center">IA<a class="ref internalNav" href="#t2fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center">R</th><th class="colsep0 rowsep0" align="center">R<sub>1</sub></th><th class="colsep0 rowsep0" align="center">R<sub>2</sub></th><th class="colsep0 rowsep0" align="center">R<sub>3</sub></th><th class="colsep0 rowsep0" align="center">R<sub>4</sub></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b></td><td class="colsep0 rowsep0" align="left">3.9</td><td class="colsep0 rowsep0" align="left">0.95</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">OMe</td><td class="colsep0 rowsep0" align="left">OMe</td><td class="colsep0 rowsep0" align="left">OMe</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9</b><a class="ref internalNav" href="#t2fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left">NA at 30 μM</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">OMe</td><td class="colsep0 rowsep0" align="left">OMe</td><td class="colsep0 rowsep0" align="left">OMe</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10</b></td><td class="colsep0 rowsep0" align="left">3.1</td><td class="colsep0 rowsep0" align="left">0.69</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">OMe</td><td class="colsep0 rowsep0" align="left">OMe</td><td class="colsep0 rowsep0" align="left">H</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>11</b></td><td class="colsep0 rowsep0" align="left">3.1</td><td class="colsep0 rowsep0" align="left">0.46</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">OMe</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">OMe</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12</b></td><td class="colsep0 rowsep0" align="left">3.9</td><td class="colsep0 rowsep0" align="left">0.28</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">Br</td><td class="colsep0 rowsep0" align="left">OMe</td><td class="colsep0 rowsep0" align="left">H</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>13</b></td><td class="colsep0 rowsep0" align="left">3.1</td><td class="colsep0 rowsep0" align="left">0.44</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="left">OMe</td><td class="colsep0 rowsep0" align="left">OMe</td><td class="colsep0 rowsep0" align="left">H</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>14</b></td><td class="colsep0 rowsep0" align="left">NA at 71.5 μM</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>15</b></td><td class="colsep0 rowsep0" align="left">>10</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">OMe</td><td class="colsep0 rowsep0" align="left">H</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>16</b></td><td class="colsep0 rowsep0" align="left">>10</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">OMe</td><td class="colsep0 rowsep0" align="left">OMe</td><td class="colsep0 rowsep0" align="left">OMe</td><td class="colsep0 rowsep0" align="left">H</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>17</b></td><td class="colsep0 rowsep0" align="left">NA at 300 μM</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">OMe</td><td class="colsep0 rowsep0" align="left">OBn</td><td class="colsep0 rowsep0" align="left">H</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>18</b></td><td class="colsep0 rowsep0" align="left">>10</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">OMe</td><td class="colsep0 rowsep0" align="left">OH</td><td class="colsep0 rowsep0" align="left">H</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>19</b></td><td class="colsep0 rowsep0" align="left">1.2</td><td class="colsep0 rowsep0" align="left">1.01</td><td class="colsep0 rowsep0" align="left">Et</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">OMe</td><td class="colsep0 rowsep0" align="left">OMe</td><td class="colsep0 rowsep0" align="left">H</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>20</b></td><td class="colsep0 rowsep0" align="left">0.79</td><td class="colsep0 rowsep0" align="left">1.05</td><td class="colsep0 rowsep0" align="left">Et</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">OMe</td><td class="colsep0 rowsep0" align="left">OMe</td><td class="colsep0 rowsep0" align="left">OMe</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>21</b></td><td class="colsep0 rowsep0" align="left">3.1</td><td class="colsep0 rowsep0" align="left">0.49</td><td class="colsep0 rowsep0" align="left">Et</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="left">OMe</td><td class="colsep0 rowsep0" align="left">H</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>22</b></td><td class="colsep0 rowsep0" align="left">0.79</td><td class="colsep0 rowsep0" align="left">1.18</td><td class="colsep0 rowsep0" align="left"><i>i</i>-Pr</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">OMe</td><td class="colsep0 rowsep0" align="left">OMe</td><td class="colsep0 rowsep0" align="left">OMe</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>23</b></td><td class="colsep0 rowsep0" align="left">2.0</td><td class="colsep0 rowsep0" align="left">0.47</td><td class="colsep0 rowsep0" align="left"><i>i</i>-Pr</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="left">OMe</td><td class="colsep0 rowsep0" align="left">H</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>24</b></td><td class="colsep0 rowsep0" align="left">2.0</td><td class="colsep0 rowsep0" align="left">0.2</td><td class="colsep0 rowsep0" align="left"><i>i</i>-Pr</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">CH<sub>2</sub>Cl</td><td class="colsep0 rowsep0" align="left">OMe</td><td class="colsep0 rowsep0" align="left">H</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>25</b></td><td class="colsep0 rowsep0" align="left">>10</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"><i>i</i>-Pr</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">OAc</td><td class="colsep0 rowsep0" align="left">OMe</td><td class="colsep0 rowsep0" align="left">H</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>26</b></td><td class="colsep0 rowsep0" align="left">1.0</td><td class="colsep0 rowsep0" align="left">0.9</td><td class="colsep0 rowsep0" align="left"><i>i</i>-Pr</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">OMe</td><td class="colsep0 rowsep0" align="left">OMe</td><td class="colsep0 rowsep0" align="left">H</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>27</b></td><td class="colsep0 rowsep0" align="left">6.3</td><td class="colsep0 rowsep0" align="left">0.29</td><td class="colsep0 rowsep0" align="left"><i>i</i>-Pr</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">OCO(CH<sub>2</sub>)<sub>2</sub>CO<sub>2</sub>H</td><td class="colsep0 rowsep0" align="left">OMe</td><td class="colsep0 rowsep0" align="left">H</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>28</b></td><td class="colsep0 rowsep0" align="left">3.9</td><td class="colsep0 rowsep0" align="left">0.19</td><td class="colsep0 rowsep0" align="left"><i>i</i>-Pr</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">OMe</td><td class="colsep0 rowsep0" align="left">OEt</td><td class="colsep0 rowsep0" align="left">H</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>29</b></td><td class="colsep0 rowsep0" align="left">0.5</td><td class="colsep0 rowsep0" align="left">0.46</td><td class="colsep0 rowsep0" align="left"><i>i</i>-Pr</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">O(CH<sub>2</sub>)<sub>2</sub>OH</td><td class="colsep0 rowsep0" align="left">OMe</td><td class="colsep0 rowsep0" align="left">H</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>30</b></td><td class="colsep0 rowsep0" align="left">0.79</td><td class="colsep0 rowsep0" align="left">0.88</td><td class="colsep0 rowsep0" align="left">Cypr</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">O(CH<sub>2</sub>)<sub>3</sub>OH</td><td class="colsep0 rowsep0" align="left">OMe</td><td class="colsep0 rowsep0" align="left">H</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>31</b></td><td class="colsep0 rowsep0" align="left">0.63</td><td class="colsep0 rowsep0" align="left">0.75</td><td class="colsep0 rowsep0" align="left">Cypr</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">OMe</td><td class="colsep0 rowsep0" align="left">OMe</td><td class="colsep0 rowsep0" align="left">H</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>32</b></td><td class="colsep0 rowsep0" align="left">0.63</td><td class="colsep0 rowsep0" align="left">0.82</td><td class="colsep0 rowsep0" align="left">Cypr</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">OMe</td><td class="colsep0 rowsep0" align="left">OMe</td><td class="colsep0 rowsep0" align="left">OMe</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>33</b></td><td class="colsep0 rowsep0" align="left">3.9</td><td class="colsep0 rowsep0" align="left">0.19</td><td class="colsep0 rowsep0" align="left">Cypr</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">O(CH<sub>2</sub>)<sub>3</sub>morpholine</td><td class="colsep0 rowsep0" align="left">OMe</td><td class="colsep0 rowsep0" align="left">H</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>34</b></td><td class="colsep0 rowsep0" align="left">0.39</td><td class="colsep0 rowsep0" align="left">0.9</td><td class="colsep0 rowsep0" align="left">Cyp</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">OMe</td><td class="colsep0 rowsep0" align="left">OMe</td><td class="colsep0 rowsep0" align="left">H</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>35</b></td><td class="colsep0 rowsep0" align="left">0.63</td><td class="colsep0 rowsep0" align="left">0.63</td><td class="colsep0 rowsep0" align="left">Cyp</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">OMe</td><td class="colsep0 rowsep0" align="left">OMe</td><td class="colsep0 rowsep0" align="left">OMe</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>36</b></td><td class="colsep0 rowsep0" align="left">2.0</td><td class="colsep0 rowsep0" align="left">0.69</td><td class="colsep0 rowsep0" align="left">Bu</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">OMe</td><td class="colsep0 rowsep0" align="left">OMe</td><td class="colsep0 rowsep0" align="left">OMe</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>37</b></td><td class="colsep0 rowsep0" align="left">1.2</td><td class="colsep0 rowsep0" align="left">1.01</td><td class="colsep0 rowsep0" align="left">Bu</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">OMe</td><td class="colsep0 rowsep0" align="left">OMe</td><td class="colsep0 rowsep0" align="left">H</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>38</b></td><td class="colsep0 rowsep0" align="left">10</td><td class="colsep0 rowsep0" align="left">0.30</td><td class="colsep0 rowsep0" align="left">COMe</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">OMe</td><td class="colsep0 rowsep0" align="left">OMe</td><td class="colsep0 rowsep0" align="left">H</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>39</b></td><td class="colsep0 rowsep0" align="left">7.9</td><td class="colsep0 rowsep0" align="left">0.62</td><td class="colsep0 rowsep0" align="left">COCypr</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">OMe</td><td class="colsep0 rowsep0" align="left">OMe</td><td class="colsep0 rowsep0" align="left">H</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>40</b></td><td class="colsep0 rowsep0" align="left">NA at 25 μM</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">CO<sub>2</sub>Me</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">OMe</td><td class="colsep0 rowsep0" align="left">OMe</td><td class="colsep0 rowsep0" align="left">OMe</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>41</b></td><td class="colsep0 rowsep0" align="left">5.0</td><td class="colsep0 rowsep0" align="left">0.1</td><td class="colsep0 rowsep0" align="left">CH<sub>2</sub>OAc</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">OMe</td><td class="colsep0 rowsep0" align="left">OMe</td><td class="colsep0 rowsep0" align="left">OMe</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>42</b></td><td class="colsep0 rowsep0" align="left">NA at 300 μM</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">CH<sub>2</sub>O<i>i</i>Pr</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">OMe</td><td class="colsep0 rowsep0" align="left">OMe</td><td class="colsep0 rowsep0" align="left">OMe</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>43</b></td><td class="colsep0 rowsep0" align="left">NA at 333 μM</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">CO<sub>2</sub>Et</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">Br</td><td class="colsep0 rowsep0" align="left">H</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>a</sup><p class="last">EC<sub>50</sub> values are mean values based on between two and eight determinations. The standard deviations for −log EC<sub>50</sub> values were <0.1 in nearly all cases (range 0.00 to 0.23).</p></div><div class="footnote" id="t2fn2"><sup>b</sup><p class="last">Intrinsic activity relative to LPS.</p></div><div class="footnote" id="t2fn3"><sup>c</sup><p class="last">Ref <a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">16</a>.</p></div></div></div><div class="NLM_p">Alkylation of the pyridine nitrogen (R<sub>5</sub>, <b>44</b>–<b>54</b>, Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>) had little effect on the intrinsic activity in most cases (<b>10</b>, R<sub>5</sub> = H, EC<sub>50</sub> 3.1 μM and <b>44</b>, R<sub>5</sub> = Me, EC<sub>50</sub> 2.5 μM; <b>19</b>, R<sub>5</sub> = H, EC<sub>50</sub> 1.2 μM and <b>45</b>, R<sub>5</sub> = Me, EC<sub>50</sub> 2.0 μM; <b>21</b>, R<sub>5</sub> = H, EC<sub>50</sub> 3.1 μM and <b>46</b>, R<sub>5</sub> = Me, EC<sub>50</sub> 3.1 μM). Other modifications to the pyranoquinolone portion of the molecule generally had a detrimental effect on the activity at the TLR4 receptor. For example, removal of either one of the <i>gem</i>-dimethyl groups from parent compound <b>1</b> resulted in a significant loss in activity (<b>1</b>, EC<sub>50</sub> 3.9 μM and <b>55</b>, <b>56</b>, EC<sub>50</sub> >10 μM). Assuming that the NH and NMe analogues (R<sub>5</sub> = H or Me) have comparable activity as noted above, introduction of a methyl group at C9 (R<sub>6</sub>) results in a decrease in activity (<b>20</b>, R = Et, R<sub>6</sub> = H, EC<sub>50</sub> 0.79 μM and <b>47</b>, R = Et, R<sub>6</sub> = Me, EC<sub>50</sub> 3.1 μM; <b>19</b>, R = Et, R<sub>6</sub> = H, EC<sub>50</sub> 1.2 μM and <b>48</b>, R = Et, R<sub>6</sub> = Me, EC<sub>50</sub> 3.1 μM; <b>22</b>, R = <i>i</i>-Pr, R<sub>6</sub> = H, EC<sub>50</sub> 0.79 μM and <b>49</b>, R = <i>i</i>-Pr, R<sub>6</sub> = Me, EC<sub>50</sub> 7.9 μM). Introduction of a methoxy group at C9 (R<sub>6</sub>) resulted in a large decrease in activity (<b>1</b>, R = Me, R<sub>6</sub> = H, EC<sub>50</sub> 3.9 μM and <b>58</b>, R = Me, R<sub>6</sub> = Me, EC<sub>50</sub> >10 μM; <b>26</b>, R = <i>i</i>-Pr, R<sub>6</sub> = H, EC<sub>50</sub> 1.0 μM and <b>57</b>, R = <i>i</i>-Pr, R<sub>6</sub> = Me, EC<sub>50</sub> > 10 μM). Pyridinone analogues (benzene ring removed from the quinolinone) did not show any activity when tested in the TLR4 assay.</div><div class="NLM_p">In summary, modifications to the trimethoxyaryl ring, the cyclobutane substituent R, the quinolinone, and pyran rings demonstrated the tight SAR requirements of the TLR4 receptor.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Pyranoquinolinone Modifications</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401321v/production/images/medium/jm-2013-01321v_0016.gif" alt="" id="fx2" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center">EC<sub>50</sub> TLR4 (μM)<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center">IA<a class="ref internalNav" href="#t3fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center">R</th><th class="colsep0 rowsep0" align="center">R<sub>1</sub></th><th class="colsep0 rowsep0" align="center">R<sub>2</sub></th><th class="colsep0 rowsep0" align="center">R<sub>3</sub></th><th class="colsep0 rowsep0" align="center">R<sub>4</sub></th><th class="colsep0 rowsep0" align="center">R<sub>5</sub></th><th class="colsep0 rowsep0" align="center">R<sub>6</sub></th><th class="colsep0 rowsep0" align="center">R<sub>7</sub></th><th class="colsep0 rowsep0" align="center">R<sub>8</sub></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>44</b></td><td class="colsep0 rowsep0" align="left">2.5</td><td class="colsep0 rowsep0" align="left">0.64</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">OMe</td><td class="colsep0 rowsep0" align="left">OMe</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">Me</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>45</b></td><td class="colsep0 rowsep0" align="left">2.0</td><td class="colsep0 rowsep0" align="left">0.61</td><td class="colsep0 rowsep0" align="left">Et</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">OMe</td><td class="colsep0 rowsep0" align="left">OMe</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">Me</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>46</b></td><td class="colsep0 rowsep0" align="left">3.1</td><td class="colsep0 rowsep0" align="left">0.36</td><td class="colsep0 rowsep0" align="left">Et</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="left">OMe</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">Me</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>47</b></td><td class="colsep0 rowsep0" align="left">3.1</td><td class="colsep0 rowsep0" align="left">0.3</td><td class="colsep0 rowsep0" align="left">Et</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">OMe</td><td class="colsep0 rowsep0" align="left">OMe</td><td class="colsep0 rowsep0" align="left">OMe</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">Me</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>48</b></td><td class="colsep0 rowsep0" align="left">3.1</td><td class="colsep0 rowsep0" align="left">0.29</td><td class="colsep0 rowsep0" align="left">Et</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">OMe</td><td class="colsep0 rowsep0" align="left">OMe</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">Me</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>49</b></td><td class="colsep0 rowsep0" align="left">7.9</td><td class="colsep0 rowsep0" align="left">0.41</td><td class="colsep0 rowsep0" align="left"><i>i</i>-Pr</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">OMe</td><td class="colsep0 rowsep0" align="left">OMe</td><td class="colsep0 rowsep0" align="left">OMe</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">Me</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>50</b></td><td class="colsep0 rowsep0" align="left">3.1</td><td class="colsep0 rowsep0" align="left">0.53</td><td class="colsep0 rowsep0" align="left"><i>i</i>-Pr</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="left">OMe</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">Me</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>51</b></td><td class="colsep0 rowsep0" align="left">3.1</td><td class="colsep0 rowsep0" align="left">0.31</td><td class="colsep0 rowsep0" align="left"><i>i</i>-Pr</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">OAc</td><td class="colsep0 rowsep0" align="left">OMe</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">Me</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>52</b></td><td class="colsep0 rowsep0" align="left">0.79</td><td class="colsep0 rowsep0" align="left">0.81</td><td class="colsep0 rowsep0" align="left">Cypr</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">OMe</td><td class="colsep0 rowsep0" align="left">OMe</td><td class="colsep0 rowsep0" align="left">OMe</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">Me</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>53</b></td><td class="colsep0 rowsep0" align="left">1.0</td><td class="colsep0 rowsep0" align="left">0.67</td><td class="colsep0 rowsep0" align="left">Cypr</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">OMe</td><td class="colsep0 rowsep0" align="left">OMe</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">Me</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>54</b></td><td class="colsep0 rowsep0" align="left">2.5</td><td class="colsep0 rowsep0" align="left">0.69</td><td class="colsep0 rowsep0" align="left">Cyp</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">OMe</td><td class="colsep0 rowsep0" align="left">OMe</td><td class="colsep0 rowsep0" align="left">OMe</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">Me</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>55</b></td><td class="colsep0 rowsep0" align="left">>10</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">OMe</td><td class="colsep0 rowsep0" align="left">OMe</td><td class="colsep0 rowsep0" align="left">OMe</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">H</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>56</b></td><td class="colsep0 rowsep0" align="left">>10</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">OMe</td><td class="colsep0 rowsep0" align="left">OMe</td><td class="colsep0 rowsep0" align="left">OMe</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">Me</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>57</b>/</td><td class="colsep0 rowsep0" align="left">>10</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"><i>i</i>-Pr</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">OMe</td><td class="colsep0 rowsep0" align="left">OMe</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">OMe</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">Me</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>58</b></td><td class="colsep0 rowsep0" align="left">>10</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">OMe</td><td class="colsep0 rowsep0" align="left">OMe</td><td class="colsep0 rowsep0" align="left">OMe</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">OMe</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">Me</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup>a</sup><p class="last">EC<sub>50</sub> values are mean values based on between two and eight determinations. The standard deviations for −log EC<sub>50</sub> values were <0.1 in nearly all cases (range 0.00 to 0.23).</p></div><div class="footnote" id="t3fn2"><sup>b</sup><p class="last">Intrinsic activity relative to LPS.</p></div></div></div><div class="NLM_p">A small number of analogues with the cyclobutane ring replaced by an acetal were also examined. On testing, these analogues (<b>62</b>–<b>64</b>) did show some promising activity in the human TLR4 SEAP assay (Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>); however, they were less active than most of the cyclobutane compounds and were not further investigated.</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Acetal Analogues</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401321v/production/images/medium/jm-2013-01321v_0017.gif" alt="" id="fx3" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center">EC<sub>50</sub> TLR4 (μM)<a class="ref internalNav" href="#t4fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center">IA</th><th class="colsep0 rowsep0" align="center">R</th><th class="colsep0 rowsep0" align="center">R<sub>1</sub></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>62</b></td><td class="colsep0 rowsep0" align="left">3.1</td><td class="colsep0 rowsep0" align="left">0.7</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">OMe</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>63</b></td><td class="colsep0 rowsep0" align="left">15.8</td><td class="colsep0 rowsep0" align="left">0.2</td><td class="colsep0 rowsep0" align="left">OMe</td><td class="colsep0 rowsep0" align="left">H</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>64</b></td><td class="colsep0 rowsep0" align="left">NA at 60 μM</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">OMe</td><td class="colsep0 rowsep0" align="left">OMe</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup>a</sup><p class="last">EC<sub>50</sub> values are mean values based on between two and eight determinations. The standard deviations for −log EC<sub>50</sub> values were <0.1 in nearly all cases (range 0.00 to 0.23).</p></div></div></div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i16">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_21032" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_21032" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">Euodenine A, a natural product of unusual architecture, is a human TLR4-selective agonist that is CD14-independent, and it requires both TLR4 and MD-2 for full efficacy. Euodenine A and a series of analogues were prepared in two to four steps from readily available starting materials. The dimethoxyphenylcyclobutane series showed good SAR at the TLR4 receptor. Thus, when the methyl group on the cyclobutane is removed, activity is lost, whereas replacing the methyl group by larger groups results in an increase in activity up to R = cyclopentyl, which was the most active compound and 10-fold more active than euodenine A. Replacing the methyl by groups larger than cyclopentyl resulted in reduced activity. Groups larger than OMe could be introduced into the meta position, allowing the introduction of solubilizing groups and resulting in analogues with improved solubility properties and sometimes improved activities. Testing for immunomodulation in PBMC cells shows the induction of the cytokines IL-8, IL-10, TNF-α, and IL-12p40 and suppression of IL-5 from activated PBMCs, indicating that compounds like <b>1</b> could modulate the Th2 immune response without causing lung damage. The results suggest that <b>1</b> would have the potential to prevent IL-5-mediated allergic inflammation while having a lower risk of inducing IL-12- and TNF-α-mediated proinflammatory responses compared to LPS.</div></div><div id="sec6" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i17">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_68405" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_68405" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec6_0_0" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> Chemistry, General Methods, and Materials</h3><div class="NLM_p last"><sup>1</sup>H NMR spectra were recorded at either 500 or 600 MHz, and <sup>13</sup>C NMR were recorded at 125 MHz. Chemical shifts are reported in parts per million (ppm) relative to the solvent (DMSO-<i>d</i><sub>6</sub>: <sup>1</sup>H, 2.49; <sup>13</sup>C, 39.51 ppm or CDCl<sub>3</sub>: <sup>1</sup>H, 7.26; <sup>13</sup>C, 77.0 ppm), and coupling constants (<i>J</i>) are reported in hertz. HPLC–MS was run in ESI mode using a C18 50 mm × 4.6 mm, 5 μm analytical column using a diode array detector over multiple wavelengths. Both HPLC–MS and HPLC were reverse-phase with a MeCN/H<sub>2</sub>O (0.01% TFA) gradient and a flow rate of 1.5 mL/min. The purity of all tested compounds was established as ≥95% by HPLC analysis using two different gradients with UV detection on a photodiode array detector (210, 254, and 280 nm). Flash chromatography was performed using silica gel (230–400 mesh) or neutral alumina.</div></div><div id="sec6_0_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> Molecular Modeling</h3><div class="NLM_p last">The structure of <b>1</b> was subjected to geometry optimization in MacroModel using the MMFF force field with H<sub>2</sub>O solvation. Default parameters and convergence criteria were used elsewhere. The reported structure is the lowest-energy conformer resulting from a mixed MCMM/Low-Mode search with 1000 steps per rotatable bond (including tetrahydropyan ring bonds).</div></div><div id="sec6_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> Isolation and Structure Determination of Euodenine A (<b>1</b>) from <i><i><i>Euodia Asteridula</i></i></i></h3><div class="NLM_p">The leaves of <i>Euodia asteridula</i> (Rutaceae) were collected by Biodiversity Research Ltd. in PNG, and a voucher sample is lodged at the Lae Herbarium, Lae, PNG.</div><div id="sec6_1_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i21" class="anchor-spacer"></div><h4 class="article-section__title" id="_i21"> Extraction and Isolation</h4><div class="NLM_p last">The air-dried material (100 g) was ground and extracted exhaustively with methanol (1 L) and dichloromethane saturated with ammonia (400 mL). The dichloromethane extract was evaporated; the dry extract was then dissolved in the methanol extract. Mass spectrometry was performed on this combined extract to confirm the target alkaloid compounds chosen by the small-scale MS survey. Strong cation-exchange resin (SCX, 30 g) was added to the extract. The mixture was shaken by hand and left for 15 min. Mass spectrometry was performed to confirm the target alkaloids were completely bound to the SCX. The mixture was then vacuum filtered with a sintered glass funnel. The load extract without alkaloid was thus separated from the alkaloid-bound SCX resin. The bound alkaloids were eluted off the SCX resin by methanol-ammonia (10%) (300 mL) and dichloromethane saturated with ammonia (100 mL). This alkaloid-enriched fraction was then evaporated (6 g) and preabsorbed onto C18 (2 g) and packed dry into a small cartridge, which was connected to a preparative C18 column (Betasil C18, 150 × 21.2 mm, 5 μm, Thermo Electro Corporation). This fraction was chromatographed using mass-directed purification on a HP1100 LC–MS and eluted at 10 mL/min with a gradient solvent system starting with 100% water (1% TFA) gradient to 60% acetonitrile (1% TFA)/40% water (1% TFA) in 50 min, then gradient to 100% acetonitrile (1% TFA) in the next 10 min. Pure <b>1</b> (20 mg) was eluted at 53–55 min. Yellow oil, optically inactive, UV (MeOH) λ<sub>max</sub> (ε) 212 (28 602), 217 (27 502), 286 (4602), 317 (4711), 329 nm (3971). IR (film) ν<sub>max</sub> 3424, 2949, 1647, 1605, 1507, 1457, 1427, 1396, 1238, 1128, 756, 505 cm<sup>–1</sup>. For <sup>13</sup>C and <sup>1</sup>H NMR data, see Tables <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a> and <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a> (numbering as in <b>1</b>, Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>). (+)-HRESIMS <i>m</i>/<i>z</i> 436.2126 (calcd for C<sub>26</sub>H<sub>30</sub>NO<sub>5</sub>, 436.2119).</div></div><div id="sec6_1_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i22" class="anchor-spacer"></div><h4 class="article-section__title" id="_i22"> Structure Determination</h4><div class="NLM_p">The <sup>13</sup>C NMR spectrum (Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>) of <b>1</b> displayed 23 carbon signals. Three of the carbons were double the intensity of the others, suggesting that there was some symmetry in the molecule. The carbons could be assigned to six methyls (two coincident), four aliphatic methines, six aromatic methines (two coincident), nine downfield quaternary carbons (two coincident), and one oxygenated quaternary carbon from interpretation of g-HSQC and <sup>1</sup>H NMR data. The most downfield carbon signal at δ 162.2 was assigned to a conjugated amide because an IR absorption band was observed at 1647 cm<sup>–1</sup>. Out of the six methyls, three were aromatic methoxy groups, two of which were coincident. Analysis of the <sup>1</sup>H NMR spectrum of euodenine A indicated that the remaining methyl groups were two quaternary methyls at δ 1.14 and 1.48 and one was a secondary methyl signal at δ 1.13 (d, 7 Hz). Both quaternary methyl protons showed a HMBC correlation to the oxygenated quaternary carbon C-2 (δ 76.5) and to an aliphatic methine C-3 at δ 45.7 ppm. This demonstrated that the molecule contained an isopropyloxy group vicinal to an aliphatic methine, C-3. The secondary methyl proton on C-8′ also correlated to C-3 as well as to another two methine carbons, C-8′ (35.2 ppm) and C-7′ (49.4 ppm), in the HMBC spectrum. Interpretation of the COSY spectrum was complicated by the observation that the signals for the protons attached to C-3 (45.7 ppm) and C-8′ (35.2 ppm) were coincident (δ 2.33) in the <sup>1</sup>H NMR spectrum. COSY correlation from the methyl protons on C-8′ to δ 2.33 indicated that the carbon at 35.2 ppm must be vicinal to the methyl group and therefore the carbons at δ 45.7 and 49.4 ppm were each vicinal to C-8′. If the secondary methyl group was vicinal to C-3, then it should have had a HMBC correlation to C-2. COSY correlations were also observed from the signal at δ 2.33 to methine signals at δ 3.30 (H-7′) and 3.69 (H-4). This could only be possible if the proton attached to C-3 (δ 2.33) was vicinal to H-4 (δ 3.69). A COSY correlation from H-4 to H-7′ indicated that they too were vicinal to each other and that AR-Q500206 contained a tetrasubstituted cyclobutyl group. The molecule contained a symmetrical tetrasubsituted phenyl group because a two-proton aromatic singlet at δ 6.12 (H-2′ and H-6′) displayed both HMBC and HSQC correlations to a carbon signal at 105.4 ppm (C-2′ and C-6′), indicating that the two protons were meta to each other. The chemical shift of the carbons C-2′ and C-6′ suggested that they were both ortho to oxygen substituents, and this was confirmed by the observation of HMBC correlations from these protons to oxygenated aromatic quaternary carbons at δ 151.7 and 135.8 ppm. HMBC correlations were also observed from the three methoxyl protons at δ 3.34 (2 methoxyls) and 3.53 to the oxygenated aromatic quaternary carbons at δ 135.8 and 151.7 ppm, respectively. The upfield chemical shift of one of these oxygenated quaternary carbons C-4′ suggested that it was flanked on either side by the other two methoxyl groups. It could therefore be concluded that the molecule contained a 1,2,3-trimethoxylphenyl group. This phenyl group was attached to C-7′ because HMBC correlations were observed from H-2′ and H-6′ to C-7′. HMBC correlations from δ 2.33 (H-3), 3.30 (H-7′), and 3.69 (H-4) to a quaternary carbon (C-4a) at 107.7 ppm indicated that this carbon was vicinal to C-4. The proton H-4 also correlated to an additional downfield quaternary carbon at δ 155.5 (C-10b) and the amide carbonyl carbon C-5 at 162.2 ppm. Both of these carbons could logically be attached only to the carbon (C-4a) at δ 107.7 ppm, and the chemical shift of C-10b suggested that it was oxygenated. A downfield exchangeable proton H-6 (δ 11.06) assigned to an amide NH also correlated to C-4a. The four remaining protons in the <sup>1</sup>H NMR spectrum were part of a 1,2-disubstituted aromatic group because correlations were observed in the COSY spectrum from H-10 and H-8 to H-6 and H-7. One of the substituents of the disubstituted aromatic group was the carbon at δ 155.5 ppm (C-10b) because a HMBC correlation was observed to this carbon from H-10. The other substituent was deduced to be a nitrogen because H-10, H-8, and the amide proton, H-6, showed HMBC correlations to a heteroatom-substituted aromatic quaternary carbon at δ 137.5 ppm. The remaining quaternary aromatic carbon C-10a correlated to H-9, H-6a, and the amide proton, H-6, and from this data, it was concluded that AR-Q500206 contained a 3-cyclobutyl-substituted quinolinone. This data indicated that 12 of the 13 degrees of unsaturation were accounted for, which dictated that the molecule must contain an extra ring. A weak HMBC correlation from the quaternary methyl proton on C-2 to the oxygenated quaternary carbon C-10b suggested that a carbon oxygen bond linked the isopropyloxy group to the oxygenated quaternary carbon C-10b, thus forming a dihydropyran ring. The gross structure of euodenine A was therefore assigned.</div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. <sup>1</sup>H (500 MHz) and <sup>13</sup>C (125 MHz) NMR Data for Euodenine A in DMSO-<i>d</i><sub>6</sub></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">position</th><th class="colsep0 rowsep0" align="center"><sup>13</sup>C NMR</th><th class="colsep0 rowsep0" align="center"><sup>1</sup>H NMR</th><th class="colsep0 rowsep0" align="center">g-COSY</th><th class="colsep0 rowsep0" align="center">g-HMBC</th><th class="colsep0 rowsep0" align="center">ROESY</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">2</td><td class="colsep0 rowsep0" align="left">76.5</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">3</td><td class="colsep0 rowsep0" align="left">45.7</td><td class="colsep0 rowsep0" align="left">2.33 (m)</td><td class="colsep0 rowsep0" align="left">4, 8′</td><td class="colsep0 rowsep0" align="left">4a, 4, 2, 8′CH<sub>3</sub>, 8′, 7′</td><td class="colsep0 rowsep0" align="left">7′, 4, 2′CH<sub>3</sub>, 2′CH<sub>3</sub></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">4</td><td class="colsep0 rowsep0" align="left">31.7</td><td class="colsep0 rowsep0" align="left">3.69 (dd, 8.4, 8.0)</td><td class="colsep0 rowsep0" align="left">3, 7′</td><td class="colsep0 rowsep0" align="left">5, 4a, 10b, 3, 8′, 7′</td><td class="colsep0 rowsep0" align="left">7′, 3, 2′CH<sub>3</sub></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">4a</td><td class="colsep0 rowsep0" align="left">107.7</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">5</td><td class="colsep0 rowsep0" align="left">162.2</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">6 (NH)</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">11.06 (s)</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">4a, 6a, 10a</td><td class="colsep0 rowsep0" align="left">9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">6a</td><td class="colsep0 rowsep0" align="left">137.5</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">7</td><td class="colsep0 rowsep0" align="left">114.6</td><td class="colsep0 rowsep0" align="left">7.15 (d, 8.5)</td><td class="colsep0 rowsep0" align="left">8</td><td class="colsep0 rowsep0" align="left">10b, 9, 8, 10a</td><td class="colsep0 rowsep0" align="left">9, NH</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">8</td><td class="colsep0 rowsep0" align="left">129.8</td><td class="colsep0 rowsep0" align="left">7.42 (dd, 8.5, 7.5)</td><td class="colsep0 rowsep0" align="left">9, 7</td><td class="colsep0 rowsep0" align="left">9, 6a</td><td class="colsep0 rowsep0" align="left">9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">9</td><td class="colsep0 rowsep0" align="left">120.9</td><td class="colsep0 rowsep0" align="left">7.13 (dd, 8.0, 7.5)</td><td class="colsep0 rowsep0" align="left">10, 8</td><td class="colsep0 rowsep0" align="left">8, 10a</td><td class="colsep0 rowsep0" align="left">10, 8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">10</td><td class="colsep0 rowsep0" align="left">121.7</td><td class="colsep0 rowsep0" align="left">7.82 (d, 8.0)</td><td class="colsep0 rowsep0" align="left">9</td><td class="colsep0 rowsep0" align="left">10b, 8, 7</td><td class="colsep0 rowsep0" align="left">9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">10a</td><td class="colsep0 rowsep0" align="left">114.8</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">10b</td><td class="colsep0 rowsep0" align="left">155.5</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">1′</td><td class="colsep0 rowsep0" align="left">135.9</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">2′</td><td class="colsep0 rowsep0" align="left">105.4</td><td class="colsep0 rowsep0" align="left">6.12 (s)</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">7′, 1′, 3′, 4′, 6′</td><td class="colsep0 rowsep0" align="left">8′,7′, OMe (C3′)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">3′</td><td class="colsep0 rowsep0" align="left">151.7</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">4′</td><td class="colsep0 rowsep0" align="left">135.8</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">5′</td><td class="colsep0 rowsep0" align="left">151.7</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">6′</td><td class="colsep0 rowsep0" align="left">105.4</td><td class="colsep0 rowsep0" align="left">6.12 (s)</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">7′, 1′, 2′, 4′, 5′</td><td class="colsep0 rowsep0" align="left">8′, 7′, OMe (C5′)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">7′</td><td class="colsep0 rowsep0" align="left">49.4</td><td class="colsep0 rowsep0" align="left">3.30 (dd, 8.4, 9.0)</td><td class="colsep0 rowsep0" align="left">4, 8′</td><td class="colsep0 rowsep0" align="left">4a, 3, 8′CH<sub>3</sub>, 8′, 1′, 2′, 6′</td><td class="colsep0 rowsep0" align="left">4,3, 8′CH<sub>3</sub>, 2′, 6′</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">8′</td><td class="colsep0 rowsep0" align="left">35.2</td><td class="colsep0 rowsep0" align="left">2.33 (m)</td><td class="colsep0 rowsep0" align="left">8′CH<sub>3</sub>, 7′, 3</td><td class="colsep0 rowsep0" align="left">4, 2, 8′CH<sub>3</sub>, 7′, 1′</td><td class="colsep0 rowsep0" align="left">8′CH<sub>3</sub>, 2′, 6′</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">2′CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">23.2</td><td class="colsep0 rowsep0" align="left">1.14 (s)</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">3, 2, 2′CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">13, 2′CH<sub>3</sub></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">2′CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">24.4</td><td class="colsep0 rowsep0" align="left">1.48 (s)</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">10b, 3, 2, 2′CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">8′, 2′CH<sub>3</sub></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">8′CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">20.2</td><td class="colsep0 rowsep0" align="left">1.13 (d, 7.0)</td><td class="colsep0 rowsep0" align="left">8′</td><td class="colsep0 rowsep0" align="left">3, 8′, 7′</td><td class="colsep0 rowsep0" align="left">8′, 7′, 2′, 6′</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">OMe (C3′)</td><td class="colsep0 rowsep0" align="left">55.0</td><td class="colsep0 rowsep0" align="left">3.34 (s)</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">3′</td><td class="colsep0 rowsep0" align="left">2′</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">OMe (C4′)</td><td class="colsep0 rowsep0" align="left">59.8</td><td class="colsep0 rowsep0" align="left">3.53 (s)</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">4′</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">OMe (C5′)</td><td class="colsep0 rowsep0" align="left">55.0</td><td class="colsep0 rowsep0" align="left">3.34 (s)</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">5′</td><td class="colsep0 rowsep0" align="left">6′</td></tr></tbody></table></div></div><div class="NLM_p">A change in deuterated solvents for NMR experiments from DMSO-<i>d</i><sub>6</sub> to methanol-<i>d</i><sub>4</sub> helped to resolve the overlapping signals of the quaternary methyl (δ 1.14), the secondary methyl (δ 1.13), H-3 (δ 2.33), and H8′ (δ 2.33) (Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a>). Correlations observed in a ROESY spectrum performed in methanol-<i>d</i><sub>4</sub> were used to deduce the relative stereochemistry of the substituents about the cyclobutyl group. The secondary methyl and the trimethoxyphenyl group were trans to each other because ROESY correlations were observed between the methyl at 8′ and H-7′. H-7′, H-4, and H-3 were all on the same face of the cyclobutyl group because ROESY correlations were observed among these three protons. The cis relationship of the quinolinone and trimethoxy phenyl ring helps to explain the significant upfield shift of the aromatic protons H-2′ and H-6′ of the trimethoxyphenyl group. In a cis configuration, the phenyl group lies in the shielding zone of the quinolinone. Thus, the structure of euodenine A was deduced as <b>1</b>.</div><div class="NLM_table-wrap" id="tbl6"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 6. <sup>1</sup>H (600 MHz) and <sup>13</sup>C (125 MHz) NMR Data for Euodenine A in Methanol-<i>d</i><sub>4</sub></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">position</th><th class="colsep0 rowsep0" align="center"><sup>13</sup>C NMR</th><th class="colsep0 rowsep0" align="center"><sup>1</sup>H NMR</th><th class="colsep0 rowsep0" align="center">g-COSY</th><th class="colsep0 rowsep0" align="center">g-HMBC</th><th class="colsep0 rowsep0" align="center">ROESY</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">2</td><td class="colsep0 rowsep0" align="left">78.7</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">3</td><td class="colsep0 rowsep0" align="left">47.7</td><td class="colsep0 rowsep0" align="left">2.39 (dd, 8.4, 9.0)</td><td class="colsep0 rowsep0" align="left">4, 8′</td><td class="colsep0 rowsep0" align="left">4a, 4, 2, 2′CH<sub>3</sub>, 8′ CH<sub>3</sub>, 8′</td><td class="colsep0 rowsep0" align="left">4, 2′CH<sub>3</sub>, 8′CH<sub>3</sub>, 7′</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">4</td><td class="colsep0 rowsep0" align="left">33.5</td><td class="colsep0 rowsep0" align="left">3.81 (dd, 8.4, 9.0)</td><td class="colsep0 rowsep0" align="left">3, 7′</td><td class="colsep0 rowsep0" align="left">5, 4a, 10b, 3, 8′, 7′</td><td class="colsep0 rowsep0" align="left">7′, 3, 2′CH<sub>3</sub></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">4a</td><td class="colsep0 rowsep0" align="left">108.9</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">5</td><td class="colsep0 rowsep0" align="left">165.4</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">6 (NH)</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">6a</td><td class="colsep0 rowsep0" align="left">138.6</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">7</td><td class="colsep0 rowsep0" align="left">116.4</td><td class="colsep0 rowsep0" align="left">7.22 (d, 9.0)</td><td class="colsep0 rowsep0" align="left">8</td><td class="colsep0 rowsep0" align="left">10b, 9,10a</td><td class="colsep0 rowsep0" align="left">8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">8</td><td class="colsep0 rowsep0" align="left">131.7</td><td class="colsep0 rowsep0" align="left">7.49 (ddd, 8.4, 9.0, 1.2)</td><td class="colsep0 rowsep0" align="left">9, 7</td><td class="colsep0 rowsep0" align="left">9, 7</td><td class="colsep0 rowsep0" align="left">9, 7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">9</td><td class="colsep0 rowsep0" align="left">123.3</td><td class="colsep0 rowsep0" align="left">7.24 (dd, 8.4, 8.4)</td><td class="colsep0 rowsep0" align="left">10, 8</td><td class="colsep0 rowsep0" align="left">8, 7, 6a, 10a</td><td class="colsep0 rowsep0" align="left">10, 8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">10</td><td class="colsep0 rowsep0" align="left">123.6</td><td class="colsep0 rowsep0" align="left">7.98 (dd, 1.2, 8.4)</td><td class="colsep0 rowsep0" align="left">9</td><td class="colsep0 rowsep0" align="left">10b, 8, 6a</td><td class="colsep0 rowsep0" align="left">9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">10a</td><td class="colsep0 rowsep0" align="left">117.2</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">10b</td><td class="colsep0 rowsep0" align="left">159.0</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">1′</td><td class="colsep0 rowsep0" align="left">137.6</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">2′</td><td class="colsep0 rowsep0" align="left">107.0</td><td class="colsep0 rowsep0" align="left">6.14 (s)</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">4, 7′, 1′, 3′, 4′, 6′</td><td class="colsep0 rowsep0" align="left">8′,7′, OMe (C3′)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">3′</td><td class="colsep0 rowsep0" align="left">153.6</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">4′</td><td class="colsep0 rowsep0" align="left">137.6</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">5′</td><td class="colsep0 rowsep0" align="left">153.6</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">6′</td><td class="colsep0 rowsep0" align="left">107.0</td><td class="colsep0 rowsep0" align="left">6.14 (s)</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">4, 7′, 1′, 2′, 4′, 5′</td><td class="colsep0 rowsep0" align="left">8′, 7′, OMe (C5′)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">7′</td><td class="colsep0 rowsep0" align="left">51.8</td><td class="colsep0 rowsep0" align="left">3.36 (dd, 10.2, 9.0)</td><td class="colsep0 rowsep0" align="left">4, 8′</td><td class="colsep0 rowsep0" align="left">4a, 4, 8′CH<sub>3</sub>, 8′, 1′, 2′, 6′</td><td class="colsep0 rowsep0" align="left">4,3, 8′CH<sub>3</sub>, 2′, 6′</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">8′</td><td class="colsep0 rowsep0" align="left">36.9</td><td class="colsep0 rowsep0" align="left">2.45 (ddq, 10.2, 9.0, 6.0)</td><td class="colsep0 rowsep0" align="left">8′CH<sub>3</sub>, 7′, 3</td><td class="colsep0 rowsep0" align="left">3, 7′, 2′</td><td class="colsep0 rowsep0" align="left">8′CH<sub>3</sub>, 2′, 6′, 2′CH<sub>3</sub></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">2′CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">24.1</td><td class="colsep0 rowsep0" align="left">1.23 (s)</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">3, 2, 2′CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">4, 3, 2′CH<sub>3</sub></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">2′CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">25.2</td><td class="colsep0 rowsep0" align="left">1.56 (s)</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">10b, 3, 2, 2′CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">8′, 2′CH<sub>3</sub></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">8′CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">20.8</td><td class="colsep0 rowsep0" align="left">1.19, (d, 6.0)</td><td class="colsep0 rowsep0" align="left">8′</td><td class="colsep0 rowsep0" align="left">3, 8′, 7′</td><td class="colsep0 rowsep0" align="left">3, 8′, 7′</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">OMe (C3′)</td><td class="colsep0 rowsep0" align="left">56.1</td><td class="colsep0 rowsep0" align="left">3.40 (s)</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">3′</td><td class="colsep0 rowsep0" align="left">2′</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">OMe (C4′)</td><td class="colsep0 rowsep0" align="left">61.1</td><td class="colsep0 rowsep0" align="left">3.64 (s)</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">4′</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">OMe (C5′)</td><td class="colsep0 rowsep0" align="left">56.1</td><td class="colsep0 rowsep0" align="left">3.40 (s)</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">5′</td><td class="colsep0 rowsep0" align="left">6′</td></tr></tbody></table></div></div></div></div><div id="sec6_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> Synthesis of <b>1</b> and Analogues</h3><div id="sec6_2_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i26" class="anchor-spacer"></div><h4 class="article-section__title" id="_i26"> General Procedure for Synthesis of Styrenes. Method A: (<i>E</i>)-1,2,3-Trimethoxy-5-(prop-1-enyl)benzene [5273-85-8] (<b>4a</b>)</h4><div class="NLM_p last">3,4,5-Trimethoxybenzaldehyde (51 mmol) was dissolved in toluene (40 mL) and cooled to 0 °C. A solution ethylmagnesium chloride (3.0 M in Et<sub>2</sub>O, 91.8 mmol) was added dropwise, and the reaction mixture was stirred for a further 16 h. To this was added 5% AcOH (200 mL), and the resulting mixture extracted with EtOAc (100 mL). The organic phase was then extracted with water (100 mL), saturated NaHCO<sub>3</sub> (100 mL), and brine (100 mL). The organic phase was dried (MgSO<sub>4</sub>), filtered, and concentrated to afford 1-(3,4,5-trimethoxyphenyl)propan-1-ol (10.86 g, 94%). <sup>1</sup>H NMR (CDCl<sub>3</sub>, 500 MHz) δ 0.97 (t, <i>J</i> = 7 Hz, 3H), 1.79 (m, 2H), 3.87 (s, 3H), 3.90 (s, 6H), 4.56 (t, <i>J</i> = 6.5 Hz, 1H), 6.61 (s, 2H). <sup>13</sup>C NMR (CDCl<sub>3</sub>, 125 MHz) δ 10.44, 21.64, 32.16, 56.34, 61.03, 76.44, 103.12, 137.50, 138.07, 140.67, 153.47. (+) LRMS (ESI) <i>m</i>/<i>z</i> 227 [M + H]<sup>+</sup>. (<i>E</i>)-(3,4,5-Trimethoxyphenyl)propan-1-ol (8 g) was dissolved in dioxan (40 mL), and orange silica gel (Riedel-de-Haën 13767, 40 g) was added. The resulting solution was heated under microwave conditions at 180 °C for 10 min. The reaction mixture was filtered, concentrated to dryness, and then purified by flash chromatography on silica gel using a gradient from 100% hexane to 20% EtOAc over 20 min to afford (<i>E</i>)-1,2,3-trimethoxy-5-(prop-1-enyl)benzene (3.86 g, 53%) as a colorless oil. <sup>1</sup>H NMR (CDCl<sub>3</sub>, 500 MHz) δ 1.84 (d, <i>J</i> = 6.5 Hz, 3H), 3.82 (s, 3H), 3.90 (s, 6H), 6.19 (dt, <i>J</i> = 6.5, 13.5 Hz, 1H), 6.37 (d, <i>J</i> = 16 Hz, 1H), 6.60 (s, 2H). (+) LRMS (ESI) <i>m</i>/<i>z</i> 209 [M + H]<sup>+</sup>.</div></div><div id="sec6_2_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i27" class="anchor-spacer"></div><h4 class="article-section__title" id="_i27"> (<i>E</i>)-1,3-Dimethoxy-5-(prop-1-enyl)benzene [146205-98-3] (<b>4b</b>)</h4><div class="NLM_p last">From 3,5-dimethoxybenzaldehyde and ethylmagnesium chloride. <sup>1</sup>H NMR (CDCl<sub>3</sub>, 500 MHz) δ 1.74 (d, <i>J</i> = 6.5 Hz, 3H), 3.66 (s, 3H), 3.68 (s, 3H), 6.08 (dt, <i>J</i> = 6.5, 13.5 Hz, 1H), 6.20 (d, <i>J</i> = 16 Hz, 1H), 6.20 (s, 1H), 6.36 (s, 2H). (+) LRMS (ESI) <i>m</i>/<i>z</i> 179 [M + H]<sup>+</sup>.</div></div><div id="sec6_2_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i28" class="anchor-spacer"></div><h4 class="article-section__title" id="_i28"> (<i>E</i>)-2-Bromo-1-methoxy-4-(prop-1-enyl)benzene (<b>4c</b>)</h4><div class="NLM_p last">From 3-bromo-4-methoxybenzaldehyde and ethylmagnesium bromide. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 500 MHz) δ 1.83 (d, <i>J</i> = 7 Hz, 6H), 3.84 (s, 3H), 6.21 (m, 1H), 6.34 (d, <i>J</i> = 15 Hz, 1H), 7.05 (d, <i>J</i> = 8 Hz, 1H), 7.36 (dd, <i>J</i> = 1.5, 8 Hz, 1H), 7.60 (d, <i>J</i> = 1.5 Hz, 1H). LRMS (ESI) <i>m</i>/<i>z</i> 228 [M<sup>79</sup>Br + H]<sup>+</sup>, 230 [M<sup>81</sup>Br + H]<sup>+</sup>.</div></div><div id="sec6_2_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i29" class="anchor-spacer"></div><h4 class="article-section__title" id="_i29"> (<i>E</i>)-2-Chloro-3,4-dimethoxy-1-(prop-1-enyl)benzene (<b>4d</b>)</h4><div class="NLM_p last">From 2-chloro-3,4-dimethoxy benzaldehyde and ethylmagnesium bromide. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 500 MHz) δ 1.83 (d, <i>J</i> = 7 Hz, 6H), 3.74 (s, 3H), 3.85 (s, 3H), 6.34 (m, 2H), 7.05 (m, 2H). LRMS (ESI) <i>m</i>/<i>z</i> 213 [M<sup>35</sup>Cl + H]<sup>+</sup>, 215 [M<sup>37</sup>Cl + H]<sup>+</sup>.</div></div><div id="sec6_2_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i30" class="anchor-spacer"></div><h4 class="article-section__title" id="_i30"> (<i>E</i>)-4-(But-1-enyl)-1,2-dimethoxybenzene [76252-28-3] (<b>4e</b>)</h4><div class="NLM_p last">From 3,4-dimethoxybenzaldehyde and propylmagnesium chloride. <sup>1</sup>H NMR (<i>d</i><sub>6</sub>-DMSO, 500 MHz) δ 1.05 (t, <i>J</i> = 6.5 Hz, 3H), 2.15 (q, <i>J</i> = 6.5 Hz, 2H), 3.74 (s, 3H), 3.77 (s, 3H), 6.20 (dt, <i>J</i> = 6.5, 13.5 Hz, 1H), 6.31 (d, <i>J</i> = 16 Hz, 1H), 6.87 (br s, 2H), 7.00 (br s, 1H). <sup>13</sup>C NMR (<i>d</i><sub>6</sub>-DMSO, 125 MHz) δ 13.6, 25.3, 55.4, 55.4, 108.9, 111.8, 118.6, 128.4, 130.0, 130.4, 148.0, 148.8. (+) LRMS (ESI) <i>m</i>/<i>z</i> 193 [M + H]<sup>+</sup>.</div></div><div id="sec6_2_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i31" class="anchor-spacer"></div><h4 class="article-section__title" id="_i31"> (<i>E</i>)-5-(But-1-enyl)-1,2,3-trimethoxybenzene [357386-06-2] (<b>4f</b>)</h4><div class="NLM_p last">From 3,4,5-trimethoxybenzaldehyde and propylmagnesium chloride. <sup>1</sup>H NMR (CDCl<sub>3</sub>, 500 MHz) δ 1.12 (t, <i>J</i> = 7.5 Hz, 3H), 2.25 (m, 2H), 3.86 (s, 3H), 3.90 (s, 6H), 6.21 (dt, <i>J</i> = 6.5, 13.5 Hz, 1H), 6.33 (d, <i>J</i> = 16 Hz, 1H), 6.60 (s, 2H). <sup>13</sup>C NMR (CDCl<sub>3</sub>, 125 MHz) δ 14.2, 19.3, 41.5, 56.3, 61.1, 74.8, 103.0,137.4, 141.0, 153.4. (+) LRMS (ESI) <i>m</i>/<i>z</i> 223 [M + H]<sup>+</sup>.</div></div><div id="sec6_2_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i32" class="anchor-spacer"></div><h4 class="article-section__title" id="_i32"> (<i>E</i>)-4-(But-1-enyl)-2-fluoro-1-methoxybenzene (<b>4g</b>)</h4><div class="NLM_p last">From 3-fluoro-4-methoxybenzaldehyde and isobutylmagnesium chloride. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 500 MHz) δ 1.03 (t, <i>J</i> = 7.5 Hz, 3H), 2.16 (q, <i>J</i> = 7.5 Hz, 2H), 3.82 (s, 3H), 6.18 (dt, <i>J</i> = 6, 14 Hz, 1H), 6.30 (d, <i>J</i> = 14 Hz, 1H), 7.07 (dd, <i>J</i> = 8, 9 Hz, 1H), 7.11 (br d <i>J</i> 8.5 Hz, 1H), 7.25 (dd, <i>J</i> = 1.5, 11 Hz, 1H). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>, 500 MHz) δ 14.2, 26.0, 56.6, 113.3 (d, <i>J</i> = 18 Hz), 114.4 (d, <i>J</i> = 17 Hz), 123.0 (d, <i>J</i> = 12 Hz), 137.9, 131.6 (d, <i>J</i> = 6 Hz), 132.2, 146.7 (d, <i>J</i> = 11 Hz), 152.4 (d, <i>J</i> = 242 Hz). (+) LRMS (ESI) <i>m</i>/<i>z</i> 181 [M + H]<sup>+</sup>.</div></div><div id="sec6_2_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i33" class="anchor-spacer"></div><h4 class="article-section__title" id="_i33"> (<i>E</i>)-1,2,3-Trimethoxy-5-(3-methylbut-1-enyl)benzene (<b>4h</b>)</h4><div class="NLM_p last">From 3,4,5-trimethoxybenzaldehyde and isobutylmagnesium chloride. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 500 MHz) δ 1.06 (d, <i>J</i> = 6.5 Hz, 6H), 2.42 (m, 1H), 3.63 (s, 3H), 3.77 (s, 6H), 6.24 (m, 2H), 6.67 (s, 2H). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>, 125 MHz) δ 13.7, 21.6, 30.9, 31.9, 55.8, 60.0, 103.2, 133.1, 136.66, 152.89. (+) LRMS (ESI) <i>m</i>/<i>z</i> 236 [M + H]<sup>+</sup>.</div></div><div id="sec6_2_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i34" class="anchor-spacer"></div><h4 class="article-section__title" id="_i34"> (<i>E</i>)-2-Chloro-1-methoxy-4-(3-methylbut-1-enyl)benzene (<b>4i</b>)</h4><div class="NLM_p last">From 3-chloro-4-methoxybenzaldehyde and isobutylmagnesium chloride. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 500 MHz) δ 1.03 (d, <i>J</i> = 7 Hz, 6H), 2.42 (m, 1H), 3.83 (s, 3H), 6.18 (dd, <i>J</i> = 6.5, 13.5 Hz, 1H), 6.33 (d, <i>J</i> = 13.5 Hz, 1H), 7.06 (d, <i>J</i> = 8 Hz, 1H), 7.30 (d <i>J</i> 8 Hz, 1H), 7.46 (s, 1H). (+) LRMS (ESI) <i>m</i>/<i>z</i> 211 [M<sup>35</sup>Cl + H]<sup>+</sup>, 213 [M<sup>37</sup>Cl + H]<sup>+</sup>.</div></div><div id="sec6_2_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i35" class="anchor-spacer"></div><h4 class="article-section__title" id="_i35"> (<i>E</i>)-2-(Chloromethyl)-1-methoxy-4-(3-methylbut-1-enyl)benzene (<b>4j</b>)</h4><div class="NLM_p last">From 3-(chloromethyl)-4-methoxybenzaldehyde and isobutylmagnesium chloride. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 600 MHz) δ 1.02 (d, <i>J</i> = 7 Hz, 6H), 2.42 (m, 1H), 3.83 (s, 3H), 4.68 (s, 2H), 6.13 (dd, <i>J</i> = 6, 13 Hz, 1H), 6.28 (d, <i>J</i> = 13 Hz, 1H), 6.97 (d, <i>J</i> = 8 Hz, 1H), 7.33 (d, <i>J</i> = 8 Hz, 1H), 7.45 (s, 1H). LRMS (ESI) <i>m</i>/<i>z</i> 243 [M<sup>35</sup>Cl + H]<sup>+</sup>, 245 [M<sup>37</sup>Cl + H]<sup>+</sup></div></div><div id="sec6_2_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i36" class="anchor-spacer"></div><h4 class="article-section__title" id="_i36"> (<i>E</i>)-2-Methoxy-5-(3-methylbut-1-enyl)phenyl Acetate (<b>4k</b>)</h4><div class="NLM_p last">(<i>E</i>)-2-methoxy-5-(3-methylbut-1-enyl)phenol (1.21 g, 6.3 mmol) was dissolved in pyridine (2 mL). Acetic anhydride (0.893 mL, 9.5 mmol) and a catalytic amount of DMAP were added, and the reaction mixture stirred at rt for 16 h. The reaction mixture was partitioned between 1 N HCl (20 mL) and EtOAc (30 mL). The organic phase was washed with brine (20 mL), dried (MgSO<sub>4</sub>), filtered, and concentrated to afford (<i>E</i>)-2-methoxy-5-(3-methylbut-1-enyl)phenyl acetate as a white solid (1.14 g, 77%). <sup>1</sup>H NMR (CDCl<sub>3</sub>, 600 MHz) δ 1.08 (d, <i>J</i> = 6.6 Hz, 6H), 2.31 (s, 3H), 2.43 (m, 1H), 3.83 (s, 3H), 6.04 (dd, <i>J</i> = 6, 13 Hz, 1H), 6.24 (d, <i>J</i> = 13 Hz, 1H), 6.89 (d, <i>J</i> = 8 Hz, 1H), 7.07 (d, <i>J</i> = 1.8 Hz, 1H), 7.15 (dd, <i>J</i> = 1.8, 8 Hz, 1H). LRMS (ESI) <i>m</i>/<i>z</i> 235 [M + H]<sup>+</sup>.</div></div><div id="sec6_2_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i37" class="anchor-spacer"></div><h4 class="article-section__title" id="_i37"> (<i>E</i>)-1,2-Dimethoxy-4-(3-methylbut-1-enyl)benzene [195192-74-6] (<b>4l</b>)</h4><div class="NLM_p last">From 3,4,-dimethoxybenzaldehyde (30.6 mmol) and isobutylmagnesium chloride. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 500 MHz) δ 1.06 (d, <i>J</i> = 6.5 Hz, 6H), 2.42 (m, 1H), 3.63 (s, 3H), 3.78 (s, 3H), 6.15 (dd, <i>J</i> = 6.5, 13.5 Hz, 1H), 6.28 (d, <i>J</i> = 16 Hz, 1H), 6.87 (s, 2H), 7.01 (s, 1H). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>, 125 MHz) δ 22.4, 30.8, 55.3, 55.4, 109.0, 111.7, 118.7, 126.4, 130.4, 135.2, 148.0, 148.8. (+) LRMS (ESI) <i>m</i>/<i>z</i> 206 [M + H]<sup>+</sup>.</div></div><div id="sec6_2_13" class="NLM_sec NLM_sec_level_3"><div id="ac_i38" class="anchor-spacer"></div><h4 class="article-section__title" id="_i38"> (<i>E</i>)-2-Methoxy-5-(3-methylbut-1-enyl)phenol (<b>4m</b>)</h4><div class="NLM_p last">From 3-hydroxy-4-methoxybenzaldehyde and isobutylmagnesium chloride. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 600 MHz) δ 1.01 (d, <i>J</i> = 6.6 Hz, 6H), 2.38 (m, 1H), 3.73 (s, 3H), 5.98 (dd, <i>J</i> = 5.5, 13 Hz, 1H), 6.17 (d, <i>J</i> = 13 Hz, 1H), 6.71 (dd, <i>J</i> = 1.8, 8.4 Hz, 1H), 6.80 (s, 1H), 6.81 (d, <i>J</i> = 8 Hz, 1H), 8.83(s, 1H). LRMS (ESI) <i>m</i>/<i>z</i> 193 [M + H]<sup>+</sup>.</div></div><div id="sec6_2_14" class="NLM_sec NLM_sec_level_3"><div id="ac_i39" class="anchor-spacer"></div><h4 class="article-section__title" id="_i39"> (<i>E</i>)-5-(Hex-1-enyl)-1,2,3-trimethoxybenzene [208192-84-1] (<b>4n</b>)</h4><div class="NLM_p last">From 3,4,5-trimethoxybenzaldehyde and pentylmagnesium bromide. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 500 MHz) δ 0.91 (t, <i>J</i> = 6.5 Hz, 3H), 1.34 (m, 2H), 1.43 (m, 2H), 2.17 (q, <i>J</i> = 6.5 Hz, 2H), 3.64 (s, 3H), 3.78 (s, 6H), 6.25 (dt, <i>J</i> = 6.5, 13.5 Hz, 1H), 6.32 (d, <i>J</i> = 16 Hz, 1H), 6.68 (br s, 2H). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>, 125 MHz) δ 13.7, 21.6, 30.9, 31.9, 55.8, 60.0, 103.2, 133.1, 136.7, 152.9. (+) LRMS (ESI) <i>m</i>/<i>z</i> 250 [M + H]<sup>+</sup>.</div></div><div id="sec6_2_15" class="NLM_sec NLM_sec_level_3"><div id="ac_i40" class="anchor-spacer"></div><h4 class="article-section__title" id="_i40"> (<i>E</i>)-4-(Hex-1-enyl)-1,2-dimethoxybenzene [195192-75-7] (<b>4o</b>)</h4><div class="NLM_p last">From 3,4-dimethoxybenzaldehyde and pentylmagnesium bromide. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 500 MHz) δ 0.91 (t, <i>J</i> = 6.5 Hz, 3H), 1.34 (m, 2H), 1.41 (m, 2H), 2.17 (q, <i>J</i> = 6.5 Hz, 2H), 3.74 (s, 3H), 3.78 (s, 3H), 6.15 (dt, <i>J</i> = 6.5, 13.5 Hz, 1H), 6.31 (d, <i>J</i> = 16 Hz, 1H), 6.86 (br s, 2H), 7.00 (s, 1H). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>, 125 MHz) δ 13.7, 21.7, 31.1, 32.0, 55.3, 55.4, 109.0, 111.4, 111.7, 118.6, 128.3, 129.3, 130.4, 148.0, 148.8. (+) LRMS (ESI) <i>m</i>/<i>z</i> 221 [M + H]<sup>+</sup>.</div></div><div id="sec6_2_16" class="NLM_sec NLM_sec_level_3"><div id="ac_i41" class="anchor-spacer"></div><h4 class="article-section__title" id="_i41"> Method B: 4-[(<i>E</i>)-2-Cyclopentylvinyl]-1,2-dimethoxybenzene (<b>4p</b>)</h4><div class="NLM_p">A solution of 3,4-dimethoxybenzyl alcohol (5.0 g, 4.26 mL, 29.7 mmol) in DCM (136 mL) was cooled to 0 °C under an atmosphere of N<sub>2</sub>, phosphorus tribromide (2.89 mL, 30.6 mmol) was added dropwise, and the reaction mixture maintained at 0 °C for 90 min. The reaction mixture was warmed to rt, stirred for a further 30 min, and then poured onto ice and extracted with DCM (2 × 100 mL). The organic phase was dried (MgSO<sub>4</sub>), filtered, and concentrated to dryness to afford 3,4-dimethoxybenzyl bromide as a pale yellow solid (7 g), which was used in the next step without further purification. <sup>1</sup>H NMR (CD<sub>2</sub>Cl<sub>2</sub>, 500 MHz) δ 3.83 (s, 3H), 3.84 (s, 3H), 4.52 (s, 2H), 6.81 (d, <i>J</i> = 1.5 Hz, 1H), 6.92 (d, <i>J</i> = 8 Hz, 1H), 6.94 (dd, <i>J</i> = 1.5, 8 Hz, 1H). A solution of 3,4-dimethoxybenzyl bromide (7.0 g, 29.7 mmol) and tetrabutyl ammonium iodide in triethyl phosphite (7.75 mL, 45.6 mmol) was heated at 110 °C overnight. Ethyl bromide and excess triethyl phosphite was removed by distillation at reduced pressure to afford an oil that was purified by flash chromatography to afford diethyl 3,4-dimethoxybenzylphosphonate (6.55 g). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 500 MHz) δ 1.18 (t, <i>J</i> = 7 Hz, 6 H), 3.10 (s, 1 H), 3.15 (s, 1H), 3.72 (s, 6H), 3.92 (m, 4H), 6.79 (d, <i>J</i> = 1.5 Hz, 1H), 6.88 (m, 2H). (+) LRMS (ESI) <i>m</i>/<i>z</i> 289 [M + H]<sup>+</sup>.</div><div class="NLM_p last">A suspension of sodium hydride (150 mg, 3.64 mmol) in THF (5 mL) was cooled to 0 °C. Cyclopentane carboxaldehyde (0.36 g, 3.64 mmol) and 3,4-dimethoxybenzylphosphonate (1 g, 3.47 mmol) were added, and the reaction mixture was allowed to warm to rt and stirred O/N. Water (10 mL) was added, and the mixture was extracted with EtOAc (2 × 50 mL). The organic phase was washed with brine, dried (MgSO<sub>4</sub>), filtered, and concentrated to dryness. The resulting oil was purified by flash chromatography on silica gel (5% EtOAc in hexane) to afford 4-[(<i>E</i>)-2-cyclopentylvinyl]-1,2-dimethoxybenzene as a colorless oil (0.39 g, 48%). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 500 MHz) δ 1.38 (m, 2H), 1.56 (m, 2H), 1.67 (m, 2H), 1.81 (m, 2H), 2.58 (m, 1H), 3.73 (s, 3H), 3.77 (s, 3H), 6.23 (dd, <i>J</i> = 6.5, 15 Hz, 1H), 6.32 (d, <i>J</i> = 15 Hz, 1H), 6.86 (s, 2H), 7.00 (s, 1H). (+) LRMS (ESI) <i>m</i>/<i>z</i> 233 [M + H]<sup>+</sup>.</div></div><div id="sec6_2_17" class="NLM_sec NLM_sec_level_3"><div id="ac_i42" class="anchor-spacer"></div><h4 class="article-section__title" id="_i42"> 4-[(<i>E</i>)-2-Cyclopentylvinyl]-1,2,3-trimethoxybenzene (<b>4q</b>)</h4><div class="NLM_p last">From 3,4,5-trimethoxy benzyl alcohol. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 600 MHz) δ 1.38 (m, 2H), 1.56 (m, 2H), 1.67 (m, 2H), 1.81 (m, 2H), 2.58 (m, 1H), 3.66 (s, 3H), 3.78 (s, 6H), 6.23 (dd, <i>J</i> = 6.5, 15 Hz, 1H), 6.32 (d, <i>J</i> = 15 Hz, 1H), 6.67 (s, 2H). (+) LRMS (ESI) <i>m</i>/<i>z</i> 263 [M + H]<sup>+</sup>.</div></div><div id="sec6_2_18" class="NLM_sec NLM_sec_level_3"><div id="ac_i43" class="anchor-spacer"></div><h4 class="article-section__title" id="_i43"> Method C: (<i>E</i>)-1-Ethoxy-2-methoxy-4-(3-methylbut-1-enyl)benzene [195192-86-6] (<b>4r</b>)</h4><div class="NLM_p">A suspension of 3-ethoxy-4-methoxybenzaldehyde (1.50 g, 8.32 mmol) and NH<sub>4</sub>OAc (0.205g, 2.66 mmol) in nitromethane (15 mL) was heated at reflux for 16 h. The reaction mixture was cooled and filtered through a plug of SiO<sub>2</sub> eluting with hexane to afford (<i>E</i>)-1-ethoxy-2-methoxy-4- (2-nitrovinyl) benzene as a yellow solid (1.58 g, 85%). <sup>1</sup>H NMR (CDCl<sub>3</sub>, 500 MHz) δ 1.51 (m, 3H), 3.92 (s, 3H), 4.17 (s, 2H), 6.90 (d, <i>J</i> = 7.0 Hz, 1H), 7.00 (s, 1H), 7.17 (d, <i>J</i> = 7.0 Hz, 1H), 7.52 (d, <i>J</i> = 11 Hz, 1H), 7.96 (d, <i>J</i> = 11 Hz, 1H). (+) LRMS (ESI) <i>m</i>/<i>z</i> 239 [M + H]<sup>+</sup>.</div><div class="NLM_p last">2-Iodopropane (4.32 mL, 43 mmol) was added to a solution of (<i>E</i>)-1-ethoxy-2-methoxy-4- (2-nitrovinyl) benzene (0.50 g, 2.24 mmol) in THF (20 mL). Air was bubbled through the solution for 5 min, triethylborane (6.48 mL, 1.0 M in hexanes, 6.48 mmol) was added, and the resulting mixture stirred for 1 h, concentrated to dryness, and purified by flash chromatography on silica gel (hexane) to afford (<i>E</i>)-1-ethoxy-2-methoxy-4- (3-methylbut-1-enyl) benzene as a colorless oil (0.30 g, 61%). <sup>1</sup>H NMR (CDCl<sub>3,</sub> 500 MHz) δ 1.08 (m, 3H), 1.09 (m, 3H), 1.45 (t, <i>J</i> = 6.0 Hz, 3H), 2.44 (m, 1H), 3.89 (s, 3H), 4.08 (q, <i>J</i> = 6.0 Hz, 2H), 6.90 (m, 1H), 6.27 (m, 1H), 6.80 (d, <i>J</i> = 7.0 Hz, 1H), 6.85 (d, <i>J</i> = 7.0 Hz, 1H), 6.91 (s, 1H). (+) LRMS (ESI) <i>m</i>/<i>z</i> 221 [M + H]<sup>+</sup>.</div></div><div id="sec6_2_19" class="NLM_sec NLM_sec_level_3"><div id="ac_i44" class="anchor-spacer"></div><h4 class="article-section__title" id="_i44"> Method D: 5-[(<i>E</i>)-2-Cyclopropylvinyl]-1,2,3-trimethoxybenzene (<b>4s</b>)</h4><div class="NLM_p last">Palladium acetate (0.023g, 0.1 mmol) was added to a solution of 5-bromo-1,2,3-trimethoxybenzene (1.0 g, 4.05 mmol), cylopropylvinyl boronic acid pinacol ester (1 mL, 4.86 mmol), triphenylphosphine (0.11 g, 4.05 mmol), and 2 M K<sub>2</sub>CO<sub>3</sub> (5.6 mL) in 1,2-dimethoxyethane (4.6 mL). The reaction mixture was heated at reflux for 18 h, cooled, poured into water (10 mL), and extracted with EtOAc (2 × 30 mL). The organic phases were combined, washed with brine (30 mL), dried (MgSO<sub>4</sub>), filtered, and concentrated to dryness. The resulting oil was purified by flash chromatography on silica gel using gradient elution (0–20% EtOAc in hexane over 20 min) to afford 5-[(<i>E</i>)-2-cyclopropylvinyl]-1,2,3-trimethoxybenzene (776 mg, 81%) as a light yellow oil that solidified on standing. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 500 MHz) δ 0.51 (m, 2H), 0.81 (m, 2H), 1.55 (m, 1H), 3.64 (s, 3H), 3.78 (s, 6H), 5.82 (dd, <i>J</i> = 9.5, 16 Hz, 1H), 6.38 (d, <i>J</i> = 16 Hz, 1H), 6.65 (s, 2H). (+) LRMS (ESI) <i>m</i>/<i>z</i> 235 [M + H]<sup>+</sup>.</div></div><div id="sec6_2_20" class="NLM_sec NLM_sec_level_3"><div id="ac_i45" class="anchor-spacer"></div><h4 class="article-section__title" id="_i45"> (<i>E</i>)-4-(2-Cyclopropylvinyl)-1,2-dimethoxybenzene (<b>4t</b>)</h4><div class="NLM_p last">From 5-bromoveratrole and cylopropylvinyl boronic acid pinacol ester. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 500 MHz) δ 0.47 (m, 2H), 0.77 (m, 2H), 1.53 (m, 1H), 3.72 (s, 3H), 3.74 (s, 3H), 5.72 (dd, <i>J</i> = 9, 16 Hz, 1H), 6.37 (d, <i>J</i> = 16 Hz, 1H), 6.80 (d, <i>J</i> = 8 Hz, 1H), 6.85 (d, <i>J</i> = 8 Hz, 1H), 6.96 (s, 1H). (+) LRMS (ESI) <i>m</i>/<i>z</i> 205 [M + H]<sup>+</sup>.</div></div><div id="sec6_2_21" class="NLM_sec NLM_sec_level_3"><div id="ac_i46" class="anchor-spacer"></div><h4 class="article-section__title" id="_i46"> (<i>E</i>)-5-(2-Cyclopropylvinyl)-2-methoxyphenol (<b>4u</b>)</h4><div class="NLM_p last">From 5-bromo-2-methoxyphenyl acetate and cylopropylvinylboronic acid pinacol ester. <sup>1</sup>H NMR (CDCl<sub>3</sub>, 500 MHz) δ 0.50 (m, 2H), 0.81 (m, 2H), 1.55 (m, 1H), 3.83 (s, 3H), 5.61 (dd, <i>J</i> = 9, 16 Hz, 1H), 6.37 (d, <i>J</i> = 16 Hz, 1H), 6.78 (s, 2H), 6.94 (s, 1H), 6.96 (s, 1H). <sup>13</sup>C NMR (CDCl<sub>3</sub>, 125 MHz) δ −7.3, 14.5, 56.2, 110.9, 111.5, 118.1, 127.1, 132.0, 133.4, 145.8, 145.9. (+) LRMS (ESI) <i>m</i>/<i>z</i> 191 [M + H]<sup>+</sup>.</div></div><div id="sec6_2_22" class="NLM_sec NLM_sec_level_3"><div id="ac_i47" class="anchor-spacer"></div><h4 class="article-section__title" id="_i47"> (<i>E</i>)-4-(2-Methoxy-5-(3-methylbut-1-enyl)phenoxy)-4-oxobutanoic acid (<b>5a</b>)</h4><div class="NLM_p last">(<i>E</i>)-2-Methoxy-5-(3-methylbut-1-enyl)phenol (0.54 g, 2.8 mmol) was dissolved in pyridine (3 mL). Succinic anhydride (0.56 g, 5.6 mmol) and a catalytic amount of DMAP were added, and the reaction mixture was allowed to stir at rtRT for 16 h. A further 2 equiv of succinic anhydride was added, and the reaction mixture was stirred for a further 24h. The reaction mixture was partitioned between EtOAc (30 mL) and water (10 mL), and the organic phase washed with 1 N HCl (20 mL) and brine (20 mL). The organic phase was dried (MgSO<sub>4</sub>), filtered, and concentrated to dryness to afford (<i>E</i>)-3-(2-methoxy-5-(3-methylbut-1-enyl)phenoxy)propanoic acid as a white solid (640 mg, 78%). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 500 MHz) δ 1.02 (d, <i>J</i> = 7 Hz, 6 H), 2.39 (m, 3H), 2.57 (dd, <i>J</i> = 5.5, 6.5 Hz, 2H), 2.77 (dd, <i>J</i> = 5.5, 7 Hz, 2H), 3.73 (s, 3H), 5.98 dd (<i>J</i> 6.5, 16 Hz, 1H), 6.18 (d, <i>J</i> = 16 Hz, 1H), 6.73 (dd, <i>J</i> = 1.5, 8 Hz, 1H), 6.80 (d, <i>J</i> = 1.5 HZ, 1H), 6.82 (d, <i>J</i> = 8 Hz, 1H), 8.83 (s, 1H).</div></div><div id="sec6_2_23" class="NLM_sec NLM_sec_level_3"><div id="ac_i48" class="anchor-spacer"></div><h4 class="article-section__title" id="_i48"> (<i>E</i>)-4-(3-(5-(2-Cyclopropylvinyl)-2-methoxyphenoxy)propyl)morpholine (<b>5b</b>)</h4><div class="NLM_p last">(<i>E</i>)-5-(2-Cyclopropylvinyl)-2-methoxyphenol (1.0g, 5.3 mmol) was dissolved in acetone (5 mL). Potassium carbonate (3.66 g, 26.5 mmol) and 4-(3-chloropropyl)morpholine (2.6 g, 15.9 mmol) were added, and the reaction mixture was heated at reflux for 16 h. The reaction mixture was cooled, concentrated to dryness, and partitioned between EtOAc (30 mL) and water (20 mL). The organic phase was dried (MgSO4), filtered, concentrated, and purified by flash chromatography on silica gel (EtOAc) to afford (<i>E</i>)-4-(3-(5-(2-cyclopropylvinyl)-2-methoxyphenoxy)propyl)morpholine as an orange oil (629 mg, 37%). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 500 MHz) δ 1.03 (d, <i>J</i> = 7 Hz, 6 H), 2.37 (m, 5H), 2.69 (m, 2H), 3.54 (m, 4H), 3.73 (s, 3H), 4.09 (t, <i>J</i> = 6 Hz, 2H), 6.12 dd (<i>J</i> 7.2, 16.2 Hz, 1H), 6.23 (d, <i>J</i> = 16.2 Hz, 1H), 6.85 (s, 2H), 7.03 (s, 1H). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>, 125 MHz) δ 7.35, 14.6, 29.8, 53.9, 55.8, 56.3, 67.2, 67.5, 110.9, 112.2, 119.0, 127.3, 131.4, 133.1, 148.7, 148.9. (+) LRMS (ESI) <i>m</i>/<i>z</i> 306 [M + H]<sup>+</sup>.</div></div><div id="sec6_2_24" class="NLM_sec NLM_sec_level_3"><div id="ac_i49" class="anchor-spacer"></div><h4 class="article-section__title" id="_i49"> (<i>E</i>)-2-(2-Methoxy-5-(3-methylbut-1-enyl)phenoxy)ethanol (<b>5c</b>)</h4><div class="NLM_p last">(<i>E</i>)-5-(2-Isopropylopropylvinyl)-2-methoxyphenol (0.73g, 3.8 mmol) was dissolved in acetone (16 mL). Potassium carbonate (2.63 g, 19 mmol) and bromoethanol (0.54 mL, 7.6 mmol) were added, and the reaction mixture was heated at reflux for 16 h. The reaction mixture was cooled, concentrated to dryness and partitioned between EtOAc (30 mL) and water (20 mL). The organic phase was dried (MgSO<sub>4</sub>), filtered, concentrated and purified by flash chromatography on silica gel (EtOAc) to afford (<b>5c</b>) as a colorless oil (190 mg, 20%). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 500 MHz) δ 1.06 (d, <i>J</i> = 7 Hz, 6 H), 2.42 (m, 1H), 3.72 (br s, 2H), 3.75 (s, 3H), 3.99 (t, <i>J</i> = 5 Hz, 1H), 4.81 (m, 1H), 6.14 (dd, <i>J</i> = 7, 16 Hz, 1H), 6.27 (d, <i>J</i> = 16 Hz, 1H), 6.88 (m, 2H), 7.02 (s, 1H). (+) LRMS (ESI) <i>m</i>/<i>z</i> 235 [M + H]<sup>+</sup>.</div></div><div id="sec6_2_25" class="NLM_sec NLM_sec_level_3"><div id="ac_i50" class="anchor-spacer"></div><h4 class="article-section__title" id="_i50"> (<i>E</i>)-3-(5-(2-Cyclopropylvinyl)-2-methoxyphenoxy)propan-1-ol (<b>5d</b>)</h4><div class="NLM_p last">(<i>E</i>)-5-(2-Cyclopropylopropylvinyl)-2-methoxyphenol (1.0 g, 5.26 mmol) was dissolved in acetone (15 mL). Potassium carbonate (3.6 g, 2.63 mmol) and 3-bromo-1-propanol (0.92 mL, 10.5 mmol) were added, and the reaction mixture was heated at reflux for 16 h. The reaction mixture was cooled, concentrated to dryness, and partitioned between EtOAc (30 mL) and water (20 mL). The organic phase was dried (MgSO<sub>4</sub>), filtered, concentrated, and purified by flash chromatography on silica gel (EtOAc:Hexane 7:3) to afford (<b>5d</b>) as a white solid (1.25 g, 96%). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 500 MHz) δ 0.48 (m, 2 H), 0.76 (m, 1H), 1.52 (m, 1H), 1.85 (m, 2H), 3.56 (m, 2H), 3.72 (s, 3H), 4.01 (t, <i>J</i> = 5 Hz, 2H), 4.50 (t, <i>J</i> = 5 Hz, 1H), 5.70 (dd, <i>J</i> = 7, 16 Hz, 1H), 6.36 (d, <i>J</i> = 16 Hz, 1H), 6.80 (d, <i>J</i> = 8 Hz, 1H), 6.85 (d, <i>J</i> = 8 Hz, 1H), 6.95 (s, 1H). (+) LRMS (ESI) <i>m</i>/<i>z</i> 249 [M + H]<sup>+</sup>.</div></div></div><div id="sec6_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i51" class="anchor-spacer"></div><h3 class="article-section__title" id="_i51"> Synthesis of Flindersine and Analogues</h3><div id="sec6_3_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i52" class="anchor-spacer"></div><h4 class="article-section__title" id="_i52"> 2,4-Dichloroquinoline</h4><div class="NLM_p last">Aniline (6.7 g, 72 mmol) and malonic acid (11.7 g, 112 mmol) were dissolved in POCl<sub>3</sub> (60 mL), heated at reflux for 5 h, cooled, and poured into ice (an exothermic reaction occurred, and some product was lost). The crude product was filtered off and purified on a short column of silica gel using hexane (500 mL) and 90% hexane/EtOAc (500 mL) to afford 2,4-dichloroquinoline (5.56 g, 39%) as a white solid. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 500 MHz) δ 7.48 (s, 2H), 7.64 (t, <i>J</i> = 8 Hz, 1H), 7.75 (t, <i>J</i> = 8 Hz, 1H), 8.03 (d, <i>J</i> = 8 Hz, 1H), 8.17 (d, <i>J</i> = 8 Hz, 1H). (+) LRMS (ESI) <i>m</i>/<i>z</i> 198:200:202 (100:60:10) [M + H]<sup>+</sup>.</div></div><div id="sec6_3_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i53" class="anchor-spacer"></div><h4 class="article-section__title" id="_i53"> 2,4-Dimethoxyquinoline</h4><div class="NLM_p last">2,4-Dichloroquinoline (5.56 g, 28 mmol) was heated under reflux in a methanolic sodium methoxide solution (6 g sodium in 150 mL of MeOH) for 20 h. The reaction mixture was cooled and poured into ice water, and the residue was filtered off and purified on a short column of silica gel using 95% hexane/EtOAc to afford 2,4-dimethoxyquinoline (3.88 g, 73%) as a white solid and 4-chloro-2-methoxyquinoline as a white solid (1.06 g, 20%). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 500 MHz) δ 4.01 (s, 3H), 4.10 (s, 3H), 6.25 (s, 1H), 7.36 (t, <i>J</i> = 8 Hz, 1H), 7.63 (t, <i>J</i> = 8 Hz, 1H), 7.82 (d, <i>J</i> = 8 Hz, 1H), 8.08 (d, <i>J</i> = 8 Hz, 1H). (+) LRMS (ESI) <i>m</i>/<i>z</i> 190 [M + H]<sup>+</sup>. 4-Chloro-2-methoxyquinoline: <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 500 MHz) δ 4.10 (s, 3H), 7.06 (s, 1H), 7.49 (t, <i>J</i> = 8 Hz, 1H), 7.70 (t, <i>J</i> = 8 Hz, 1H), 7.89 (d, <i>J</i> = 8 Hz, 1H), 8.13 (d, <i>J</i> = 8 Hz, 1H). (+) LRMS (ESI) <i>m</i>/<i>z</i> 194:196 (3:1) [M + H]<sup>+</sup>.</div></div><div id="sec6_3_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i54" class="anchor-spacer"></div><h4 class="article-section__title" id="_i54"> 2,4-Dimethoxy-3-(3-methylbut-2-enyl)quinoline</h4><div class="NLM_p last">2,4-Dimethoxyquinoline (0.95 g, 5 mmol) was dissolved in dry THF (20 mL) and cooled to 0 °C under an atmosphere of argon. <i>n</i>-BuLi (2.5M, 2.8 mL, 7 mmol) was added dropwise with stirring, and the reaction mixture was stirred for a further 30 min at 0 °C. 1-Bromo-3-methylbut-2-ene (1.27 g, 1 mL, 8.55 mmol) was added dropwise, and the reaction was stirred for a further 30 min at 0 °C. The reaction mixture was then warmed to rt and stirred for a further 1 h. The reaction mixture was concentrated to dryness and purified by flash chromatography on silica gel (9:1 hexane/EtOAc) to afford 2,4-dimethoxy-3-(3-methylbut-2-enyl)quinoline as a clear oil (0.870 g, 67%). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 500 MHz) δ 1.72 (s, 3H), 1.84 (s, 3H), 3.49 (d, <i>J</i> = 7 Hz, 2H), 3.99 (s, 3H), 4.12 (s, 3H), 5.25 (br t, <i>J</i> = 7 Hz, 1H), 7.39 (t, <i>J</i> = 7.5 Hz, 1H), 7.59 (t, <i>J</i> = 7.5 Hz, 1H), 7.87 (t, <i>J</i> = 7.5 Hz, 1H), 7.94 (d, <i>J</i> = 7.5 Hz, 1H). (+) LRMS (ESI) <i>m</i>/<i>z</i> 258 [M + H]<sup>+</sup>.</div></div><div id="sec6_3_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i55" class="anchor-spacer"></div><h4 class="article-section__title" id="_i55"> 3-((3,3-Dimethyloxiran-2-yl)methyl)-2,4-dimethoxyquinoline</h4><div class="NLM_p last">2,4-Dimethoxy-3-(3-methylbut-2-enyl)quinoline (0.870 g, 3.4 mmol) was dissolved in CHCl<sub>3</sub> (10 mL), mCPBA (2.91 g, 16.9 mmol) was added, and the reaction mixture was stirred for 4 h. The reaction mixture was extracted with 2 N NaCO<sub>3</sub> (4 × 50 mL), dried with MgSO4, filtered, and concentrated to afford the crude epoxide (0.956 g, 100%), which was used in the next reaction without further purification. <sup>1</sup>H NMR (CDCl<sub>3</sub>, 500 MHz) δ 1.33 (s, 3H), 1.48 (s, 3H), 2.94 (dd, <i>J</i> = 13, 5 Hz, 1H), 3.08 (dd, <i>J</i> = 11.5, 6.5 Hz, 1H), 3.13 (t, <i>J</i> = 7.5 Hz, 1H), 4.03 (s, 3H), 4.13 (s, 3H), 7.40 (t, <i>J</i> = 7.5 Hz, 1H), 7.62 (t, <i>J</i> = 7.5 Hz, 1H), 7.86 (t, <i>J</i> = 7.5 Hz, 1H), 7.95 (d, <i>J</i> = 7.5 Hz, 1H). <sup>13</sup>C NMR (CDCl<sub>3</sub>, 125 MHz) δ 19.23, 24.33, 25.03, 53.95, 59.40, 62.97, 63.37, 113.73, 121.24, 122.29, 124.02, 127.59, 129.49, 146.72, 162.55, 163.03. (+) LRMS (ESI) <i>m</i>/<i>z</i> 274 [M + H]<sup>+</sup>.</div></div><div id="sec6_3_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i56" class="anchor-spacer"></div><h4 class="article-section__title" id="_i56"> 5-Methoxy-2,2-dimethyl-<i>2H-</i>pyrano[3,2-<i>c</i>]quinoline (<b>3</b>)</h4><div class="NLM_p last">A solution of 3-((3,3-dimethyloxiran-2-yl)methyl)-2,4-dimethoxyquinoline (5.8 g, 21.2 mmol) in DMSO (150 mL) and 2 N KOH (30 mL) was heated at 90 °C for 20 h. The reaction mixture was poured into water and extracted with CHCl<sub>3</sub> (2 × 100 mL). The aqueous phase was neutralized with HCl to pH 7. Extraction with CHCl<sub>3</sub> (3 × 100 mL) gave a brown oil that was dried (MgSO<sub>4</sub>), filtered, and concentrated. Purification on silica gel using flash chromatography (15% EtOAc in hexane) gave 5-methoxy-2,2-dimethyl-2<i>H</i>-pyrano[3,2-<i>c</i>]quinoline (<b>3</b>) (2.3g, 45%) and the diol, 1-(2,4-dimethoxyquinolin-3-yl)-3-methylbutane-2,3-diol (0.326 g). <b>3</b>: <sup>1</sup>H NMR (CDCl<sub>3</sub>, 500 MHz) δ 1.56 (s, 6H), 4.10 (s, 3H), 5.60 (d, <i>J</i> = 8 Hz, 1H), 6.67 (d, <i>J</i> = 8 Hz, 1H), 7.34 (t, <i>J</i> = 7.5 Hz, 1H), 7.58 (t, <i>J</i> = 7.5 Hz, 1H), 7.76 (t, <i>J</i> = 7.5 Hz, 1H), 8.03 (d, <i>J</i> = 7.5 Hz, 1H). (+) LRMS (ESI) <i>m</i>/<i>z</i> 242 [M + H]<sup>+</sup>. 1-(2,4-Dimethoxyquinolin-3-yl)-3-methylbutane-2,3-diol: <sup>1</sup>H NMR (CDCl<sub>3</sub>, 500 MHz) δ 1.50 (s, 6H), 3.94 (s, 3H), 4.14 (s, 3H), 6.86 (d, <i>J</i> = 15 Hz, 1H), 6.93 (d, <i>J</i> = 15 Hz, 1H), 7.39 (t, <i>J</i> = 7.5 Hz, 1H), 7.60 (t, <i>J</i> = 7.5 Hz, 1H), 7.83 (t, <i>J</i> = 7.5 Hz, 1H), 7.98 (d, <i>J</i> = 7.5 Hz, 1H). (+) LRMS (ESI) <i>m</i>/<i>z</i> 274 [M + H]<sup>+</sup>.</div></div><div id="sec6_3_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i57" class="anchor-spacer"></div><h4 class="article-section__title" id="_i57"> 2,2-Dimethyl-<i>2H-</i>pyrano[3,2-<i>c</i>]quinolin-5(6<i>H</i>)-one Flindersine (<b>2a</b>)</h4><div class="NLM_p last">2,4-Dihidroxyquinolinone (6.5 g, 40.3 mmol) and methylcrotonaldehyde (6.79 g, 7.7 mL, 80.6 mmol) were suspended in acetonitrile (400 mL). Ytterbium trifluoromethanesulfonate (2.5 g, 4.03 mmol) was added, and the reaction mixture was refluxed for 16 h. The reaction mixture was cooled, filtered, and concentrated to dryness. Purification on silica using flash chromatography afforded <b>2a</b> (3.8 g, 42%) as a yellow solid. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 500 MHz) δ 1.50 (s, 6H), 5.67 (d, <i>J</i> = 10 Hz, 1H), 6.53 (d, <i>J</i> = 10 Hz, 1H), 7.19 (t, <i>J</i> = 8 Hz, 1H), 7.28 (d, <i>J</i> = 8 Hz, 1H), 7.51 (t, <i>J</i> = 8 Hz, 1H), 7.77 (d, <i>J</i> = 8 Hz, 1H). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>, 125 MHz) δ 27.67, 78.57, 105.45, 114.05, 115.23, 116.58, 121.53, 121.87, 126.66, 130.78, 138.15, 155.36, 160.18. (+) LRMS (ESI) <i>m</i>/<i>z</i> 228 [M + H]<sup>+</sup>.</div></div><div id="sec6_3_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i58" class="anchor-spacer"></div><h4 class="article-section__title" id="_i58"> 2,2,6-Trimethyl-2<i>H</i>-pyrano[3,2-<i>c</i>]quinolin-5(6<i>H</i>)-one (<b>2b</b>)</h4><div class="NLM_p last">A mixture of 3-methyl-2-butenal (1.64 mL, 17.1 mmol) and magnesium sulfate (5.43 g) in pyridine (15 mL) was refluxed for a few minutes. A solution of 4-hydroxy-1-methyl-2(1<i>H</i>)-quinolone (2.5 g, 14.3 mmol) in pyridine (9 mL) was then added slowly (over 20 min) to the above mixture, and the mixture was refluxed overnight. The reaction mixture was cooled to room temperature, and the pyridine was removed by evaporation. The resulting residue was diluted with water and extracted with DCM. The organic phase was washed with 1 N HCl, aqueous sodium bicarbonate, and brine solution and dried over anhydrous MgSO<sub>4</sub>. The organic phase was then concentrated to dryness to afford 2,2,6-trimethyl-2<i>H</i>-pyrano[3,2-<i>c</i>]quinolin-5(6<i>H</i>)-one (<b>2b</b>) as a brown oil (3.38 g, 98%). <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub><i>6</i></sub>) δ ppm 1.48 (s, 6H), 3.59 (s, 3H), 5.68 (d, 1H, <i>J</i> = 10 Hz), 6.57 (d, 1H, <i>J</i> = 10 Hz), 7.27 (t, 1H, <i>J</i> = 7.5 Hz), 7.49 (d, 1H, <i>J</i> = 11 Hz), 7.62 (t, 1H, <i>J</i> = 16 Hz), 7.86 (d, 1H, <i>J</i> = 8 Hz).</div></div><div id="sec6_3_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i59" class="anchor-spacer"></div><h4 class="article-section__title" id="_i59"> 2,2,9-Trimethyl-2<i>H</i>-pyrano[3,2-<i>c</i>]quinolin-5(6<i>H</i>)-one (<b>2c</b>)</h4><div class="NLM_p last">A mixture of 3-methyl-2-butenal (1.92 mL, 20 mmol) and magnesium sulfate (6.34 g) in pyridine (17.5 mL) was refluxed for a few minutes. A solution of 4-hydroxy-6-methylquinolin-2(1<i>H</i>)-one (2.92 g, 16.7 mmol) in pyridine (10.5 mL) was then added slowly (over 20 min) to the above mixture, and the mixture was refluxed overnight. The reaction mixture was cooled to room temperature, and the pyridine was removed by evaporation. The resulting residue was diluted with water and extracted with DCM. The organic phase was washed with 1 N HCl, aqueous sodium bicarbonate, and brine solution and dried over anhydrous MgSO<sub>4</sub>. The organic phase was then concentrated to dryness to afford 2,2,9-trimethyl-2<i>H</i>-pyrano[3,2-<i>c</i>]quinolin-5(6<i>H</i>)-one (<b>2c</b>) as a brown oil (3.81 g, 95%). <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i>) δ 1.48 (s, 6H), 2.35 (s, 3H), 5.64 (d, 1H, <i>J</i> = 10 Hz), 6.51 (d, 1H, <i>J</i> = 9.5 Hz), 7.17 (d, 1H, <i>J</i> = 8.5 Hz), 7.32 (d, 1H, <i>J</i> = 7.5 Hz), 7.54 (s, 1H), 11.37 (s, 1H).</div></div><div id="sec6_3_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i60" class="anchor-spacer"></div><h4 class="article-section__title" id="_i60"> 2-Methyl-2<i>H</i>-pyrano[3,2-<i>c</i>]quinolin-5(6<i>H</i>)-one (<b>2e</b>,<b>f</b>)</h4><div class="NLM_p last">2,4-Dihydroxyquinolinone (1.27 g, 7.8 mmol) and crotonaldehyde (1.1 g, 1.4 mL, 15.6 mmol) were suspended in acetonitrile (40 mL). Ytterbium trifluoromethanesulfonate (230 mg, 0.37 mmol) was added, and the reaction mixture was refluxed for 16 h. The reaction mixture was cooled, filtered, and concentrated to dryness. Purification on silica using flash chromatography afforded <b>2e</b>,<b>f </b>(341 mg, 18%) as a yellow solid. <sup>1</sup>H NMR (CDCl<sub>3</sub>, 500 MHz) δ 1.58 (s, 3H), 5.29 (m, 1H), 5.64 (dd, <i>J</i> = 2, 9.5 Hz, 1H), 6.83 (d, <i>J</i> = 10 Hz, 1H), 7.23 (t, <i>J</i> = 8 Hz, 1H), 7.41 (d, <i>J</i> = 8 Hz, 1H), 7.52 (t, <i>J</i> = 8 Hz, 1H), 7.89 (d, <i>J</i> = 8 Hz, 1H), 11.82 (br s, 1H). <sup>13</sup>C NMR (CDCl<sub>3</sub>, 125 MHz) δ 21.81, 73.83, 106.25, 115.32 116.48, 118.53, 122.56, 122.77 122.78, 131.35, 137.98, 158.44, 162.58. (+) LRMS (ESI) <i>m</i>/<i>z</i> 214 [M + H]<sup>+</sup>.</div></div><div id="sec6_3_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i61" class="anchor-spacer"></div><h4 class="article-section__title" id="_i61"> 2,2-Dimethyl-2<i>H</i>-pyrano[3,2-<i>c</i>]pyridin-5(6<i>H</i>)-one (<b>6</b>)</h4><div class="NLM_p last">A mixture of 3-methyl-2-butenal (2.59 mL, 27 mmol) and magnesium sulfate (8.55 g) in pyridine (23 mL) was refluxed for a few minutes. A solution of 2,4-dihydroxypyridine (2.5 g, 22.5 mmol) in pyridine (14 mL) was then added slowly (over 30 min) to the above mixture and refluxed overnight. The reaction mixture was cooled to room temperature, and the pyridine was removed. The resulting residue was diluted with water and extracted with DCM. The organic phase was washed with 1 N HCl, aqueous sodium bicarbonate, and brine and then dried over anhydrous MgSO<sub>4</sub>. The organic phase was then concentrated to dryness to afford 2,2-dimethyl-2<i>H</i>-pyrano[3,2-<i>c</i>]pyridin-5(6<i>H</i>)-one (<b>6</b>) as a light yellow solid (3.18 g, 80%). <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub><i>6</i></sub>) δ 1.37 (s, 6H), 5.46 (d, <i>J</i> = 10 Hz, 1H), 5.81 (d, <i>J</i> = 7 Hz, 1H), 6.38 (d, 1H, <i>J</i> = 10 Hz, 1H), 7.18 (d, <i>J</i> = 7 Hz, 1H), 11.18 (br s, 1H). (+) LRMS (ESI) <i>m</i>/<i>z</i> 178.1 [M + H]<sup>+</sup>.</div></div></div><div id="sec6_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i62" class="anchor-spacer"></div><h3 class="article-section__title" id="_i62"> Photochemical 2 + 2 Cycloaddition. General Procedure</h3><div class="NLM_p">The corresponding flindersine analogue (1 equiv) and styrene (2 equiv) were dissolved in CHCl<sub>3</sub> (2 mL) and added to either a 250 mL jacketed round-bottomed flask or a pyrex test tube. The solvent was evaporated to form a thin film, and the flask was then cooled and irradiated with UV light (125 or 400 W, 16 h). The resulting brown gum was purified by reverse-phase HPLC to afford the title compound.</div><div id="sec6_4_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i63" class="anchor-spacer"></div><h4 class="article-section__title" id="_i63"> (1<i>R</i>,2<i>R</i>,2a<i>R</i>,10a<i>S</i>)-3-Methoxy-1,10,10-trimethyl-2-(3,4,5-trimethoxyphenyl)-2,2a,10,10a-tetrahydro-1<i>H</i>-cyclobuta[4,5]pyrano[3,2-<i>c</i>]quinoline and (1<i>S</i>,2<i>S</i>,2a<i>S</i>,10a<i>R</i>)-3-Methoxy-1,10,10-trimethyl-2-(3,4,5-trimethoxyphenyl)-2,2a,10,10a-tetrahydro-1<i>H</i>-cyclobuta[4,5]pyrano[3,2-<i>c</i>]quinoline (Racemic Precursor of <b>1</b>, Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>)</h4><div class="NLM_p last">From 5-methoxy-2,2-dimethyl-4a,10b-dihydro-2<i>H</i>-pyrano[3,2-<i>c</i>]quinoline (<b>3</b>) (0.5 mmol) and <b>4a</b> (1.0 mmol). Purified by isocratic elution MeOH/H<sub>2</sub>O (1% TFA, 3:2) (102.3 mg, 36%). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 600 MHz) δ 1.12 (d, <i>J</i> = 6 Hz, 3H), 1.16 (s, 3H), 1.50 (s, 3H), 2.36 (m, 2H), 3.23 (s, 3H), 3.24 (s, 6H), 3.36 (t, <i>J</i> = 8 Hz, 1H), 3.51 (s, 3H), 3.71 (t, <i>J</i> = 6.5 Hz, 1H), 7.35 (t, <i>J</i> = 7.5 Hz, 1H), 7.56 (t, <i>J</i> = 7.5 Hz, 1H), 7.57 (d, <i>J</i> = 7.5 Hz, 1H), 8.03 (d, <i>J</i> = 8 Hz, 1H). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>, 150 MHz) δ 20.97, 24.33, 25.64, 35.24, 46.00, 50.46, 53.08, 55.72, 60.47, 76.08, 102.64, 105.88, 118.57, 122.90, 123.02, 126.18, 129.22, 135.18, 135.84, 145.38, 156.97, 151.51, 161.79. (+) LRMS (ESI) <i>m</i>/<i>z</i> 450 [M + H]<sup>+</sup>. HRMS (ESI): calcd for C<sub>27</sub>H<sub>32</sub>NO<sub>5</sub> [M + H]<sup>+</sup>, 450.2275; found, 450.2256.</div></div><div id="sec6_4_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i64" class="anchor-spacer"></div><h4 class="article-section__title" id="_i64"> (1<i>R</i>,2<i>R</i>,2a<i>R</i>,10a<i>S</i>)-1,10,10-Trimethyl-2-(3,4,5-trimethoxyphenyl)-1,2,2a,4,10,10a-hexahydro-3<i>H</i>-cyclobuta[4,5]pyrano[3,2-<i>c</i>]quinolin-3-one and (1<i>S</i>,2<i>S</i>,2a<i>S</i>,10a<i>R</i>)-1,10,10-Trimethyl-2-(3,4,5-trimethoxyphenyl)-1,2,2a,4,10,10a-hexahydro-3<i>H</i>-cyclobuta[4,5]pyrano[3,2-<i>c</i>]quinolin-3-one (<b>1</b>)</h4><div class="NLM_p">The previous compound (39 mg, 0.07 mmol) was dissolved in acetic acid (2 mL). Potassium iodide (12 mg, 0.14 mmol) was added, and the reaction mixture was heated at 50 °C for 4 h. The reaction mixture was extracted with a 10% NaHSO<sub>4</sub> solution and CHCl<sub>3</sub> (3 × 30 mL), dried with MgSO<sub>4</sub>, filtered, and concentrated to dryness to afford <b>1</b> (35.4 mg, 83%) as a white solid. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 500 MHz) δ 1.12 (d, <i>J</i> = 6 Hz, 3H), 1.13 (s, 3H), 1.47 (s, 3H), 2.33 (m, 2H), 3.16 (m, 1H), 3.29 (s, 3H), 3.33 (s, 3H), 3.68 (t, <i>J</i> = 7.5 Hz, 1H), 4.06 (m, 1H), 6.11 (s, 2H), 7.13 (d, <i>J</i> = 7.5 Hz, 1H), 7.13 (t, <i>J</i> = 7.5 Hz, 1H), 7.42 (t, <i>J</i> = 7.5 Hz, 1H), 7.81 (d, <i>J</i> = 8 Hz, 1H), 11.05 (s, 1H). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>, 150 MHz) δ 20.3, 23.3, 24.4, 31.7, 35.2, 45.7 49.4, 55.0, 59.8, 76.5, 105.4, 107.8, 114.6, 114.8, 120.9, 121.7, 129.8, 135.8, 135.9, 137.5, 151.7, 155.5, 162.2. (+) LRMS (ESI) <i>m</i>/<i>z</i> 436 [M + H]<sup>+</sup>. HRMS (ESI): calcd for C<sub>26</sub>H<sub>29</sub>NO<sub>5</sub>Na [M + Na]<sup>+</sup>, 458.1938; found, 458.1928. (for other data, see the <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>).</div><div class="NLM_p last">Synthesis of <b>1</b> from flindersine (<b>2a</b>, 0.6 mmol) and <b>4a</b> (1.2 mmol). Purified by flash chromatography on neutral alumina (DCM, then 1:1 DCM/CHCl<sub>3</sub> then CHCl<sub>3</sub>). The fractions containing MH<sup>+</sup> 436 were combined and purified by isocratic elution with MeCN/H<sub>2</sub>O (55:45) (41 mg, 16%), which was identical to the sample above by <sup>1</sup>H and <sup>13</sup>C NMR and MS. There were small differences in the <sup>1</sup>H NMR between the synthetic <b>1</b> and the natural product (euodenine A), attributable to the fact that the natural product contained some TFA (present in the solvent used for HPLC purification). They were shown to be identical by mixing the two NMR samples together and rerunning the <sup>1</sup>H NMR spectrum. A single spectrum was obtained, identical to that of euodenine A.</div></div><div id="sec6_4_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i65" class="anchor-spacer"></div><h4 class="article-section__title" id="_i65"> (1<i>R</i>,2<i>R</i>,2a<i>R</i>,10a<i>S</i>)-3-Methoxy-1,10,10-trimethyl-2-(3,4,-dimethoxyphenyl)-2,2a,10,10a-tetrahydro-1<i>H</i>-cyclobuta[4,5]pyrano[3,2-<i>c</i>]quinoline and (1<i>S</i>,2<i>S</i>,2a<i>S</i>,10a<i>R</i>)-3-Methoxy-1,10,10-trimethyl-2-(3,4,-dimethoxyphenyl)-2,2a,10,10a-tetrahydro-1<i>H</i>-cyclobuta[4,5]pyrano[3,2-<i>c</i>]quinoline (Racemic Precursor of <b>10</b>)</h4><div class="NLM_p last">From 5-methoxy-2,2-dimethyl-4a,10b-dihydro-2<i>H</i>-pyrano[3,2-<i>c</i>]quinoline (<b>3</b>, 0.5 mmol) and 1,2-dimethoxy-4-propenylbenzene (1.0 mmol). Purified by isocratic elution MeCN/H<sub>2</sub>O (1% TFA, 55:45) (36.4 mg, 17%). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 600 MHz) δ 1.12 (d, <i>J</i> = 5.5 Hz, 3H), 1.17 (s, 3H), 1.52 (s, 3H), 2.38 (m, 2H), 3.06 (s, 3H), 3.26 (s, 3H), 3.23 (t, <i>J</i> = 9 Hz, 1H), 3.63 (s, 3H), 3.73 (t, <i>J</i> = 9 Hz, 1H), 5.97 (d, <i>J</i> = 1.5 Hz, 1H), 6.40 (dd, <i>J</i> = 2, 8 Hz, 1H), 6.65 (d, <i>J</i> = 8 Hz, 1H), 7.37 (t, <i>J</i> = 8 Hz, 1H), 7.59 (m, 2H), 8.04 (d, <i>J</i> = 8 Hz, 1H). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>, 150 MHz) δ 20.88, 24.52, 25.83, 33.12, 35.45, 46.53, 50.17, 53.38, 55.42, 56.59, 77.07, 103.68, 111.82, 111.83, 119.56, 121.37, 122.05, 123.72, 127.57, 129.83, 132.91, 145.69, 147.73, 148.26, 156.63, 162.28. (+) LRMS (ESI) <i>m</i>/<i>z</i> 420 [M + H]<sup>+</sup>. HRMS (ESI): calcd for C<sub>26</sub>H<sub>31</sub>NO<sub>4</sub> [M + H]<sup>+</sup>, 420.2169; found, 420.2159.</div></div><div id="sec6_4_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i66" class="anchor-spacer"></div><h4 class="article-section__title" id="_i66"> (1<i>R</i>,2<i>R</i>,2a<i>R</i>,10a<i>S</i>)-1,10,10-Trimethyl-2-(3,4-dimethoxyphenyl)-1,2,2a,4,10,10a-hexahydro-3<i>H</i>-cyclobuta[4,5]pyrano[3,2-<i>c</i>]quinolin-3-one and (1<i>S</i>,2<i>S</i>,2a<i>S</i>,10a<i>R</i>)-1,10,10-Trimethyl-2-(3,4-dimethoxyphenyl)-1,2,2a,4,10,10a-hexahydro-3<i>H</i>-cyclobuta[4,5]pyrano[3,2-<i>c</i>]quinolin-3-one (<b>10</b>)</h4><div class="NLM_p last">The previous compound (16.6 mg, 0.04 mmol) was dissolved in acetic acid (2 mL). Potassium iodide (9.4 mg, 0.056 mmol) was added, and the reaction mixture was heated at 50 °C for 20 h. The reaction mixture was partitioned between with a 10% NaHSO<sub>4</sub> solution and CHCl<sub>3</sub> (3 × 30 mL), and the organic layer was then extracted with aqueous ammonia solution (10%, 20 mL), dried with MgSO<sub>4</sub>, filtered, and concentrated to dryness to afford <b>10</b> (9.3 mg, 57%) as a white solid. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 500 MHz) δ 1.16 (d, <i>J</i> = 6 Hz, 3H), 1.17 (s, 3H), 1.53 (s, 3H), 2.39 (m, 2H), 3.28 (s, 3H), 3.38 (m, 1H), 3.67 (s, 3H), 3.74 (t, <i>J</i> = 7.5 Hz, 1H), 6.39 (br s, 1H), 6.52 (d, <i>J</i> = 8 Hz, 1H), 6.66 (d, <i>J</i> = 8 Hz, 1H), 7.19 (t, <i>J</i> = 8 Hz, 1H), 7.19 (d, <i>J</i> = 7.5 Hz, 1H), <i>7</i>.78 (t, <i>J</i> = 7.5 Hz, 1H), 7.87 (d, <i>J</i> = 8 Hz, 1H), 11.07 (s, 1H). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>, 125 MHz) δ 21.66, 22.95, 25.64, 32.97, 35.96, 46.72, 49.86, 55.54, 56.14, 77.19, 108.54, 111.59, 112.59, 115.38, 115.59, 121.40, 121.74, 122.52, 130.77, 133.24, 138.18, 147.87, 148.07, 156.17, 162.66. (+) LRMS (ESI) <i>m</i>/<i>z</i> 406 [M + H]<sup>+</sup>. HRMS (ESI): calcd for C<sub>25</sub>H<sub>27</sub>NO<sub>4</sub>Na [M + Na]<sup>+</sup>, 428.1832; found, 428.1843.</div></div><div id="sec6_4_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i67" class="anchor-spacer"></div><h4 class="article-section__title" id="_i67"> (1<i>R</i>,2<i>R</i>,2a<i>R</i>,10a<i>S</i>)-1,10,10-Trimethyl-2-(3,5-dimethoxyphenyl)-1,2,2a,4,10,10a-hexahydro-3<i>H</i>-cyclobuta[4,5]pyrano[3,2-<i>c</i>]quinolin-3-one and (1<i>S</i>,2<i>S</i>,2a<i>S</i>,10a<i>R</i>)-1,10,10-Trimethyl-2-(3,5-dimethoxyphenyl)-1,2,2a,4,10,10a-hexahydro-3<i>H</i>-cyclobuta[4,5]pyrano[3,2-<i>c</i>]quinolin-3-one (<b>11</b>)</h4><div class="NLM_p last">From flindersine (<b>2a</b>, 0.39 mmol) and (<i>E</i>)-1,3-dimethoxy-5-(prop-1-enyl)benzene (<b>4b</b>, 0.79 mmol). The residue was then partially purified by flash chromatography on neutral alumina using dichloromethane/chloroform (1:1) and then further purified by isocratic elution MeCN/H<sub>2</sub>O (60:40) (10 mg, 6%). <sup>1</sup>H NMR (CDCl<sub>3</sub>, 500 MHz) δ 1.23 (s, 6H), 1.57 (s, 3H), 2.32 (app t, <i>J</i> = 8.5 Hz, 1H), 2.55 (m, 1H), 3.41 (app t, <i>J</i> = 9.5 Hz, 1H), 3.45 (s, 3H), 3.91 (m, 1H), 6.14 (s, 2H), 6.17 (s, 1H), 7.14 (d, <i>J</i> = 8 Hz, 1H), 7.26 (app t, <i>J</i> = 7.5 Hz, 1H), 7.49 (app t, <i>J</i> = 8 Hz, 1H), 8.00 (d, <i>J</i> = 8 Hz, 1H), 10.25 (br s, 1H). <sup>13</sup>C NMR (CDCl<sub>3</sub>, 125 MHz) δ 20.64, 24.24, 25.09, 32.41, 35.12, 46.86, 50.63, 55.15, 77.95, 99.43, 106.55, 107.23, 115.95, 116.40, 122.77, 122.84, 130.79, 136.62, 142.17, 158.60, 160.22, 163.77. (+) LRMS (ESI) <i>m</i>/<i>z</i> 406 [M + H]<sup>+</sup>. HPLC (Betasil C18 150 × 4.6 mm, acetonitrile/water (70:30) at 1.5 mL/min) <i>t</i><sub>R</sub> = 3.459 min. HRMS (ESI): calcd for C<sub>25</sub>H<sub>27</sub>NO<sub>4</sub>Na [M + Na]<sup>+</sup>, 428.1832; found, 428.1837.</div></div><div id="sec6_4_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i68" class="anchor-spacer"></div><h4 class="article-section__title" id="_i68"> (1<i>R</i>,2<i>R</i>,2a<i>R</i>,10a<i>S</i>)-2-(3-Bromo-4-methoxyphenyl)-10,10,dimethyl-1-(1-methyl)-1,2,2a,4,10,10a-hexahydro-3<i>H</i>-cyclobuta[4,5]pyrano[3,2-<i>c</i>]quinolin-3-one and (1<i>S</i>,2<i>S</i>,2a<i>S</i>,10a<i>R</i>)-2-(3-Bromo-4-methoxyphenyl)-10,10,dimethyl-1-(1-methyl)-1,2,2a,4,10,10a-hexahydro-3<i>H</i>-cyclobuta[4,5]pyrano[3,2-<i>c</i>]quinolin-3-one (<b>12</b>)</h4><div class="NLM_p last">From <b>2a</b> (0.5 mmol) and <b>4c</b> (1.0 mmol). Purified by flash chromatography on neutral alumina (DCM, then 1:1 DCM/CHCl<sub>3</sub> then CHCl<sub>3</sub>). The fractions containing MH<sup>+</sup> 454/456 were combined and purified by reverse-phase HPLC with isocratic elution MeCN/H<sub>2</sub>O (2:3) over 60 min to afford 30.1 mg (13%). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 500 MHz) δ 1.10 (d, <i>J</i> = 6.5 Hz, 3H), 1.11 (s, 3H), 1.47 (s, 3H), 2.32 (m, 2H), 3.32 (dd, <i>J</i> = 9, 10 Hz, 1H), 3.69 (s, 3H), 3.63 (dd, <i>J</i> = 7.5, 8.5 Hz, 1H), 6.74 (d, <i>J</i> = 8 Hz, 1H), 6.80 (dd, <i>J</i> = 1.8, 8 Hz, 1H), 7.05 (d, <i>J</i> = 1.8 Hz, 1H), 7.12 (dd, <i>J</i> = 7.5 Hz, 1H), 7.13 (d, <i>J</i> = 7.5 Hz, 1H), 7.41 (dd, <i>J</i> = 7.5 Hz, 1H), 7.80 (d, <i>J</i> = 7.5 Hz, 1H), 11.04 (s, 1H). (+) LRMS (ESI) <i>m</i>/<i>z</i> 454 [M + H<sup>79</sup>Br]<sup>+</sup>, 456 [M + H<sup>81</sup>Br]<sup>+</sup>. HRMS (ESI): calcd for C<sub>24</sub>H<sub>25</sub>BrNO<sub>3</sub>Na [M + Na]<sup>+</sup>, 476.0832; found, 476.0831.</div></div><div id="sec6_4_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i69" class="anchor-spacer"></div><h4 class="article-section__title" id="_i69"> (1<i>R</i>,2<i>R</i>,2a<i>R</i>,10a<i>S</i>)-2-(2-Chloro-3,4-dimethoxyphenyl)-10,10,dimethyl-1-(1-methyl)-1,2,2a,4,10,10a-hexahydro-3<i>H</i>-cyclobuta[4,5]pyrano[3,2-<i>c</i>]quinolin-3-one and (1<i>S</i>,2<i>S</i>,2a<i>S</i>,10a<i>R</i>)-2-(2-Chloro-3,4-dimethoxyphenyl)-10,10,dimethyl-1-(1-methyl)-1,2,2a,4,10,10a-hexahydro-3<i>H</i>-cyclobuta[4,5]pyrano[3,2-<i>c</i>]quinolin-3-one (<b>13</b>)</h4><div class="NLM_p last">From flindersine (<b>2a</b>, 0.5 mmol) and <b>4d</b> (1.0 mmol). Purified by flash chromatography on neutral palumina (DCM, then 1:1 DCM/CHCl<sub>3</sub> then CHCl<sub>3</sub>). The fractions containing MH<sup>+</sup> 440 were combined and purified by reverse-phase HPLC with isocratic elution MeCN/H<sub>2</sub>O (2:3) over 60 min to give 20.4 mg (9%). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 500 MHz) δ 1.14 (d, <i>J</i> = 6.5 Hz, 3H), 1.15 (s, 3H), 1.49 (s, 3H), 2.36 (m, 2H), 3.36 (dd, <i>J</i> = 9, 10 Hz, 1H), 3.63 (s, 3H), 3.69 (dd, <i>J</i> = 7.5, 8.5 Hz, 1H), 3.73 (s, 3H), 6.34 (m, 1H), 7.16 (dd, <i>J</i> = 7.5 Hz, 1H), 7.16 (d, <i>J</i> = 7.5 Hz, 1H), 7.45 (dd, <i>J</i> = 7.5 Hz, 1H), 7.82 (d, <i>J</i> = 7.5 Hz, 1H), 11.04 (s, 1H). (+) LRMS (ESI) <i>m</i>/<i>z</i> 440 [M + H<sup>35</sup>Cl]<sup>+</sup>, 442 [M + H<sup>37</sup>Cl]<sup>+</sup> HRMS (ESI): calcd for C<sub>25</sub>H<sub>27</sub>ClNO<sub>4</sub>Na [M + Na]<sup>+</sup>, 462.1443; found, 462.1452.</div></div><div id="sec6_4_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i70" class="anchor-spacer"></div><h4 class="article-section__title" id="_i70"> (1<i>R</i>,2<i>R</i>,2a<i>R</i>,10a<i>S</i>)-1,10,10-Trimethyl-2-(phenyl)-1,2,2a,4,10,10a-hexahydro-3<i>H</i>-cyclobuta[4,5]pyrano[3,2-<i>c</i>]quinolin-3-one and (1<i>S</i>,2<i>S</i>,2a<i>S</i>,10a<i>R</i>)-1,10,10-Trimethyl-2-(phenyl)-1,2,2a,4,10,10a-hexahydro-3<i>H</i>-cyclobuta[4,5]pyrano[3,2-<i>c</i>]quinolin-3-one: (<b>14</b>)</h4><div class="NLM_p last">From <b>3</b> and (<i>E</i>)-prop-1-enylbenzene. Purified by isocratic elution MeOH/H<sub>2</sub>O (1% TFA, 7:3) to afford 20 mg (5%). <sup>1</sup>H NMR (CDCl<sub>3</sub>, 500 MHz) δ 1.24 (d, <i>J</i> = 6.5 Hz, 3H), 1.31 (s, 3H), 1.67 (s, 3H), 2.43 (t, <i>J</i> = 9 Hz, 1H), 2.59 (m, 1H), 3.50 (t, <i>J</i> = 11.5 Hz, 1H), 3.63 (s, 3H), 3.83 (t, <i>J</i> = 8.5 Hz, 1H), 6.77 (d, <i>J</i> = 7 Hz, 2H), 7.13 (t, <i>J</i> = 7 Hz, 2H), 7.18 (t, <i>J</i> = 7 Hz, 1H), 7.62 (t, <i>J</i> = 7.5 Hz, 1H), 7.82 (t, <i>J</i> = 7.5 Hz, 1H), 8.16 (d, <i>J</i> = 7.5 Hz, 1H), 8.25 (d, <i>J</i> = 7.5 Hz, 1H). <sup>13</sup>C NMR (CDCl<sub>3</sub>, 125 MHz) δ 19.8, 24.2 (2×), 24.2, 32.2, 34.0, 45.5, 58.8, 80.1, 103.2, 118.0, 120.6, 122.4, 126.5, 127.3, 127.4 (2×), 128.3 (2×), 133.2, 134.7, 137.9, 163.4. (+) LRMS (ESI) <i>m</i>/<i>z</i> 360 [M + H]<sup>+</sup>. HRMS (ESI): calcd for C<sub>24</sub>H<sub>26</sub>NO<sub>2</sub> [M + H]<sup>+</sup>, 360.1958; found, 360.1969. This compound (10 mg, 0.028 mmol) was dissolved in acetic acid (2 mL). Potassium iodide (9.4 mg, 0.056 mmol) was added, and the reaction mixture was heated at 50 °C for 20 h. The reaction mixture was extracted with a 10% NaHSO<sub>4</sub> solution and CHCl<sub>3</sub> (3 × 30 mL), dried with MgSO<sub>4</sub>, filtered, and concentrated to dryness to afford <b>14</b> (2.6 mg, 27%) as a white solid. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 500 MHz) δ 1.13 (d, <i>J</i> = 6 Hz, 3H), 1.14 (s, 3H), 1.50 (s, 3H), 2.36 (m, 2H), 2.46 (m, 1H), 3.39 (t, <i>J</i> = 8 Hz, 1H), 3.71 (t, <i>J</i> = 6.5 Hz, 1H), 6.89 (m, 2H), 7.02 (m, 3H), 7.12 (t, <i>J</i> = 7.5 Hz, 1H), 7.15 (t, <i>J</i> = 7.5 Hz, 1H), 7.42 (t, <i>J</i> = 7.5 Hz, 1H), 7.82 (d, <i>J</i> = 8 Hz, 1H). (+) LRMS (ESI) <i>m</i>/<i>z</i> 346 [M + H]<sup>+</sup>. HRMS (ESI): calcd for C<sub>23</sub>H<sub>24</sub>NO<sub>2</sub> [M + H]<sup>+</sup>, 346.1801; found, 346.1791.</div></div><div id="sec6_4_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i71" class="anchor-spacer"></div><h4 class="article-section__title" id="_i71"> (1<i>R</i>,2<i>R</i>,2a<i>R</i>,10a<i>S</i>)-1,10,10-Trimethyl-2-(4-methoxyphenyl)-1,2,2a,4,10,10a-hexahydro-3<i>H</i>-cyclobuta[4,5]pyrano[3,2-<i>c</i>]quinolin-3-one and (1<i>S</i>,2<i>S</i>,2a<i>S</i>,10a<i>R</i>)-1,10,10-Trimethyl-2-(4-methoxyphenyl)-1,2,2a,4,10,10a-hexahydro-3<i>H</i>-cyclobuta[4,5]pyrano[3,2-<i>c</i>]quinolin-3-one (<b>15</b>)</h4><div class="NLM_p last">From <b>3</b> (0.5 mmol) and <i>trans</i> anethole (1.0 mmol). Purified by isocratic elution MeCN/H<sub>2</sub>O (1% TFA, 55:45) (12.6 mg, 6%). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 500 MHz) δ 1.12 (d, <i>J</i> = 5.5 Hz, 3H), 1.15 (s, 3H), 1.52 (s, 3H), 2.37 (m, 1H), 2.43 (m, 1H), 3.28 (s, 3H), 3.40 (t, <i>J</i> = 9 Hz, 1H), 3.62 (s, 3H), 3.73 (t, <i>J</i> = 9 Hz, 1H), 6.58 (d, <i>J</i> = 8 Hz, 2H), 6.63 (d, <i>J</i> = 8 Hz, 2H), 7.36 (br t, <i>J</i> = 8 Hz, 1H), 7.57 (m, 2H), 8.02 (d, <i>J</i> = 8 Hz, 1H). (+) LRMS (ESI) <i>m</i>/<i>z</i> 390 [M + H]<sup>+</sup>. HRMS (ESI): calcd for C<sub>25</sub>H<sub>28</sub>NO<sub>3</sub> [M + H]<sup>+</sup>, 390.2064; found, 390.2080. This compound (6.4 mg, 0.016 mmol) was dissolved in acetic acid (2 mL). Potassium iodide (9.4 mg, 0.056 mmol) was added, and the reaction mixture was heated at 50 °C for 20 h. The reaction mixture was partitioned between a 10% NaHSO<sub>4</sub> solution and CHCl<sub>3</sub> (3 × 30 mL), and the organic layer was then extracted with aqueous ammonia solution (10%, 20 mL), dried with MgSO<sub>4</sub>, filtered, and concentrated to dryness to afford <b>15</b> (4.6 mg, 100%) as a white solid. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 500 MHz) δ 1.16 (d, <i>J</i> = 5.5 Hz, 3H), 1.17 (s, 3H), 1.53 (s, 3H), 2.37 (t, <i>J</i> = 9 Hz, 1H), 2.44 (m, 1H), 3.37(t, <i>J</i> = 9 Hz, 1H), 3.67 (s, 3H), 3.72 (t, <i>J</i> = 9 Hz, 1H), 6.63 (d, <i>J</i> = 8 Hz, 2H), 6.85 (d, <i>J</i> = 8 Hz, 2H), 7.18 (d, <i>J</i> = 8 Hz, 1H), 7.20 (t, <i>J</i> = 8 Hz, 1H), 7.47 (t, <i>J</i> = 6.5 Hz, 1H), 7.86 (d, <i>J</i> = 8 Hz, 1H), 11.02 (s, 1H). (+) LRMS (ESI) <i>m</i>/<i>z</i> 376 [M + H]<sup>+</sup>. HRMS (ESI): calcd for C<sub>24</sub>H<sub>25</sub>NO<sub>3</sub>Na [M + Na]<sup>+</sup>, 398.1727; found, 398.1727.</div></div><div id="sec6_4_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i72" class="anchor-spacer"></div><h4 class="article-section__title" id="_i72"> (1<i>R</i>,2<i>R</i>,2a<i>R</i>,10a<i>S</i>)-1,10,10-Trimethyl-2-(2,4,5-trimethoxyphenyl)-1,2,2a,4,10,10a-hexahydro-3<i>H</i>-cyclobuta[4,5]pyrano[3,2-<i>c</i>]quinolin-3-one and (1<i>S</i>,2<i>S</i>,2a<i>S</i>,10a<i>R</i>)-1,10,10-Trimethyl-2-(2,4,5-trimethoxyphenyl)-1,2,2a,4,10,10a-hexahydro-3<i>H</i>-cyclobuta[4,5]pyrano[3,2-<i>c</i>]quinolin-3-one (<b>16</b>)</h4><div class="NLM_p last">Two-hundred milligrams of flindersine (<b>2a</b>, 0.88 mmol) and α-asarone (1.66 mmol). Purified by isocratic elution MeCN/H<sub>2</sub>O (1% TFA, 55:45) (43.9 mg, 0.1 mmol, 12%). <sup>1</sup>H NMR (CDCl<sub>3</sub>, 500 MHz) δ 1.19 (d, <i>J</i> = 6.5 Hz, 3H), 1.25 (s, 3H), 1.58 (s, 3H), 2.33 (t, <i>J</i> = 8.5 Hz, 1H), 2.50 (m, 1H), 3.04 (s, 3H), 3.71 (s, 3H), 3.89 (s, 3H), 3.89 (m, 1H), 3.96 (dd, <i>J</i> = 8, Hz, 1H), 6.02 (s, 1H), 6.40 (s, 1H), 7.19 (d, <i>J</i> = 8 Hz, 1H), 7.28 (t, <i>J</i> = 8 Hz, 1H), 7.49 (t, <i>J</i> = 8 Hz, 1H), 8.03 (d, <i>J</i> = 8 Hz, 1H), 10.51 (br s, 1H). <sup>13</sup>C NMR (CDCl<sub>3</sub>, 125 MHz) δ 20.64, 24.12, 25.12, 32.10, 34.13, 41.64, 46.84, 56.03, 56.42, 57.73, 78.17, 78.17, 98.59, 107.19, 112.09, 116.27, 120.18, 122.70, 122.93, 130.77, 136.31, 142.53, 148.34, 153.09, 158.70, 163.58. (+) LRMS (ESI) <i>m</i>/<i>z</i> 436 [M + H]<sup>+</sup>. HRMS (ESI): calcd for C<sub>26</sub>H<sub>29</sub>NO<sub>5</sub> [M + H]<sup>+</sup>, 458.1938; found, 458.1928.</div></div><div id="sec6_4_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i73" class="anchor-spacer"></div><h4 class="article-section__title" id="_i73"> (1<i>R</i>,2<i>R</i>,2a<i>R</i>,10a<i>S</i>)-1,10,10-Trimethyl-2-(3-methoxy-4-benzyloxyphenyl)-1,2,2a,4,10,10a-hexahydro-3<i>H</i>-cyclobuta[4,5]pyrano[3,2-<i>c</i>]quinolin-3-one and (1<i>S</i>,2<i>S</i>,2a<i>S</i>,10a<i>R</i>)-1,10,10-Trimethyl-2-(3-methoxy-4-benzyloxyphenyl)-1,2,2a,4,10,10a-hexahydro-3<i>H</i>-cyclobuta[4,5]pyrano[3,2-<i>c</i>]quinolin-3-one (<b>17</b>)</h4><div class="NLM_p last">From flindersine (<b>2a</b>, 0.5 mmol) and isoeugenol benzylether (1.0 mmol). Purified by flash chromatography on neutral alumina (DCM, then 1:1 DCM/CHCl<sub>3</sub>, then CHCl<sub>3</sub>) and then reverse-phase HPLC with isocratic elution MeCN/H<sub>2</sub>O (1% TFA, 7:3) to afford 8.3 mg (3%). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 500 MHz) δ 1.10 (d, <i>J</i> = 6.5 Hz, 3H), 1.12 (s, 3H), 1.47 (s, 3H), 2.33 (m, 2H), 3.09 (m, 1H), 3.23 (s, 3H), 3.68 (t, <i>J</i> = 9 Hz, 1H), 4.90 s, 2H), 3.96 (dd, <i>J</i> = 8, Hz, 1H), 6.36 (s, 1H), 6.46 (d, <i>J</i> = 7.5 Hz, 1H), 6.70 (d, <i>J</i> = 7.5 Hz, 1H), 7.13 (m, 2H), 7.27–7.43 (m, 6H), 7.80 (d, <i>J</i> = 7.5 Hz, 1H), 11.02 (s, 1H). (+) LRMS (ESI) <i>m</i>/<i>z</i> 482 [M + H]<sup>+</sup>. HRMS (ESI): calcd for C<sub>31</sub>H<sub>31</sub>NO<sub>4</sub>Na [M + Na]<sup>+</sup>, 504.2145; found, 504.2129.</div></div><div id="sec6_4_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i74" class="anchor-spacer"></div><h4 class="article-section__title" id="_i74"> (1<i>R</i>,2<i>R</i>,2a<i>R</i>,10a<i>S</i>)-1,10,10-Trimethyl-2-(3-methoxy-4-hydroxyphenyl)-1,2,2a,4,10,10a-hexahydro-3<i>H</i>-cyclobuta[4,5]pyrano[3,2-<i>c</i>]quinolin-3-one and (1<i>S</i>,2<i>S</i>,2a<i>S</i>,10a<i>R</i>)-1,10,10-Trimethyl-2-(3-methoxy-4-hydroxyphenyl)-1,2,2a,4,10,10a-hexahydro-3<i>H</i>-cyclobuta[4,5]pyrano[3,2-<i>c</i>]quinolin-3-one (<b>18</b>)</h4><div class="NLM_p last"><b>17</b> (7 mg, 0.014 mmol) was dissolved in MeOH, and Pd/C (10%, 2 mg) was added. Hydrogen gas was bubbled through the reaction mixture for 20 min, and the resulting solution was stirred under an atmosphere of hydrogen for 20 h. Filtration through Celite and concentration afforded <b>18</b> as a white solid (5.4 mg, 100%). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 500 MHz) δ 1.10 (d, <i>J</i> = 6.5 Hz, 3H), 1.11 (s, 3H), 1.47 (s, 3H), 2.33 (m, 2H), 3.23 (m, 4H), 3.68 (t, <i>J</i> = 9 Hz, 1H), 6.26 (s, 1H), 6.32 (d, <i>J</i> = 7.5 Hz, 1H), 6.41 (d, <i>J</i> = 7.5 Hz, 1H), 7.13 (m, 2H), 7.41 (t, <i>J</i> = 7.5 Hz, 1H), 7.80 (d, <i>J</i> = 7.5 Hz, 1H), 10.99 (s, 1H). (+) LRMS (ESI) <i>m</i>/<i>z</i> 392 [M + H]<sup>+</sup>. HRMS (ESI): calcd for C<sub>24</sub>H<sub>25</sub>NO<sub>4</sub>Na [M + Na]<sup>+</sup>, 414.1676; found, 414.1665.</div></div><div id="sec6_4_13" class="NLM_sec NLM_sec_level_3"><div id="ac_i75" class="anchor-spacer"></div><h4 class="article-section__title" id="_i75"> (1<i>R</i>,2<i>R</i>,2a<i>R</i>,10a<i>S</i>)-1-Ethyl-10,10-trimethyl-2-(3,4,-dimethoxyphenyl)-1,2,2a,4,10,10a-hexahydro-3<i>H</i>-cyclobuta[4,5]pyrano[3,2-<i>c</i>]quinolin-3-one and 1<i>S</i>,2<i>S</i>,2a<i>S</i>,10a<i>R</i>)-1-Ethyl-10,10-trimethyl-2-(3,4,-dimethoxyphenyl)-1,2,2a,4,10,10a-hexahydro-3<i>H</i>-cyclobuta[4,5]pyrano[3,2-<i>c</i>]quinolin-3-one (<b>19</b>)</h4><div class="NLM_p last">From flindersine (<b>2a</b>, 0.5 mmol) and <b>4e</b> (1.0 mmol). Purified by flash chromatography on neutral alumina (DCM, then 1:1 DCM/CHCl<sub>3</sub>, then CHCl<sub>3</sub>). The fractions containing MH<sup>+</sup> 420 were combined and purified by reverse-phase HPLC with isocratic elution MeCN/H<sub>2</sub>O (3:2) to afford 12.2 mg (6%). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 500 MHz) δ 0.65 (t, <i>J</i> = 5.5 Hz, 3H), 1.12 (s, 3H), 1.46 (s, 3H), 1.49 (m, 3H), 1.68 (m, 1H), 2.28 (m, 1H), 2.36 (t, <i>J</i> = 9 Hz, 1H), 3.16 (s, 3H), 3.37 (t, <i>J</i> = 9 Hz, 1H), 3.60 (s, 3H), 3.65 (t, <i>J</i> = 9 Hz, 1H), 6.28 (br s, 1H), 6.48 (d, <i>J</i> = 8.5 Hz, 1H), 6.58 (d, <i>J</i> = 8.5 Hz, 1H), 7.12(m, 2H), 7.41 (t, <i>J</i> = 8 Hz, 1H), 7.80 (d, <i>J</i> = 8 Hz, 1H), 10.97 (s, 1H). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>, 150 MHz) δ 12.59, 24.55, 26.21, 29.41, 32.33, 41.79, 44.71, 48.05, 55.42, 56.81, 77.04, 109.01, 111.33, 112.31, 115.48, 115.65, 121.49, 121.90, 122.60, 130.8, 134.39, 137.97, 147.50, 148.59, 156.02, 162.57. (+) LRMS (ESI) <i>m</i>/<i>z</i> 420 [M + H]<sup>+</sup>. HRMS (ESI): calcd for C<sub>26</sub>H<sub>29</sub>NO<sub>4</sub>Na [M + Na]<sup>+</sup>, 442.1989; found, 442.1971.</div></div><div id="sec6_4_14" class="NLM_sec NLM_sec_level_3"><div id="ac_i76" class="anchor-spacer"></div><h4 class="article-section__title" id="_i76"> (1<i>R</i>,2<i>R</i>,2a<i>R</i>,10a<i>S</i>)-1-Ethyl-10,10-dimethyl-2-(2,3,4-trimethoxyphenyl)-1,2,2a,4,10,10a-hexahydro-3<i>H</i>-cyclobuta[4,5]pyrano[3,2-<i>c</i>]quinolin-3-one and (1<i>S</i>,2<i>S</i>,2a<i>S</i>,10a<i>R</i>)-1-Ethyl-10,10-dimethyl-2-(2,3,4-trimethoxyphenyl)-1,2,2a,4,10,10a-hexahydro-3<i>H</i>-cyclobuta[4,5]pyrano[3,2-<i>c</i>]quinolin-3-one (<b>20</b>)</h4><div class="NLM_p last">From flindersine (<b>2a</b>, 0.5 mmol) and <b>4f</b> (1.0 mmol). Purified by isocratic elution MeCN/H<sub>2</sub>O (60:40) (29.3 mg, 13%). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 600 MHz) δ 0.65 (t, <i>J</i> = 7.2 Hz, 3H), 1.12 (s, 3H), 1.45 (s, 3H), 1.49 (m, 1H), 1.65 (m, 1H), 2.27 (m, 1H), 2.36 (t, <i>J</i> = 9 Hz, 1H), 3.30 (s, 6H), 3.37 (t, <i>J</i> = 9 Hz, 1H), 3.51 (s, 3H), 3.66 (dd, <i>J</i> = 8, 9 Hz, 1H), 6.09 (s, 2H), 7.12(m, 2H), 7.41 (ddd, <i>J</i> = 1.2, 7.5, 8.4 Hz, 1H), 7.80 (dd, <i>J</i> = 1.2, 8.4 Hz, 1H), 11.02 (s, 1H). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>, 150 MHz) δ 12.4, 24.3, 25.8, 29.6, 32.4, 42.5, 44.5, 48.7, 56.1, 60.5, 77.6, 106.7, 107.5, 115.5, 115.6, 121.8, 122.7, 130.7, 136.8, 138.6, 139.1, 153.3, 156.0, 163.5. (+) LRMS (ESI) <i>m</i>/<i>z</i> 450 [M + H]<sup>+</sup>. HRMS (ESI): calcd for C<sub>27</sub>H<sub>32</sub>NO<sub>5</sub> [M + H]<sup>+</sup>, 450.2275; found, 450.2257.</div></div><div id="sec6_4_15" class="NLM_sec NLM_sec_level_3"><div id="ac_i77" class="anchor-spacer"></div><h4 class="article-section__title" id="_i77"> (1<i>R</i>,2<i>R</i>,2a<i>R</i>,10a<i>S</i>)-1-Ethyl-2-(3-fluoro-4-methoxyphenyl)-10,10-dimethyl-1,2,2a,4,10,10a-hexahydro-3<i>H</i>-cyclobuta[4,5]pyrano[3,2-<i>c</i>]quinolin-3-one and (1<i>R</i>,2<i>R</i>,2a<i>R</i>,10a<i>S</i>)-1-Ethyl-2-(3-fluoro-4-methoxyphenyl)-10,10-dimethyl-1,2,2a,4,10,10a-hexahydro-3<i>H</i>-cyclobuta[4,5]pyrano[3,2-<i>c</i>]quinolin-3-one (<b>21</b>)</h4><div class="NLM_p last">From flindersine (<b>2a</b>, 0.5 mmol) and <b>4g</b> (1.0 mmol). Purified by flash chromatography on neutral alumina (DCM, then 1:1 DCM/CHCl<sub>3</sub>, then CHCl<sub>3</sub>). The fractions containing MH<sup>+</sup> 408 were combined and purified by reverse-phase HPLC with isocratic elution MeCN/H<sub>2</sub>O (3:2) to MeCN over 60 min to afford 24 mg (12%). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 600 MHz) δ 0.65 (t, <i>J</i> = 8 Hz, 3H), 1.19 (s, 3H), 1.50 (s, 3H), 1.52 (m, 1H), 1.67 (m, 1H), 2.32 (m, 1H), 2.35 (m, 1H), 3.42 (t, <i>J</i> = 9 Hz, 1H), 3.64 (t, <i>J</i> = 9 Hz, 1H), 3.83 (s, 3H), 6.63 (d, <i>J</i> = 9.6 Hz, 1H), 6.67 (br d, <i>J =</i> 8 Hz, 1H), 6.78 (dd, <i>J</i> = 6, 8 Hz, 1H), 7.14 (d, <i>J</i> = 7.5 Hz, 1H), 7.15 (t, <i>J</i> = 7.5 Hz, 1H), 7.43 (t, <i>J</i> = 8 Hz, 1H), 11.01 (s, 1H). (+) LRMS (ESI) <i>m</i>/<i>z</i> 408 [M + H]<sup>+</sup>. HRMS (ESI): calcd for C<sub>25</sub>H<sub>26</sub>FNO<sub>3</sub>Na [M + Na]<sup>+</sup>, 430.1789; found, 430.1776.</div></div><div id="sec6_4_16" class="NLM_sec NLM_sec_level_3"><div id="ac_i78" class="anchor-spacer"></div><h4 class="article-section__title" id="_i78"> (1<i>R</i>,2<i>R</i>,2a<i>R</i>,10a<i>S</i>)-1,10,10-Trimethyl-2-(3,4,5-trimethoxyphenyl)-1,2,2a,4,10,10a-hexahydro-3<i>H</i>-cyclobuta[4,5]pyrano[3,2-<i>c</i>]quinolin-3-one and (1<i>S</i>,2<i>S</i>,2a<i>S</i>,10a<i>R</i>)-1,10,10-Trimethyl-2-(3,4,5-trimethoxyphenyl)-1,2,2a,4,10,10a-hexahydro-3<i>H</i>-cyclobuta[4,5]pyrano[3,2-<i>c</i>]quinolin-3-one (<b>22</b>)</h4><div class="NLM_p last">From flindersine (<b>2a</b>, 0.88 mmol) and <b>4h</b> (1.76 mmol). Purified by flash chromatography on neutral alumina (DCM, then 1:1 DCM/CHCl<sub>3</sub>, then CHCl<sub>3</sub>). The fractions containing MH<sup>+</sup> 464 were combined and purified by reverse-phase HPLC with isocratic elution MeCN/H<sub>2</sub>O (7:3) to afford 27.6 mg (12%). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 500 MHz) δ 0.73 (d, <i>J</i> = 6.5 Hz, 3H), 0.88 (d, <i>J</i> = 6.5 Hz, 3H), 1.15 (s, 3H), 1.49 (s, 3H), 1.80 (m, 1H), 2.33 (m, 2H), 3.31 (s, 6H), 3.52 (s, 3H), 3.52 (t, <i>J</i> = 9 Hz, 1H), 3.67 (t, <i>J</i> = 9 Hz, 1H), 6.12 (s, 2H), 7.13 (d, <i>J</i> = 7.5 Hz, 1H), 7.14 (d, <i>J</i> = 7.5 Hz, 1H), 7.43 (t, <i>J</i> = 7.5 Hz, 1H), 7.82 (d, <i>J</i> = 7.5 Hz, 1H), 11.00 (s, 1H). (+) LRMS (ESI) <i>m</i>/<i>z</i> 464 [M + H]<sup>+</sup>. HRMS (ESI): calcd for C<sub>28</sub>H<sub>33</sub>NO<sub>5</sub>Na [M + Na]<sup>+</sup>, 486.2251; found, 486.2236.</div></div><div id="sec6_4_17" class="NLM_sec NLM_sec_level_3"><div id="ac_i79" class="anchor-spacer"></div><h4 class="article-section__title" id="_i79"> (1<i>R</i>,2<i>R</i>,2a<i>R</i>,10a<i>S</i>)-2-(3-Chloro-4-methoxyphenyl)-10,10-dimethyl-1-(1-methylethyl)-1,2,2a,4,10,10a-hexahydro-3<i>H</i>-cyclobuta[4,5]pyrano[3,2-<i>c</i>]quinolin-3-one and (1<i>S</i>,2<i>S</i>,2a<i>S</i>,10a<i>R</i>)-2-(3-Chloro-4-methoxyphenyl)-10,10-dimethyl-1-(1-methylethyl)-1,2,2a,4,10,10a-hexahydro-3<i>H</i>-cyclobuta[4,5]pyrano[3,2-<i>c</i>]quinolin-3-one (<b>23</b>)</h4><div class="NLM_p last">From flindersine (<b>2a</b>, 0.88 mmol) and <b>4i</b> (1.76 mmol). Purified by reverse-phase HPLC with gradient elution MeCN/H<sub>2</sub>O (3:7) to MeCN over 60 min. Then repurified by flash chromatography (2% MeOH/DCM) to give 45 mg (11.7%) as a white solid. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 600 MHz) δ 0.68 (d, <i>J</i> = 6.8 Hz, 3H), 0.85 (d, <i>J</i> = 6.88 Hz, 3H), 1.12 (s, 3H), 1.48 (s, 3H), 1.80 (dd, <i>J</i> = 12.8, 6.5 Hz, 1H), 2.30–2.36 (m, 1H), 2.50 (m, 1H), 3.53 (t, <i>J</i> = 9.4 Hz, 1H), 3.61 (t, <i>J</i> = 8.8 Hz, 1H), 3.69 (s, 3H), 6.70–6.78 (m, 2H), 6.88 (d, <i>J</i> = 1.56 Hz, 1H), 7.10–7.16 (m, 2H), 7.42 (t, <i>J</i> = 7.50 Hz, 1H), 7.81 (d, <i>J</i> = 7.82 Hz, 1H), 11.00 (s, 1H). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>, 150 MHz) δ 17.16, 20.29, 22.42, 24.42, 29.73, 30.16, 39.31, 41.19, 44.20, 54.56, 75.43, 106.79, 110.07, 113.54, 119.78, 120.68, 126.23, 128.48, 128.65, 133.65, 136.22, 151.25, 154.70, 160.80. (+) LRMS (ESI) <i>m</i>/<i>z</i> 437.8 [M + H]<sup>+</sup>. HRMS (ESI): calcd for C<sub>26</sub>H<sub>28</sub>ClNO<sub>3</sub>Na [M + Na]<sup>+</sup>, 460.1650; found, 460.1657.</div></div><div id="sec6_4_18" class="NLM_sec NLM_sec_level_3"><div id="ac_i80" class="anchor-spacer"></div><h4 class="article-section__title" id="_i80"> (1<i>R</i>,2<i>R</i>,2a<i>R</i>,10a<i>S</i>)-2-(3-Chloromethyl-4-methoxyphenyl)-10,10-dimethyl-1-(1-methylethyl)-1,2,2a,4,10,10a-hexahydro-3<i>H</i>-cyclobuta[4,5]pyrano[3,2-<i>c</i>]quinolin-3-one and (1<i>S</i>,2<i>S</i>,2a<i>S</i>,10a<i>R</i>)-2-(3-Chloromethyl-4-methoxyphenyl)-10,10-dimethyl-1-(1-methylethyl)-1,2,2a,4,10,10a-hexahydro-3<i>H</i>-cyclobuta[4,5]pyrano[3,2-<i>c</i>]quinolin-3-one (<b>24</b>)</h4><div class="NLM_p last">From flindersine (<b>2a</b>, 0.44 mmol) and <b>4j</b> (0.88 mmol). Purified by reverse-phase HPLC with gradient elution MeCN/H<sub>2</sub>O + 1% TFA (3:7) to MeCN over 60 min. Then flash chromatography (DCM to 2% MeOH/DCM) to give 6.7 mg (3.4%) as a white solid. <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>) δ 0.68 (d, <i>J</i> = 6.9 Hz, 3H), 0.85 (d, <i>J</i> = 6.9 Hz, 3H), 1.13 (s, 3H), 1.49 (s, 3H), 1.81 (td, <i>J</i> = 13, 6.3 Hz, 1H), 2.36 (dd, <i>J</i> = 15.6, 9.4 Hz, 1H), 2.5 (m, 1H), 3.52 (t, <i>J</i> = 9.4 Hz, 1H), 3.58–3.64 (m, 1H), 3.69 (s, 3H), 4.30–4.38 (m, 2H), 6.6 (d, <i>J</i> = 0.5 Hz 1H), 6.80–6.86 (m, 2H), 7.08–7.16 (m, 2H), 7.40 (t, <i>J</i> = 7.7 Hz, 1H), 7.81 (d, <i>J</i> = 7.8 Hz, 1H), 10.94 (s, 1H). (+) LRMS (ESI) <i>m</i>/<i>z</i> 452.3 [M + H]<sup>+</sup>. HRMS (ESI): calcd for C<sub>27</sub>H<sub>30</sub>ClNO<sub>3</sub> [M + H]<sup>+</sup>, 452.1987; found, 452.2002.</div></div><div id="sec6_4_19" class="NLM_sec NLM_sec_level_3"><div id="ac_i81" class="anchor-spacer"></div><h4 class="article-section__title" id="_i81"> 5-[(1<i>R</i>,2<i>R</i>,2a<i>R</i>,10a<i>S</i>)-1-Isopropyl-10,10-dimethyl-3-oxo-2,2a,3,4,10,10<i>a-</i>hexahydro-1<i>H</i>-cyclobuta[4,5]pyrano[3,2,<i>-c</i>]quinolinyl]-2-methoxyphenylacetate and 5-[(1<i>S</i>,2<i>S</i>,2a<i>S</i>,10a<i>R</i>)-1-Isopropyl-10,10-dimethyl-3-oxo-2,2a,3,4,10,10<i>a-</i>hexahydro-1<i>H</i>-cyclobuta[4,5]pyrano[3,2,<i>-c</i>]quinolinyl]-2-methoxyphenylacetate (<b>25</b>)</h4><div class="NLM_p last">From flindersine (<b>2a</b>, 0.88 mmol) and <b>4k</b> (1.76 mmol). Purified by flash chromatography on neutral alumina (DCM, then 1:1 DCM/CHCl<sub>3</sub>, then CHCl<sub>3</sub>). The fractions containing MH<sup>+</sup> 462 were combined and purified by reverse-phase HPLC with gradient elution MeCN/H<sub>2</sub>O (5:95) to MeCN/H<sub>2</sub>O (2:3) over 60 min (18.6 mg, 4.6%). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 600 MHz) δ 0.68 (d, <i>J</i> = 6.5 Hz, 3H), 0.86 (d, <i>J</i> = 6.5 Hz, 3H), 1.11 (s, 3H), 1.46 (s, 3H), 1.79 (m, 1H), 2.01 (s, 3H), 2.22 (m, 1H), 2.31 (m, 1H), 3.50 (dd, <i>J</i> = 9.5, 10 Hz, 1H), 3.59 (s, 3H), 3.61 (dd, <i>J</i> = 9, 10 Hz, 1H), 6.53 (br s, 1H), 6.68 (m, 2H), 7.11 (m, 2H), 7.39 (d, <i>J</i> = 7.5 Hz, 1H), 7.78 (d, <i>J</i> = 8 Hz). (+) LRMS (ESI) <i>m</i>/<i>z</i> 462 [M + H]<sup>+</sup>. HRMS (ESI): calcd for C<sub>28</sub>H<sub>31</sub>NO<sub>5</sub> Na [M + Na]<sup>+</sup>, 484.2094; found, 484.2113.</div></div><div id="sec6_4_20" class="NLM_sec NLM_sec_level_3"><div id="ac_i82" class="anchor-spacer"></div><h4 class="article-section__title" id="_i82"> (1<i>R</i>,2<i>R</i>,2a<i>R</i>,10a<i>S</i>)-1-Isopropyl,10,10-dimethyl-2-(3,4,-dimethoxyphenyl)-1,2,2a,4,10,10a-hexahydro-3<i>H</i>-cyclobuta[4,5]pyrano[3,2-<i>c</i>]quinolin-3-one and (1<i>S</i>,2<i>S</i>,2a<i>S</i>,10a<i>R</i>)-1-Isopropyl,10,10-dimethyl-2-(3,4,-dimethoxyphenyl)-1,2,2a,4,10,10a-hexahydro-3<i>H</i>-cyclobuta[4,5]pyrano[3,2-<i>c</i>]quinolin-3-one (<b>26</b>)</h4><div class="NLM_p last">From flindersine (<b>2a</b>, 0.88 mmol) and <b>4l</b> (1.76 mmol). Purified by flash chromatography on neutral alumina (DCM, then 1:1 DCM/CHCl<sub>3</sub>, then CHCl<sub>3</sub>). The fractions containing MH<sup>+</sup> 434 were combined and purified by reverse-phase HPLC with isocratic elution MeCN/H<sub>2</sub>O (7:3) (14 mg, 6%). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 500 MHz) δ 0.68 (d, <i>J</i> = 6.5 Hz, 3H), 0.84 (d, <i>J</i> = 6.5 Hz, 3H), 1.12 (s, 3H), 1.47 (s, 3H), 1.79 (m, 1H), 2.32 (m, 2H), 3.12 (m, 3H), 3.49 (t, <i>J</i> = 9 Hz, 1H), 3.61 (s, 3H), 3.63 (t, <i>J</i> = 9 Hz, 1H), 6.26 (s, 1H), 6.49 (d, <i>J</i> = 7.5 Hz, 1H), 6.57 (d, <i>J</i> = 7.5 Hz, 1H), 7.13 (d, <i>J</i> = 7.5 Hz, 1H), 7.13 (d, <i>J</i> = 7.5 Hz, 1H), 7.41 (t, <i>J</i> = 7.5 Hz, 1H), 7.80 (d, <i>J</i> = 7.5 Hz, 1H), 10.95 (s, 1H). (+) LRMS (ESI) <i>m</i>/<i>z</i> 434 [M + H]<sup>+</sup>. HRMS (ESI): calcd for C<sub>27</sub>H<sub>31</sub>NO<sub>4</sub>Na [M + Na]<sup>+</sup>, 456.2145; found, 456.2140.</div></div><div id="sec6_4_21" class="NLM_sec NLM_sec_level_3"><div id="ac_i83" class="anchor-spacer"></div><h4 class="article-section__title" id="_i83"> (1<i>R</i>,2<i>R</i>,2a<i>R</i>,10a<i>S</i>)-2-[4-Methoxy-3-(oxobutanoicacid)phenyl]-10,10-dimethyl-1-(1-methylethyl)-1,2,2a,4,10,10a-hexahydro-3<i>H</i>-cyclobuta[4,5]pyrano[3,2-<i>c</i>]quinolin-3-one and (1<i>S</i>,2<i>S</i>,2a<i>S</i>,10a<i>R</i>)-2-[4-Methoxy-3-(oxobutanoicacid)phenyl]-10,10-dimethyl-1-(1-methylethyl)-1,2,2a,4,10,10a-hexahydro-3<i>H</i>-cyclobuta[4,5]pyrano[3,2-<i>c</i>]quinolin-3-one (<b>27</b>)</h4><div class="NLM_p last">From flindersine (<b>2a</b>, 0.55 mmol) and <b>5a</b> (1.1 mmol). Purified by flash chromatography (2% up to 5% MeOH/DCM). The resulting residue was repurified by reverse-phase HPLC with isocratic elution MeCN/H<sub>2</sub>O + 1% TFA (1:1) to give 1.6 mg (0.56%) of a tan solid. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 500 MHz) δ 0.69 (d, <i>J</i> = 6.9 Hz, 3H), 0.84 (d, <i>J</i> = 6.6 Hz, 3H), 1.10–1.12 (s, 3H), 1.47 (s, 3H), 1.77–1.82 (m, 1H), 2.30–2.36 (m, 1H), 2.41–2.46 (m, 2H), 2.49–2.51 (m, 1H), 2.58 (t, <i>J</i> = 6.9 Hz, 2H), 3.51 (t, <i>J</i> = 9.5 Hz, 1H), 3.58–3.64 (m, 4H), 6.57 (s, 1H), 6.64–6.70 (m, 2H), 7.09–7.14 (m, 2H), 7.40 (t, <i>J</i> = 7.6 Hz, 1H), 7.79 (d, <i>J</i> = 8.2 Hz, 1H), 10.96 (s, 1H). (+) LRMS (ESI) <i>m</i>/<i>z</i> 520.3 [M + H]<sup>+</sup>.</div></div><div id="sec6_4_22" class="NLM_sec NLM_sec_level_3"><div id="ac_i84" class="anchor-spacer"></div><h4 class="article-section__title" id="_i84"> (1<i>R</i>,2<i>R</i>,2a<i>R</i>,10a<i>S</i>)-1-Isopropyl-2-(4-ethoxy-3-methoxyphenyl)-10,10-dimethyl-1,2,2a,4,10,10a-hexahydro-3<i>H</i>-cyclobuta[4,5]pyrano[3,2-<i>c</i>]quinolin-3-one and (1<i>S</i>,2<i>S</i>,2a<i>S</i>,10a<i>R</i>)-1-Isopropyl-2-(4-ethoxy-3-methoxyphenyl)-10,10-dimethyl-1,2,2a,4,10,10a-hexahydro-3<i>H</i>-cyclobuta[4,5]pyrano[3,2-<i>c</i>]quinolin-3-one (<b>28</b>)</h4><div class="NLM_p last">From flindersine (<b>2a</b>, 0.5 mmol) and <b>4r</b> (1.0 mmol). Purified by flash chromatography on neutral alumina (DCM, then 1:1 DCM/CHCl<sub>3</sub>, then CHCl<sub>3</sub>). The fractions containing MH<sup>+</sup> 448 were combined and purified by reverse-phase HPLC with isocratic elution MeCN/H<sub>2</sub>O (2:3) over 60 min to afford 11 mg (5%). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 500 MHz) δ 0.71 (d, <i>J</i> = 6.5 Hz, 3H), 0.87 (d, <i>J</i> = 6.5 Hz, 1H), 1.15 (s, 3H), 1.25 (t, <i>J</i> = 6.5 Hz, 3H), 1.50 (s, 3H), 1.81 (m, 1H), 2.34 (m, 1H), 2.45 (m, 1H), 3.45 (m, 1H), 3.52 (t, <i>J</i> = 9 Hz, 1H), 3.63 (m, 1H), 3.84 (q, <i>J</i> = 6.5 Hz, 2H), 6.23 (d, <i>J</i> = 1.5 Hz, 1H), 6.43 (dd, <i>J</i> = 1.5, 7.5 Hz, 1H), 6.78 (d, <i>J</i> = 7.5 Hz, 1H), 7.16 (d, <i>J</i> = 7.5 Hz, 1H), 7.16 (d, <i>J</i> = 7.5 Hz, 1H), 7.43 (dd, <i>J</i> = 7.5 Hz, 1H), 7.83 (d, <i>J</i> = 7.5 Hz, 1H), 10.96 (s, 1H). (+) LRMS (ESI) <i>m</i>/<i>z</i> 448 [M + H]<sup>+</sup>.</div></div><div id="sec6_4_23" class="NLM_sec NLM_sec_level_3"><div id="ac_i85" class="anchor-spacer"></div><h4 class="article-section__title" id="_i85"> (1<i>S</i>,2<i>S</i>,2a<i>S</i>,10a<i>R</i>)-2-[4-Methoxy-3-(2-hydroxyethyl)phenyl]-10,10-dimethyl-1-(1-methylethyl)-1,2,2a,4,10,10a-hexahydro-3<i>H</i>-cyclobuta[4,5]pyrano[3,2-<i>c</i>]quinolin-3-one and (1<i>R</i>,2<i>R</i>,2a<i>R</i>,10a<i>S</i>)-2-[4-Methoxy-3-(2-hydroxyethyl)phenyl]-10,10-dimethyl-1-(1-methylethyl)-1,2,2a,4,10,10a-hexahydro-3<i>H</i>-cyclobuta[4,5]pyrano[3,2-<i>c</i>]quinolin-3-one (<b>29</b>)</h4><div class="NLM_p last">From flindersine (<b>2a</b>, 0.4 mmol) and <b>5d</b> (0.8 mmol). Purified by reverse-phase HPLC with gradient elution (3:7) MeCN/H<sub>2</sub>O + 1% TFA to (3:2) MeCN/H<sub>2</sub>O + 1%TFA over 60 min to give 32.4 mg (17%) of white solid. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 0.70 (d, <i>J</i> = 7 Hz, 3H), 0.85 (d, <i>J</i> = 7 Hz, 3H), 1.13 (s, 3H), 1.48 (s, 3H), 1.77–1.81 (m, 1H), 2.29–2.36 (m, 1H), 2.49–2.54 (m, 1H), 3.1–3.16 (m, 2H), 3.41–3.50 (m, 3H), 3.61– 3.64 (m, 5H), 6.31 (s, 1H), 6.47 (d, <i>J</i> = 8.5 Hz, 1H), 6.57 (d, <i>J</i> = 8.2 Hz, 1H), 7.10–7.15 (m, 2H), 7.41 (t, <i>J</i> = 7.4 Hz, 1H), 7.81 (d, <i>J</i> = 8.5 Hz, 1H), 10.94 (s, 1H). (+) LRMS (ESI) <i>m</i>/<i>z</i> 464.0 [M + H]<sup>+</sup></div></div><div id="sec6_4_24" class="NLM_sec NLM_sec_level_3"><div id="ac_i86" class="anchor-spacer"></div><h4 class="article-section__title" id="_i86"> (1<i>R</i>,2<i>R</i>,2a<i>R</i>,10a<i>S</i>)-2-[4-Methoxy-3-(3-hydroxypropyl)phenyl]-10,10-dimethyl-1-(1-cyclopropyl)-1,2,2a,4,10,10a-hexahydro-3<i>H</i>-cyclobuta[4,5]pyrano[3,2-<i>c</i>]quinolin-3-one and (1<i>S</i>,2<i>S</i>,2a<i>S</i>,10a<i>R</i>)-2-[4-Methoxy-3-(3-hydroxypropyl)phenyl]-10,10-dimethyl-1-(1-cyclopropyl)-1,2,2a,4,10,10a-hexahydro-3<i>H</i>-cyclobuta[4,5]pyrano[3,2-<i>c</i>]quinolin-3-one (<b>30</b>)</h4><div class="NLM_p last">From flindersine (<b>2a</b>, 0.88 mmol) and <b>5c</b> (1.76 mmol). Purified by reverse-phase HPLC with gradient elution (7:13) MeCN/H<sub>2</sub>O + 1% TFA to (13:7) MeCN/H<sub>2</sub>O + 1%TFA over 60 min. Resulting residue was repurified by flash chromatography (1:99 MeOH/DCM to 4:96 MeOH/DCM) to give 10.4 mg (2.5%) of a light yellow solid. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 0.01–0.05 (m, 2H), 0.26–0.36 (m, 2H), 0.90–0.94 (m, 1H), 1.14 (s, 3H), 1.47–1.57 (m, 5H), 2.06 (d, <i>J</i> = 8.5 Hz, 1H), 2.46 (t, <i>J</i> = 9 Hz, 1H), 3.10–3.12 (m, 1H), 3.25–3.28 (m, 1H), 3.36–3.41 (m, 1H), 3.49–3.52 (m, 1H), 3.60–3.62 (m, 4H), 4.36 (t, <i>J</i> = 5 Hz, 1H), 6.23 (s, 1H), 6.46 (d, <i>J</i> = 8 Hz, 1H), 6.59 (d, <i>J</i> = 8.2 Hz, 1H), 7.12–7.16 (m, 2H), 7.42 (t, <i>J</i> = 7.69 Hz, 1H), 7.81 (d, <i>J</i> = 7.96 Hz, 1H), 10.97 (s, 1H). (+) LRMS (ESI) <i>m</i>/<i>z</i> 476.0 [M + H]<sup>+</sup>. HRMS (ESI): calcd for C<sub>29</sub>H<sub>34</sub>NO<sub>5</sub> [M + H]<sup>+</sup>, 476.2432; found, 476.2424.</div></div><div id="sec6_4_25" class="NLM_sec NLM_sec_level_3"><div id="ac_i87" class="anchor-spacer"></div><h4 class="article-section__title" id="_i87"> (1<i>R</i>,2<i>R</i>,2a<i>R</i>,10a<i>S</i>)-2-(3,4-Dimethoxyphenyl)-10,10-dimethyl-1-(1-cyclopropyl)-1,2,2a,4,10,10a-hexahydro-3<i>H</i>-cyclobuta[4,5]pyrano[3,2<i>-c</i>]quinolin-3-one and (1<i>S</i>,2<i>S</i>,2a<i>S</i>,10a<i>R</i>)-2-(3,4-Dimethoxyphenyl)-10,10-dimethyl-1-(1-cyclopropyl)-1,2,2a,4,10,10a-hexahydro-3<i>H</i>-cyclobuta[4,5]pyrano[3,2<i>-c</i>]quinolin-3-one (<b>31</b>)</h4><div class="NLM_p last">From flindersine (<b>2a</b>, 0.88 mmol) and <b>4t</b> (1.76 mmol). Purified by reverse-phase HPLC with isocratic elution MeCN/H<sub>2</sub>O + 1% TFA (53:47) and then flash chromatography (1% up to 3% MeOH/DCM) to give 11.9 mg (3.1%) as a white solid. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6,</sub> 500 MHz) δ 0.01–0.08 (m, 2H), 0.25–0.30 (m, 1H), 0.33–0.39 (m, 1H), 0.89–0.96 (m, 1H), 1.14 (s, 3H), 1.53 (s, 3H), 2.06–2.12 (m, 1H), 2.47 (t, <i>J</i> = 8.8 Hz, 1H), 3.19 (s, 3H), 3.35–3.41 (m, 1H), 3.60–3.65 (m, 4H), 6.27 (d, <i>J</i> = 1.7 Hz, 1H), 6.45 (dd, <i>J</i> = 8.2, 1.7 Hz, 1H), 6.59 (d, <i>J</i> = 8.2 Hz, 1H), 7.11–7.15 (m, 2H), 7.39–7.44 (m, 1H), 7.81 (d, <i>J</i> = 8.2 Hz, 1H), 10.99 (s, 1H). (+) LRMS (ESI) <i>m</i>/<i>z</i> 431.8 [M + H]<sup>+</sup>. HRMS (ESI): calcd for C<sub>27</sub>H<sub>29</sub>NO<sub>4</sub>Na [M + Na]<sup>+</sup>, 454.1989; found, 454.1986.</div></div><div id="sec6_4_26" class="NLM_sec NLM_sec_level_3"><div id="ac_i88" class="anchor-spacer"></div><h4 class="article-section__title" id="_i88"> (1<i>R</i>,2<i>R</i>,2a<i>R</i>,10a<i>S</i>)-2-(3,4,5-Trimethoxyphenyl)-10,10-dimethyl-1-(1-cyclopropyl)-1,2,2a,4,10,10a-hexahydro-3<i>H</i>-cyclobuta[4,5]pyrano[3,2<i>-c</i>]quinolin-3-one and (1<i>S</i>,2<i>S</i>,2a<i>S</i>,10a<i>R</i>)-2-(3,4,5-Trimethoxyphenyl)-10,10-dimethyl-1-(1-cyclopropyl)-1,2,2a,4,10,10a-hexahydro-3<i>H</i>-cyclobuta[4,5]pyrano[3,2<i>-c</i>]quinolin-3-one (<b>32</b>)</h4><div class="NLM_p last">From flindersine (<b>2a</b>, 0.88 mmol) and <b>4s</b> (1.76 mmol). Purified by reverse-phase HPLC isocratic elution MeCN/ H<sub>2</sub>O + 1% TFA (1:1) over 60 min. Then flash chromatography (0% up to 2% MeOH/DCM) to give 8.8 mg (2.2%) as a white solid. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6,</sub> 500 MHz) δ 0.03–0.12 (m, 2H), 0.28–0.40 (m, 2H), 0.90–0.97 (m, 1H), 1.15 (s, 3H), 1.53 (s, 3H), 2.09 (q, <i>J</i> = 8.9 Hz, 1 H) 2.45–2.49 (m, 1H), 3.35–3.41 (m, 1H), 3.53 (s, 3H), 3.64 (t, <i>J</i> = 8.5 Hz, 1 H) 6.08 (s, 2H), 7.11–7.16 (m, 2H), 7.42 (t, <i>J</i> = 7.6 Hz, 1H), 7.81 (d, <i>J</i> = 8 Hz, 1H), 11.03 (s, 1H). (+) LRMS (ESI) <i>m</i>/<i>z</i> 461.6 [M + H]<sup>+</sup>. HRMS (ESI): calcd for C<sub>28</sub>H<sub>31</sub>NO<sub>5</sub>Na [Na]<sup>+</sup>, 484.2094; found, 484.2085.</div></div><div id="sec6_4_27" class="NLM_sec NLM_sec_level_3"><div id="ac_i89" class="anchor-spacer"></div><h4 class="article-section__title" id="_i89"> (1<i>R</i>,2<i>R</i>,2a<i>R</i>,10a<i>S</i>)-2-(4-Methoxy-3-(2-morpholine-4-ylpropoxy)phenyl)-10,10,6-trimethyl-1-(1-cyclopropyl)-1,2,2a,4,10,10a-hexahydro-3<i>H</i>-cyclobuta[4,5]pyrano[3,2-<i>c</i>]quinolin-3-one and (1<i>S</i>,2<i>S</i>,2a<i>S</i>,10a<i>R</i>)-2-(4-Methoxy-3-(2-morpholine-4-ylpropoxy)phenyl)-10,10,6-trimethyl-1-(1-cyclopropyl)-1,2,2a,4,10,10a-hexahydro-3<i>H</i>-cyclobuta[4,5]pyrano[3,2-<i>c</i>]quinolin-3-one (<b>33</b>)</h4><div class="NLM_p last">From flindersine (<b>2a</b>, 0.5 mmol) and <b>5b</b> (1.0 mmol). Purified by flash chromatography on neutral alumina (DCM, then 1:1 DCM/CHCl<sub>3</sub>, then CHCl<sub>3</sub>). The fractions containing MH<sup>+</sup> 545 were combined and purified by reverse-phase HPLC with XBridge gradient elution MeCN/H<sub>2</sub>O (10 mM NH<sub>4</sub>OAc) 95:5 to MeCN over 60 min to afford 5.8 mg (2%). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 500 MHz) δ 0.02 (m, 2H), 0.27 (m, 1H), 0.35 (m, 1H), 0.92 (m, 1H), 1.13 (s, 3H), 1.53 (s, 3H), 2.07 (m, 3H), 2.47 (m, 1H), 2.54 (m, 6H), 3.60 (m, 5H), 3.62 (s, 3H), 3.98 (m, 2H), 6.46 (d, <i>J</i> = 1.5 Hz), 6.47 (dd, <i>J</i> = 1.5, 8 Hz, 1H), 6.60 (d, <i>J</i> = 8.5 Hz, 1H), 7.12 (d, <i>J</i> = 8 Hz, 1H), 7.13 (dd, <i>J</i> = 7.5, 8 Hz, 1H), 7.42 (dd, <i>J</i> = 7.5, 8.5 Hz, 1H), 7.57 (dd, <i>J</i> = 7.5, 8.5 Hz, 1H), 7.93 (d, <i>J</i> = 8 Hz, 1H). (+) LRMS (ESI) <i>m</i>/<i>z</i> 545 [M + H]<sup>+</sup>. HRMS (ESI): calcd for C<sub>33</sub>H<sub>41</sub>N<sub>2</sub>O<sub>5</sub> [M + H]<sup>+</sup>, 545.3010; found, 545.3010.</div></div><div id="sec6_4_28" class="NLM_sec NLM_sec_level_3"><div id="ac_i90" class="anchor-spacer"></div><h4 class="article-section__title" id="_i90"> (1<i>R</i>,2<i>R</i>,2a<i>R</i>,10a<i>S</i>)-1-Cyclopentyl-2-(3,4-dimethoxyphenyl)-10,10-dimethyl-1,2,2a,4,10,10a-hexahydro-3<i>H</i>-cyclobuta[4,5]pyrano[3,2-<i>c</i>]quinolin-3-one and (1<i>S</i>,2<i>S</i>,2a<i>S</i>,10a<i>R</i>)-1-Cyclopentyl-2-(3,4-dimethoxyphenyl)-10,10-dimethyl-1,2,2a,4,10,10a-hexahydro-3<i>H</i>-cyclobuta[4,5]pyrano[3,2-<i>c</i>]quinolin-3-one (<b>34</b>)</h4><div class="NLM_p last">From flindersine (<b>2a</b>, 0.50 mmol) and <b>4p</b> (1.0 mmol). Purified by reverse-phase HPLC with isocratic elution MeCN/H<sub>2</sub>O (3:2) (19.4 mg, 8.5%). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 600 MHz) δ 0.89 (m, 1H), 1.11 (m, 1H), 1.55 (m, 2H), 1.44 (m, 4H), 1.12 (s, 3H), 1.49 (s, 3H), 1.97 (m, 1H), 2.41 (m, 1H), 2.42 (m, 1H), 3.12 (s, 3H), 3.48 (m, 1H), 3.60 (s, 3H), 3.64 (t, <i>J</i> = 9 Hz, 1H), 6.25 (br s, 1H), 6.48 (dd, <i>J</i> = 1.5, 8.4 Hz, 1H), 6.57 (d, <i>J</i> = 8.4 Hz, 1H), 7.13 (t, <i>J</i> = 8 Hz, 1H), 7.14 (d, <i>J</i> = 8 Hz, 1H), 7.42 (t, <i>J</i> = 8.4 Hz, 1H), 7.81 (d, <i>J</i> = 8.4 Hz, 1H), 10.95 (s, 1H). <sup>13</sup>C NMR (CDCl<sub>3</sub>, 150 MHz) δ 24.2, 25.2, 26.2, 29.1, 31.5, 32.1, 40.5, 44.0, 45.2, 45.6, 55.0, 55.8, 78.1, 109.5, 111.1, 112.0, 115.3, 115.8, 121.5, 121.7, 122.5, 130.5, 135.9, 138.4, 147.6, 148.3, 155.8, 162.7. (+) LRMS (ESI) <i>m</i>/<i>z</i> 460 [M + H]<sup>+</sup>. HRMS (ESI): calcd for C<sub>29</sub>H<sub>33</sub>NO<sub>4</sub>Na [M + Na]<sup>+</sup>, 482.2302; found, 482.2322.</div></div><div id="sec6_4_29" class="NLM_sec NLM_sec_level_3"><div id="ac_i91" class="anchor-spacer"></div><h4 class="article-section__title" id="_i91"> (1<i>R</i>,2<i>R</i>,2a<i>R</i>,10a<i>S</i>)-2-(3,4,5-Trimethoxyphenyl)-10,10-dimethyl-1-(1-cyclopentyl)-1,2,2a,4,10,10a-hexahydro-3<i>H</i>-cyclobuta[4,5]pyrano[3,2-<i>c</i>]quinolin-3-one and (1<i>S</i>,2<i>S</i>,2a<i>S</i>,10a<i>R</i>)-2-(3,4,5-Trimethoxyphenyl)-10,10-dimethyl-1-(1-cyclopentyl)-1,2,2a,4,10,10a-hexahydro-3<i>H</i>-cyclobuta[4,5]pyrano[3,2-<i>c</i>]quinolin-3-one (<b>35</b>)</h4><div class="NLM_p last">From flindersine (<b>2a</b>, 0.88 mmol) and <b>4q</b> (1.76 mmol). Purified by reverse-phase HPLC with isocratic elution MeCN/H<sub>2</sub>O (1:1) over 60 min. Then flash chromatography (DCM to 2% MeOH/DCM) to give 1 mg (0.23%) as a white solid. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6,</sub> 500 MHz) δ 1.12–1.19 (m, 5H), 1.39–1.48 (m, 4H), 1.51 (s, 3H), 1.56–1.63 (m, 2H), 1.95–2.01 (m, 1H), 2.37–2.51 (m, 2H), 3.29–3.41 (m, 6H), 3.49–3.53 (m, 4H), 3.68 (t, <i>J</i> = 8.7 Hz, 1H), 6.10 (s, 2H), 7.11–7.15 (m, 2H), 7.41–7.43 (m, 1H), 7.81 (d, <i>J</i> = 8 Hz, 1 H) 11.00 (s, 1H). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>, 150 MHz) δ 23.18, 24.18, 24.34, 25.31, 30.91, 39.51, 43.64, 44.71, 44.85, 54.76, 59.56, 76.08, 105.36, 108.24, 114.26, 114.64, 120.55, 121.38, 129.52, 135.49, 137.30, 137.63, 151.30, 155.14, 161.83. (+) LRMS (ESI) <i>m</i>/<i>z</i> 490.3 [M + H]<sup>+</sup>. HRMS (ESI): calcd for C<sub>30</sub>H<sub>35</sub>NO<sub>5</sub>Na [M + Na]<sup>+</sup>, 512.2407; found, 512.2426.</div></div><div id="sec6_4_30" class="NLM_sec NLM_sec_level_3"><div id="ac_i92" class="anchor-spacer"></div><h4 class="article-section__title" id="_i92"> (1<i>R</i>,2<i>R</i>,2a<i>R</i>,10a<i>S</i>)-1-Butyl,10,10-trimethyl-2-(3,4,5-trimethoxyphenyl)-1,2,2a,4,10,10a-hexahydro-3<i>H</i>-cyclobuta[4,5]pyrano[3,2-<i>c</i>]quinolin-3-one and (1<i>S</i>,2<i>S</i>,2a<i>S</i>,10a<i>R</i>)-1-Butyl,10,10-trimethyl-2-(3,4,5-trimethoxyphenyl)-1,2,2a,4,10,10a-hexahydro-3<i>H</i>-cyclobuta[4,5]pyrano[3,2-<i>c</i>]quinolin-3-one (<b>36</b>)</h4><div class="NLM_p last">From flindersine (<b>2a</b>, 0.5 mmol) and <b>4n</b> (1.0 mmol). Purified by isocratic elution MeCN/H<sub>2</sub>O (60:40) (34 mg, 14%). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 600 MHz) δ 0.72 (t, <i>J</i> = 7 Hz, 3H), 0.99 (m, 1H), 1.06 (m, 1H), 1.13 (s, 3H), 1.14 (m, 2H), 1.48 (s, 3H), 1.52 (m, 1H), 1.64 (m, 1H), 2.32 (m, 1H), 2.38 (t, <i>J</i> = 9 Hz, 1H), 3.31 (s, 6H), 3.39 (t, <i>J</i> = 9 Hz, 1H), 3.53 (s, 3H), 3.69 (t, <i>J</i> = 9 Hz, 1H), 6.11 (d, <i>J</i> = 8 Hz, 2H), 7.12 (d, <i>J</i> = 7.5 Hz, 1H), 7.13 (t, <i>J</i> = 7.5 Hz, 1H), 7.43 (t, <i>J</i> = 7.5 Hz, 1H), 7.83 (d, <i>J</i> = 8 Hz, 1H), 11.03 (s, 1H). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>, 150 MHz) δ 14.60, 22.69, 24.38, 25.50, 29.23, 32.20, 36.62, 40.45, 44.75, 49.08, 55.94, 60.40, 77.19, 106.32, 108.78, 115.46, 115.52, 121.79, 122.61, 130.48, 136.36, 137.60, 137.69, 152.20, 156.16, 162.76. (+) LRMS (ESI) <i>m</i>/<i>z</i> 478 [M + H]<sup>+</sup>. HRMS (ESI): calcd for C<sub>29</sub>H<sub>36</sub>NO<sub>5</sub> [M + H]<sup>+</sup>, 478.2588; found, 478.2596.</div></div><div id="sec6_4_31" class="NLM_sec NLM_sec_level_3"><div id="ac_i93" class="anchor-spacer"></div><h4 class="article-section__title" id="_i93"> (1<i>R</i>,2<i>R</i>,2a<i>R</i>,10a<i>S</i>)-1-Butyl,10,10-trimethyl-2-(3,4,-dimethoxyphenyl)-1,2,2a,4,10,10a-hexahydro-3<i>H</i>-cyclobuta[4,5]pyrano[3,2-<i>c</i>]quinolin-3-one and (1<i>S</i>,2<i>S</i>,2a<i>S</i>,10a<i>R</i>)-1-Butyl,10,10-trimethyl-2-(3,4,-dimethoxyphenyl)-1,2,2a,4,10,10a-hexahydro-3<i>H</i>-cyclobuta[4,5]pyrano[3,2-<i>c</i>]quinolin-3-one (<b>37</b>)</h4><div class="NLM_p last">From flindersine (<b>2a</b>, 0.5 mmol) and <b>4o</b> (1.0 mmol). Purified by flash chromatography on neutral alumina (DCM, then 1:1 DCM/CHCl<sub>3</sub>, then CHCl<sub>3</sub>). The fractions containing MH<sup>+</sup> 448 were combined and purified by reverse-phase HPLC with isocratic elution MeCN/H<sub>2</sub>O (7:3) (13.2 mg, 7%). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 500 MHz) δ 0.69 (t, <i>J</i> = 7 Hz, 3H), 0.94 (m, 1H), 0.99 (m, 1H), 1.11 (s, 3H), 1.11 (m, 2H), 1.48 (s, 3H), 1.49 (m, 1H), 1.63 (m, 1H), 2.34 (m, 2H), 3.14 (s, 3H), 3.36 (t, <i>J</i> = 9 Hz, 1H), 3.60 (s, 3H), 3.65 (t, <i>J</i> = 9 Hz, 1H), 6.26 (s, 1H), 6.48 (d, <i>J</i> = 7.5 Hz, 1H), 6.58 (d, <i>J</i> = 7.5 Hz, 1H), 7.12(d, <i>J</i> = 7.5 Hz, 1H), 7.13 (t, <i>J</i> = 7.5 Hz, 1H), 7.41 (t, <i>J</i> = 7.5 Hz, 1H), 7.81 (d, <i>J</i> = 8 Hz, 1H), 10.97 (s, 1H). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>, 150 MHz) δ 13.54, 21.56, 23.23, 24.60, 28.31, 35.36, 31.17, 39.23, 43.81, 47.65, 53.92, 54.92, 76.36, 107.98, 110.06, 111.08, 114.47, 114.49, 120.42, 120.72, 121.54, 129.54, 133.42, 137.11, 146.63, 146.98, 155.30, 161.43. (+) LRMS (ESI) <i>m</i>/<i>z</i> 448 [M + H]<sup>+</sup>. HRMS (ESI): calcd for C<sub>28</sub>H<sub>33</sub>NO<sub>4</sub>Na [M + Na]<sup>+</sup>, 470.2302; found, 458.2289.</div></div><div id="sec6_4_32" class="NLM_sec NLM_sec_level_3"><div id="ac_i94" class="anchor-spacer"></div><h4 class="article-section__title" id="_i94"> (1<i>R</i>,2<i>R</i>,2a<i>R</i>,10a<i>S</i>)-1-Ethanone-2-(3,4-dimethoxyphenyl)-10,10-dimethyl-1,2,2a,4,10,10a-hexahydro-3<i>H</i>-cyclobuta[4,5]pyrano[3,2-<i>c</i>]quinolin-3-one and (1<i>S</i>,2<i>S</i>,2a<i>S</i>,10a<i>R</i>)-1-Ethanone-2-(3,4-dimethoxyphenyl)-10,10-dimethyl-1,2,2a,4,10,10a-hexahydro-3<i>H</i>-cyclobuta[4,5]pyrano[3,2-<i>c</i>]quinolin-3-one (<b>38</b>)</h4><div class="NLM_p last">From flindersine (<b>2a</b>, 0.5 mmol) and (<i>E</i>)-4-(3,4-dimethoxyphenyl)but-3-en-2-one (1.0 mmol). Purified by flash chromatography on neutral alumina (DCM, then 1:1 DCM/CHCl<sub>3</sub>, then CHCl<sub>3</sub>). The fractions containing MH<sup>+</sup> 434 were combined and purified by reverse-phase HPLC with gradient elution MeCN/H<sub>2</sub>O (3:7) to MeCN over 60 min to give 12.3 mg (6%). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 500 MHz) δ 0.73 (d, <i>J</i> = 6.5 Hz, 3H), 0.88 (d, <i>J</i> = 6.5 Hz, 3H), 1.15 (s, 3H), 1.49 (s, 3H), 1.86 (m, 3H), 2.98 (dd, <i>J</i> = 9 Hz, 1H), 3.23 (s, 3H), 3.31 (m, 1H), 3.41 (dd, <i>J</i> = 10.5 Hz, 1H), 3.66 (s, 3H), 3.74 (dd, <i>J</i> = 10 Hz, 1H), 6.44 (d, <i>J</i> = 1.5 Hz, 1H), 6.62 (dd, <i>J</i> = 1.5, 8.5 Hz, 1H), 6.67 (d, <i>J</i> = 8.5 Hz, 1H), 7.16 (d, <i>J</i> = 7.5 Hz, 1H), 7.17 (dd, <i>J</i> = 7.5 Hz, 1H), 7.46 (dd, <i>J</i> = 7.5 Hz, 1H), 7.84 (d, <i>J</i> = 7.5 Hz, 1H), 11.07 (s, 1H). (+) LRMS (ESI) <i>m</i>/<i>z</i> 434 [M + H]<sup>+</sup>. HRMS (ESI): calcd for C<sub>26</sub>H<sub>27</sub>NO<sub>5</sub> [M + H]<sup>+</sup>, 434.1962; found, 434.1942.</div></div><div id="sec6_4_33" class="NLM_sec NLM_sec_level_3"><div id="ac_i95" class="anchor-spacer"></div><h4 class="article-section__title" id="_i95"> (1<i>R</i>,2<i>R</i>,2a<i>R</i>,10a<i>S</i>)-1-Cyclopropylmethanone-2-(3,4-dimethoxyphenyl)-10,10-dimethyl-1,2,2a,4,10,10a-hexahydro-3<i>H</i>-cyclobuta[4,5]pyrano[3,2-<i>c</i>]quinolin-3-one and (1<i>S</i>,2<i>S</i>,2a<i>S</i>,10a<i>R</i>)-1-Cyclopropylmethanone-2-(3,4-dimethoxyphenyl)-10,10-dimethyl-1,2,2a,4,10,10a-hexahydro-3<i>H</i>-cyclobuta[4,5]pyrano[3,2-<i>c</i>]quinolin-3-one (<b>39</b>)</h4><div class="NLM_p last">From flindersine (<b>2a</b>, 0.5 mmol) and (<i>E</i>)-1-cyclopropyl-3-(3,4-dimethoxyphenyl)prop-2-en-1-one (1.76 mmol). Purified by flash chromatography on neutral alumina (DCM, then 1:1 DCM/CHCl<sub>3</sub>, then CHCl<sub>3</sub>). The fractions containing MH<sup>+</sup> 460 were combined and purified by reverse-phase HPLC with gradient elution MeCN/H<sub>2</sub>O (3:7) to MeCN over 60 min to give 24.6 mg (11%). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 600 MHz) δ 0.75 (m, 4H), 1.16 (s, 3H), 1.36 (s, 3H), 1.67 (m, 1H), 2.98 (dd, <i>J</i> = 8.4, 9.5 Hz, 1H), 3.20 (s, 3H), 3.52 (dd, <i>J</i> = 8.4, 9.6 Hz, 1H), 3.61 (s, 3H), 3.64 (dd, <i>J</i> = 8.4, 9.5 Hz, 1H), 3.77 (dd, <i>J</i> = 8.4, 9 Hz, 1H), 6.44 (br s, 1H), 6.59 (br d, <i>J</i> = 8.4 Hz, 1H), 6.63 (d, <i>J</i> = 8.4 Hz, 1H), 7.14 (d, <i>J</i> = 7.8 Hz, 1H), 7.14 (dd, <i>J</i> = 7.8 Hz, 1H), 7.43 (dd, <i>J</i> = 7.5 Hz, 1H), 7.82 (d, <i>J</i> = 7.5 Hz, 1H), 11.06 (s, 1H). <sup>13</sup>C NMR (CDCl<sub>3</sub>, 150 MHz) δ 11.01, 19.73, 23.54, 25.35, 31.94, 40.41, 46.01, 50.79, 55.19, 55.91, 76.74, 108.25, 111.31, 111.95, 115.42, 115.66, 121.32, 121.68, 122.72, 130.72, 132.36, 138.25, 148.08, 148.28, 156.74, 162.87, 210.44. (+) LRMS (ESI) <i>m</i>/<i>z</i> 460 [M + H]<sup>+</sup>. HRMS (ESI): calcd for C<sub>28</sub>H<sub>29</sub>NO<sub>5</sub>Na [M + Na]<sup>+</sup>, 482.1938; found, 482.1947.</div></div><div id="sec6_4_34" class="NLM_sec NLM_sec_level_3"><div id="ac_i96" class="anchor-spacer"></div><h4 class="article-section__title" id="_i96"> (1<i>R</i>,2<i>R</i>,2a<i>R</i>,10a<i>S</i>)-1-Carbomethoxy-10,10-dimethyl-2-(3,4,5-trimethoxyphenyl)-1,2,2a,4,10,10a-hexahydro-3<i>H</i>-cyclobuta[4,5]pyrano[3,2-<i>c</i>]quinolin-3-one and (1<i>S</i>,2<i>S</i>,2a<i>S</i>,10a<i>R</i>)-1-Carbomethoxy-10,10-dimethyl-2-(3,4,5-trimethoxyphenyl)-1,2,2a,4,10,10a-hexahydro-3<i>H</i>-cyclobuta[4,5]pyrano[3,2-<i>c</i>]quinolin-3-one (<b>40</b>)</h4><div class="NLM_p last">From flindersine (<b>2a</b>, 0.5 mmol) and (<i>E</i>)-methyl-3-(3,4,5-trimethoxyphenyl)acrylate (1.0 mmol). Purified by gradient elution MeCN/H<sub>2</sub>O (1% TFA, 3:7 for 45 min then gradient elution to 75:25 over 25 min) to afford a white solid (5.4 mg, 2.2%). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 500 MHz) δ 1.18 (s, 3H), 1.46 (s, 3H), 3.02 (t, <i>J</i> = 8.5 Hz, 1H), 3.20 (t, <i>J</i> = 8.5 Hz, 1H), 3.37 (s, 6H), 3.54 (s, 3H), 3.62 (s, 3H), 3.76 (t, <i>J</i> = 8 Hz, 1H), 3.95 (t, <i>J</i> = 9 Hz, 1H), 6.19 (s, 2H), 7.13 (m, 2H), 7.46 (t, <i>J</i> = 7.5 Hz, 1H), 7.84 (d, <i>J</i> = 8 Hz, 1H), 11.14 (s, 1H). (+) LRMS (ESI) <i>m</i>/<i>z</i> 480 [M + H]<sup>+</sup>. HRMS (ESI): calcd for C<sub>27</sub>H<sub>30</sub>NO<sub>7</sub> [M + H]<sup>+</sup>, 480.2017; found, 480.1997.</div></div><div id="sec6_4_35" class="NLM_sec NLM_sec_level_3"><div id="ac_i97" class="anchor-spacer"></div><h4 class="article-section__title" id="_i97"> (1<i>R</i>,2<i>R</i>,2a<i>R</i>,10a<i>S</i>)-1-Acetoxymethyl-10,10-dimethyl-2-(3,4,5-trimethoxyphenyl)-1,2,2a,4,10,10a-hexahydro-3<i>H</i>-cyclobuta[4,5]pyrano[3,2-<i>c</i>]quinolin-3-one and (1<i>S</i>,2<i>S</i>,2a<i>S</i>,10a<i>R</i>)-1-Acetoxymethyl-10,10-dimethyl-2-(3,4,5-trimethoxyphenyl)-1,2,2a,4,10,10a-hexahydro-3<i>H</i>-cyclobuta[4,5]pyrano[3,2-<i>c</i>]quinolin-3-one (<b>41</b>)</h4><div class="NLM_p last">From flindersine (<b>2a</b>, 0.5 mmol) and (<i>E</i>)-3-(3,4,5-trimethoxyphenyl)allylacetate (1.0 mmol). Purified by gradient elution MeCN/H<sub>2</sub>O (1% TFA, 3:7 for 45 min then gradient elution to 75:25 over 25 min) to afford a white solid (44.3 mg, 9%). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 500 MHz) δ 1.17 (s, 3H), 1.47 (s, 3H), 1.89 (s, 3H), 2.60 (t, <i>J</i> = 9 Hz, 1H), 2.66 (t, <i>J</i> = 9 Hz, 1H), 3.34 (s, 6H), 3.51 (s, 3H), 3.58 (t, <i>J</i> = 9 Hz, 1H), 3.74 (t, <i>J</i> = 8 Hz, 1H), 6.13 (s, 2H), 7.13 (m, 2H), 7.42 (t, <i>J</i> = 7.5 Hz, 1H), 7.81 (d, <i>J</i> = 8 Hz, 1H), 11.08 (s, 1H). (+) LRMS (ESI) <i>m</i>/<i>z</i> 494 [M + H]<sup>+</sup>.</div></div><div id="sec6_4_36" class="NLM_sec NLM_sec_level_3"><div id="ac_i98" class="anchor-spacer"></div><h4 class="article-section__title" id="_i98"> (1<i>R</i>,2<i>R</i>,2a<i>R</i>,10a<i>S</i>)-1-Isopropyloxymethyl-10,10-dimethyl-2-(3,4,5-trimethoxyphenyl)-1,2,2a,4,10,10a-hexahydro-3<i>H</i>-cyclobuta[4,5]pyrano[3,2-<i>c</i>]quinolin-3-one and (1<i>S</i>,2<i>S</i>,2a<i>S</i>,10a<i>R</i>)-1-Isopropyloxymethyl-10,10-dimethyl-2-(3,4,5-trimethoxyphenyl)-1,2,2a,4,10,10a-hexahydro-3<i>H</i>-cyclobuta[4,5]pyrano[3,2-<i>c</i>]quinolin-3-one (<b>42</b>)</h4><div class="NLM_p last">From flindersine (<b>2a</b>, 0.5 mmol) and (<i>E</i>)-5-(3-isopropoxyprop-1-enyl)-1,2,3-trimethoxybenzene (1.0 mmol). Purified by gradient elution MeCN/H<sub>2</sub>O (1% TFA, 35:65 for 30 min then gradient elution to 75:25 over 30 min) to afford a white solid (34.2 mg, 13%). <sup>1</sup>H NMR (CDCl<sub>3</sub>, 500 MHz) δ 1.13–1.22 (m, 9H), 1.45 (s, 3H), 2.96 (t, <i>J</i> = 9 Hz, 1H), 3.10 (t, <i>J</i> = 9 Hz, 1H), 3.37 (s, 6H), 3.52 (s, 3H), 3.61 (m, 1H), 3.75 (m, 1H), 3.95 (t, <i>J</i> = 9 Hz, 1H), 6.16 (s, 2H), 7.13 (m, 2H), 7.43 (t, <i>J</i> = 7.5 Hz, 1H), 7.81 (d, <i>J</i> = 8 Hz, 1H), 11.11 (s, 1H). (+) LRMS (ESI) <i>m</i>/<i>z</i> 504 [M + H]<sup>+</sup>. HRMS (ESI): calcd for C<sub>29</sub>H<sub>33</sub>NO<sub>7</sub> [M + Na]<sup>+</sup>, 530.2149; found, 530.2125.</div></div><div id="sec6_4_37" class="NLM_sec NLM_sec_level_3"><div id="ac_i99" class="anchor-spacer"></div><h4 class="article-section__title" id="_i99"> (1<i>R</i>,2<i>R</i>,2a<i>R</i>,10a<i>S</i>)-1-Carboethoxy-10,10-dimethyl-2-(3,4,5-trimethoxyphenyl)-1,2,2a,4,10,10a-hexahydro-3<i>H</i>-cyclobuta[4,5]pyrano[3,2-<i>c</i>]quinolin-3-one and (1<i>S</i>,2<i>S</i>,2a<i>S</i>,10a<i>R</i>)-1-Carboethoxy-10,10-dimethyl-2-(3,4,5-trimethoxyphenyl)-1,2,2a,4,10,10a-hexahydro-3<i>H</i>-cyclobuta[4,5]pyrano[3,2-<i>c</i>]quinolin-3-one (<b>43</b>)</h4><div class="NLM_p last">From <b>3</b> and (<i>E</i>)-ethyl-3-(4-bromophenyl)acrylate. Purified by isocratic elution MeOH/H<sub>2</sub>O (1% TFA, 6:4) (59.7 mg, 12%). <sup>1</sup>H NMR (CDCl<sub>3</sub>, 500 MHz) δ 1.11 (t, <i>J</i> = 7 Hz, 3H), 1.16 (s, 3H), 1.49 (s, 3H), 3.04 (t, <i>J</i> = 9 Hz, 1H), 3.23 (t, <i>J</i> = 10 Hz, 1H), 3.28 (s, 3H), 3.79 (t, <i>J</i> = 8 Hz, 1H), 3.99 (m, 1H), 4.08 (m, 2H), 6.72 (d, <i>J</i> = 7 Hz, 2H), 7.21 (d, <i>J</i> = 7 Hz, 2H), 7.37 (t, <i>J</i> = 7 Hz, 1H), 7.58 (m, Hz, 2H), 8.02 (d, <i>J</i> = 8 Hz, 1H). <sup>13</sup>C NMR (CDCl<sub>3</sub>, 125 MHz) δ 13.95, 22.90, 24.46, 31.71, 41.13, 41.37, 43.78, 52.19, 60.23, 75.74, 101.53, 118.51, 119.54, 121.46, 123.43, 126.43, 129.43, 129.77, 130.1, 137.47, 145.00, 156.34, 160.99, 172.53. (+) LRMS (ESI) <i>m</i>/<i>z</i> 496:498 (1:1) [M + H]<sup>+</sup>. HRMS (ESI): calcd for C<sub>26</sub>H<sub>27</sub>BrNO<sub>4</sub> [M + H]<sup>+</sup>, 496.1118; found, 496.1121. This compound was (26.3 mg, 0.050 mmol) was dissolved in acetic acid (2 mL). Potassium iodide (0.066 mmol) was added, and the reaction mixture was heated at 50 °C for 20 h. The reaction mixture was extracted with a 10% NaHSO<sub>4</sub> solution and CHCl<sub>3</sub> (3 × 30 mL), dried with MgSO<sub>4</sub>, filtered, and concentrated to dryness to afford <b>43</b> (20 mg, 83%) as a white solid. <sup>1</sup>H NMR (CDCl<sub>3</sub>, 500 MHz) δ 1.18 (t, <i>J</i> = 7 Hz, 3H), 1.14 (s, 3H), 1.46 (s, 3H), 2.99 (t, <i>J</i> = 9 Hz, 1H), 3.19 (t, <i>J</i> = 10 Hz, 1H), 3.72 (t, <i>J</i> = 8 Hz, 1H), 3.99 (m, 2H), 4.08 (m, 1H), 6.89 (d, <i>J</i> = 7 Hz, 2H), 7.14 (t, <i>J</i> = 7 Hz, 2H), 7.22 (d, <i>J</i> = 7.5 Hz, 2H), 7.43 (t, <i>J</i> = 7 Hz, 1H), 7.82 (d, <i>J</i> = 7.5 Hz, 1H), 11.10 (s, 1H). (+) LRMS (ESI) <i>m</i>/<i>z</i> 482:484 (1:1) [M + H]<sup>+</sup>. HRMS (ESI): calcd for C<sub>25</sub>H<sub>24</sub> BrNO<sub>4</sub> [M + Na]<sup>+</sup>, 504.0781; found, 504.0777.</div></div><div id="sec6_4_38" class="NLM_sec NLM_sec_level_3"><div id="ac_i100" class="anchor-spacer"></div><h4 class="article-section__title" id="_i100"> (1<i>R</i>,2<i>R</i>,2a<i>R</i>,10a<i>S</i>)-1,4,10,10-Tetramethyl-2-(3,4-dimethoxyphenyl)-1,2,2a,4,10,10a-hexahydro-3<i>H</i>-cyclobuta[4,5]pyrano[3,2-<i>c</i>]quinolin-3-one and (1<i>S</i>,2<i>S</i>,2a<i>S</i>,10a<i>R</i>)-1,4,10,10-Tetramethyl-2-(3,4-dimethoxyphenyl)-1,2,2a,4,10,10a-hexahydro-3<i>H</i>-cyclobuta[4,5]pyrano[3,2-<i>c</i>]quinolin-3-one (<b>44</b>)</h4><div class="NLM_p last">From <i>N</i>-Me-flindersine (<b>2b</b>, 0.93 mmol) and <b>4a</b> (1.87 mmol). Purified by reverse-phase HPLC with isocratic elution MeCN/H<sub>2</sub>O (55:45) over 60 min to give 15.4 mg (3.7%) as a light brown solid. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6,</sub> 600 MHz) δ 1.10–1.17 (m, 6H), 1.49 (s, 3H), 2.30–2.37 (m, 2H), 3.23 (s, 3H), 3.30–3.32 (m, 7H), 3.51 (s, 3H), 3.71 (t, <i>J</i> = 7.8 Hz, 1H), 6.06 (s, 2H), 7.26 (t, <i>J</i> = 7.5 Hz, 1H), 7.41 (d, <i>J</i> = 8.2 Hz, 1H), 7.59 (t, <i>J</i> = 7.8 Hz, 1H), 7.95 (d, <i>J</i> = 7.8 Hz, 1H). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>, 150 MHz) δ 20.04, 22.91, 24.09, 32.04, 34.58, 45.39, 49.17, 54.68, 59.53, 76.29, 104.91, 107.10, 114.83, 115.49, 120.98, 121.85, 130.11, 135.63, 135.79, 138.32, 151.29, 154.14, 161.15. (+) LRMS (ESI) <i>m</i>/<i>z</i> 449.8 [M + H]<sup>+</sup>. HRMS (ESI): calcd for C<sub>26</sub>H<sub>31</sub>NO<sub>5</sub>Na [M + Na]<sup>+</sup>, 472.2094; found, 472.2104.</div></div><div id="sec6_4_39" class="NLM_sec NLM_sec_level_3"><div id="ac_i101" class="anchor-spacer"></div><h4 class="article-section__title" id="_i101"> (1<i>R</i>,2<i>R</i>,2a<i>R</i>,10a<i>S</i>)-2-(3,4-Dimethoxyphenyl)-1-ethyl-4,10,10-trimethyl-1,2,2a,4,10,10a-hexahydro-3<i>H</i>-cyclobuta[4,5]pyrano[3,2-<i>c</i>]quinolin-3-one and (1<i>S</i>,2<i>S</i>,2a<i>S</i>,10a<i>R</i>)-2-(3,4-Dimethoxyphenyl)-1-ethyl-4,10,10-trimethyl-1,2,2a,4,10,10a-hexahydro-3<i>H</i>-cyclobuta[4,5]pyrano[3,2-<i>c</i>]quinolin-3-one (<b>45</b>)</h4><div class="NLM_p last">From <i>N</i>-Me-flindersine (<b>2b</b>, 0.50 mmol) and <b>4e</b> (1.0 mmol). Purified by flash chromatography on neutral alumina (DCM, then 1:1 DCM/CHCl<sub>3</sub>, then CHCl<sub>3</sub>). The fractions containing MH<sup>+</sup> 435 were combined and purified by reverse-phase HPLC with isocratic elution MeCN/H<sub>2</sub>O (3:2) over 60 min to afford 21.1 mg (10%). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 500 MHz) δ 0.64 (t, <i>J</i> = 6.5 Hz, 3H), 1.51 (m, 1H), 1.67 (m, 1H), 1.13 (s, 3H), 1.47 (s, 3H), 2.29 (m, 1H), 2.37 (t, <i>J</i> = 9 Hz, 1H), 3.13 (s, 3H), 3.20 (s, 3H), 3.60 (s, 3H), 3.69 (t, <i>J</i> = 9 Hz, 1H), 6.25 (br s, 1H), 6.44 (dd, <i>J</i> = 1.5, 7.5 Hz, 1H), 6.58 (d, <i>J</i> = 7.5 Hz), 7.25 (t, <i>J</i> = 7.5 Hz, 1H), 7.38 (d, <i>J</i> = 7.5 Hz, 1H), 7.57 (t, <i>J</i> = 7.5 Hz, 1H), 7.95 (d, <i>J</i> = 7.5 Hz, 1H). <sup>13</sup>C NMR (CDCl<sub>3</sub>, 150 MHz) δ 12.50, 23.82, 25.32, 29.32, 30.68, 33.28, 41.82, 48.51, 55.84, 56.90, 77.68, 109.51, 112.00, 113.11, 115.02, 115.97, 122.31, 123.08, 123.82, 132.39, 135.88, 140.10, 148.68, 149.26, 156.38, 163.88. (+) LRMS (ESI) <i>m</i>/<i>z</i> 435 [M + H]<sup>+</sup>. HRMS (ESI): calcd for C<sub>27</sub>H<sub>31</sub>NO<sub>4</sub>Na [M + Na]<sup>+</sup>, 456.2145; found, 456.2138.</div></div><div id="sec6_4_40" class="NLM_sec NLM_sec_level_3"><div id="ac_i102" class="anchor-spacer"></div><h4 class="article-section__title" id="_i102"> (1<i>R</i>,2<i>R</i>,2a<i>R</i>,10a<i>S</i>)-1-Ethyl-2-(3-fluoro-4-methoxyphenyl)-4,10,10-trimethyl-1,2,2a,4,10,10a-hexahydro-3<i>H</i>-cyclobuta[4,5]pyrano[3,2-<i>c</i>]quinolin-3-one and (1<i>S</i>,2<i>S</i>,2a<i>S</i>,10a<i>R</i>)-1-Ethyl-2-(3-fluoro-4-methoxyphenyl)-4,10,10-trimethyl-1,2,2a,4,10,10a-hexahydro-3<i>H</i>-cyclobuta[4,5]pyrano[3,2-<i>c</i>]quinolin-3-one (<b>46</b>)</h4><div class="NLM_p last">From <i>N</i>-Me-flindersine (<b>2b</b>, 0.50 mmol) and <b>4g</b> (1.0 mmol). Purified by flash chromatography on neutral alumina (DCM, then 1:1 DCM/CHCl<sub>3</sub>, then CHCl<sub>3</sub>). The fractions containing MH<sup>+</sup> 422 were combined and purified by reverse-phase HPLC with isocratic elution MeCN/H<sub>2</sub>O (3:2) to MeCN over 60 min to afford 9.8 mg (5%). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 600 MHz) δ 0.63 (t, <i>J</i> = 8 Hz, 3H), 1.11 (s, 3H), 1.46 (s, 3H), 1.52 (m, 1H), 1.66 (m, 1H), 2.27 (m, 1H), 2.36 (t, <i>J</i> = 10 Hz, 1H), 3.20 (s, 3H), 3.43 (t, <i>J</i> = 9 Hz, 1H), 3.64 (t, <i>J</i> = 9 Hz, 1H), 3.75 (s, 3H), 6.54 (br d, <i>J</i> = 9.6 Hz, 1H), 6.59 (br d, <i>J</i> = 8 Hz, 1H), 6.73 (dd, <i>J</i> = 6, 8 Hz, 1H), 7.25 (t, <i>J</i> = 7.5 Hz, 1H), 7.38 (d, <i>J</i> = 7.5 Hz, 1H), 7.56 (t, <i>J</i> = 8 Hz, 1H), 7.93 (d, <i>J</i> = 8 Hz). (+) LRMS (ESI) <i>m</i>/<i>z</i> 422 [M + H]<sup>+</sup>. HRMS (ESI): calcd for C<sub>26</sub>H<sub>28</sub>FNO<sub>3</sub>Na [M + Na]<sup>+</sup>, 444.1945; found, 444.1951.</div></div><div id="sec6_4_41" class="NLM_sec NLM_sec_level_3"><div id="ac_i103" class="anchor-spacer"></div><h4 class="article-section__title" id="_i103"> (1<i>R</i>,2<i>R</i>,2a<i>R</i>,10a<i>S</i>)-1-Ethyl-7,10,10-trimethyl-2-(3,4,5-trimethoxyphenyl)-1,2,2a,4,10,10a-hexahydro-3<i>H</i>-cyclobuta[4,5]pyrano[3,2-<i>c</i>]quinolin-3-one and (1<i>S</i>,2<i>S</i>,2a<i>S</i>,10a<i>R</i>)-1-Ethyl-7,10,10-trimethyl-2-(3,4,5-trimethoxyphenyl)-1,2,2a,4,10,10a-hexahydro-3<i>H</i>-cyclobuta[4,5]pyrano[3,2-<i>c</i>]quinolin-3-one (<b>47</b>)</h4><div class="NLM_p last">From <b>2c</b> (0.5 mmol) and <b>4a</b> (1.0 mmol). Purified by flash chromatography on neutral alumina (DCM, then 1:1 DCM/CHCl<sub>3</sub>, then CHCl<sub>3</sub>). The fractions containing MH<sup>+</sup> 464 were combined and purified by reverse-phase HPLC with isocratic elution MeCN/H<sub>2</sub>O (55:45) to MeCN over 60 min (12.6 mg, 6%). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 600 MHz) δ 0.68 (d, <i>J</i> = 8.5 Hz, 3H), 1.14 (s, 3H), 1.49 (s, 3H), 1.52 (m, 1H), 1.67 (m, 1H), 2.28 (m, 2H), 2.36 (s, 3H), 3.31 (s, 6H), 3.38 (t, <i>J</i> = 9 Hz, 1H), 3.52 (s, 3H), 3.66 (t, <i>J</i> = 9 Hz, 1H), 6.11 (s, 2H), 7.05 (d, <i>J</i> = 7.5 Hz, 1H), 7.26 (d, <i>J</i> = 7.5 Hz, 1H), 7.63 (br s, 1H), 10.95 (s, 1H). (+) LRMS (ESI) <i>m</i>/<i>z</i> 464 [M + H]<sup>+</sup>. HRMS (ESI): calcd for C<sub>28</sub>H<sub>33</sub>NO<sub>5</sub>Na [M + Na]<sup>+</sup>, 486.2251; found, 486.2273.</div></div><div id="sec6_4_42" class="NLM_sec NLM_sec_level_3"><div id="ac_i104" class="anchor-spacer"></div><h4 class="article-section__title" id="_i104"> (1<i>R</i>,2<i>R</i>,2a<i>R</i>,10a<i>S</i>)-2-(3,4-Dimethoxyphenyl)-1-ethyl-7,10,10-trimethyl-1,2,2a,4,10,10a-hexahydro-3<i>H</i>-cyclobuta[4,5]pyrano[3,2-<i>c</i>]quinolin-3-one and (1<i>S</i>,2<i>S</i>,2a<i>S</i>,10a<i>R</i>)-2-(3,4-Dimethoxyphenyl)-1-ethyl-7,10,10-trimethyl-1,2,2a,4,10,10a-hexahydro-3<i>H</i>-cyclobuta[4,5]pyrano[3,2-<i>c</i>]quinolin-3-one (<b>48</b>)</h4><div class="NLM_p last">From <b>2c</b> (0.83 mmol) and <b>4e</b> (1.67 mmol). Purified by flash chromatography on neutral alumina (DCM, then 1:1 DCM/CHCl<sub>3</sub>, then CHCl<sub>3</sub>). The fractions containing MH<sup>+</sup> 434 were combined and purified by reverse-phase HPLC with isocratic elution MeCN/H<sub>2</sub>O (3:2) to MeCN over 60 min (9.7 mg, 3%). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 600 MHz) δ 0.65 (t, <i>J</i> = 8 Hz, 3H), 1.13 (s, 3H), 1.48 (s, 3H), 1.53 (m, 1H), 1.67 (m, 1H), 2.31 (m, 1H), 2.34 (s, 3H), 2.49 9m, 1H), 3.20 (s, 3H), 3.38 (t, <i>J</i> = 9 Hz, 1H), 3.62 (s, 3H), 3.64 (t, <i>J</i> = 9 Hz, 1H), 6.30 (s, 1H), 6.48 (d, <i>J</i> = 8 Hz, 1H), 6.59 (d, <i>J</i> = 8 Hz, 1H), 7.06 (d, <i>J</i> = 7.5 Hz, 1H), 7.25 (d, <i>J</i> = 7.5 Hz, 1H), 7.62 (br s, 1H), 10.91 (s, 1H). (+) LRMS (ESI) <i>m</i>/<i>z</i> 434 [M + H]<sup>+</sup>. HRMS (ESI): calcd for C<sub>27</sub>H<sub>31</sub>NO<sub>4</sub> [M + H]<sup>+</sup>, 434.2326; found, 434.2329.</div></div><div id="sec6_4_43" class="NLM_sec NLM_sec_level_3"><div id="ac_i105" class="anchor-spacer"></div><h4 class="article-section__title" id="_i105"> (1<i>R</i>,2<i>R</i>,2a<i>R</i>,10a<i>S</i>)-7,10,10-Trimethyl-1-(1-methylethyl)-2-(3,4,5-trimethoxyphenyl)-1,2,2a,4,10,10a-hexahydro-3<i>H</i>-cyclobuta[4,5]pyrano[3,2-<i>c</i>]quinolin-3-one and (1<i>S</i>,2<i>S</i>,2a<i>S</i>,10a<i>R</i>)-7,10,10-Trimethyl-1-(1-methylethyl)-2-(3,4,5-trimethoxyphenyl)-1,2,2a,4,10,10a-hexahydro-3<i>H</i>-cyclobuta[4,5]pyrano[3,2-<i>c</i>]quinolin-3-one (<b>49</b>)</h4><div class="NLM_p last">From <b>2c</b> (0.83 mmol) and <b>4h</b> (1.67 mmol). Purified by flash chromatography on neutral alumina (DCM, then 1:1 DCM/CHCl<sub>3</sub>, then CHCl<sub>3</sub>). The fractions containing MH<sup>+</sup> 480 were combined and purified by reverse-phase HPLC with isocratic elution MeCN/H<sub>2</sub>O (58:42) to MeCN over 60 min to afford 17.3 mg (4%). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 600 MHz) δ 0.72 (d, <i>J</i> = 8 Hz, 3H), 0.88 (d, <i>J</i> = 8 Hz, 3H), 1.15 (s, 3H), 1.49 (s, 3H), 1.80 (m, 1H), 1.67 (m, 1H), 2.29 (m, 1H), 2.36 (s, 3H), 2.49 (m, 1H), 3.32 (s, 6H), 3.38 (t, <i>J</i> = 9 Hz, 1H), 3.52 (s, 3H), 3.66 (t, <i>J</i> = 9 Hz, 1H), 6.11 (s, 2H), 7.04 (d, <i>J</i> = 7.5 Hz, 1H), 7.25 (d, <i>J</i> = 7.5 Hz, 1H), 7.62 (br s, 1H), 10.92 (s, 1H). <sup>13</sup>C NMR (CDCl<sub>3</sub>, 150 MHz) δ 18.26, 20.39, 21.12, 23.22, 25.17, 30.52, 31.17, 40.94, 43.66, 45.45, 77.20, 105.34, 109.12, 114.2, 115.51, 120.93, 130.52, 130.72, 136.11, 136.23, 136.40, 155.96, 162.63. (+) LRMS (ESI) <i>m</i>/<i>z</i> 480 [M + H]<sup>+</sup>. HRMS (ESI): calcd for C<sub>29</sub>H<sub>35</sub>NO<sub>5</sub>Na [M + Na]<sup>+</sup>, 500.2407; found, 500.2421.</div></div><div id="sec6_4_44" class="NLM_sec NLM_sec_level_3"><div id="ac_i106" class="anchor-spacer"></div><h4 class="article-section__title" id="_i106"> (1<i>R</i>,2<i>R</i>,2a<i>R</i>,10a<i>S</i>)-2-(3-Chloro-4-methoxyphenyl)-4,10,10-trimethyl-1-(1-methylethyl)-1,2,2a,4,10,10a-hexahydro-3<i>H</i>-cyclobuta[4,5]pyrano[3,2-<i>c</i>]quinolin-3-one and (1<i>S</i>,2<i>S</i>,2a<i>S</i>,10a<i>R</i>)-2-(3-Chloro-4-methoxyphenyl)-4,10,10-trimethyl-1-(1-methylethyl)-1,2,2a,4,10,10a-hexahydro-3<i>H</i>-cyclobuta[4,5]pyrano[3,2-<i>c</i>]quinolin-3-one (<b>50</b>)</h4><div class="NLM_p last">From <i>N</i>-Me-flindersine (<b>2b</b>, 0.5 mmol) and <b>4i</b> (1.0 mmol). Purified by flash chromatography on neutral alumina (DCM, then 1:1 DCM/CHCl<sub>3</sub>, then CHCl<sub>3</sub>). The fractions containing MH<sup>+</sup> 452 were combined and purified by reverse-phase HPLC with isocratic elution MeCN/H<sub>2</sub>O (3:2) over 60 min to give 12.4 mg (5.5%). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 600 MHz) δ 0.68 (d, <i>J</i> = 8.4 Hz, 3H), 0.86 (d, <i>J</i> = 8.4 Hz, 3H), 1.15 (s, 3H), 1.49 (s, 3H), 1.52 (m, 1H), 1.81 (m, 1H), 2.30 (m, 1H), 2.51 (m, 1H), 3.20 (s, 3H), 3.55 (t, <i>J</i> = 9 Hz, 1H), 3.65 (t, <i>J</i> = 9 Hz, 1H), 3.70 (s, 3H), 6.73 (m, 3H), 7.26 (t, <i>J</i> = 7.5 Hz, 1H), 7.38 (d, <i>J</i> = 7.5 Hz, 1H), 7.58 (t, <i>J</i> = 8 Hz, 1H), 7.94 (d, <i>J</i> = 8 Hz). (+) LRMS (ESI) <i>m</i>/<i>z</i> 452 [M + H<sup>35</sup>Cl]<sup>+</sup>, 454 [M + H<sup>37</sup>Cl]<sup>+</sup>. HRMS (ESI): calcd for C<sub>27</sub>H<sub>30</sub>ClNO<sub>3</sub>Na [M + Na]<sup>+</sup>, 474.1806; found, 458.1795.</div></div><div id="sec6_4_45" class="NLM_sec NLM_sec_level_3"><div id="ac_i107" class="anchor-spacer"></div><h4 class="article-section__title" id="_i107"> (1<i>R</i>,2<i>R</i>,2a<i>R</i>,10a<i>S</i>)-2-(3-Acetoxy-4-methoxyphenyl)-4,10,10-trimethyl-1-(1-methylethyl)-1,2,2a,4,10,10a-hexahydro-3<i>H</i>-cyclobuta[4,5]pyrano[3,2-<i>c</i>]quinolin-3-one and (1<i>S</i>,2<i>S</i>,2a<i>S</i>,10a<i>R</i>)-2-(3-Acetoxy-4-methoxyphenyl)-4,10,10-trimethyl-1-(1-methylethyl)-1,2,2a,4,10,10a-hexahydro-3<i>H</i>-cyclobuta[4,5]pyrano[3,2-<i>c</i>]quinolin-3-one (<b>51</b>)</h4><div class="NLM_p last">From <i>N</i>-Me-flindersine (<b>2b</b>, 0.83 mmol) and <b>4k</b> (1.76 mmol). Purified by flash chromatography on neutral alumina (DCM, then 1:1 DCM/CHCl<sub>3</sub>, then CHCl<sub>3</sub>). The fractions containing MH<sup>+</sup> 476 were combined and purified by reverse-phase HPLC with gradient elution MeCN/H<sub>2</sub>O (5:95) to MeCN/H<sub>2</sub>O (2:3) over 60 min to afford 17.6 mg (4.5%). <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>) δ 0.69 (d, <i>J</i> = 6.6 Hz, 3H), 0.85 (d, <i>J</i> = 6.57 Hz, 3H), 1.13 (s, 3H), 1.48 (s, 3H), 1.79 (m, Hz, 1 H), 1.95 (s, 3H), 2.29 (m, 1H), 2.26 (m, 1H), 3.21 (s, 3H), 3.52 (m, 1H), 3.61 (s, 3H), 3.67 (m, 1H), 6.35 (s, 1 H), 6.67–6.76 (m, 2 H), 7.24 (t, <i>J</i> = 7.5 Hz, 1H), 7.35 (d, <i>J</i> = 8 Hz, 1H), 7.56 (dd, <i>J</i> = 7.5, 8 Hz, 1H), 7.92 (d, <i>J</i> = 8 Hz, 1H). (+) LRMS (ESI) <i>m</i>/<i>z</i> 476 [M + H]<sup>+</sup>. HRMS (ESI): calcd for C<sub>29</sub>H<sub>33</sub>NO<sub>5</sub> [M + H]<sup>+</sup>, 476.2432; found, 476.2425.</div></div><div id="sec6_4_46" class="NLM_sec NLM_sec_level_3"><div id="ac_i108" class="anchor-spacer"></div><h4 class="article-section__title" id="_i108"> (1<i>R</i>,2<i>R</i>,2a<i>R</i>,10a<i>S</i>)-1-Cyclopropyl-2-(3,4,5-trimethoxyphenyl)-10,10,6-trimethyl-1,2,2a,4,10,10a-hexahydro-3<i>H</i>-cyclobuta[4,5]pyrano[3,2-<i>c</i>]quinolin-3-one and (1<i>S</i>,2<i>S</i>,2a<i>S</i>,10a<i>R</i>)-1-Cyclopropyl-2-(3,4,5-trimethoxyphenyl)-10,10,6-trimethyl-1,2,2a,4,10,10a-hexahydro-3<i>H</i>-cyclobuta[4,5]pyrano[3,2-<i>c</i>]quinolin-3-one (<b>52</b>)</h4><div class="NLM_p last">From <i>N</i>-Me-flindersine (<b>2b</b>, 0.5 mmol) and <b>4s</b> (1.0 mmol). Purified by flash chromatography on neutral alumina (DCM, then 1:1 DCM/CHCl<sub>3</sub>, then CHCl<sub>3</sub>). The fractions containing MH<sup>+</sup> 476 were combined and purified by reverse-phase HPLC with isocratic elution MeCN/H<sub>2</sub>O (42.5:57.5) over 60 min to give 8.6 mg (4%). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 500 MHz) δ 0.07 (m, 2H), 0.30 (m, 1H), 0.36 (m, 1H), 0.93 (m, 1H), 1.15 (s, 3H), 1.53 (s, 3H), 2.06 (m, 1H), 2.47 (m, 1H), 3.20 (s, 3H), 3.28 (s, 6H), 3.39 (dd, <i>J</i> = 10 Hz, 1H), 3.50 (s, 3H), 3.65 (dd, <i>J</i> = 8.5, 10 Hz, 1H), 6.01 (s, 2H), 7.24 (dd, <i>J</i> = 7.5, 8 Hz, 1H), 7.38 (d, <i>J</i> = 8.5 Hz, 1H), 7.57 (ddd, <i>J</i> = 1.5, 7.5, 8.5 Hz, 1H), 7.93 (d, <i>J</i> = 8 Hz, 1H). (+) LRMS (ESI) <i>m</i>/<i>z</i> 476 [M + H]<sup>+</sup>. HRMS (ESI): calcd for C<sub>29</sub>H<sub>33</sub>NO<sub>5</sub> [M + H]<sup>+</sup>, 476.2432; found, 476.2452.</div></div><div id="sec6_4_47" class="NLM_sec NLM_sec_level_3"><div id="ac_i109" class="anchor-spacer"></div><h4 class="article-section__title" id="_i109"> (1<i>R</i>,2<i>R</i>,2a<i>R</i>,10a<i>S</i>)-1-Cyclopropyl-2-(3,4-dimethoxyphenyl)-10,10,6-trimethyl-1,2,2a,4,10,10a-hexahydro-3<i>H</i>-cyclobuta[4,5]pyrano[3,2-<i>c</i>]quinolin-3-one and (1<i>S</i>,2<i>S</i>,2a<i>S</i>,10a<i>R</i>)-1-Cyclopropyl-2-(3,4-dimethoxyphenyl)-10,10,6-trimethyl-1,2,2a,4,10,10a-hexahydro-3<i>H</i>-cyclobuta[4,5]pyrano[3,2-<i>c</i>]quinolin-3-one (<b>53</b>)</h4><div class="NLM_p last">From <i>N</i>-Me-flindersine (<b>2b</b>, 0.5 mmol) and <b>4t</b> (1.0 mmol). Purified by flash chromatography on neutral alumina (DCM, then 1:1 DCM/CHCl<sub>3</sub>, then CHCl<sub>3</sub>). The fractions containing MH<sup>+</sup> 446 were combined and purified by reverse-phase HPLC with isocratic elution MeCN/H<sub>2</sub>O (42.5:57.5) over 60 min to afford 9.4 mg (4%). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 500 MHz) δ 0.03 (m, 2H), 0.27 (m, 1H), 0.35 (m, 1H), 0.91 (m, 1H), 1.14 (s, 3H), 1.53 (s, 3H), 2.06 (m, 1H), 2.47 (m, 1H), 3.15 (s, 3H), 3.20 (s, 3H), 3.38 (dd, <i>J</i> = 9.5, 10 Hz, 1H), 3.60 (s, 3H), 3.65 (dd, <i>J</i> = 8.5, 10 Hz, 1H), 6.22 (br s, 1H), 6.39 (br d, <i>J</i> = 8.5 Hz, 1H), 6.57 (d, <i>J</i> = 8.5 Hz, 1H), 7.24 (dd, <i>J</i> = 7.5, 8 Hz, 1H), 7.37 (d, <i>J</i> = 8.5 Hz, 1H), 7.56 (dd, <i>J</i> = 7.5, 8.5 Hz, 1H), 7.92 (d, <i>J</i> = 8 Hz, 1H). (+) LRMS (ESI) <i>m</i>/<i>z</i> 446 [M + H]<sup>+</sup>. HRMS (ESI): calcd for C<sub>28</sub>H<sub>31</sub>NO<sub>5</sub> Na [M + Na]<sup>+</sup>, 484.2094; found, 484.2113.</div></div><div id="sec6_4_48" class="NLM_sec NLM_sec_level_3"><div id="ac_i110" class="anchor-spacer"></div><h4 class="article-section__title" id="_i110"> (1<i>R</i>,2<i>R</i>,2a<i>R</i>,10a<i>S</i>)-1-Cyclopentyl-2-(3,4,5-trimethoxyphenyl)-4,10,10-trimethyl-1,2,2a,4,10,10a-hexahydro-3<i>H</i>-cyclobuta[4,5]pyrano[3,2-<i>c</i>]quinolin-3-one and (1<i>S</i>,2<i>S</i>,2a<i>S</i>,10a<i>R</i>)-1-Cyclopentyl-2-(3,4,5-trimethoxyphenyl)-4,10,10-trimethyl-1,2,2a,4,10,10a-hexahydro-3<i>H</i>-cyclobuta[4,5]pyrano[3,2-<i>c</i>]quinolin-3-one (<b>54</b>)</h4><div class="NLM_p last">From <i>N</i>-Me-flindersine (<b>2b</b>, 0.5 mmol) and <b>4q</b> (1.0 mmol). Purified by flash chromatography on neutral alumina (DCM, then 1:1 DCM/CHCl<sub>3</sub>, then CHCl<sub>3</sub>). The fractions containing MH<sup>+</sup> 504 were combined and purified by reverse-phase HPLC with gradient elution MeCN/H<sub>2</sub>O (5:95) to MeCN/H<sub>2</sub>O (2:3) over 60 min to afford 18.6 mg (4.6%). <sup>1</sup>H NMR (DMSO-<i>d</i><sub><i>6</i></sub>, 600 MHz) δ 95 (m, 1H), 1.16 (m, 1H), 1.16 (s, 3H), 1.45 (m, 4H), 1.52 (s, 3H), 1.62 (m, 2H), 2.01 (m, 1H), 2.41 (ddd, <i>J</i> = 7.5, 9.5 Hz, 1H), 2.48 (dd, <i>J</i> = 8.5 Hz, 1H), 3.21 (s, 3H), 3.28 (s), 3.51 (s, 6H), 3.54 (dd, <i>J</i> = 8.5, 9 Hz, 1H), 3.71 (t, <i>J</i> = 8.5, 9 Hz, 1H), 6.06 (s, 3H), 7.27 (dd, <i>J</i> = 7.5, 8.5 Hz, 1H), 7.40 (d, <i>J</i> = 8.5 Hz, 1H), 7.59 (dd, <i>J</i> = 7.5, 8.5 Hz, 1H), 7.96 (d, <i>J</i> = 8.5 Hz). (+) LRMS (ESI) <i>m</i>/<i>z</i> 504 [M + H]<sup>+</sup>. HRMS (ESI): calcd for C<sub>31</sub>H<sub>37</sub>NO<sub>5</sub> [M + H]<sup>+</sup>, 504.2745; found, 504.2736.</div></div><div id="sec6_4_49" class="NLM_sec NLM_sec_level_3"><div id="ac_i111" class="anchor-spacer"></div><h4 class="article-section__title" id="_i111"> (1<i>R</i>,2<i>R</i>,2a<i>R</i>,10a<i>S</i>)-1,10-Dimethyl-2-(3,4,5-trimethoxyphenyl)-1,2,2a,4,10,10a-hexahydro-3<i>H</i>-cyclobuta[4,5]pyrano[3,2-<i>c</i>]quinolin-3-one and (1<i>S</i>,2<i>S</i>,2a<i>S</i>,10a<i>R</i>)-1,10-Dimethyl-2-(3,4,5-trimethoxyphenyl)-1,2,2a,4,10,10a-hexahydro-3<i>H</i>-cyclobuta[4,5]pyrano[3,2-<i>c</i>]quinolin-3-one (<b>55</b> and <b>56</b>)</h4><div class="NLM_p last">From <b>2e</b>–<b>f</b> (0.5 mmol) and <b>4a</b> (1.0 mmol). Purified by gradient elution MeCN/H<sub>2</sub>O (55:45 for 45 min then gradient elution to 100% MeCN over 5 min) to afford a white solid (6.3 mg, 4%). <b>56</b>: <sup>1</sup>H NMR (<i>d</i><sub>6</sub> DMSO, 500 MHz) δ 1.08 (d, <i>J</i> = 6 Hz, 3H), 1.16 (d, <i>J</i> = 6 Hz, 3H), 2.37 (m, 2H), 3.35 (s, 6H), 3.52 (s, 3H), 3.66 (m, 1H), 3.78 (m, 1H), 4.62 (m, 1H), 6.17 (s, 2H), 7.16 (m, 2H), 7.41 (m, 1H), 7.82 (m, 1H), 11.05 (s, 1H). (+) LRMS (ESI) <i>m</i>/<i>z</i> 422 [M + H]<sup>+</sup>. HRMS (ESI): calcd for C<sub>25</sub>H<sub>28</sub>NO<sub>5</sub> [M + H]<sup>+</sup>, 422.1962; found, 422.1976. The next fraction afforded the alternate isomer (<b>55</b>) (4.5 mg, 3%). <b>55</b>: <sup>1</sup>H NMR (<i>d</i><sub>6</sub> DMSO, 500 MHz); 1.22 (d, <i>J</i> = 6 Hz, 3H), 1.43 (d, <i>J</i> = 6 Hz, 3H), 2.42 (m, 2H), 3.33 (s, 6H), 3.58 (s, 3H), 3.64 (m, 1H), 3.75 (m, 1H), 4.03 (m, 1H), 6.16 (s, 2H), 7.18 (m, 2H), 7.43 (m, 1H), 7.83 (m, 1H), 11.03 (s, 1H). (+) LRMS (ESI) <i>m</i>/<i>z</i> 422 [M + H]<sup>+</sup>. HRMS (ESI): calcd for C<sub>27</sub>H<sub>30</sub>NO<sub>7</sub>Na [M + Na]<sup>+</sup>, 444.1781; found, 444.1780.</div></div><div id="sec6_4_50" class="NLM_sec NLM_sec_level_3"><div id="ac_i112" class="anchor-spacer"></div><h4 class="article-section__title" id="_i112"> (1<i>R</i>,2<i>R</i>,2a<i>R</i>,10a<i>S</i>)-7-Methoxy-10,10-dimethyl-1-(1-methylethyl)-2-(3,4-dimethoxyphenyl)-1,2,2a,4,10,10a-hexahydro-3<i>H</i>-cyclobuta[4,5]pyrano[3,2-<i>c</i>]quinolin-3-one and (1<i>S</i>,2<i>S</i>,2a<i>S</i>,10a<i>R</i>)-7-Methoxy-10,10-dimethyl-1-(1-methylethyl)-2-(3,4-dimethoxyphenyl)-1,2,2a,4,10,10a-hexahydro-3<i>H</i>-cyclobuta[4,5]pyrano[3,2-<i>c</i>]quinolin-3-one (<b>57</b>)</h4><div class="NLM_p last"><b>2d</b> (0.15 mmol) and <b>4l</b> (0.30 mmol). Purified by isocratic elution MeCN/H<sub>2</sub>O (1% TFA, 55:45 for 60 min) to afford a white solid (10.9 mg, 16%). <sup>1</sup>H NMR (CDCl<sub>3</sub>, 500 MHz) δ 1.12 (s, H), 1.12 (d, <i>J</i> = 7 Hz, 3H), 1.47 (s, 3H), 2.32 (m, 2H), 3.28 (m, 1H), 3.35 (s, 6H), 3.52 (s, 3H), 3.76 (m, 1H), 3.78 (s, 3H), 6.11 (s, 2H), 7.09 (m, 2H), 7.25 (m, 1H), 10.95 (s, 1H). (+) LRMS (ESI) <i>m</i>/<i>z</i> 466 [M + H]<sup>+</sup>. HRMS (ESI): calcd for C<sub>28</sub>H<sub>34</sub>NO<sub>5</sub> [M + H]<sup>+</sup>, 466.2224; found, 466.2224.</div></div><div id="sec6_4_51" class="NLM_sec NLM_sec_level_3"><div id="ac_i113" class="anchor-spacer"></div><h4 class="article-section__title" id="_i113"> (1<i>R</i>,2<i>R</i>,2a<i>R</i>,10a<i>S</i>)-7-Methoxy-1,10,10-trimethyl-2-(3,4,5-trimethoxyphenyl)-1,2,2a,4,10,10a-hexahydro-3<i>H</i>-cyclobuta[4,5]pyrano[3,2-<i>c</i>]quinolin-3-one and (1<i>S</i>,2<i>S</i>,2a<i>S</i>,10a<i>R</i>)-7-Methoxy-1,10,10-trimethyl-2-(3,4,5-trimethoxyphenyl)-1,2,2a,4,10,10a-hexahydro-3<i>H</i>-cyclobuta[4,5]pyrano[3,2-<i>c</i>]quinolin-3-one (<b>58</b>)</h4><div class="NLM_p last">From <b>2d</b> (0.19 mmol) and <b>4a</b> (0.38 mmol). Purified by isocratic elution MeCN/H<sub>2</sub>O (1% TFA, 2:3 for 60 min) to afford a white solid (12.7 mg, 14%). <sup>1</sup>H NMR (CDCl<sub>3</sub>, 500 MHz) δ 0.69 (d, <i>J</i> = 6.5 Hz, 3H), 0.85 (d, <i>J</i> = 6.5 Hz, 3H), 1.13 (s, 3H), 1.48 (s, 3H), 1.80 (m, 1H), 2.30 (m, 2H), 3.15 (s, 3H), 3.49 (m, 1H), 3.59 (s, 3H), 3.63 (m, 1H), 3.79 (s, 3H), 6.27 (s, 1H), 6.48 (d, <i>J 8</i> Hz, 1H), 6.57 (d, <i>J</i> = 8 Hz, 1H), 7.07 (m, 2H), 7.24 (m, 1H), 10.84 (s, 1H). (+) LRMS (ESI) <i>m</i>/<i>z</i> 464 [M + H]<sup>+</sup>. HRMS (ESI): calcd for C<sub>27</sub>H<sub>32</sub>NO<sub>6</sub> [M + H]<sup>+</sup>, 464.2432; found, 464.2432.</div></div><div id="sec6_4_52" class="NLM_sec NLM_sec_level_3"><div id="ac_i114" class="anchor-spacer"></div><h4 class="article-section__title" id="_i114"> (1<i>R</i>,2<i>R</i>,2a<i>R</i>,8a<i>S</i>)-2-(3,4,5-Trimethoxyphenyl)-1,8,8-trimethyl-1,2,2a,4,8,8a-hexahydro-3<i>H</i>-cyclobuta[4,5]pyrano[3,2-<i>c</i>]pyridine-3-one and (1<i>S</i>,2<i>S</i>,2a<i>S</i>,8a<i>R</i>)-2-(3,4,5-Trimethoxyphenyl)-1,8,8-trimethyl-1,2,2a,4,8,8a-hexahydro-3<i>H</i>-cyclobuta[4,5]pyrano[3,2-<i>c</i>]pyridine-3-one (<b>59</b>)</h4><div class="NLM_p last">From <b>6</b> (0.088 g, 0.5 mmol) and <b>4a</b> (0.21 g, 1 mmol). Purified by reverse-phase HPLC with isocratic elution MeCN/H<sub>2</sub>O (1:1) to give 12.8 mg (6.6%) of an off-white solid. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 1.06 (s, 3H), 1.09 (s, 3H), 1.33 (s, 3H), 2.18 (m, 1H), 2.21 (m, 1H), 3.17 (t, <i>J</i> = 8.5 Hz, 1H), 3.75–3.50 (m, 10H), 5.83 (d, <i>J</i> = 7 Hz, 1H), 6.16 (apparent s, 2H), 7.07 (d, 1H, <i>J</i> = 7 Hz), 10.75 (bs, 1H). Using a combination of HSQC and ROESY, correlations were observed between the methyl group on the cyclobutane ring (δ 1.07 ppm) and H-3 (δ 2.18 ppm) and H-7′ (δ 3.17 ppm) and between H-7′ and H-3 and H-4 (δ 3.50 ppm). LRMS (ESI) <i>m</i>/<i>z</i> 386.4 [M + H]<sup>+</sup>.</div></div><div id="sec6_4_53" class="NLM_sec NLM_sec_level_3"><div id="ac_i115" class="anchor-spacer"></div><h4 class="article-section__title" id="_i115"> (1<i>R</i>,2<i>R</i>,2a<i>R</i>,8a<i>S</i>)-1-Ethyl-2-(3,4,5-trimethoxyphenyl)-8,8-dimethyl-1,2,2a,4,8,8a-hexahydro-3<i>H</i>-cyclobuta[4,5]pyrano[3,2-<i>c</i>]pyridine-3-one and (1<i>S</i>,2<i>S</i>,2a<i>S</i>,8a<i>R</i>)-1-Ethyl-2-(3,4,5-trimethoxyphenyl)-8,8-dimethyl-1,2,2a,4,8,8a-hexahydro-3<i>H</i>-cyclobuta[4,5]pyrano[3,2-<i>c</i>]pyridine-3-one (<b>60</b>)</h4><div class="NLM_p last">From <b>6</b> (0.088 g, 0.5 mmol) and <b>4f</b> (0.21 g, 1 mmol). Purified by reverse-phase HPLC with isocratic elution MeCN/H<sub>2</sub>O (1:1) to give (22 mg, 11%). <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 0.66 (t, <i>J</i> = 7.5 Hz, 3H), 1.07 (s, 3H), 1.32 (s, 3H), 1.45 (m, 1H), 1.60 (m, 1H), 2.20 (m, 1H), 2.26 (m, 1H), 2.19 (m, 2H), 3.30 (t, <i>J</i> = 9 Hz, 1H), 3.77–3.59 (m, 10H), 5.83 (t, <i>J</i> = 5.5 Hz, 1H), 6.16 (apparent s, 2H), 7.06 (d, <i>J</i> = 6.5 Hz, 1H), 10.75 (bs, 1H). Using a combination of HSQC and ROESY, correlations were observed between one of the methylene hydrogens (δ 1.45 ppm) and H-3 (δ 2.26 ppm) and between H-3 and H-4 (δ 3.50 ppm). LRMS (ESI) <i>m</i>/<i>z</i> 400.4 [M + H]<sup>+</sup>.</div></div><div id="sec6_4_54" class="NLM_sec NLM_sec_level_3"><div id="ac_i116" class="anchor-spacer"></div><h4 class="article-section__title" id="_i116"> (1<i>R</i>,2<i>R</i>,2a<i>R</i>,8a<i>S</i>)-1-Ethyl-2-(3,4-dimethoxyphenyl)-8,8-dimethyl-1,2,2a,4,8,8a-hexahydro-3<i>H</i>-cyclobuta[4,5]pyrano[3,2-<i>c</i>]pyridine-3-one and (1<i>S</i>,2<i>S</i>,2a<i>S</i>,8a<i>R</i>)-1-Ethyl-2-(3,4-dimethoxyphenyl)-8,8-dimethyl-1,2,2a,4,8,8a-hexahydro-3<i>H</i>-cyclobuta[4,5]pyrano[3,2-<i>c</i>]pyridine-3-one (<b>61</b>)</h4><div class="NLM_p last">From <b>6</b> (0.088 g, 0.5 mmol) and <b>4e</b> (0.21 g, 1 mmol). Purified by reverse-phase HPLC with isocratic elution MeCN/H<sub>2</sub>O (1:1) to give an off-white solid (15.6 mg, 8.5%). <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub><i>6</i></sub>) δ 0.63 (t, <i>J</i> = 7.5 Hz, 3H), 1.06 (s, 3H), 1.32 (s, 3H), 1.46 (m, 1H), 1.60 (m, 1H), 2.25 (m, 2H), 3.29 (t, <i>J</i> = 9.5 Hz, 1H), 3.51 (s, 3H), 3.65–3.62 (m, 4H), 5.83 (d, <i>J</i> = 7.5 Hz, 1H), 6.35 (s, 1H), 6.35 (d, <i>J</i> = 8.5 Hz, 1H), 6.48 (d, <i>J</i> = 8.5 Hz, 1H), 7.05 (d, <i>J</i> = 7.5 Hz, 1H), 10.75 (br s, 1H). Using a combination of HSQC and ROESY, correlations were observed between H-7′ (δ 3.29 ppm) and the methyl of the ethyl group (δ 0.63 ppm), H-3 (δ 2.25 ppm), H-4 (δ 3.50 ppm), and one of the methylene hydrogens (δ 1.46 ppm). LRMS (ESI) <i>m</i>/<i>z</i> 370.4 [M + H]<sup>+</sup>.</div></div></div><div id="sec6_4_55" class="NLM_sec NLM_sec_level_2"><div id="ac_i117" class="anchor-spacer"></div><h3 class="article-section__title" id="_i117"> General Procedure: Preparation of Acetals <b>62</b>–<b>64</b></h3><div class="NLM_p last">To a solution of flindersine (<b>2a</b>, 1.00 g, 4.4 mmol) and 4-methylmorpholine <i>N</i>-oxide (1.90 g, 16 mmol) in 2-methyl-2-propanol (100 mL), tetrahydrofuran (30 mL), and water (10 mL) was added a solution of 2.5% osmium tetroxide in 2-methyl-2propanol (2.45 mL). The resulting solution was stirred for 2 days. Saturated sodium hydrogen sulfite (50 mL) was added, and the mixture was extracted with dichloromethane (3 × 200 mL). The combined organic phase was dried (MgSO<sub>4</sub>) and filtered, and the solvent was removed in vacuo. The residue was purified by flash chromatography using methanol/chloroform (2:98) to give the flindersine diol <b>7</b> as a white solid (1.10 g, 96%). <sup>1</sup>H NMR (CDCl<sub>3</sub>, 500 MHz) δ 1.37 (s, 3H), 1.46 (s, 3H), 3.67 (dd, <i>J</i> = 4.5, 4.5 Hz, 1H), 4.78 (d, <i>J</i> = 4.5 Hz, 1H), 4.78 (dd <i>J</i> = 1.5, 4.5 Hz, 1H), 5.63 (d, <i>J</i> = 1.5 Hz, 1H), 7.18 (app t, <i>J</i> = 8 Hz, 1H), 7.31 (d, <i>J</i> = 8.5 Hz, 1H), 7.52 (app t, <i>J</i> = 8 Hz, 1H), 7.76 (d, <i>J</i> = 7.5 Hz, 1H), 11.56 (s, 1H). <sup>13</sup>C NMR (CDCl<sub>3</sub>, 125 MHz) δ 23.25, 25.96, 62.71, 70.67, 80.97, 106.78, 115.05, 115.93, 122.29, 123.28, 131.48, 138.54, 156.14, 164.36. (+) LRMS (ESI) <i>m</i>/<i>z</i> 262 [M + H]<sup>+</sup>. HPLC (Betasil C18 150 × 4.6 mm, 0–95% acetonitrile (0.1% TFA) in water (0.1% TFA)/9 min at 1.5 mL/min). <i>t</i><sub>R</sub> = 7.040 min.</div></div><div id="sec6_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i118" class="anchor-spacer"></div><h3 class="article-section__title" id="_i118"> 1-(3,5-Dimethoxyphenyl)butan-1-ol</h3><div class="NLM_p last">3,5-Dimethoxybenzaldehyde (2 g, 12 mmol) was dissolved in toluene (30 mL) and cooled to 0 °C. Propylmagnesium chloride (2.0 M in Et<sub>2</sub>O, 30 mL, 60 mmol) was added dropwise, and the reaction mixture was allowed to warm to rt and stirred for a further 16 h. To this was added 5% AcOH (30 mL), and the resulting mixture was extracted with EtOAc (80 mL). The organic phase was then extracted with water (50 mL), saturated NaHCO<sub>3</sub> (50 mL), and brine (50 mL). The organic phase was dried (MgSO<sub>4</sub>), filtered, and concentrated to afford 1-(3,5-dimethoxyphenyl)butan-1-ol (2.22 g, 88%) as a colorless oil. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 500 MHz) δ 0.85 (t, <i>J</i> = 7 Hz, 3H), 1.23 (m, 1H), 1.34 (m, 1H), 1.57 (m, 1H), 1.68 (m, 1H), 3.70 (s, 6H), 4.50 (m, 1H), 6.28 (dd, <i>J</i> = 1.5, 2 Hz, 1H), 6.41 (d, <i>J</i> = 2.5 Hz, 2H). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>, 125 MHz) δ 14.19, 19.27, 41.37, 74.68, 99.58, 104.08, 147.90, 161.10. (+) LRMS (ESI) <i>m</i>/<i>z</i> 211 [M + H]<sup>+</sup>.</div></div><div id="sec6_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i119" class="anchor-spacer"></div><h3 class="article-section__title" id="_i119"> 1-(3,5-Dimethoxyphenyl)butan-1-one</h3><div class="NLM_p">A solution of 1-(3,5-dimethoxyphenyl)butan-1-ol (2.22 g, 10.6 mmol) and manganese(IV) oxide (14.59 g, 176 mmol) in dichloromethane (20 mL) was stirred for 18 h. The reaction mixture was then filtered through a plug of silica, the residue was washed with chloroform, and the solvent was removed from the combined filtrate in vacuo. The residue was purified by flash chromatography using ethyl acetate/hexane (1:9) to give 1-(3,5-dimethoxyphenyl)butan-1-one (1.74 g, 79%). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 500 MHz) δ 0.94 (t, <i>J</i> = 7 Hz, 3H), 1.63 (app hx, <i>J</i> = 7 Hz, 2H), 2.98 (t, <i>J</i> = 7 Hz, 2H), 3.82 (s, 6H), 6.76 (app t, <i>J</i> = 2 Hz, 1H), 7.08 (d, <i>J</i> = 2 Hz, 2H). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>, 125 MHz) δ 14.29, 17.98, 40.56, 56.20, 105.55, 106.35, 139.63, 161.32, 200.38. (+) LRMS (ESI) <i>m</i>/<i>z</i> 209 [M + H]<sup>+</sup>.</div><div id="sec6_6_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i120" class="anchor-spacer"></div><h4 class="article-section__title" id="_i120"> 2-Butyl-2-(3,5-dimethoxyphenyl)-11,11-dimethyl-3a,5,11,11a-tetrahydro-1,3-dioxolo[4,5]pyrano[3,2-<i>c</i>]quinolin-4-one (<b>62</b>)</h4><div class="NLM_p last">To a solution of 1-(3,5-dimethoxyphenyl)butan-1-one (790 mg, 3.79 mmol) in methanol (4 mL) were added trimethyl orthoformate (2.00 mL, 18.28 mmol) and concentrated sulfuric acid (1 drop), and the resulting mixture was stirred under nitrogen for 18 h. Saturated sodium hydrogen carbonate (20 mL) and dichloromethane (50 mL) were then added, and the resulting mixture was filtered through a 1PS filter paper. The solvent was then removed from the organic phase in vacuo to give acetal <b>8a</b>. Without purification, <b>8a</b> was dissolved in dichloromethane (2 mL), and <b>7</b> (100 mg, 0.38 mmol) and pyridinium <i>p</i>-toulenesulfonate (220 mg) were added. The resulting solution was allowed to stir for 18 h, after which saturated sodium hydrogen carbonate (20 mL) and dichloromethane (50 mL) were added. The mixture was filtered through a 1PS filter paper, and the solvent was removed from the organic phase in vacuo. The residue was purified by flash chromatography using chloroform to give <b>62</b> (86 mg, 50%). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 500 MHz) δ 0.86 (t, <i>J</i> = 7 Hz, 3H), 1.21 (s, 3H), 1.32 (m, 2H), 1.66 (s, 3H), 1.75 (m, 2H), 3.51 (s, 6H), 4.40 (d, <i>J</i> = 5.5 Hz, 1H), 5.36 (d, <i>J</i> = 5.5 Hz, 1H), 5.82 (s, 1H), 6.38 (s, 2H), 7.01 (app t, <i>J</i> = 7.5 Hz, 1H), 7.09 (d, <i>J</i> = 8.5 Hz, 1H), 7.39 (app t, <i>J</i> = 7.5 Hz, 1H), 7.49 (d, <i>J</i> = 7.5 Hz, 1H), 11.18 (s, 1H). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>, 125 MHz) δ 14.64, 17.19, 21.94, 25.85, 44.05, 55.43, 68.57, 78.47, 79.33, 99.16, 103.29, 105.55, 110.92, 114.37, 115.26, 121.40, 122.91, 131.21, 138.95, 147.15, 156.49, 159.88, 162.48. ROESY correlations were observed between the 11a methine H (δ 4.40 ppm) and the 3a methine H (δ 5.36 ppm) and between the 11a methine H (δ 4.40 ppm) and the methylene hydrogens of the butyl group (δ 1.75 and 1.32 ppm), confirming the cis relationship of the dimethoxyphenyl and the pyranoquinolinone ring systems. (+) LRMS (ESI) <i>m</i>/<i>z</i> 474 [M + Na]<sup>+</sup>. HRMS (ESI): calcd for C<sub>26</sub>H<sub>30</sub>NO<sub>6</sub> [M + H]<sup>+</sup>, 452.2068; found, 452.2069.</div></div><div id="sec6_6_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i121" class="anchor-spacer"></div><h4 class="article-section__title" id="_i121"> 2-Butyl-2-(3,4-dimethoxyphenyl)-11,11-dimethyl-3a,5,11,11a-tetrahydro-1,3-dioxolo[4,5]pyrano[3,2-<i>c</i>]quinolin-4-one (<b>63</b>)</h4><div class="NLM_p last">From 1-(3,4-dimethoxyphenyl)butan-1-one (790 mg, 3.79 mmol) and <b>7</b> (100 mg, 0.38 mmol) was obtained <b>63</b> (171 mg, 99%). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 500 MHz) δ 0.85 (t, <i>J</i> = 7 Hz, 3H), 1.20 (s, 3H), 1.32 (m, 2H), 1.65 (s, 3H), 1.78 (m, 2H), 3.37 (s, 3H), 3.57 (s, 3H), 4.40 (d, <i>J</i> = 6.5 Hz, 1H), 5.35 (d, <i>J</i> = 6.5 Hz, 1H), 6.46 (d, <i>J</i> = 8.5 Hz, 1H), 6.75 (dd, <i>J</i> = 8.5, 1.5 Hz, 1H), 6.80 (d, <i>J</i> = 1.5 Hz, 1H), 7.01 (app t, <i>J</i> = 7.5 Hz, 1H), 7.09 (d, <i>J</i> = 8.5 Hz, 1H), 7.37 (app t, <i>J</i> = 8 Hz, 1H), 7.50 (d, <i>J</i> = 8 Hz, 1H), 11.18 (s, 1H). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>, 125 MHz) δ 14.66, 17.35, 22.04, 25.78, 44.17, 55.71, 56.18, 68.50, 78.61, 79.25, 105.82, 109.40, 111.04, 111.82, 114.47, 115.32, 117.46, 121.51, 122.90, 131.18, 137.50, 138.86, 148.12, 148.19, 156.34, 162.47. ROESY correlations were observed between the 11a methine H (δ 4.40 ppm) and the 3a methine H (δ 5.35 ppm) and between the 11a methine H (δ 4.40 ppm) and the methylene hydrogens of the butyl group (δ 1.78 and 1.32 ppm), confirming the cis relationship of the dimethoxyaryl and the pyranoquinolinone ring systems. (+) LRMS (ESI) <i>m</i>/<i>z</i> 474 [M + Na]<sup>+</sup>. HRMS (ESI): calcd for C<sub>26</sub>H<sub>30</sub>NO<sub>6</sub> [M + H]<sup>+</sup>, 452.2068; found, 452.2072.</div></div><div id="sec6_6_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i122" class="anchor-spacer"></div><h4 class="article-section__title" id="_i122"> 2-Butyl-2-(3,4,5-trimethoxyphenyl)-11,11-dimethyl-3<i>a</i>,5,11,11<i>a</i>-tetrahydro-1,3-dioxolo[4,5]pyrano[3,2-<i>c</i>]quinolin-4-one (<b>64</b>)</h4><div class="NLM_p last">From 1-(3,4,5-trimethoxyphenyl)butan-1-one (238 mg, 3.29 mmol) and <b>7</b> (100 mg, 0.38 mmol) was obtained <b>64</b> (56 mg, 30%). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 500 MHz) δ 0.87 (t, <i>J</i> = 7.5 Hz, 3H), 1.19 (s, 3H), 1.37 (m, 2H), 1.70 (s, 3H), 1.74 (m, 2H), 2.96 (s, 3H), 3.63 (s, 6H), 4.39 (d, <i>J</i> = 6.5 Hz, 1H), 5.36 (d, <i>J</i> = 6.5 Hz, 1H), 6.51 (s, 2H), 6.99 (app t, <i>J</i> = 7.5 Hz, 1H), 7.05 (d, <i>J</i> = 8 Hz, 1H), 7.33 (app t, <i>J</i> = 7.5 Hz, 1H), 7.47 (d, <i>J</i> = 8 Hz, 1H), 11.16 (s, 1H). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>, 125 MHz) δ 19.39, 21.83, 26.67, 30.68, 48.99, 60.86, 64.71, 73.29, 83.36, 84.34, 107.40, 110.49, 115.62, 119.12, 120.04, 126.25, 127.44, 135.84, 141.39, 143.64, 145.63, 156.75, 161.22, 167.13. ROESY correlations were observed between the 11a methine H (δ 4.39 ppm) and the 3a methine H (δ 5.36 ppm) and between the 11a methine H (δ 4.39 ppm) and H-8′ (methylene hydrogens of the butyl group, δ 1.37 ppm), confirming the cis relationship of the trimethoxyaryl and the pyranoquinolinone ring systems. (+) LRMS (ESI) <i>m</i>/<i>z</i> 482 [M + H]<sup>+</sup>, 504 [M + Na]<sup>+</sup>. HRMS (ESI): calcd for C<sub>27</sub>H<sub>32</sub>NO<sub>7</sub> [M + H]<sup>+</sup>, 482.2173; found, 482.2168.</div></div></div><div id="sec7" class="NLM_sec NLM_sec_level_2"><div id="ac_i123" class="anchor-spacer"></div><h3 class="article-section__title" id="_i123"> Biological Assays</h3><div id="sec7_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i124" class="anchor-spacer"></div><h4 class="article-section__title" id="_i124"> Human TLR4 Reporter Assays</h4></div><div id="sec7_1_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i125" class="anchor-spacer"></div><h4 class="article-section__title" id="_i125"> Stable TLR4/CD14/MD-2 Transfectants</h4><div class="NLM_p last">HEK293-human TLR4/CD14/MD-2 cells, stably transfected with human TLR4 (pUNO expression vector), CD14, MD-2 (pDUO expression vector), and pNiFty2-SEAP reporter plasmid were maintained in Dulbecco’s modified Eagle’s medium supplemented with 10% FCS (v/v), 2 mM <span class="smallcaps smallerCapital">l</span>-glutamine, nonessential amino acids, 10 μg/mL blasticidin S, 50 μg/mL hygromycin, and 100 μg/mL zeocin. Cells were seeded in tissue culture-treated clear flat-bottom polystyrene 96- or 384-well plates (Costar, 3598) at 1 × 10<sup>4</sup> cells/well. Dose–response curves were generated by addition of test compounds and incubation for 20 h at 37 °C in an atmosphere of 5% CO<sub>2</sub>. LPS (<i>Escherichia coli</i> 0111:B4 (Ultrapure, Invivogen) was used as a positive control. The SEAP released was quantified using <i>p</i>-nitrophenyl phosphate as a substrate, and the absorbance at 405 nm was measured at 30 s intervals over several minutes using a microplate reader. Data is expressed as <i>V</i><sub>max</sub> calculated over the linear portion of the kinetic absorbance measurements.</div></div><div id="sec7_1_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i126" class="anchor-spacer"></div><h4 class="article-section__title" id="_i126"> Transient Transfections with Human CD14 and MD-2</h4><div class="NLM_p last">TLR4-expressing HEK293 cells (stably transfected with human TLR4 (pUNO expression plasmid) plus pNiFty2-SEAP reporter plasmid were transiently transfected using either pUNO-human MD-2, pUNO-human CD14, pDUO-CD14/MD-2, or pUNO-(empty) and then seeded in tissue culture-treated clear flat-bottom polystyrene 96-well plates (Costar, 3598) at 10 000 cells per well in 100 μL of media (DMEM, 10% FCS, and 2 mM <span class="smallcaps smallerCapital">l</span>-glutamine). Cells were incubated overnight at 37 °C/5% CO<sub>2</sub> in a humidified incubator. Compound treatments and SEAP assay were performed as above.</div></div><div id="sec7_1_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i127" class="anchor-spacer"></div><h4 class="article-section__title" id="_i127"> Transient Transfections with Different Combinations of Human and Mouse TLR4, CD14, and MD-2</h4><div class="NLM_p last">HEK293 cells stably transfected with pNiFty2-SEAP reporter plasmid were transiently transfected with either human or mouse TLR4 (pUNO expression vector) in combination with either human or mouse CD14/MD-2 (pDUO expression vector) and then seeded in tissue culture-treated clear flat-bottom polystyrene 96-well plates (Costar, 3598) at 30 000 cells per well in 100 μL of media (DMEM, 10% FCS, and 2 mM <span class="smallcaps smallerCapital">l</span>-glutamine). Cells were incubated overnight at 37 °C/5% CO<sub>2</sub> in a humidified incubator. Compound treatments and SEAP assay were performed as above. Results are expressed as the percent of the maximal response to TNF-α in the same experiment.</div></div><div id="sec7_1_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i128" class="anchor-spacer"></div><h4 class="article-section__title" id="_i128"> Testing Human/Mouse Chimeric TLR4 Receptors</h4><div class="NLM_p">Chimeric TLR4 constructs were made that expressed the human TLR4 extracellular domain fused to the mouse transmembrane and cytoplasmic domains or the mouse TLR4 extracellular domain fused to the human transmembrane and cytoplasmic domains. Site-directed mutagenesis of human and mouse TLR4 was performed to introduce a PciI restriction site at a conserved position in the coding region for the extracellular domain, close to the predicted transmembrane domain, without affecting the amino acid sequence. Constructs encoding the chimeric receptors were generated in the pUNO expression vector using this restriction site to join the coding sequences for the human and mouse domains.</div><div class="NLM_p last">HEK293 cells stably transfected with human CD14/MD-2 (pDUO expression vector) and the pNiFty2-SEAP reporter plasmid were transiently transfected with either human, mouse, human/mouse, or mouse/human TLR4 construct and then seeded in tissue culture-treated clear flat-bottom polystyrene 96-well plates (Costar, 3598) at 30 000 cells per well in 100 μL of media (as described above). Cells were incubated overnight at 37 °C/5% CO<sub>2</sub> in a humidified incubator. Compound treatments and SEAP assay were performed as above.</div></div><div id="sec7_1_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i129" class="anchor-spacer"></div><h4 class="article-section__title" id="_i129"> TLR Selectivity Testing</h4><div class="NLM_p">HEK293 cells stably expressing pNiFty2-SEAP reporter plasmid and a pUNO or pDUO expression plasmid containing either human TLR2, 2/6, 3, 5, 7 or 8 were maintained as above for the human TLR4/CD14/MD-2 cells. Cells were seeded in tissue culture-treated clear polystyrene 384-well plates at 7500 cells per well. Compound treatment was performed as above. The SEAP released was quantified using DDAO phosphate as a substrate, and fluorescence was measured at an excitation of 620 nm and emission of 665 nm in a PerkinElmer Envision spectrophotometer. Positive control compounds for each cell line are given in Table <a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">7</a>.</div><div class="NLM_table-wrap" id="tbl7">Table 7<div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col></colgroup><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">TLR2, 2/6</td><td class="colsep0 rowsep0" align="left">Pam3cysk4 (Invivogen, France)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">TLR3</td><td class="colsep0 rowsep0" align="left">Poly(I:C) (Invivogen, France)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">TLR5</td><td class="colsep0 rowsep0" align="left">Flagellin (Invivogen, France)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">TLR4</td><td class="colsep0 rowsep0" align="left">Ultrapure LPS (Invivogen, France)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">TLR7 and 8</td><td class="colsep0 rowsep0" align="left">R848 (AstraZeneca, UK)</td></tr></tbody></table></div></div></div><div id="sec7_1_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i130" class="anchor-spacer"></div><h4 class="article-section__title" id="_i130"> Human PBMC Preparation</h4><div class="NLM_p last">Blood from healthy, consenting volunteers was collected into heparin, layered onto Lymphoprep (Axis-Shield Diagnostics), and centrifuged at 700<i>g</i> for 25 min. The PBMC layer was removed, diluted to 50 mL with PBS, and centrifuged at 400<i>g</i> for 10 min. The supernatant was removed, and the pellet was resuspended in 50 mL of PBS and centrifuged at 300<i>g</i> for 5 min. The cells were then washed in 50 mL of PBS and recovered by centrifuging at 200<i>g</i> for 5 min. PBMCs were resuspended in assay medium (RPMI 1640 with 25 mM HEPES, 10% FCS (v/v), 2 mM <span class="smallcaps smallerCapital">l</span>-glutamine, 10 U/mL penicillin, and 10 μg/mL streptomycin).</div></div><div id="sec7_1_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i131" class="anchor-spacer"></div><h4 class="article-section__title" id="_i131"> PBMC Incubations</h4><div class="NLM_p last">Twenty microliters of test compound or assay medium with 1% DMSO (v/v), vehicle control, were added to each well of a 96-well polystyrene tissue culture-treated clear flat-bottom plate (Costar 3598) followed by 180 μL of PBMC cell suspension (prepared as above) in assay medium (200 000 cells). PBMCs and compounds were incubated at 37 °C in an atmosphere of air/CO<sub>2</sub> (95:5 v/v) for 20 h for cytokine stimulation and 44 h for IL-5 suppression studies (see below).</div></div><div id="sec7_1_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i132" class="anchor-spacer"></div><h4 class="article-section__title" id="_i132"> Cytokine Determinations</h4><div class="NLM_p last">Cytokines were determined from PBMC supernatants using the following commercial kits (OptEIA kits, BD, Oxford, UK) following the manufacturer’s instructions: human IL-5 (555202), human TNF-α (555212), human IL-12p40 (555171), human IL-8 (555244), and human IL-10 (555157).</div></div><div id="sec7_1_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i133" class="anchor-spacer"></div><h4 class="article-section__title" id="_i133"> Human PBMC IL-5 Suppression Assay</h4><div class="NLM_p last">Human PBMCs were prepared and plated out with compounds as described above. Phytohemeagglutinin (PHA) (Sigma, Dorset, UK) was added at a final concentration of 1 μg/mL, and the PBMCs were then incubated for 44 h before the supernatant was removed for determination of the amount of IL-5 produced.</div></div><div id="sec7_1_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i134" class="anchor-spacer"></div><h4 class="article-section__title" id="_i134"> Cytotoxicity Measurements</h4><div class="NLM_p last">Cytotoxicity was determined in PBMC assays by measuring cellular metabolic activity using the WST-1 cell proliferation reagent (Roche Diagnostics, UK).</div></div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i135"><a href="/doi/suppl/10.1021/jm401321v">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_22717" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_22717" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">Representative NMR data for the 10 most active compounds from the cyclobutane series (compounds <b>1</b>, <b>20</b>, <b>22</b>, <b>26</b>, <b>31</b>, <b>32</b>, <b>34</b>, <b>35</b>, <b>52</b>, and <b>53</b>) and two of the acetal analogues (compounds <b>63</b> and <b>64</b>). Selectivity data for euodenine A, LPS, and the positive controls across the TLR lines. This material is available free of charge via the Internet at <a href="http://pubs.acs.org" class="extLink">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm401321v/suppl_file/jm401321v_si_001.pdf">jm401321v_si_001.pdf (2.52 MB)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/jm401321v" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_21464" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_21464" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ronald J. Quinn</span> - <span class="hlFld-Affiliation affiliation">Eskitis
Institute for Drug Discovery, Griffith University, Nathan, 4111 Queensland, Australia</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#7e2c502f0b1710103e190c171818170a16501b1a0b501f0b"><span class="__cf_email__" data-cfemail="3a68146b4f5354547a5d48535c5c534e52145f5e4f145b4f">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Juliette E. Neve</span> - <span class="hlFld-Affiliation affiliation">Eskitis
Institute for Drug Discovery, Griffith University, Nathan, 4111 Queensland, Australia</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Hasanthi P. Wijesekera</span> - <span class="hlFld-Affiliation affiliation">Eskitis
Institute for Drug Discovery, Griffith University, Nathan, 4111 Queensland, Australia</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sandra Duffy</span> - <span class="hlFld-Affiliation affiliation">Eskitis
Institute for Drug Discovery, Griffith University, Nathan, 4111 Queensland, Australia</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ian D. Jenkins</span> - <span class="hlFld-Affiliation affiliation">Eskitis
Institute for Drug Discovery, Griffith University, Nathan, 4111 Queensland, Australia</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Justin A. Ripper</span> - <span class="hlFld-Affiliation affiliation">Eskitis
Institute for Drug Discovery, Griffith University, Nathan, 4111 Queensland, Australia</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Simon J. Teague</span> - <span class="hlFld-Affiliation affiliation">AstraZeneca
R&D Charnwood, Bakewell
Road, Loughborough, LE11
5RH Leicestershire, United Kingdom</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Marc Campitelli</span> - <span class="hlFld-Affiliation affiliation">Eskitis
Institute for Drug Discovery, Griffith University, Nathan, 4111 Queensland, Australia</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Agatha Garavelas</span> - <span class="hlFld-Affiliation affiliation">Eskitis
Institute for Drug Discovery, Griffith University, Nathan, 4111 Queensland, Australia</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">George Nikolakopoulos</span> - <span class="hlFld-Affiliation affiliation">Eskitis
Institute for Drug Discovery, Griffith University, Nathan, 4111 Queensland, Australia</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Phuc V. Le</span> - <span class="hlFld-Affiliation affiliation">Eskitis
Institute for Drug Discovery, Griffith University, Nathan, 4111 Queensland, Australia</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Priscila de A. Leone</span> - <span class="hlFld-Affiliation affiliation">Eskitis
Institute for Drug Discovery, Griffith University, Nathan, 4111 Queensland, Australia</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ngoc B. Pham</span> - <span class="hlFld-Affiliation affiliation">Eskitis
Institute for Drug Discovery, Griffith University, Nathan, 4111 Queensland, Australia</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Philip Shelton</span> - <span class="hlFld-Affiliation affiliation">AstraZeneca
R&D Charnwood, Bakewell
Road, Loughborough, LE11
5RH Leicestershire, United Kingdom</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Neil Fraser</span> - <span class="hlFld-Affiliation affiliation">AstraZeneca
R&D Charnwood, Bakewell
Road, Loughborough, LE11
5RH Leicestershire, United Kingdom</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Anthony R. Carroll</span> - <span class="hlFld-Affiliation affiliation">Eskitis
Institute for Drug Discovery, Griffith University, Nathan, 4111 Queensland, Australia</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Vicky M. Avery</span> - <span class="hlFld-Affiliation affiliation">Eskitis
Institute for Drug Discovery, Griffith University, Nathan, 4111 Queensland, Australia</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Christopher McCrae</span> - <span class="hlFld-Affiliation affiliation">AstraZeneca
R&D Mölndal, Translational Science, Respiratory & Inflammation
iMed, Pepperedsleden
1, SE-431 83 Mölndal, Sweden</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Nicola Williams</span> - <span class="hlFld-Affiliation affiliation">AstraZeneca
R&D Charnwood, Bakewell
Road, Loughborough, LE11
5RH Leicestershire, United Kingdom</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d1061e13190-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i136">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_81723" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_81723" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We thank Hoan T. Vu for HRMS measurements and Mark Furber for assistance in the preparation of this manuscript.</p></div><div class="postAsapNotesSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="postAsapNotesSection">Note Added After ASAP Publication</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_82331" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_82331" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="first last">Dr. George Nikolakopoulos' name was misspelled in the version published ASAP on February 7, 2014. The corrected version was re-posted on February 11,  2014.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i137" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i137"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i138" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i138"> Abbreviations Used</h2><tr><td class="NLM_term">CD14</td><td class="NLM_def"><p class="first last">cluster of differentiation 14</p></td></tr><tr><td class="NLM_term">MD-2</td><td class="NLM_def"><p class="first last">MD-2 is a 160-amino acid protein that is associated with TLR4 on the cell surface and enables TLR4 to respond to LPS</p></td></tr><tr><td class="NLM_term">PBMC</td><td class="NLM_def"><p class="first last">peripheral blood mononuclear cells</p></td></tr><tr><td class="NLM_term">SEAP</td><td class="NLM_def"><p class="first last">secreted embryonic alkaline phosphatase</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i139">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_45246" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_45246" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 22 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Hashimoto, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hudson, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, K. V.</span><span> </span><span class="NLM_article-title">The Toll gene of Drosophila, required for dorsal-ventral embryonic polarity, appears to encode a transmembrane protein</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1988</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">269</span><span class="NLM_x">–</span> <span class="NLM_lpage">279</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=1988&pages=269-279&author=C.+Hashimotoauthor=K.+L.+Hudsonauthor=K.+V.+Anderson&title=The+Toll+gene+of+Drosophila%2C+required+for+dorsal-ventral+embryonic+polarity%2C+appears+to+encode+a+transmembrane+protein"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHashimoto%26aufirst%3DC.%26aulast%3DHudson%26aufirst%3DK.%2BL.%26aulast%3DAnderson%26aufirst%3DK.%2BV.%26atitle%3DThe%2520Toll%2520gene%2520of%2520Drosophila%252C%2520required%2520for%2520dorsal-ventral%2520embryonic%2520polarity%252C%2520appears%2520to%2520encode%2520a%2520transmembrane%2520protein%26jtitle%3DCell%26date%3D1988%26volume%3D52%26spage%3D269%26epage%3D279" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Medzhitov, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Preston-Hurlburt, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janeway, C. A.,  Jr.</span><span> </span><span class="NLM_article-title">A human homologue of the Drosophila Toll protein signals activation of adaptive immunity</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">388</span><span class="NLM_x">, </span> <span class="NLM_fpage">394</span><span class="NLM_x">–</span> <span class="NLM_lpage">397</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm401321v&amp;key=10.1038%2F41131" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm401321v&amp;key=9237759" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm401321v&amp;key=1%3ACAS%3A528%3ADyaK2sXkvVChurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=388&publication_year=1997&pages=394-397&author=R.+Medzhitovauthor=P.+Preston-Hurlburtauthor=C.+A.+Janeway&title=A+human+homologue+of+the+Drosophila+Toll+protein+signals+activation+of+adaptive+immunity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">A human homolog of the Drosophila Toll protein signals activation of adaptive immunity</span></div><div class="casAuthors">Medzhitov, Rusian; Preston-Hurlburt, Paula; Janeway, Charles A., Jr.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London)</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">388</span>
        (<span class="NLM_cas:issue">6640</span>),
    <span class="NLM_cas:pages">394-396</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Macmillan Magazines</span>)
        </div><div class="casAbstract">Induction of the adaptive immune response depends on the expression of co-stimulatory mols. and cytokines by antigen-presenting cells.  The mechanisms that control the initial induction of these signals upon infection are poorly understood.  It has been proposed that their expression is controlled by the non-clonal, or innate, component of immunity that preceded in evolution the development of an adaptive immune system in vertebrates.  The authors report here the cloning and characterization of a human homolog of the Drosophila toll protein (Toll) which has been shown to induce the innate immune response in adult Drosophila.  Like Drosophila Toll, human Toll is a type I transmembrane protein with an extracellular domain consisting of a leucine-rich repeat (LRR) domain, and a cytoplasmic domain homologous to the cytoplasmic domain of the human interleukin (IL)-1 receptor.  Both Drosophila Toll and the IL-1 receptor are known to signal through the NF-κB pathway.  The authors show that a constitutively active mutant of human Toll transfected into human cell lines can induce the activation of NF-κB and the expression of NF-κB-controlled genes for the inflammatory cytokines IL-1, IL-6 and IL-8, as well as the expression of the co-stimulatory mol. B7.1, which is required for the activation of naive T cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq3V83d3kAO07Vg90H21EOLACvtfcHk0lhI_6xJGAXaFQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXkvVChurc%253D&md5=88d3d9bcebce8c0df8ad09e2d9fc13f2</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1038%2F41131&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F41131%26sid%3Dliteratum%253Aachs%26aulast%3DMedzhitov%26aufirst%3DR.%26aulast%3DPreston-Hurlburt%26aufirst%3DP.%26aulast%3DJaneway%26aufirst%3DC.%2BA.%26atitle%3DA%2520human%2520homologue%2520of%2520the%2520Drosophila%2520Toll%2520protein%2520signals%2520activation%2520of%2520adaptive%2520immunity%26jtitle%3DNature%26date%3D1997%26volume%3D388%26spage%3D394%26epage%3D397" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Andreakos, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foxwell, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feldmann, M.</span><span> </span><span class="NLM_article-title">Is targeting Toll-like receptors and their signaling pathway a useful therapeutic approach to modulating cytokine-driven inflammation?</span> <span class="citation_source-journal">Immunol. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">202</span><span class="NLM_x">, </span> <span class="NLM_fpage">250</span><span class="NLM_x">–</span> <span class="NLM_lpage">265</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm401321v&amp;key=10.1111%2Fj.0105-2896.2004.00202.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Fjm401321v&amp;key=15546398" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm401321v&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhs1Ohug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=202&publication_year=2004&pages=250-265&author=E.+Andreakosauthor=B.+Foxwellauthor=M.+Feldmann&title=Is+targeting+Toll-like+receptors+and+their+signaling+pathway+a+useful+therapeutic+approach+to+modulating+cytokine-driven+inflammation%3F"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Is targeting Toll-like receptors and their signaling pathway a useful therapeutic approach to modulating cytokine-driven inflammation?</span></div><div class="casAuthors">Andreakos, Evangelos; Foxwell, Brian; Feldmann, Marc</div><div class="citationInfo"><span class="NLM_cas:title">Immunological Reviews</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">202</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">250-265</span>CODEN:
                <span class="NLM_cas:coden">IMRED2</span>;
        ISSN:<span class="NLM_cas:issn">0105-2896</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">A review.  Cytokine-driven inflammation and tissue destruction is a common theme of chronic inflammatory diseases such as rheumatoid arthritis, Crohn's disease, ulcerative colitis, psoriasis, chronic obstructive pulmonary disease, and atherosclerosis.  Research over the last two decades demonstrated the importance of cytokines that are not only expressed chronically but also are capable of signaling at sites of chronic inflammation.  Cytokines thus regulate major pathol. processes that include inflammation, angiogenesis, tissue remodeling, and fibrosis.  This research led to the identification of key cytokines involved in these processes, two of which, tumor necrosis factor-α and interleukin-1, have also been successfully targeted in the clinic.  However, what triggers and maintains cytokine gene expression in chronic inflammation remains a mystery.  Here, the authors review current progress in the understanding of cytokine-driven inflammation and discuss current evidence implicating Toll-like receptors (TLRs), recently identified as the receptors recognizing self vs. non-self mol. patterns, in the regulation of cytokine-driven inflammation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpqh_TV08KZTbVg90H21EOLACvtfcHk0lhI_6xJGAXaFQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhs1Ohug%253D%253D&md5=c2d6c510bc3e7f495a8c100f886583e7</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1111%2Fj.0105-2896.2004.00202.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.0105-2896.2004.00202.x%26sid%3Dliteratum%253Aachs%26aulast%3DAndreakos%26aufirst%3DE.%26aulast%3DFoxwell%26aufirst%3DB.%26aulast%3DFeldmann%26aufirst%3DM.%26atitle%3DIs%2520targeting%2520Toll-like%2520receptors%2520and%2520their%2520signaling%2520pathway%2520a%2520useful%2520therapeutic%2520approach%2520to%2520modulating%2520cytokine-driven%2520inflammation%253F%26jtitle%3DImmunol.%2520Rev.%26date%3D2004%26volume%3D202%26spage%3D250%26epage%3D265" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Gangloff, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guenounou, M.</span><span> </span><span class="NLM_article-title">Toll-like receptors and immune response in allergic disease</span> <span class="citation_source-journal">Clin. Rev. Allergy Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">115</span><span class="NLM_x">–</span> <span class="NLM_lpage">125</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm401321v&amp;key=10.1007%2Fs12016-004-0006-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm401321v&amp;key=15146108" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm401321v&amp;key=1%3ACAS%3A528%3ADC%252BD2cXlsFyhs7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2004&pages=115-125&author=S.+C.+Gangloffauthor=M.+Guenounou&title=Toll-like+receptors+and+immune+response+in+allergic+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Toll-like receptors and immune response in allergic disease</span></div><div class="casAuthors">Gangloff, Sophie C.; Guenounou, Moncef</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Reviews in Allergy & Immunology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">115-125</span>CODEN:
                <span class="NLM_cas:coden">CRAIF2</span>;
        ISSN:<span class="NLM_cas:issn">1080-0549</span>.
    
            (<span class="NLM_cas:orgname">Humana Press Inc.</span>)
        </div><div class="casAbstract">A review.  Allergic reactions are dominated by the preferential development of specific Th2 responses against innocuous antigens in atopic individuals.  This can reflect alterations in innate immune mechanisms.  Toll-like receptors (TLRs) have evolved as key mols. in innate and adaptive immunity.  Their activation by structurally distinct exogenous or endogenous ligands present at the cell microenvironment plays a crit. role in antimicrobial defense.  The global view is that TLR activation induces antigen-presenting cells to produce cytokines that favor Th1-type immune responses, suggesting that it might prevent the development of deleterious Th2 responses in allergy.  On the basis of epidemiol. studies and recent data, it has been established that TLRs play a role in the development of Th2 responses.  However, more information is needed to fully understand the mechanism of TLR involvement and the implication of immune cells that express TLRs in the Th1/Th2 cytokine profiles.  Several TLRs, such as TLR9, TLR7, and TLR8, can be considered as good target candidates.  Some TLR ligands, such as CpG DNA, are effective adjuvants, strong inducers of both IL-5 and eosinophilia downregulation.  They are also potential links to allergen epitopes that could provide new allergen-specific immunotherapy regimens for the treatment of allergic disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpcFaeJV-TwgLVg90H21EOLACvtfcHk0livGaPLCIW4ZQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXlsFyhs7k%253D&md5=942277305e3fb731efd9ec24b86b7d76</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1007%2Fs12016-004-0006-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs12016-004-0006-0%26sid%3Dliteratum%253Aachs%26aulast%3DGangloff%26aufirst%3DS.%2BC.%26aulast%3DGuenounou%26aufirst%3DM.%26atitle%3DToll-like%2520receptors%2520and%2520immune%2520response%2520in%2520allergic%2520disease%26jtitle%3DClin.%2520Rev.%2520Allergy%2520Immunol.%26date%3D2004%26volume%3D26%26spage%3D115%26epage%3D125" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Hennessy, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parker, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Neill, L. A. J.</span><span> </span><span class="NLM_article-title">Targetting Toll-like receptors: Emerging therapeutics</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">293</span><span class="NLM_x">–</span> <span class="NLM_lpage">301</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2010&pages=293-301&author=E.+J.+Hennessyauthor=A.+E.+Parkerauthor=L.+A.+J.+O%E2%80%99Neill&title=Targetting+Toll-like+receptors%3A+Emerging+therapeutics"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHennessy%26aufirst%3DE.%2BJ.%26aulast%3DParker%26aufirst%3DA.%2BE.%26aulast%3DO%25E2%2580%2599Neill%26aufirst%3DL.%2BA.%2BJ.%26atitle%3DTargetting%2520Toll-like%2520receptors%253A%2520Emerging%2520therapeutics%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2010%26volume%3D9%26spage%3D293%26epage%3D301" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Ishihara, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rumi, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ortega-Cava, C. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kazumori, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kadowaki, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishimura, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kinoshita, Y.</span><span> </span><span class="NLM_article-title">Therapeutic targeting of toll-like receptors in gastrointestinal inflammation</span> <span class="citation_source-journal">Curr. Pharm. Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">4215</span><span class="NLM_x">–</span> <span class="NLM_lpage">4228</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm401321v&amp;key=10.2174%2F138161206778743448" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm401321v&amp;key=17100624" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm401321v&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht1Grtr3K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2006&pages=4215-4228&author=S.+Ishiharaauthor=M.+A.+Rumiauthor=C.+F.+Ortega-Cavaauthor=H.+Kazumoriauthor=Y.+Kadowakiauthor=N.+Ishimuraauthor=Y.+Kinoshita&title=Therapeutic+targeting+of+toll-like+receptors+in+gastrointestinal+inflammation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Therapeutic targeting of Toll-like receptors in gastrointestinal inflammation</span></div><div class="casAuthors">Ishihara, Shunji; Rumi, Mohammad A. K.; Ortega-Cava, Cesar-F.; Kazumori, Hideaki; Kadowaki, Yasunori; Ishimura, Norihisa; Kinoshita, Yoshikazu</div><div class="citationInfo"><span class="NLM_cas:title">Current Pharmaceutical Design</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">32</span>),
    <span class="NLM_cas:pages">4215-4228</span>CODEN:
                <span class="NLM_cas:coden">CPDEFP</span>;
        ISSN:<span class="NLM_cas:issn">1381-6128</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Toll-like receptors (TLRs) are sensors of microbial products that initiate host defense responses in multicellular organisms.  They are mainly linked to innate immunity and bridging to adaptive immunity, signaling through different TLRs responsible for a wide range of biol. responses.  The intracellular signaling pathways through Toll/interleukin-1 receptor (IL-1R) domains result in recruitment of the cytoplasmic adaptor mols., with subsequent activation of a signaling cascade leading to nuclear factor-κB (NF-κB).  TLR-signaling induces host inflammatory response and the inflammation becomes more severe in the absence of several extra and intra cellular neg. regulators of TLR-signaling.  In the intestine, TLR-dependent activation of NF-κB plays a vital role in maintaining epithelial homeostasis as well as regulating infections and inflammation, while dysregulation of TLR-signaling is assocd. with the pathogenesis of inflammatory bowel diseases (IBD).  Recent findings regarding innate immunity-mediated regulation of intestinal pathophysiol. prove that development of new drugs targeting TLRs including antagonists of TLR-signaling and agonists of their neg. regulators has a potential impact on therapeutic strategies for intestinal inflammatory diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqNSSVr9K9JibVg90H21EOLACvtfcHk0livGaPLCIW4ZQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht1Grtr3K&md5=7e0958c49e989093150792b6c721c0b4</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.2174%2F138161206778743448&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138161206778743448%26sid%3Dliteratum%253Aachs%26aulast%3DIshihara%26aufirst%3DS.%26aulast%3DRumi%26aufirst%3DM.%2BA.%26aulast%3DOrtega-Cava%26aufirst%3DC.%2BF.%26aulast%3DKazumori%26aufirst%3DH.%26aulast%3DKadowaki%26aufirst%3DY.%26aulast%3DIshimura%26aufirst%3DN.%26aulast%3DKinoshita%26aufirst%3DY.%26atitle%3DTherapeutic%2520targeting%2520of%2520toll-like%2520receptors%2520in%2520gastrointestinal%2520inflammation%26jtitle%3DCurr.%2520Pharm.%2520Des.%26date%3D2006%26volume%3D12%26spage%3D4215%26epage%3D4228" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Lewis, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loram, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hutchinson, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maier, S. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rice, K. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watkins, L. R.</span><span> </span><span class="NLM_article-title">(+)-Naloxone, an opioid-inactive toll-like receptor 4 signaling inhibitor, reverses multiple models of chronic neuropathic pain in rats</span> <span class="citation_source-journal">J. Pain</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">498</span><span class="NLM_x">–</span> <span class="NLM_lpage">506</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Fjm401321v&amp;key=10.1016%2Fj.jpain.2012.02.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Fjm401321v&amp;key=22520687" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm401321v&amp;key=1%3ACAS%3A528%3ADC%252BC38XmslyhsLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2012&pages=498-506&author=S.+S.+Lewisauthor=L.+C.+Loramauthor=M.+R.+Hutchinsonauthor=C.+M.+Liauthor=Y.+Zhangauthor=S.+F.+Maierauthor=Y.+Huangauthor=K.+C.+Riceauthor=L.+R.+Watkins&title=%28%2B%29-Naloxone%2C+an+opioid-inactive+toll-like+receptor+4+signaling+inhibitor%2C+reverses+multiple+models+of+chronic+neuropathic+pain+in+rats"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">(+)-Naloxone, an Opioid-Inactive Toll-Like Receptor 4 Signaling Inhibitor, Reverses Multiple Models of Chronic Neuropathic Pain in Rats</span></div><div class="casAuthors">Lewis, Susannah S.; Loram, Lisa C.; Hutchinson, Mark R.; Li, Chien-Ming; Zhang, Yingning; Maier, Steven F.; Huang, Yong; Rice, Kenner C.; Watkins, Linda R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pain</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">498-506</span>CODEN:
                <span class="NLM_cas:coden">JPOAB5</span>;
        ISSN:<span class="NLM_cas:issn">1526-5900</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Previous work demonstrated that both the opioid antagonist (-)-naloxone and the non-opioid (+)-naloxone inhibit toll-like receptor 4 (TLR4) signaling and reverse neuropathic pain expressed shortly after chronic constriction injury.  The present studies reveal that the TLR4 contributes to neuropathic pain in another major model (spinal nerve ligation) and to long established (2-4 mo) neuropathic pain, not just to pain shortly after nerve damage.  Addnl., analyses of plasma levels of (+)-naloxone after s.c. administration indicate that (+)-naloxone has comparable pharmacokinetics to (-)-naloxone with a relatively short half-life.  This finding accounts for the rapid onset and short duration of allodynia reversal produced by s.c. (+)-naloxone.  Given that toll-like receptor 2 (TLR2) has also recently been implicated in neuropathic pain, cell lines transfected with either TLR4 or TLR2, necessary co-signaling mols., and a reporter gene were used to define whether (+)-naloxone effects could be accounted for by actions at TLR2 in addn. to TLR4.  (+)-Naloxone inhibited signaling by TLR4 but not TLR2.  These studies provide evidence for broad involvement of TLR4 in neuropathic pain, both early after nerve damage and months later.  Addnl., they provide further support for the TLR4 inhibitor (+)-naloxone as a novel candidate for the treatment of neuropathic pain.  Perspective: These studies demonstrated that (+)-naloxone, a systemically available, blood-brain barrier permeable, small mol. TLR4 inhibitor can reverse neuropathic pain in rats, even months after nerve injury.  These findings suggest that (+)-naloxone, or similar compds., be considered as a candidate novel, first-in-class treatment for neuropathic pain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoNVO43Bz_AdbVg90H21EOLACvtfcHk0lgCwuHQL_zJ4A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XmslyhsLo%253D&md5=302b4b13665ab5f6036de8bca8995437</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1016%2Fj.jpain.2012.02.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jpain.2012.02.005%26sid%3Dliteratum%253Aachs%26aulast%3DLewis%26aufirst%3DS.%2BS.%26aulast%3DLoram%26aufirst%3DL.%2BC.%26aulast%3DHutchinson%26aufirst%3DM.%2BR.%26aulast%3DLi%26aufirst%3DC.%2BM.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DMaier%26aufirst%3DS.%2BF.%26aulast%3DHuang%26aufirst%3DY.%26aulast%3DRice%26aufirst%3DK.%2BC.%26aulast%3DWatkins%26aufirst%3DL.%2BR.%26atitle%3D%2528%252B%2529-Naloxone%252C%2520an%2520opioid-inactive%2520toll-like%2520receptor%25204%2520signaling%2520inhibitor%252C%2520reverses%2520multiple%2520models%2520of%2520chronic%2520neuropathic%2520pain%2520in%2520rats%26jtitle%3DJ.%2520Pain%26date%3D2012%26volume%3D13%26spage%3D498%26epage%3D506" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">O’Neill, L. A.</span><span> </span><span class="NLM_article-title">Therapeutic targeting of Toll-like receptors for inflammatory and infectious diseases</span> <span class="citation_source-journal">Curr. Opin. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">396</span><span class="NLM_x">–</span> <span class="NLM_lpage">403</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Fjm401321v&amp;key=10.1016%2FS1471-4892%2803%2900080-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Fjm401321v&amp;key=12901949" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm401321v&amp;key=1%3ACAS%3A528%3ADC%252BD3sXlvFGju7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2003&pages=396-403&author=L.+A.+O%E2%80%99Neill&title=Therapeutic+targeting+of+Toll-like+receptors+for+inflammatory+and+infectious+diseases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Therapeutic targeting of Toll-like receptors for inflammatory and infectious diseases</span></div><div class="casAuthors">O'Neill, Luke A. J.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Pharmacology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">396-403</span>CODEN:
                <span class="NLM_cas:coden">COPUBK</span>;
        ISSN:<span class="NLM_cas:issn">1471-4892</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A review.  Roles for Toll-like receptors (TLRs) are emerging in conditions such as sepsis syndrome, systemic lupus erythromatosis, rheumatoid arthritis and asthma, suggesting that the selective targeting of TLRs might be useful therapeutically.  TLRs are defined by the presence of extracellular leucine-rich repeats and an intracellular Toll/interleukin-1 receptor domain, and play a role in host defense and inflammation.  Signalling pathways activated by TLRs show remarkable similarity to those activated by the pro-inflammatory cytokine interleukin-1 (the receptor for which also has a Toll/interleukin-1 receptor domain), although adaptor proteins specific for certain TLRs are starting to emerge (e.g. Mal and Trif).  The common signalling pathways used by all members of the TLR superfamily are being targeted, with drugs that block nuclear factor-κB and p38b mitogen-activated protein kinase in clin. development for diseases such as rheumatoid arthritis and psoriasis.  As we learn more about TLR signal transduction, more options are presenting themselves for pharmacol. targeting.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoXDeIEFYRSwrVg90H21EOLACvtfcHk0lgCwuHQL_zJ4A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXlvFGju7s%253D&md5=38d89f8c1840a9bf90003364217fe529</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1016%2FS1471-4892%2803%2900080-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1471-4892%252803%252900080-8%26sid%3Dliteratum%253Aachs%26aulast%3DO%25E2%2580%2599Neill%26aufirst%3DL.%2BA.%26atitle%3DTherapeutic%2520targeting%2520of%2520Toll-like%2520receptors%2520for%2520inflammatory%2520and%2520infectious%2520diseases%26jtitle%3DCurr.%2520Opin.%2520Pharmacol.%26date%3D2003%26volume%3D3%26spage%3D396%26epage%3D403" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">O’Neill, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bryant, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doyle, S. L.</span><span> </span><span class="NLM_article-title">Therapeutic targeting of Toll-like receptors for infectious and inflammatory diseases and cancer</span> <span class="citation_source-journal">Pharmacol. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">61</span><span class="NLM_x">, </span> <span class="NLM_fpage">177</span><span class="NLM_x">–</span> <span class="NLM_lpage">197</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2009&pages=177-197&author=L.+A.+O%E2%80%99Neillauthor=C.+E.+Bryantauthor=S.+L.+Doyle&title=Therapeutic+targeting+of+Toll-like+receptors+for+infectious+and+inflammatory+diseases+and+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DO%25E2%2580%2599Neill%26aufirst%3DL.%2BA.%26aulast%3DBryant%26aufirst%3DC.%2BE.%26aulast%3DDoyle%26aufirst%3DS.%2BL.%26atitle%3DTherapeutic%2520targeting%2520of%2520Toll-like%2520receptors%2520for%2520infectious%2520and%2520inflammatory%2520diseases%2520and%2520cancer%26jtitle%3DPharmacol.%2520Rev.%26date%3D2009%26volume%3D61%26spage%3D177%26epage%3D197" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Uematsu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishii, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akira, S.</span><span> </span><span class="NLM_article-title">Therapeutic targetng of Toll-like receptors</span> <span class="citation_source-journal">Drug Discovery Today: Ther. Strategies</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">299</span><span class="NLM_x">–</span> <span class="NLM_lpage">304</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Fjm401321v&amp;key=10.1016%2Fj.ddstr.2004.10.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm401321v&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtFSgurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2004&pages=299-304&author=S.+Uematsuauthor=K.+J.+Ishiiauthor=S.+Akira&title=Therapeutic+targetng+of+Toll-like+receptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Therapeutic targeting of Toll-like receptors</span></div><div class="casAuthors">Uematsu, Satoshi; Ishii, Ken J.; Akira, Shizuo</div><div class="citationInfo"><span class="NLM_cas:title">Drug Discovery Today: Therapeutic Strategies</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">299-304</span>CODEN:
                <span class="NLM_cas:coden">DDTTC6</span>;
        ISSN:<span class="NLM_cas:issn">1740-6773</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Toll-like receptors (TLRs) play a crucial role in innate immune response in mammals.  Individual TLRs recognize microbial components that are conserved among pathogens and activate their signaling pathways.  Each TLR has its own cascade of signaling pathway for exhibiting its specific responses through selective utilization of TIR domain-contg. adaptors.  Increasing evidence for roles of TLRs in various diseases provides us new insights for a basis of new therapies.  In this review, we discuss the possibilities of therapeutics targeting TLRs in various diseases and explain potential problems assocd. with such approaches.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr-cmaR8YLLvbVg90H21EOLACvtfcHk0ljPqZy-TEenKg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtFSgurk%253D&md5=703f945debf0d475d9bb19532ea28bf4</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1016%2Fj.ddstr.2004.10.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ddstr.2004.10.009%26sid%3Dliteratum%253Aachs%26aulast%3DUematsu%26aufirst%3DS.%26aulast%3DIshii%26aufirst%3DK.%2BJ.%26aulast%3DAkira%26aufirst%3DS.%26atitle%3DTherapeutic%2520targetng%2520of%2520Toll-like%2520receptors%26jtitle%3DDrug%2520Discovery%2520Today%253A%2520Ther.%2520Strategies%26date%3D2004%26volume%3D1%26spage%3D299%26epage%3D304" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Kanzler, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barrat, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hessel, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coffman, R. L.</span><span> </span><span class="NLM_article-title">Therapeutic targeting of innate immunity with Toll-like receptor agonists and antagonists</span> <span class="citation_source-journal">Nat. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">552</span><span class="NLM_x">–</span> <span class="NLM_lpage">559</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Fjm401321v&amp;key=10.1038%2Fnm1589" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Fjm401321v&amp;key=17479101" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Fjm401321v&amp;key=1%3ACAS%3A528%3ADC%252BD2sXkvVOgsrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2007&pages=552-559&author=H.+Kanzlerauthor=F.+J.+Barratauthor=E.+M.+Hesselauthor=R.+L.+Coffman&title=Therapeutic+targeting+of+innate+immunity+with+Toll-like+receptor+agonists+and+antagonists"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Therapeutic targeting of innate immunity with Toll-like receptor agonists and antagonists</span></div><div class="casAuthors">Kanzler, Holger; Barrat, Franck J.; Hessel, Edith M.; Coffman, Robert L.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">552-559</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The identification of the antigen recognition receptors for innate immunity, most notably the Toll-like receptors, has sparked great interest in therapeutic manipulation of the innate immune system.  Toll-like receptor agonists are being developed for the treatment of cancer, allergies and viral infections, and as adjuvants for potent new vaccines to prevent or treat cancer and infectious diseases.  As recognition grows of the role of inappropriate Toll-like receptor stimulation in inflammation and autoimmunity, significant efforts have begun to develop antagonists to Toll-like receptors as well.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqypI4d-NCX7LVg90H21EOLACvtfcHk0ljPqZy-TEenKg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXkvVOgsrs%253D&md5=5fcd32926d9b24f84ff9fd611dec2175</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1038%2Fnm1589&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm1589%26sid%3Dliteratum%253Aachs%26aulast%3DKanzler%26aufirst%3DH.%26aulast%3DBarrat%26aufirst%3DF.%2BJ.%26aulast%3DHessel%26aufirst%3DE.%2BM.%26aulast%3DCoffman%26aufirst%3DR.%2BL.%26atitle%3DTherapeutic%2520targeting%2520of%2520innate%2520immunity%2520with%2520Toll-like%2520receptor%2520agonists%2520and%2520antagonists%26jtitle%3DNat.%2520Med.%26date%3D2007%26volume%3D13%26spage%3D552%26epage%3D559" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Matsunaga, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsuchimori, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsumoto, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ii, M.</span><span> </span><span class="NLM_article-title">TAK-242 (resatorvid), a small-molecule inhibitor of Toll-like receptor (TLR) 4 signaling, binds selectively to TLR4 and interferes with interactions between TLR4 and its adaptor molecules</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">79</span><span class="NLM_x">, </span> <span class="NLM_fpage">34</span><span class="NLM_x">–</span> <span class="NLM_lpage">41</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=79&publication_year=2011&pages=34-41&author=N.+Matsunagaauthor=N.+Tsuchimoriauthor=T.+Matsumotoauthor=M.+Ii&title=TAK-242+%28resatorvid%29%2C+a+small-molecule+inhibitor+of+Toll-like+receptor+%28TLR%29+4+signaling%2C+binds+selectively+to+TLR4+and+interferes+with+interactions+between+TLR4+and+its+adaptor+molecules"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMatsunaga%26aufirst%3DN.%26aulast%3DTsuchimori%26aufirst%3DN.%26aulast%3DMatsumoto%26aufirst%3DT.%26aulast%3DIi%26aufirst%3DM.%26atitle%3DTAK-242%2520%2528resatorvid%2529%252C%2520a%2520small-molecule%2520inhibitor%2520of%2520Toll-like%2520receptor%2520%2528TLR%2529%25204%2520signaling%252C%2520binds%2520selectively%2520to%2520TLR4%2520and%2520interferes%2520with%2520interactions%2520between%2520TLR4%2520and%2520its%2520adaptor%2520molecules%26jtitle%3DMol.%2520Pharmacol.%26date%3D2011%26volume%3D79%26spage%3D34%26epage%3D41" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Peri, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piazza, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calabrese, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Damore, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cighetti, R.</span><span> </span><span class="NLM_article-title">Exploring the LPS/TLR4 signal pathway with small molecules</span> <span class="citation_source-journal">Biochem. Soc. Trans.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">38</span><span class="NLM_x">, </span> <span class="NLM_fpage">1390</span><span class="NLM_x">–</span> <span class="NLM_lpage">1395</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Fjm401321v&amp;key=10.1042%2FBST0381390" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Fjm401321v&amp;key=20863319" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Fjm401321v&amp;key=1%3ACAS%3A528%3ADC%252BC3cXht1Srt7jM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2010&pages=1390-1395&author=F.+Periauthor=M.+Piazzaauthor=V.+Calabreseauthor=G.+Damoreauthor=R.+Cighetti&title=Exploring+the+LPS%2FTLR4+signal+pathway+with+small+molecules"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Exploring the LPS/TLR4 signal pathway with small molecules</span></div><div class="casAuthors">Peri, Francesco; Piazza, Matteo; Calabrese, Valentina; Damore, Gaetana; Cighetti, Roberto</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Society Transactions</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1390-1395</span>CODEN:
                <span class="NLM_cas:coden">BCSTB5</span>;
        ISSN:<span class="NLM_cas:issn">0300-5127</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">A review.  The identification of the bacterial endotoxin receptors for innate immunity, most notably TLR4 (Toll-like receptor 4), has sparked great interest in therapeutic manipulation of the innate immune system.  In the present mini-review, several natural and synthetic mols. that modulate the TLR4-mediated LPS (lipopolysaccharide) signalling in animals and humans are considered, and their mechanisms of action are discussed.  The process of LPS sensing and signal amplification in humans is based on the sequential action of specific receptors situated in the extracellular side of the innate immunity cells, which bind and transfer LPS to TLR4: LBP (LPS-binding protein), CD14, MD-2 (myeloid differentiation protein 2).  We classified the compds. active on TLR4 pathway depending on the specific mol. targets (LPS, LBP, CD14, MD-2 or TLR4).  Small mols. developed by our group are described that inhibit LPS-stimulated TLR4 activation by selectively targeting the LPS-CD14 interaction.  These compds. have an interesting antiseptic shock, anti-inflammatory and anti-neuropathic pain activity in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqnaiwFrBsLXLVg90H21EOLACvtfcHk0li7DqWRjdyOLA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXht1Srt7jM&md5=d5ef593c1fed4b262f6bbdb188c8cb6b</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1042%2FBST0381390&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FBST0381390%26sid%3Dliteratum%253Aachs%26aulast%3DPeri%26aufirst%3DF.%26aulast%3DPiazza%26aufirst%3DM.%26aulast%3DCalabrese%26aufirst%3DV.%26aulast%3DDamore%26aufirst%3DG.%26aulast%3DCighetti%26aufirst%3DR.%26atitle%3DExploring%2520the%2520LPS%252FTLR4%2520signal%2520pathway%2520with%2520small%2520molecules%26jtitle%3DBiochem.%2520Soc.%2520Trans.%26date%3D2010%26volume%3D38%26spage%3D1390%26epage%3D1395" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Zhang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yin, H.</span><span> </span><span class="NLM_article-title">Selection, synthesis, and anti-inflammatory evaluation of the arylidene malonate derivatives as TLR4 signaling inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">6073</span><span class="NLM_x">–</span> <span class="NLM_lpage">6079</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2012&pages=6073-6079&author=S.+Zhangauthor=K.+Chengauthor=X.+Wangauthor=H.+Yin&title=Selection%2C+synthesis%2C+and+anti-inflammatory+evaluation+of+the+arylidene+malonate+derivatives+as+TLR4+signaling+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DS.%26aulast%3DCheng%26aufirst%3DK.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DYin%26aufirst%3DH.%26atitle%3DSelection%252C%2520synthesis%252C%2520and%2520anti-inflammatory%2520evaluation%2520of%2520the%2520arylidene%2520malonate%2520derivatives%2520as%2520TLR4%2520signaling%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2012%26volume%3D20%26spage%3D6073%26epage%3D6079" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Nakashima, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oyama, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ito, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Witono, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Darnaedi, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanaka, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murata, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iinuma, M.</span><span> </span><span class="NLM_article-title">Novel quinolinone alkaloids bearing a lignoid moiety and related constituents in the leaves of <i>Melicope denhamii</i></span> <span class="citation_source-journal">Tetrahedron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">68</span><span class="NLM_x">, </span> <span class="NLM_fpage">2421</span><span class="NLM_x">–</span> <span class="NLM_lpage">2428</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2012&pages=2421-2428&author=K.+Nakashimaauthor=M.+Oyamaauthor=T.+Itoauthor=Y.+Akaoauthor=J.+R.+Witonoauthor=D.+Darnaediauthor=T.+Tanakaauthor=J.+Murataauthor=M.+Iinuma&title=Novel+quinolinone+alkaloids+bearing+a+lignoid+moiety+and+related+constituents+in+the+leaves+of+Melicope+denhamii"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNakashima%26aufirst%3DK.%26aulast%3DOyama%26aufirst%3DM.%26aulast%3DIto%26aufirst%3DT.%26aulast%3DAkao%26aufirst%3DY.%26aulast%3DWitono%26aufirst%3DJ.%2BR.%26aulast%3DDarnaedi%26aufirst%3DD.%26aulast%3DTanaka%26aufirst%3DT.%26aulast%3DMurata%26aufirst%3DJ.%26aulast%3DIinuma%26aufirst%3DM.%26atitle%3DNovel%2520quinolinone%2520alkaloids%2520bearing%2520a%2520lignoid%2520moiety%2520and%2520related%2520constituents%2520in%2520the%2520leaves%2520of%2520Melicope%2520denhamii%26jtitle%3DTetrahedron%26date%3D2012%26volume%3D68%26spage%3D2421%26epage%3D2428" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Teague, S. J.</span> Unpublished results.<span class="NLM_x"> </span><span class="NLM_year">2006</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Teague%2C+S.+J.+Unpublished+results.+2006."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dunpublished%26sid%3Dliteratum%253Aachs%26aulast%3DTeague%26aufirst%3DS.%2BJ.%26date%3D2006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Bowman, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grundon, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">James, K. J.</span><span> </span><span class="NLM_article-title">Quinoline alkaloids. Part XVI. 2,2-Dimethylpyranoquinolines from base-catalysed rearrangement of isoprenyl epoxides. Synthesis and biogenesis of flindersine</span> <span class="citation_source-journal">J. Chem. Soc., Perkin Trans. 1</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1973</span><span class="NLM_x">, </span> <span class="NLM_fpage">1055</span><span class="NLM_x">–</span> <span class="NLM_lpage">1059</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1973&pages=1055-1059&author=R.+M.+Bowmanauthor=M.+F.+Grundonauthor=K.+J.+James&title=Quinoline+alkaloids.+Part+XVI.+2%2C2-Dimethylpyranoquinolines+from+base-catalysed+rearrangement+of+isoprenyl+epoxides.+Synthesis+and+biogenesis+of+flindersine"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBowman%26aufirst%3DR.%2BM.%26aulast%3DGrundon%26aufirst%3DM.%2BF.%26aulast%3DJames%26aufirst%3DK.%2BJ.%26atitle%3DQuinoline%2520alkaloids.%2520Part%2520XVI.%25202%252C2-Dimethylpyranoquinolines%2520from%2520base-catalysed%2520rearrangement%2520of%2520isoprenyl%2520epoxides.%2520Synthesis%2520and%2520biogenesis%2520of%2520flindersine%26jtitle%3DJ.%2520Chem.%2520Soc.%252C%2520Perkin%2520Trans.%25201%26date%3D1973%26spage%3D1055%26epage%3D1059" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Jones, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roset, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rossiter, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whitfield, P.</span><span> </span><span class="NLM_article-title">Demethylation of 2,4-dimethoxyquinolines: the synthesis of atanine</span> <span class="citation_source-journal">Org. Biomol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">4380</span><span class="NLM_x">–</span> <span class="NLM_lpage">4383</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2003&pages=4380-4383&author=K.+Jonesauthor=X.+Rosetauthor=S.+Rossiterauthor=P.+Whitfield&title=Demethylation+of+2%2C4-dimethoxyquinolines%3A+the+synthesis+of+atanine"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJones%26aufirst%3DK.%26aulast%3DRoset%26aufirst%3DX.%26aulast%3DRossiter%26aufirst%3DS.%26aulast%3DWhitfield%26aufirst%3DP.%26atitle%3DDemethylation%2520of%25202%252C4-dimethoxyquinolines%253A%2520the%2520synthesis%2520of%2520atanine%26jtitle%3DOrg.%2520Biomol.%2520Chem.%26date%3D2003%26volume%3D1%26spage%3D4380%26epage%3D4383" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Holla, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jenkins, I. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neve, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pouwer, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pham, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teague, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quinn, R. J.</span><span> </span><span class="NLM_article-title">Synthesis of melicodenines C, D and E</span> <span class="citation_source-journal">Tetrahedron Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">7101</span><span class="NLM_x">–</span> <span class="NLM_lpage">7103</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2012&pages=7101-7103&author=H.+Hollaauthor=I.+D.+Jenkinsauthor=J.+E.+Neveauthor=R.+H.+Pouwerauthor=N.+Phamauthor=S.+J.+Teagueauthor=R.+J.+Quinn&title=Synthesis+of+melicodenines+C%2C+D+and+E"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHolla%26aufirst%3DH.%26aulast%3DJenkins%26aufirst%3DI.%2BD.%26aulast%3DNeve%26aufirst%3DJ.%2BE.%26aulast%3DPouwer%26aufirst%3DR.%2BH.%26aulast%3DPham%26aufirst%3DN.%26aulast%3DTeague%26aufirst%3DS.%2BJ.%26aulast%3DQuinn%26aufirst%3DR.%2BJ.%26atitle%3DSynthesis%2520of%2520melicodenines%2520C%252C%2520D%2520and%2520E%26jtitle%3DTetrahedron%2520Lett.%26date%3D2012%26volume%3D53%26spage%3D7101%26epage%3D7103" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Sharma, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joshi, B. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sinha, A. K.</span><span> </span><span class="NLM_article-title">An effective system to synthesize hypolipidemic active alpha-asarone and related methoxylated (E)-arylalkenes</span> <span class="citation_source-journal">Bull. Chem. Soc. Jpn.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">77</span><span class="NLM_x">, </span> <span class="NLM_fpage">2231</span><span class="NLM_x">–</span> <span class="NLM_lpage">2235</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=77&publication_year=2004&pages=2231-2235&author=A.+Sharmaauthor=B.+P.+Joshiauthor=A.+K.+Sinha&title=An+effective+system+to+synthesize+hypolipidemic+active+alpha-asarone+and+related+methoxylated+%28E%29-arylalkenes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSharma%26aufirst%3DA.%26aulast%3DJoshi%26aufirst%3DB.%2BP.%26aulast%3DSinha%26aufirst%3DA.%2BK.%26atitle%3DAn%2520effective%2520system%2520to%2520synthesize%2520hypolipidemic%2520active%2520alpha-asarone%2520and%2520related%2520methoxylated%2520%2528E%2529-arylalkenes%26jtitle%3DBull.%2520Chem.%2520Soc.%2520Jpn.%26date%3D2004%26volume%3D77%26spage%3D2231%26epage%3D2235" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Liu, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jang, Y. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shih, Y. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chu, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yao, C. F.</span><span> </span><span class="NLM_article-title">Novel synthesis of alkenes via triethylborane-induced free-radical reactions of alkyl iodides and beta-nitrostyrenes</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x">, </span> <span class="NLM_fpage">6021</span><span class="NLM_x">–</span> <span class="NLM_lpage">6028</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo010213m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2001&pages=6021-6028&author=J.+T.+Liuauthor=Y.+J.+Jangauthor=Y.+K.+Shihauthor=S.+R.+Huauthor=C.+M.+Chuauthor=C.+F.+Yao&title=Novel+synthesis+of+alkenes+via+triethylborane-induced+free-radical+reactions+of+alkyl+iodides+and+beta-nitrostyrenes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Fjo010213m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo010213m%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DJ.%2BT.%26aulast%3DJang%26aufirst%3DY.%2BJ.%26aulast%3DShih%26aufirst%3DY.%2BK.%26aulast%3DHu%26aufirst%3DS.%2BR.%26aulast%3DChu%26aufirst%3DC.%2BM.%26aulast%3DYao%26aufirst%3DC.%2BF.%26atitle%3DNovel%2520synthesis%2520of%2520alkenes%2520via%2520triethylborane-induced%2520free-radical%2520reactions%2520of%2520alkyl%2520iodides%2520and%2520beta-nitrostyrenes%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2001%26volume%3D66%26spage%3D6021%26epage%3D6028" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Wang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, Y. R.</span><span> </span><span class="NLM_article-title">Efficient synthesis of substituted pyranoquinolinones from 2,4-dihydroxyquinoline: Total synthesis of zanthosimuline, cis-3′,4′-dihydroxy-3′,4′-dihydroflindersine, and orixalone D</span> <span class="citation_source-journal">Synthesis</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_fpage">3044</span><span class="NLM_x">–</span> <span class="NLM_lpage">3050</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Fjm401321v&amp;key=1%3ACAS%3A528%3ADC%252BD2sXht1ynsrnM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2007&pages=3044-3050&author=X.+Wangauthor=Y.+R.+Lee&title=Efficient+synthesis+of+substituted+pyranoquinolinones+from+2%2C4-dihydroxyquinoline%3A+Total+synthesis+of+zanthosimuline%2C+cis-3%E2%80%B2%2C4%E2%80%B2-dihydroxy-3%E2%80%B2%2C4%E2%80%B2-dihydroflindersine%2C+and+orixalone+D"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Efficient synthesis of substituted pyranoquinolinones from 2,4-dihydroxyquinoline: total synthesis of zanthosimuline, cis-3',4'-dihydroxy-3',4'-dihydroflindersine, and orixalone D</span></div><div class="casAuthors">Wang, Xue; Lee, Yong Rok</div><div class="citationInfo"><span class="NLM_cas:title">Synthesis</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume"></span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">3044-3050</span>CODEN:
                <span class="NLM_cas:coden">SYNTBF</span>;
        ISSN:<span class="NLM_cas:issn">0039-7881</span>.
    
            (<span class="NLM_cas:orgname">Georg Thieme Verlag</span>)
        </div><div class="casAbstract">A convenient and efficient synthesis of pyranoquinolinones (e.g. I) was achieved using the ethylenediamine diacetate catalyzed reactions of 2,4-dihydroxyquinoline and a variety of α,β-unsatd. aldehydes in good yield.  The key feature of these reactions is the formal [3+3] cycloaddn.  This new methodol. was applied successfully to the total synthesis of naturally occurring pyranoquinolinone alkaloids, zanthosimuline, cis-3',4'-dihydroxy-3',4'-dihydroflindersine, and orixalone D.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrHn8aODSTDgbVg90H21EOLACvtfcHk0ljlaXz92PVI-A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXht1ynsrnM&md5=37e64a12c2467ab129a27da0bb927e18</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DX.%26aulast%3DLee%26aufirst%3DY.%2BR.%26atitle%3DEfficient%2520synthesis%2520of%2520substituted%2520pyranoquinolinones%2520from%25202%252C4-dihydroxyquinoline%253A%2520Total%2520synthesis%2520of%2520zanthosimuline%252C%2520cis-3%25E2%2580%25B2%252C4%25E2%2580%25B2-dihydroxy-3%25E2%2580%25B2%252C4%25E2%2580%25B2-dihydroflindersine%252C%2520and%2520orixalone%2520D%26jtitle%3DSynthesis%26date%3D2007%26spage%3D3044%26epage%3D3050" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 31 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Wen-Hao Li, <span class="NLM_string-name hlFld-ContribAuthor">Yan-Mei Li</span>. </span><span class="cited-content_cbyCitation_article-title">Chemical Strategies to Boost Cancer Vaccines. </span><span class="cited-content_cbyCitation_journal-name">Chemical Reviews</span><span> <strong>2020,</strong> <em>120 </em>
                                    (20)
                                     , 11420-11478. <a href="https://doi.org/10.1021/acs.chemrev.9b00833" title="DOI URL">https://doi.org/10.1021/acs.chemrev.9b00833</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.chemrev.9b00833&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.chemrev.9b00833%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Reviews%26atitle%3DChemical%252BStrategies%252Bto%252BBoost%252BCancer%252BVaccines%26aulast%3DLi%26aufirst%3DWen-Hao%26date%3D2020%26date%3D2020%26date%3D2019%26date%3D23122019%26date%3D11092020%26volume%3D120%26issue%3D20%26spage%3D11420%26epage%3D11478" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">José Tiago M. Correia, Gustavo Piva da Silva, Camila M. Kisukuri, Elias André, Bruno Pires, Pablo S. Carneiro, <span class="NLM_string-name hlFld-ContribAuthor">Márcio W. Paixão</span>. </span><span class="cited-content_cbyCitation_article-title">Metal-Free Photoinduced Hydroalkylation Cascade Enabled by an Electron-Donor–Acceptor Complex. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2020,</strong> <em>85 </em>
                                    (15)
                                     , 9820-9834. <a href="https://doi.org/10.1021/acs.joc.0c01130" title="DOI URL">https://doi.org/10.1021/acs.joc.0c01130</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.joc.0c01130&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.joc.0c01130%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DMetal-Free%252BPhotoinduced%252BHydroalkylation%252BCascade%252BEnabled%252Bby%252Ban%252BElectron-Donor%2525E2%252580%252593Acceptor%252BComplex%26aulast%3DCorreia%26aufirst%3DJos%25C3%25A9%2BTiago%2BM.%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D10052020%26date%3D09072020%26date%3D26062020%26volume%3D85%26issue%3D15%26spage%3D9820%26epage%3D9834" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Ke-Qiang Hou, Xue-Ping Chen, Yiyou Huang, Albert S. C. Chan, Hai-Bin Luo, <span class="NLM_string-name hlFld-ContribAuthor">Xiao-Feng Xiong</span>. </span><span class="cited-content_cbyCitation_article-title">Asymmetric Total Synthesis and Biological Evaluation of the Natural PDE4 Inhibitor Toddacoumalone. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2020,</strong> <em>22 </em>
                                    (2)
                                     , 584-588. <a href="https://doi.org/10.1021/acs.orglett.9b04355" title="DOI URL">https://doi.org/10.1021/acs.orglett.9b04355</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.orglett.9b04355&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.orglett.9b04355%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DAsymmetric%252BTotal%252BSynthesis%252Band%252BBiological%252BEvaluation%252Bof%252Bthe%252BNatural%252BPDE4%252BInhibitor%252BToddacoumalone%26aulast%3DHou%26aufirst%3DKe-Qiang%26date%3D2020%26date%3D2020%26date%3D2019%26date%3D04122019%26date%3D06012020%26volume%3D22%26issue%3D2%26spage%3D584%26epage%3D588" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Lijing Su, Ying Wang, Junmei Wang, Yuto Mifune, Matthew D. Morin, Brian T. Jones, Eva Marie Y. Moresco, Dale L. Boger, Bruce Beutler, <span class="NLM_string-name hlFld-ContribAuthor">Hong Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Structural Basis of TLR2/TLR1 Activation by the Synthetic Agonist Diprovocim. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (6)
                                     , 2938-2949. <a href="https://doi.org/10.1021/acs.jmedchem.8b01583" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b01583</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b01583&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b01583%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DStructural%252BBasis%252Bof%252BTLR2%25252FTLR1%252BActivation%252Bby%252Bthe%252BSynthetic%252BAgonist%252BDiprovocim%26aulast%3DSu%26aufirst%3DLijing%26date%3D2019%26date%3D2019%26date%3D2018%26date%3D15102018%26date%3D13032019%26date%3D04032019%26volume%3D62%26issue%3D6%26spage%3D2938%26epage%3D2949" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Matthew
D. Morin, Ying Wang, Brian T. Jones, Yuto Mifune, Lijing Su, Hexin Shi, Eva Marie Y. Moresco, Hong Zhang, Bruce Beutler, <span class="NLM_string-name hlFld-ContribAuthor">Dale L. Boger</span>. </span><span class="cited-content_cbyCitation_article-title">Diprovocims: A New and Exceptionally Potent Class of Toll-like Receptor Agonists. </span><span class="cited-content_cbyCitation_journal-name">Journal of the American Chemical Society</span><span> <strong>2018,</strong> <em>140 </em>
                                    (43)
                                     , 14440-14454. <a href="https://doi.org/10.1021/jacs.8b09223" title="DOI URL">https://doi.org/10.1021/jacs.8b09223</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jacs.8b09223&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjacs.8b09223%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520the%2520American%2520Chemical%2520Society%26atitle%3DDiprovocims%25253A%252BA%252BNew%252Band%252BExceptionally%252BPotent%252BClass%252Bof%252BToll-like%252BReceptor%252BAgonists%26aulast%3DMorin%26aufirst%3DMatthew%2BD.%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D27082018%26date%3D16102018%26date%3D01102018%26volume%3D140%26issue%3D43%26spage%3D14440%26epage%3D14454" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="NLM_string-name hlFld-ContribAuthor">Tanaji T. Talele</span>. </span><span class="cited-content_cbyCitation_article-title">Natural-Products-Inspired Use of the gem-Dimethyl Group in Medicinal Chemistry. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (6)
                                     , 2166-2210. <a href="https://doi.org/10.1021/acs.jmedchem.7b00315" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b00315</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b00315&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.7b00315%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DNatural-Products-Inspired%252BUse%252Bof%252Bthe%252Bgem-Dimethyl%252BGroup%252Bin%252BMedicinal%252BChemistry%26aulast%3DTalele%26aufirst%3DTanaji%2BT.%26date%3D2018%26date%3D2017%26date%3D2017%26date%3D27022017%26date%3D08092017%26date%3D29082017%26volume%3D61%26issue%3D6%26spage%3D2166%26epage%3D2210" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Bob J. Ignacio, Tyler J. Albin, Aaron P. Esser-Kahn, <span class="NLM_string-name hlFld-ContribAuthor">Martijn Verdoes</span>. </span><span class="cited-content_cbyCitation_article-title">Toll-like Receptor Agonist Conjugation: A Chemical Perspective. </span><span class="cited-content_cbyCitation_journal-name">Bioconjugate Chemistry</span><span> <strong>2018,</strong> <em>29 </em>
                                    (3)
                                     , 587-603. <a href="https://doi.org/10.1021/acs.bioconjchem.7b00808" title="DOI URL">https://doi.org/10.1021/acs.bioconjchem.7b00808</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.bioconjchem.7b00808&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.bioconjchem.7b00808%26sid%3Dliteratum%253Aachs%26jtitle%3DBioconjugate%2520Chemistry%26atitle%3DToll-like%252BReceptor%252BAgonist%252BConjugation%25253A%252BA%252BChemical%252BPerspective%26aulast%3DIgnacio%26aufirst%3DBob%2BJ.%26date%3D2018%26date%3D2018%26date%3D2017%26date%3D2018%26date%3D18122017%26date%3D25012018%26date%3D16022018%26date%3D29012018%26volume%3D29%26issue%3D3%26spage%3D587%26epage%3D603" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Michael  Chan</span>, <span class="hlFld-ContribAuthor ">Yuhei  Kakitsubata</span>, <span class="hlFld-ContribAuthor ">Tomoko  Hayashi</span>, <span class="hlFld-ContribAuthor ">Alast  Ahmadi</span>, <span class="hlFld-ContribAuthor ">Shiyin  Yao</span>, <span class="hlFld-ContribAuthor ">Nikunj M.  Shukla</span>, <span class="hlFld-ContribAuthor ">Shin-ya  Oyama</span>, <span class="hlFld-ContribAuthor ">Akihito  Baba</span>, <span class="hlFld-ContribAuthor ">Brandon  Nguyen</span>, <span class="hlFld-ContribAuthor ">Maripat  Corr</span>, <span class="hlFld-ContribAuthor ">Yasuo  Suda</span>, <span class="hlFld-ContribAuthor ">Dennis A.  Carson</span>, <span class="hlFld-ContribAuthor ">Howard B.  Cottam</span>, and <span class="hlFld-ContribAuthor ">Masahiro  Wakao</span>  . </span><span class="cited-content_cbyCitation_article-title">Structure–Activity Relationship Studies of Pyrimido[5,4-b]indoles as Selective Toll-Like Receptor 4 Ligands. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>60 </em>
                                    (22)
                                     , 9142-9161. <a href="https://doi.org/10.1021/acs.jmedchem.7b00797" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b00797</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b00797&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.7b00797%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DStructure%2525E2%252580%252593Activity%252BRelationship%252BStudies%252Bof%252BPyrimido%25255B5%25252C4-b%25255Dindoles%252Bas%252BSelective%252BToll-Like%252BReceptor%252B4%252BLigands%26aulast%3DChan%26aufirst%3DMichael%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D31052017%26date%3D03112017%26date%3D22112017%26date%3D19102017%26volume%3D60%26issue%3D22%26spage%3D9142%26epage%3D9161" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Saner  Poplata</span>, <span class="hlFld-ContribAuthor ">Andreas  Tröster</span>, <span class="hlFld-ContribAuthor ">You-Quan  Zou</span>, and <span class="hlFld-ContribAuthor ">Thorsten  Bach</span>  . </span><span class="cited-content_cbyCitation_article-title">Recent Advances in the Synthesis of Cyclobutanes by Olefin [2 + 2] Photocycloaddition Reactions. </span><span class="cited-content_cbyCitation_journal-name">Chemical Reviews</span><span> <strong>2016,</strong> <em>116 </em>
                                    (17)
                                     , 9748-9815. <a href="https://doi.org/10.1021/acs.chemrev.5b00723" title="DOI URL">https://doi.org/10.1021/acs.chemrev.5b00723</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.chemrev.5b00723&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.chemrev.5b00723%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Reviews%26atitle%3DRecent%252BAdvances%252Bin%252Bthe%252BSynthesis%252Bof%252BCyclobutanes%252Bby%252BOlefin%252B%25255B2%2525E2%252580%2525AF%25252B%2525E2%252580%2525AF2%25255D%252BPhotocycloaddition%252BReactions%26aulast%3DPoplata%26aufirst%3DSaner%26date%3D2016%26date%3D2016%26date%3D2015%26date%3D15122015%26date%3D28032016%26date%3D14092016%26volume%3D116%26issue%3D17%26spage%3D9748%26epage%3D9815" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Matthew D.  Morin</span>, <span class="hlFld-ContribAuthor ">Ying  Wang</span>, <span class="hlFld-ContribAuthor ">Brian T.  Jones</span>, <span class="hlFld-ContribAuthor ">Lijing  Su</span>, <span class="hlFld-ContribAuthor ">Murali M. R. P.  Surakattula</span>, <span class="hlFld-ContribAuthor ">Michael  Berger</span>, <span class="hlFld-ContribAuthor ">Hua  Huang</span>, <span class="hlFld-ContribAuthor ">Elliot K.  Beutler</span>, <span class="hlFld-ContribAuthor ">Hong  Zhang</span>, <span class="hlFld-ContribAuthor ">Bruce  Beutler</span>, and <span class="hlFld-ContribAuthor ">Dale L.  Boger</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery and Structure–Activity Relationships of the Neoseptins: A New Class of Toll-like Receptor-4 (TLR4) Agonists. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>59 </em>
                                    (10)
                                     , 4812-4830. <a href="https://doi.org/10.1021/acs.jmedchem.6b00177" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b00177</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b00177&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.6b00177%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Band%252BStructure%2525E2%252580%252593Activity%252BRelationships%252Bof%252Bthe%252BNeoseptins%25253A%252BA%252BNew%252BClass%252Bof%252BToll-like%252BReceptor-4%252B%252528TLR4%252529%252BAgonists%26aulast%3DMorin%26aufirst%3DMatthew%2BD.%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D02022016%26date%3D25042016%26date%3D26052016%26date%3D06042016%26volume%3D59%26issue%3D10%26spage%3D4812%26epage%3D4830" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">José Tiago M.  Correia</span>, <span class="hlFld-ContribAuthor ">Marilia S.  Santos</span>, <span class="hlFld-ContribAuthor ">Emanuele F.  Pissinati</span>, <span class="hlFld-ContribAuthor ">Gustavo P.  Silva</span>, <span class="hlFld-ContribAuthor ">Márcio W.  Paixão</span>. </span><span class="cited-content_cbyCitation_article-title">Recent Advances on Photoinduced Cascade Strategies for the Synthesis of
              N
              ‐Heterocycles. </span><span class="cited-content_cbyCitation_journal-name">The Chemical Record</span><span> <strong>2021,</strong> <em>23 </em><a href="https://doi.org/10.1002/tcr.202100160" title="DOI URL">https://doi.org/10.1002/tcr.202100160</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/tcr.202100160&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Ftcr.202100160%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Chemical%2520Record%26atitle%3DRecent%252BAdvances%252Bon%252BPhotoinduced%252BCascade%252BStrategies%252Bfor%252Bthe%252BSynthesis%252Bof%252BN%252B%2525E2%252580%252590Heterocycles%26aulast%3DCorreia%26aufirst%3DJos%25C3%25A9%2BTiago%2BM.%26date%3D2021%26date%3D2021%26volume%3D23" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Thanh Hoa  Nguyen</span>, <span class="hlFld-ContribAuthor ">Thi Hoai Thu  Nguyen</span>, <span class="hlFld-ContribAuthor ">Thi Phuong Thao  Dang</span>, <span class="hlFld-ContribAuthor ">Pham Anh Thu  Nguyen</span>, <span class="hlFld-ContribAuthor ">Thi Bich Ngoc  Truong</span>, <span class="hlFld-ContribAuthor ">Nguyen Kim Phi  Phung</span>, <span class="hlFld-ContribAuthor ">Thi Anh Tuyet  Nguyen</span>. </span><span class="cited-content_cbyCitation_article-title">Three quinolinone alkaloid − phenylpropanoid adducts from
              Melicope pteleifolia. </span><span class="cited-content_cbyCitation_journal-name">Natural Product Research</span><span> <strong>2021,</strong> <em>29 </em>, 1-7. <a href="https://doi.org/10.1080/14786419.2021.1892669" title="DOI URL">https://doi.org/10.1080/14786419.2021.1892669</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/14786419.2021.1892669&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F14786419.2021.1892669%26sid%3Dliteratum%253Aachs%26jtitle%3DNatural%2520Product%2520Research%26atitle%3DThree%252Bquinolinone%252Balkaloid%2525E2%252580%252589%2525E2%252588%252592%2525E2%252580%252589phenylpropanoid%252Badducts%252Bfrom%252BMelicope%252Bpteleifolia%26aulast%3DNguyen%26aufirst%3DThanh%2BHoa%26date%3D2021%26date%3D2021%26volume%3D29%26spage%3D1%26epage%3D7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Simon  Van Herck</span>, <span class="hlFld-ContribAuthor ">Bruno G.  De Geest</span>. </span><span class="cited-content_cbyCitation_article-title">Nanomedicine-mediated alteration of the pharmacokinetic profile of small molecule cancer immunotherapeutics. </span><span class="cited-content_cbyCitation_journal-name">Acta Pharmacologica Sinica</span><span> <strong>2020,</strong> <em>41 </em>
                                    (7)
                                     , 881-894. <a href="https://doi.org/10.1038/s41401-020-0425-3" title="DOI URL">https://doi.org/10.1038/s41401-020-0425-3</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41401-020-0425-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41401-020-0425-3%26sid%3Dliteratum%253Aachs%26jtitle%3DActa%2520Pharmacologica%2520Sinica%26atitle%3DNanomedicine-mediated%252Balteration%252Bof%252Bthe%252Bpharmacokinetic%252Bprofile%252Bof%252Bsmall%252Bmolecule%252Bcancer%252Bimmunotherapeutics%26aulast%3DVan%2BHerck%26aufirst%3DSimon%26date%3D2020%26date%3D2020%26volume%3D41%26issue%3D7%26spage%3D881%26epage%3D894" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jian  Li</span>, <span class="hlFld-ContribAuthor ">Qi-Long  Hu</span>, <span class="hlFld-ContribAuthor ">Xue-Ping  Chen</span>, <span class="hlFld-ContribAuthor ">Ke-Qiang  Hou</span>, <span class="hlFld-ContribAuthor ">Albert S.C.  Chan</span>, <span class="hlFld-ContribAuthor ">Xiao-Feng  Xiong</span>. </span><span class="cited-content_cbyCitation_article-title">Asymmetric synthesis of tetrahydropyran[3,2-c]quinolinones via an organocatalyzed formal [3 + 3] annulation of quinolinones and MBH 2-naphthoates of nitroolefin. </span><span class="cited-content_cbyCitation_journal-name">Chinese Chemical Letters</span><span> <strong>2020,</strong> <em>31 </em>
                                    (3)
                                     , 697-700. <a href="https://doi.org/10.1016/j.cclet.2019.08.040" title="DOI URL">https://doi.org/10.1016/j.cclet.2019.08.040</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.cclet.2019.08.040&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.cclet.2019.08.040%26sid%3Dliteratum%253Aachs%26jtitle%3DChinese%2520Chemical%2520Letters%26atitle%3DAsymmetric%252Bsynthesis%252Bof%252Btetrahydropyran%25255B3%25252C2-c%25255Dquinolinones%252Bvia%252Ban%252Borganocatalyzed%252Bformal%252B%25255B3%252B%25252B%252B3%25255D%252Bannulation%252Bof%252Bquinolinones%252Band%252BMBH%252B2-naphthoates%252Bof%252Bnitroolefin%26aulast%3DLi%26aufirst%3DJian%26date%3D2020%26volume%3D31%26issue%3D3%26spage%3D697%26epage%3D700" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Miaomiao  Liu</span>, <span class="hlFld-ContribAuthor ">Peter  Karuso</span>, <span class="hlFld-ContribAuthor ">Yunjiang  Feng</span>, <span class="hlFld-ContribAuthor ">Esther  Kellenberger</span>, <span class="hlFld-ContribAuthor ">Fei  Liu</span>, <span class="hlFld-ContribAuthor ">Can  Wang</span>, <span class="hlFld-ContribAuthor ">Ronald J.  Quinn</span>. </span><span class="cited-content_cbyCitation_article-title">Is it time for artificial intelligence to predict the function of natural products based on 2D-structure. </span><span class="cited-content_cbyCitation_journal-name">MedChemComm</span><span> <strong>2019,</strong> <em>10 </em>
                                    (10)
                                     , 1667-1677. <a href="https://doi.org/10.1039/C9MD00128J" title="DOI URL">https://doi.org/10.1039/C9MD00128J</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C9MD00128J&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC9MD00128J%26sid%3Dliteratum%253Aachs%26jtitle%3DMedChemComm%26atitle%3DIs%252Bit%252Btime%252Bfor%252Bartificial%252Bintelligence%252Bto%252Bpredict%252Bthe%252Bfunction%252Bof%252Bnatural%252Bproducts%252Bbased%252Bon%252B2D-structure%26aulast%3DLiu%26aufirst%3DMiaomiao%26date%3D2019%26date%3D2019%26volume%3D10%26issue%3D10%26spage%3D1667%26epage%3D1677" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Gunnar R.  Leitner</span>, <span class="hlFld-ContribAuthor ">Tyler J.  Wenzel</span>, <span class="hlFld-ContribAuthor ">Nick  Marshall</span>, <span class="hlFld-ContribAuthor ">Ellen J.  Gates</span>, <span class="hlFld-ContribAuthor ">Andis  Klegeris</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting toll-like receptor 4 to modulate neuroinflammation in central nervous system disorders. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Therapeutic Targets</span><span> <strong>2019,</strong> <em>23 </em>
                                    (10)
                                     , 865-882. <a href="https://doi.org/10.1080/14728222.2019.1676416" title="DOI URL">https://doi.org/10.1080/14728222.2019.1676416</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/14728222.2019.1676416&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F14728222.2019.1676416%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Therapeutic%2520Targets%26atitle%3DTargeting%252Btoll-like%252Breceptor%252B4%252Bto%252Bmodulate%252Bneuroinflammation%252Bin%252Bcentral%252Bnervous%252Bsystem%252Bdisorders%26aulast%3DLeitner%26aufirst%3DGunnar%2BR.%26date%3D2019%26date%3D2019%26volume%3D23%26issue%3D10%26spage%3D865%26epage%3D882" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Vinita  Mishra</span>, <span class="hlFld-ContribAuthor ">Chandramani  Pathak</span>. </span><span class="cited-content_cbyCitation_article-title">Human Toll-Like Receptor 4 (hTLR4): Structural and functional dynamics in cancer. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Biological Macromolecules</span><span> <strong>2019,</strong> <em>122 </em>, 425-451. <a href="https://doi.org/10.1016/j.ijbiomac.2018.10.142" title="DOI URL">https://doi.org/10.1016/j.ijbiomac.2018.10.142</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ijbiomac.2018.10.142&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ijbiomac.2018.10.142%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Biological%2520Macromolecules%26atitle%3DHuman%252BToll-Like%252BReceptor%252B4%252B%252528hTLR4%252529%25253A%252BStructural%252Band%252Bfunctional%252Bdynamics%252Bin%252Bcancer%26aulast%3DMishra%26aufirst%3DVinita%26date%3D2019%26volume%3D122%26spage%3D425%26epage%3D451" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Floris  van Dalen</span>, <span class="hlFld-ContribAuthor ">Marleen  van Stevendaal</span>, <span class="hlFld-ContribAuthor ">Felix  Fennemann</span>, <span class="hlFld-ContribAuthor ">Martijn  Verdoes</span>, <span class="hlFld-ContribAuthor ">Olga  Ilina</span>. </span><span class="cited-content_cbyCitation_article-title">Molecular Repolarisation of Tumour-Associated Macrophages. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2019,</strong> <em>24 </em>
                                    (1)
                                     , 9. <a href="https://doi.org/10.3390/molecules24010009" title="DOI URL">https://doi.org/10.3390/molecules24010009</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules24010009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules24010009%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DMolecular%252BRepolarisation%252Bof%252BTumour-Associated%252BMacrophages%26aulast%3Dvan%2BDalen%26aufirst%3DFloris%26date%3D2019%26date%3D2018%26volume%3D24%26issue%3D1%26spage%3D9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shuheng  Huang</span>, <span class="hlFld-ContribAuthor ">Hu  Mei</span>, <span class="hlFld-ContribAuthor ">Duo  Zhang</span>, <span class="hlFld-ContribAuthor ">Yubin  Ren</span>, <span class="hlFld-ContribAuthor ">MuliadiYeremia  Kevin</span>, <span class="hlFld-ContribAuthor ">Xianchao  Pan</span>. </span><span class="cited-content_cbyCitation_article-title">The emerging chemical patterns applied in predicting human toll-like receptor 8 agonists. </span><span class="cited-content_cbyCitation_journal-name">MedChemComm</span><span> <strong>2018,</strong> <em>9 </em>
                                    (11)
                                     , 1961-1971. <a href="https://doi.org/10.1039/C8MD00276B" title="DOI URL">https://doi.org/10.1039/C8MD00276B</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C8MD00276B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC8MD00276B%26sid%3Dliteratum%253Aachs%26jtitle%3DMedChemComm%26atitle%3DThe%252Bemerging%252Bchemical%252Bpatterns%252Bapplied%252Bin%252Bpredicting%252Bhuman%252Btoll-like%252Breceptor%252B8%252Bagonists%26aulast%3DHuang%26aufirst%3DShuheng%26date%3D2018%26date%3D2018%26volume%3D9%26issue%3D11%26spage%3D1961%26epage%3D1971" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Moaz M.  Abdou</span>. </span><span class="cited-content_cbyCitation_article-title">Chemistry of 4-hydroxy-2(1H)-quinolone. Part 2. As synthons in heterocyclic synthesis. </span><span class="cited-content_cbyCitation_journal-name">Arabian Journal of Chemistry</span><span> <strong>2018,</strong> <em>11 </em>
                                    (7)
                                     , 1061-1071. <a href="https://doi.org/10.1016/j.arabjc.2014.11.021" title="DOI URL">https://doi.org/10.1016/j.arabjc.2014.11.021</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.arabjc.2014.11.021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.arabjc.2014.11.021%26sid%3Dliteratum%253Aachs%26jtitle%3DArabian%2520Journal%2520of%2520Chemistry%26atitle%3DChemistry%252Bof%252B4-hydroxy-2%2525281H%252529-quinolone.%252BPart%252B2.%252BAs%252Bsynthons%252Bin%252Bheterocyclic%252Bsynthesis%26aulast%3DAbdou%26aufirst%3DMoaz%2BM.%26date%3D2018%26volume%3D11%26issue%3D7%26spage%3D1061%26epage%3D1071" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiao-Fei  Shang</span>, <span class="hlFld-ContribAuthor ">Susan L.  Morris-Natschke</span>, <span class="hlFld-ContribAuthor ">Guan-Zhou  Yang</span>, <span class="hlFld-ContribAuthor ">Ying-Qian  Liu</span>, <span class="hlFld-ContribAuthor ">Xiao  Guo</span>, <span class="hlFld-ContribAuthor ">Xiao-Shan  Xu</span>, <span class="hlFld-ContribAuthor ">Masuo  Goto</span>, <span class="hlFld-ContribAuthor ">Jun-Cai  Li</span>, <span class="hlFld-ContribAuthor ">Ji-Yu  Zhang</span>, <span class="hlFld-ContribAuthor ">Kuo-Hsiung  Lee</span>. </span><span class="cited-content_cbyCitation_article-title">Biologically active quinoline and quinazoline alkaloids part II. </span><span class="cited-content_cbyCitation_journal-name">Medicinal Research Reviews</span><span> <strong>2018,</strong> <em>38 </em>
                                    (5)
                                     , 1614-1660. <a href="https://doi.org/10.1002/med.21492" title="DOI URL">https://doi.org/10.1002/med.21492</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/med.21492&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fmed.21492%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicinal%2520Research%2520Reviews%26atitle%3DBiologically%252Bactive%252Bquinoline%252Band%252Bquinazoline%252Balkaloids%252Bpart%252BII%26aulast%3DShang%26aufirst%3DXiao-Fei%26date%3D2018%26date%3D2018%26volume%3D38%26issue%3D5%26spage%3D1614%26epage%3D1660" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Meng  Wang</span>, <span class="hlFld-ContribAuthor ">Jun  Chen</span>, <span class="hlFld-ContribAuthor ">Zongjia  Chen</span>, <span class="hlFld-ContribAuthor ">Changxu  Zhong</span>, <span class="hlFld-ContribAuthor ">Ping  Lu</span>. </span><span class="cited-content_cbyCitation_article-title">Enantioselective Desymmetrization of Cyclobutanones Enabled by Synergistic Palladium/Enamine Catalysis. </span><span class="cited-content_cbyCitation_journal-name">Angewandte Chemie</span><span> <strong>2018,</strong> <em>130 </em>
                                    (10)
                                     , 2737-2741. <a href="https://doi.org/10.1002/ange.201711845" title="DOI URL">https://doi.org/10.1002/ange.201711845</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ange.201711845&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fange.201711845%26sid%3Dliteratum%253Aachs%26jtitle%3DAngewandte%2520Chemie%26atitle%3DEnantioselective%252BDesymmetrization%252Bof%252BCyclobutanones%252BEnabled%252Bby%252BSynergistic%252BPalladium%25252FEnamine%252BCatalysis%26aulast%3DWang%26aufirst%3DMeng%26date%3D2018%26date%3D2018%26volume%3D130%26issue%3D10%26spage%3D2737%26epage%3D2741" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Meng  Wang</span>, <span class="hlFld-ContribAuthor ">Jun  Chen</span>, <span class="hlFld-ContribAuthor ">Zongjia  Chen</span>, <span class="hlFld-ContribAuthor ">Changxu  Zhong</span>, <span class="hlFld-ContribAuthor ">Ping  Lu</span>. </span><span class="cited-content_cbyCitation_article-title">Enantioselective Desymmetrization of Cyclobutanones Enabled by Synergistic Palladium/Enamine Catalysis. </span><span class="cited-content_cbyCitation_journal-name">Angewandte Chemie International Edition</span><span> <strong>2018,</strong> <em>57 </em>
                                    (10)
                                     , 2707-2711. <a href="https://doi.org/10.1002/anie.201711845" title="DOI URL">https://doi.org/10.1002/anie.201711845</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/anie.201711845&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fanie.201711845%26sid%3Dliteratum%253Aachs%26jtitle%3DAngewandte%2520Chemie%2520International%2520Edition%26atitle%3DEnantioselective%252BDesymmetrization%252Bof%252BCyclobutanones%252BEnabled%252Bby%252BSynergistic%252BPalladium%25252FEnamine%252BCatalysis%26aulast%3DWang%26aufirst%3DMeng%26date%3D2018%26date%3D2018%26volume%3D57%26issue%3D10%26spage%3D2707%26epage%3D2711" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiaodi  Niu</span>, <span class="hlFld-ContribAuthor ">Yiding  Yu</span>, <span class="hlFld-ContribAuthor ">Hui  Guo</span>, <span class="hlFld-ContribAuthor ">Yanan  Yang</span>, <span class="hlFld-ContribAuthor ">Guizhen  Wang</span>, <span class="hlFld-ContribAuthor ">Lin  Sun</span>, <span class="hlFld-ContribAuthor ">Yawen  Gao</span>, <span class="hlFld-ContribAuthor ">Zhiling  Yu</span>, <span class="hlFld-ContribAuthor ">Hongsu  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Molecular modeling reveals the inhibition mechanism and binding mode of ursolic acid to TLR4-MD2. </span><span class="cited-content_cbyCitation_journal-name">Computational and Theoretical Chemistry</span><span> <strong>2018,</strong> <em>1123 </em>, 73-78. <a href="https://doi.org/10.1016/j.comptc.2017.11.016" title="DOI URL">https://doi.org/10.1016/j.comptc.2017.11.016</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.comptc.2017.11.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.comptc.2017.11.016%26sid%3Dliteratum%253Aachs%26jtitle%3DComputational%2520and%2520Theoretical%2520Chemistry%26atitle%3DMolecular%252Bmodeling%252Breveals%252Bthe%252Binhibition%252Bmechanism%252Band%252Bbinding%252Bmode%252Bof%252Bursolic%252Bacid%252Bto%252BTLR4-MD2%26aulast%3DNiu%26aufirst%3DXiaodi%26date%3D2018%26volume%3D1123%26spage%3D73%26epage%3D78" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Gengzheng  Zhu</span>, <span class="hlFld-ContribAuthor ">Yao  Xu</span>, <span class="hlFld-ContribAuthor ">Xiaohong  Cen</span>, <span class="hlFld-ContribAuthor ">Kutty Selva  Nandakumar</span>, <span class="hlFld-ContribAuthor ">Shuwen  Liu</span>, <span class="hlFld-ContribAuthor ">Kui  Cheng</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting pattern-recognition receptors to discover new small molecule immune modulators. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>144 </em>, 82-92. <a href="https://doi.org/10.1016/j.ejmech.2017.12.026" title="DOI URL">https://doi.org/10.1016/j.ejmech.2017.12.026</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2017.12.026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2017.12.026%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DTargeting%252Bpattern-recognition%252Breceptors%252Bto%252Bdiscover%252Bnew%252Bsmall%252Bmolecule%252Bimmune%252Bmodulators%26aulast%3DZhu%26aufirst%3DGengzheng%26date%3D2018%26volume%3D144%26spage%3D82%26epage%3D92" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Florent  Cochet</span>, <span class="hlFld-ContribAuthor ">Francesco  Peri</span>. </span><span class="cited-content_cbyCitation_article-title">The Role of Carbohydrates in the Lipopolysaccharide (LPS)/Toll-Like Receptor 4 (TLR4) Signalling. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Molecular Sciences</span><span> <strong>2017,</strong> <em>18 </em>
                                    (11)
                                     , 2318. <a href="https://doi.org/10.3390/ijms18112318" title="DOI URL">https://doi.org/10.3390/ijms18112318</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ijms18112318&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fijms18112318%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Molecular%2520Sciences%26atitle%3DThe%252BRole%252Bof%252BCarbohydrates%252Bin%252Bthe%252BLipopolysaccharide%252B%252528LPS%252529%25252FToll-Like%252BReceptor%252B4%252B%252528TLR4%252529%252BSignalling%26aulast%3DCochet%26aufirst%3DFlorent%26date%3D2017%26date%3D2017%26volume%3D18%26issue%3D11%26spage%3D2318" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Manuela S.  Murgueitio</span>, <span class="hlFld-ContribAuthor ">Christin  Rakers</span>, <span class="hlFld-ContribAuthor ">Anne  Frank</span>, <span class="hlFld-ContribAuthor ">Gerhard  Wolber</span>. </span><span class="cited-content_cbyCitation_article-title">Balancing Inflammation: Computational Design of Small-Molecule Toll-like Receptor Modulators. </span><span class="cited-content_cbyCitation_journal-name">Trends in Pharmacological Sciences</span><span> <strong>2017,</strong> <em>38 </em>
                                    (2)
                                     , 155-168. <a href="https://doi.org/10.1016/j.tips.2016.10.007" title="DOI URL">https://doi.org/10.1016/j.tips.2016.10.007</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tips.2016.10.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tips.2016.10.007%26sid%3Dliteratum%253Aachs%26jtitle%3DTrends%2520in%2520Pharmacological%2520Sciences%26atitle%3DBalancing%252BInflammation%25253A%252BComputational%252BDesign%252Bof%252BSmall-Molecule%252BToll-like%252BReceptor%252BModulators%26aulast%3DMurgueitio%26aufirst%3DManuela%2BS.%26date%3D2017%26volume%3D38%26issue%3D2%26spage%3D155%26epage%3D168" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhen  Chen</span>, <span class="hlFld-ContribAuthor ">Zhiyong  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">An efficient route to diverse 2H-pyrano[3,2-c]quinolin-5(6H)-ones via electrophilic cyclization reactions. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron</span><span> <strong>2016,</strong> <em>72 </em>
                                    (29)
                                     , 4288-4293. <a href="https://doi.org/10.1016/j.tet.2016.05.075" title="DOI URL">https://doi.org/10.1016/j.tet.2016.05.075</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tet.2016.05.075&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tet.2016.05.075%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%26atitle%3DAn%252Befficient%252Broute%252Bto%252Bdiverse%252B2H-pyrano%25255B3%25252C2-c%25255Dquinolin-5%2525286H%252529-ones%252Bvia%252Belectrophilic%252Bcyclization%252Breactions%26aulast%3DChen%26aufirst%3DZhen%26date%3D2016%26volume%3D72%26issue%3D29%26spage%3D4288%26epage%3D4293" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rafael  Dolezal</span>, <span class="hlFld-ContribAuthor ">Jan  Trejbal</span>, <span class="hlFld-ContribAuthor ">Jakub  Mesicek</span>, <span class="hlFld-ContribAuthor ">Agata  Milanov</span>, <span class="hlFld-ContribAuthor ">Veronika  Racakova</span>, <span class="hlFld-ContribAuthor ">Jiri  Krenek</span>. </span><span class="cited-content_cbyCitation_article-title">Designing QSAR Models for Promising TLR4 Agonists Isolated from Euodia Asteridula by Artificial Neural Networks Enhanced by Optimal Brain Surgeon. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2016,</strong>,, 271-281. <a href="https://doi.org/10.1007/978-3-319-45246-3_26" title="DOI URL">https://doi.org/10.1007/978-3-319-45246-3_26</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-3-319-45246-3_26&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-3-319-45246-3_26%26sid%3Dliteratum%253Aachs%26atitle%3DDesigning%252BQSAR%252BModels%252Bfor%252BPromising%252BTLR4%252BAgonists%252BIsolated%252Bfrom%252BEuodia%252BAsteridula%252Bby%252BArtificial%252BNeural%252BNetworks%252BEnhanced%252Bby%252BOptimal%252BBrain%252BSurgeon%26aulast%3DDolezal%26aufirst%3DRafael%26date%3D2016%26date%3D2016%26spage%3D271%26epage%3D281%26pub%3DSpringer%2520International%2520Publishing%26atitle%3DComputational%252BCollective%252BIntelligence%26aulast%3DNguyen%26aufirst%3DNgoc%2BThanh%26date%3D2016%26volume%3D9876" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Peter  Wipf</span>, <span class="hlFld-ContribAuthor ">Benjamin R.  Eyer</span>, <span class="hlFld-ContribAuthor ">Yukihiro  Yamaguchi</span>, <span class="hlFld-ContribAuthor ">Feng  Zhang</span>, <span class="hlFld-ContribAuthor ">Matthew D.  Neal</span>, <span class="hlFld-ContribAuthor ">Chhinder P.  Sodhi</span>, <span class="hlFld-ContribAuthor ">Misty  Good</span>, <span class="hlFld-ContribAuthor ">Maria  Branca</span>, <span class="hlFld-ContribAuthor ">Thomas  Prindle</span>, <span class="hlFld-ContribAuthor ">Peng  Lu</span>, <span class="hlFld-ContribAuthor ">Jeffrey L.  Brodsky</span>, <span class="hlFld-ContribAuthor ">David J.  Hackam</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of anti -inflammatory α-and β-linked acetamidopyranosides as inhibitors of toll-like receptor 4 (TLR4). </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron Letters</span><span> <strong>2015,</strong> <em>56 </em>
                                    (23)
                                     , 3097-3100. <a href="https://doi.org/10.1016/j.tetlet.2014.11.048" title="DOI URL">https://doi.org/10.1016/j.tetlet.2014.11.048</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tetlet.2014.11.048&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tetlet.2014.11.048%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%2520Letters%26atitle%3DSynthesis%252Bof%252Banti%252B-inflammatory%252B%2525CE%2525B1-and%252B%2525CE%2525B2-linked%252Bacetamidopyranosides%252Bas%252Binhibitors%252Bof%252Btoll-like%252Breceptor%252B4%252B%252528TLR4%252529%26aulast%3DWipf%26aufirst%3DPeter%26date%3D2015%26volume%3D56%26issue%3D23%26spage%3D3097%26epage%3D3100" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Afshin  Nour</span>, <span class="hlFld-ContribAuthor ">Tomoko  Hayashi</span>, <span class="hlFld-ContribAuthor ">Michael  Chan</span>, <span class="hlFld-ContribAuthor ">Shiyin  Yao</span>, <span class="hlFld-ContribAuthor ">Rommel I.  Tawatao</span>, <span class="hlFld-ContribAuthor ">Brian  Crain</span>, <span class="hlFld-ContribAuthor ">Igor F.  Tsigelny</span>, <span class="hlFld-ContribAuthor ">Valentina L.  Kouznetsova</span>, <span class="hlFld-ContribAuthor ">Alast  Ahmadiiveli</span>, <span class="hlFld-ContribAuthor ">Karen  Messer</span>, <span class="hlFld-ContribAuthor ">Minya  Pu</span>, <span class="hlFld-ContribAuthor ">Maripat  Corr</span>, <span class="hlFld-ContribAuthor ">Dennis A.  Carson</span>, <span class="hlFld-ContribAuthor ">Howard B.  Cottam</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of substituted 4-aminoquinazolines as selective Toll-like receptor 4 ligands. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2014,</strong> <em>24 </em>
                                    (21)
                                     , 4931-4938. <a href="https://doi.org/10.1016/j.bmcl.2014.09.039" title="DOI URL">https://doi.org/10.1016/j.bmcl.2014.09.039</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2014.09.039&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2014.09.039%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252Bsubstituted%252B4-aminoquinazolines%252Bas%252Bselective%252BToll-like%252Breceptor%252B4%252Bligands%26aulast%3DNour%26aufirst%3DAfshin%26date%3D2014%26volume%3D24%26issue%3D21%26spage%3D4931%26epage%3D4938" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401321v/production/images/medium/jm-2013-01321v_0018.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401321v/production/images/large/jm-2013-01321v_0018.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401321v&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401321v/production/images/medium/jm-2013-01321v_0020.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401321v/production/images/large/jm-2013-01321v_0020.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Small-molecule inhibitors of TLR4: Tak-242 (a), (+)-naloxone (b), and dimethyl 2-(2-nitrobenzylidene)malonate (c).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401321v/production/images/large/jm-2013-01321v_0020.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401321v&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401321v/production/images/medium/jm-2013-01321v_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401321v/production/images/large/jm-2013-01321v_0001.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Structure and 3D shape of euodenine A (<b>1</b>) (relative stereochemistry and MacroModel/MMFF force field with H<sub>2</sub>O solvation of the lowest-energy conformer are shown).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401321v/production/images/large/jm-2013-01321v_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401321v&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401321v/production/images/medium/jm-2013-01321v_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401321v/production/images/large/jm-2013-01321v_0002.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Structures related to euodenine A, melicodenines C–F (relative stereochemistry shown).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401321v/production/images/large/jm-2013-01321v_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401321v&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401321v/production/images/medium/jm-2013-01321v_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401321v/production/images/large/jm-2013-01321v_0003.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Extracellular site of action of euodenine A (<b>1</b>). A HEK293/NFκB reporter cell line stably transfected with human MD-2 and CD14 was transiently transfected with a chimeric construct consisting of either the human or mouse TLR4 extracellular domain fused to either the human or mouse transmembrane and intracellular domains. Cells were subsequently treated with LPS or <b>1</b>, and reporter gene activity was measured 24 h later. Data are representative of at least two independent experiments and are expressed as the mean of triplicate determinations. (A) LPS is active in all human/mouse chimeric assays. (B) <b>1</b> is a human-selective agonist and only shows a response when the extracellular domain of human TLR4 is present.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401321v/production/images/large/jm-2013-01321v_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401321v&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401321v/production/images/medium/jm-2013-01321v_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401321v/production/images/large/jm-2013-01321v_0004.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. LPS activation of TLR4 via the CD14, TLR4, and MD-2 complex proceeds via MyD88 and the IRAK/TRAF6 pathway, leading to activation of proinflammatory cytokines.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401321v/production/images/large/jm-2013-01321v_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401321v&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401321v/production/images/medium/jm-2013-01321v_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401321v/production/images/large/jm-2013-01321v_0005.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. LPS and <b>1</b> require MD-2 and TLR4 for agonism. A HEK293/NFκB reporter cell line stably transfected with human TLR4 was transiently transfected with constructs containing either human MD-2, human CD14, a combination of human MD-2 and CD14, or empty vector. Cells were subsequently treated with (A) LPS or <b>1</b>, and reporter gene activity was measured 24 h later. TNF-α was used as a control to stimulate maximal reporter gene activity, and results were calculated as the percent of the maximal TNF-α response. Data are representative of at least two independent experiments and are expressed as the mean of triplicate determinations. Signaling only occurs when both TLR4 and MD-2 are present.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401321v/production/images/large/jm-2013-01321v_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401321v&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401321v/production/images/medium/jm-2013-01321v_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401321v/production/images/large/jm-2013-01321v_0006.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. <b>1</b> is human-selective. A HEK293 NFκB reporter cell line was transiently transfected with a construct containing either human or mouse TLR4 together with a construct containing human or mouse MD-2 and CD14. Cells were subsequently treated with LPS or <b>1</b>, and reporter gene activity was measured 24 h later. Data are representative of at least two independent experiments and are expressed as the mean of triplicate determinations. (A) LPS is nonselective against human and mouse TLR4. (B) <b>1</b> is human selective for both TLR4 and MD-2, and mouse MD-2 cannot substitute.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401321v/production/images/large/jm-2013-01321v_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401321v&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig8" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401321v/production/images/medium/jm-2013-01321v_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401321v/production/images/large/jm-2013-01321v_0007.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Cytokine induction time-course data: IL-8 (A), IL-12p40 (B), IL-10 (C), and TNF-α (D). (E) IL-5 suppression from activated PBMCs by <b>1</b> and (F) IL-5 suppression from activated PBMCs by LPS. In PBMC, <b>1</b> suppresses PHA-induced IL-5 release and, compared to LPS, stimulates lower levels of three out of four cytokines tested. (A–F) Human PBMCs were treated with LPS or <b>1</b> for 20 h. Levels of IL-8 (A), IL-12p40 (B), IL-10 (C), and TNF-α (D) were measured in the cell supernatants by ELISA. (E, F) Human PBMC were stimulated for 44 h with 1 μg/mL of phytohemeagglutinin (PHA) in the presence or absence of LPS or <b>1</b>. Levels of IL-5 were measured in the cell supernatants by ELISA. Data are from a representative experiment in PBMC from 1 of 8 donors (cytokine stimulation) or 9 donors (IL-5 suppression) and are expressed as the mean ± standard deviation of triplicate determinations.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401321v/production/images/large/jm-2013-01321v_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401321v&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401321v/production/images/medium/jm-2013-01321v_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401321v/production/images/large/jm-2013-01321v_0008.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of <b>1</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401321v/production/images/large/jm-2013-01321v_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401321v&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Relative stereochemistry shown. Reagents and conditions: (i) UV light (hv), 125 W, neat 16 h; (ii) KI, HOAc, 50 °C, 4 h.</p></p></figure><figure data-id="sch2" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401321v/production/images/medium/jm-2013-01321v_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401321v/production/images/large/jm-2013-01321v_0009.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. General Synthetic Approach<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401321v/production/images/large/jm-2013-01321v_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401321v&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Relative stereochemistry shown. Reagents and conditions: (i) UV light (hv), 125 or 400 W, neat 16 h. Yields: 2–36% (generally, 5–10%).</p></p></figure><figure data-id="sch3" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401321v/production/images/medium/jm-2013-01321v_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401321v/production/images/large/jm-2013-01321v_0010.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Methods for Synthesis of Styrenes<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401321v/production/images/large/jm-2013-01321v_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401321v&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) RCH<sub>2</sub>MgX, MePh; (ii) 1,4-dioxan, silica, microwave, 160 °C, 30 min; (iii) PBr<sub>3</sub>, DCM; (iv) P(OEt)<sub>3</sub>, (Bu)<sub>4</sub>NI, 110 °C 16 h; (v) NaH, RCHO, THF, 0 °C to rt, O/N; (vi) CH<sub>3</sub>NO<sub>2</sub>, NH<sub>4</sub>OAc, 48 h, reflux; (vii) RI, B(Et)<sub>3</sub>, rt, 24 h; (viii) Pd(OAc)<sub>2</sub>, 2 M K<sub>2</sub>CO<sub>3</sub>, DME, 80 °C, 16 h. Overall yields for methods A–C were 40–60% and for D (Suzuki coupling), ∼80%.</p></p></figure><figure data-id="sch4" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401321v/production/images/medium/jm-2013-01321v_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401321v/production/images/large/jm-2013-01321v_0011.jpeg" id="rightTab-gr12" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of Functionalized Styrenes<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401321v/production/images/large/jm-2013-01321v_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401321v&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) DMAP, pyridine; (ii) K<sub>2</sub>CO<sub>3</sub>, acetone. Yields: <b>5a</b> (78%), <b>5b</b> (37%), <b>5c</b> (20%), and <b>5d</b> (96%).</p></p></figure><figure data-id="sch5" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401321v/production/images/medium/jm-2013-01321v_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401321v/production/images/large/jm-2013-01321v_0012.jpeg" id="rightTab-gr13" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Synthesis of Flindersine Analogues<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401321v/production/images/large/jm-2013-01321v_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401321v&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) (a) Yb(OTf)<sub>3</sub>, MeCN, 80 °C, 12 h or (b) MgSO<sub>4</sub>, pyridine, reflux 16 h. Yields: <b>2a</b> (42%), <b>2b</b> (98%), <b>2c</b> (95%), and <b>2e</b>,<b>f</b> (18%).</p></p></figure><figure data-id="sch6" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401321v/production/images/medium/jm-2013-01321v_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401321v/production/images/large/jm-2013-01321v_0013.jpeg" id="rightTab-gr14" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 6. Synthesis of Pyridinone Analogues<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401321v/production/images/large/jm-2013-01321v_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401321v&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) (a) Yb(OTf)<sub>3</sub>, MeCN, 80 °C, 12 h or (b) MgSO<sub>4</sub>, pyridine, reflux 16 h; (ii) UV light (hv), 125 or 400 W, neat 16 h. Yields: <b>6</b> (80%), <b>59</b> (6.6%), <b>60</b> (11%), and <b>61</b> (8.5%).</p></p></figure><figure data-id="sch7" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Scheme 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401321v/production/images/medium/jm-2013-01321v_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401321v/production/images/large/jm-2013-01321v_0014.jpeg" id="rightTab-gr15" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 7. Synthesis of Acetal Analogues<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401321v/production/images/large/jm-2013-01321v_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401321v&amp;id=sch7"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) PropylMgBr, MePh, rt, 26 h; (ii) MnO<sub>2</sub>, DCM, rt, 24 h; (iii) H<sub>2</sub>SO<sub>4</sub>, MeOH, (MeO)<sub>3</sub>CH; (iv) DCM, PPTS, 18 h. Overall yields: <b>62</b> (50%), <b>63</b> (78%), and <b>64</b> (30%).</p></p></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i139">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_28460" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_28460" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 22 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Hashimoto, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hudson, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, K. V.</span><span> </span><span class="NLM_article-title">The Toll gene of Drosophila, required for dorsal-ventral embryonic polarity, appears to encode a transmembrane protein</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1988</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">269</span><span class="NLM_x">–</span> <span class="NLM_lpage">279</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=1988&pages=269-279&author=C.+Hashimotoauthor=K.+L.+Hudsonauthor=K.+V.+Anderson&title=The+Toll+gene+of+Drosophila%2C+required+for+dorsal-ventral+embryonic+polarity%2C+appears+to+encode+a+transmembrane+protein"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHashimoto%26aufirst%3DC.%26aulast%3DHudson%26aufirst%3DK.%2BL.%26aulast%3DAnderson%26aufirst%3DK.%2BV.%26atitle%3DThe%2520Toll%2520gene%2520of%2520Drosophila%252C%2520required%2520for%2520dorsal-ventral%2520embryonic%2520polarity%252C%2520appears%2520to%2520encode%2520a%2520transmembrane%2520protein%26jtitle%3DCell%26date%3D1988%26volume%3D52%26spage%3D269%26epage%3D279" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Medzhitov, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Preston-Hurlburt, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janeway, C. A.,  Jr.</span><span> </span><span class="NLM_article-title">A human homologue of the Drosophila Toll protein signals activation of adaptive immunity</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">388</span><span class="NLM_x">, </span> <span class="NLM_fpage">394</span><span class="NLM_x">–</span> <span class="NLM_lpage">397</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm401321v&amp;key=10.1038%2F41131" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm401321v&amp;key=9237759" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm401321v&amp;key=1%3ACAS%3A528%3ADyaK2sXkvVChurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=388&publication_year=1997&pages=394-397&author=R.+Medzhitovauthor=P.+Preston-Hurlburtauthor=C.+A.+Janeway&title=A+human+homologue+of+the+Drosophila+Toll+protein+signals+activation+of+adaptive+immunity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">A human homolog of the Drosophila Toll protein signals activation of adaptive immunity</span></div><div class="casAuthors">Medzhitov, Rusian; Preston-Hurlburt, Paula; Janeway, Charles A., Jr.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London)</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">388</span>
        (<span class="NLM_cas:issue">6640</span>),
    <span class="NLM_cas:pages">394-396</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Macmillan Magazines</span>)
        </div><div class="casAbstract">Induction of the adaptive immune response depends on the expression of co-stimulatory mols. and cytokines by antigen-presenting cells.  The mechanisms that control the initial induction of these signals upon infection are poorly understood.  It has been proposed that their expression is controlled by the non-clonal, or innate, component of immunity that preceded in evolution the development of an adaptive immune system in vertebrates.  The authors report here the cloning and characterization of a human homolog of the Drosophila toll protein (Toll) which has been shown to induce the innate immune response in adult Drosophila.  Like Drosophila Toll, human Toll is a type I transmembrane protein with an extracellular domain consisting of a leucine-rich repeat (LRR) domain, and a cytoplasmic domain homologous to the cytoplasmic domain of the human interleukin (IL)-1 receptor.  Both Drosophila Toll and the IL-1 receptor are known to signal through the NF-κB pathway.  The authors show that a constitutively active mutant of human Toll transfected into human cell lines can induce the activation of NF-κB and the expression of NF-κB-controlled genes for the inflammatory cytokines IL-1, IL-6 and IL-8, as well as the expression of the co-stimulatory mol. B7.1, which is required for the activation of naive T cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq3V83d3kAO07Vg90H21EOLACvtfcHk0lhaLlvyFdaL0w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXkvVChurc%253D&md5=88d3d9bcebce8c0df8ad09e2d9fc13f2</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1038%2F41131&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F41131%26sid%3Dliteratum%253Aachs%26aulast%3DMedzhitov%26aufirst%3DR.%26aulast%3DPreston-Hurlburt%26aufirst%3DP.%26aulast%3DJaneway%26aufirst%3DC.%2BA.%26atitle%3DA%2520human%2520homologue%2520of%2520the%2520Drosophila%2520Toll%2520protein%2520signals%2520activation%2520of%2520adaptive%2520immunity%26jtitle%3DNature%26date%3D1997%26volume%3D388%26spage%3D394%26epage%3D397" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Andreakos, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foxwell, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feldmann, M.</span><span> </span><span class="NLM_article-title">Is targeting Toll-like receptors and their signaling pathway a useful therapeutic approach to modulating cytokine-driven inflammation?</span> <span class="citation_source-journal">Immunol. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">202</span><span class="NLM_x">, </span> <span class="NLM_fpage">250</span><span class="NLM_x">–</span> <span class="NLM_lpage">265</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm401321v&amp;key=10.1111%2Fj.0105-2896.2004.00202.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Fjm401321v&amp;key=15546398" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm401321v&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhs1Ohug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=202&publication_year=2004&pages=250-265&author=E.+Andreakosauthor=B.+Foxwellauthor=M.+Feldmann&title=Is+targeting+Toll-like+receptors+and+their+signaling+pathway+a+useful+therapeutic+approach+to+modulating+cytokine-driven+inflammation%3F"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Is targeting Toll-like receptors and their signaling pathway a useful therapeutic approach to modulating cytokine-driven inflammation?</span></div><div class="casAuthors">Andreakos, Evangelos; Foxwell, Brian; Feldmann, Marc</div><div class="citationInfo"><span class="NLM_cas:title">Immunological Reviews</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">202</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">250-265</span>CODEN:
                <span class="NLM_cas:coden">IMRED2</span>;
        ISSN:<span class="NLM_cas:issn">0105-2896</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">A review.  Cytokine-driven inflammation and tissue destruction is a common theme of chronic inflammatory diseases such as rheumatoid arthritis, Crohn's disease, ulcerative colitis, psoriasis, chronic obstructive pulmonary disease, and atherosclerosis.  Research over the last two decades demonstrated the importance of cytokines that are not only expressed chronically but also are capable of signaling at sites of chronic inflammation.  Cytokines thus regulate major pathol. processes that include inflammation, angiogenesis, tissue remodeling, and fibrosis.  This research led to the identification of key cytokines involved in these processes, two of which, tumor necrosis factor-α and interleukin-1, have also been successfully targeted in the clinic.  However, what triggers and maintains cytokine gene expression in chronic inflammation remains a mystery.  Here, the authors review current progress in the understanding of cytokine-driven inflammation and discuss current evidence implicating Toll-like receptors (TLRs), recently identified as the receptors recognizing self vs. non-self mol. patterns, in the regulation of cytokine-driven inflammation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpqh_TV08KZTbVg90H21EOLACvtfcHk0ljMJGb2jsi6vw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhs1Ohug%253D%253D&md5=c2d6c510bc3e7f495a8c100f886583e7</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1111%2Fj.0105-2896.2004.00202.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.0105-2896.2004.00202.x%26sid%3Dliteratum%253Aachs%26aulast%3DAndreakos%26aufirst%3DE.%26aulast%3DFoxwell%26aufirst%3DB.%26aulast%3DFeldmann%26aufirst%3DM.%26atitle%3DIs%2520targeting%2520Toll-like%2520receptors%2520and%2520their%2520signaling%2520pathway%2520a%2520useful%2520therapeutic%2520approach%2520to%2520modulating%2520cytokine-driven%2520inflammation%253F%26jtitle%3DImmunol.%2520Rev.%26date%3D2004%26volume%3D202%26spage%3D250%26epage%3D265" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Gangloff, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guenounou, M.</span><span> </span><span class="NLM_article-title">Toll-like receptors and immune response in allergic disease</span> <span class="citation_source-journal">Clin. Rev. Allergy Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">115</span><span class="NLM_x">–</span> <span class="NLM_lpage">125</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm401321v&amp;key=10.1007%2Fs12016-004-0006-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm401321v&amp;key=15146108" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm401321v&amp;key=1%3ACAS%3A528%3ADC%252BD2cXlsFyhs7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2004&pages=115-125&author=S.+C.+Gangloffauthor=M.+Guenounou&title=Toll-like+receptors+and+immune+response+in+allergic+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Toll-like receptors and immune response in allergic disease</span></div><div class="casAuthors">Gangloff, Sophie C.; Guenounou, Moncef</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Reviews in Allergy & Immunology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">115-125</span>CODEN:
                <span class="NLM_cas:coden">CRAIF2</span>;
        ISSN:<span class="NLM_cas:issn">1080-0549</span>.
    
            (<span class="NLM_cas:orgname">Humana Press Inc.</span>)
        </div><div class="casAbstract">A review.  Allergic reactions are dominated by the preferential development of specific Th2 responses against innocuous antigens in atopic individuals.  This can reflect alterations in innate immune mechanisms.  Toll-like receptors (TLRs) have evolved as key mols. in innate and adaptive immunity.  Their activation by structurally distinct exogenous or endogenous ligands present at the cell microenvironment plays a crit. role in antimicrobial defense.  The global view is that TLR activation induces antigen-presenting cells to produce cytokines that favor Th1-type immune responses, suggesting that it might prevent the development of deleterious Th2 responses in allergy.  On the basis of epidemiol. studies and recent data, it has been established that TLRs play a role in the development of Th2 responses.  However, more information is needed to fully understand the mechanism of TLR involvement and the implication of immune cells that express TLRs in the Th1/Th2 cytokine profiles.  Several TLRs, such as TLR9, TLR7, and TLR8, can be considered as good target candidates.  Some TLR ligands, such as CpG DNA, are effective adjuvants, strong inducers of both IL-5 and eosinophilia downregulation.  They are also potential links to allergen epitopes that could provide new allergen-specific immunotherapy regimens for the treatment of allergic disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpcFaeJV-TwgLVg90H21EOLACvtfcHk0ljMJGb2jsi6vw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXlsFyhs7k%253D&md5=942277305e3fb731efd9ec24b86b7d76</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1007%2Fs12016-004-0006-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs12016-004-0006-0%26sid%3Dliteratum%253Aachs%26aulast%3DGangloff%26aufirst%3DS.%2BC.%26aulast%3DGuenounou%26aufirst%3DM.%26atitle%3DToll-like%2520receptors%2520and%2520immune%2520response%2520in%2520allergic%2520disease%26jtitle%3DClin.%2520Rev.%2520Allergy%2520Immunol.%26date%3D2004%26volume%3D26%26spage%3D115%26epage%3D125" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Hennessy, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parker, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Neill, L. A. J.</span><span> </span><span class="NLM_article-title">Targetting Toll-like receptors: Emerging therapeutics</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">293</span><span class="NLM_x">–</span> <span class="NLM_lpage">301</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2010&pages=293-301&author=E.+J.+Hennessyauthor=A.+E.+Parkerauthor=L.+A.+J.+O%E2%80%99Neill&title=Targetting+Toll-like+receptors%3A+Emerging+therapeutics"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHennessy%26aufirst%3DE.%2BJ.%26aulast%3DParker%26aufirst%3DA.%2BE.%26aulast%3DO%25E2%2580%2599Neill%26aufirst%3DL.%2BA.%2BJ.%26atitle%3DTargetting%2520Toll-like%2520receptors%253A%2520Emerging%2520therapeutics%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2010%26volume%3D9%26spage%3D293%26epage%3D301" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Ishihara, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rumi, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ortega-Cava, C. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kazumori, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kadowaki, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishimura, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kinoshita, Y.</span><span> </span><span class="NLM_article-title">Therapeutic targeting of toll-like receptors in gastrointestinal inflammation</span> <span class="citation_source-journal">Curr. Pharm. Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">4215</span><span class="NLM_x">–</span> <span class="NLM_lpage">4228</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm401321v&amp;key=10.2174%2F138161206778743448" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm401321v&amp;key=17100624" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm401321v&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht1Grtr3K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2006&pages=4215-4228&author=S.+Ishiharaauthor=M.+A.+Rumiauthor=C.+F.+Ortega-Cavaauthor=H.+Kazumoriauthor=Y.+Kadowakiauthor=N.+Ishimuraauthor=Y.+Kinoshita&title=Therapeutic+targeting+of+toll-like+receptors+in+gastrointestinal+inflammation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Therapeutic targeting of Toll-like receptors in gastrointestinal inflammation</span></div><div class="casAuthors">Ishihara, Shunji; Rumi, Mohammad A. K.; Ortega-Cava, Cesar-F.; Kazumori, Hideaki; Kadowaki, Yasunori; Ishimura, Norihisa; Kinoshita, Yoshikazu</div><div class="citationInfo"><span class="NLM_cas:title">Current Pharmaceutical Design</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">32</span>),
    <span class="NLM_cas:pages">4215-4228</span>CODEN:
                <span class="NLM_cas:coden">CPDEFP</span>;
        ISSN:<span class="NLM_cas:issn">1381-6128</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Toll-like receptors (TLRs) are sensors of microbial products that initiate host defense responses in multicellular organisms.  They are mainly linked to innate immunity and bridging to adaptive immunity, signaling through different TLRs responsible for a wide range of biol. responses.  The intracellular signaling pathways through Toll/interleukin-1 receptor (IL-1R) domains result in recruitment of the cytoplasmic adaptor mols., with subsequent activation of a signaling cascade leading to nuclear factor-κB (NF-κB).  TLR-signaling induces host inflammatory response and the inflammation becomes more severe in the absence of several extra and intra cellular neg. regulators of TLR-signaling.  In the intestine, TLR-dependent activation of NF-κB plays a vital role in maintaining epithelial homeostasis as well as regulating infections and inflammation, while dysregulation of TLR-signaling is assocd. with the pathogenesis of inflammatory bowel diseases (IBD).  Recent findings regarding innate immunity-mediated regulation of intestinal pathophysiol. prove that development of new drugs targeting TLRs including antagonists of TLR-signaling and agonists of their neg. regulators has a potential impact on therapeutic strategies for intestinal inflammatory diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqNSSVr9K9JibVg90H21EOLACvtfcHk0lh0Akc3d0jr8w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht1Grtr3K&md5=7e0958c49e989093150792b6c721c0b4</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.2174%2F138161206778743448&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138161206778743448%26sid%3Dliteratum%253Aachs%26aulast%3DIshihara%26aufirst%3DS.%26aulast%3DRumi%26aufirst%3DM.%2BA.%26aulast%3DOrtega-Cava%26aufirst%3DC.%2BF.%26aulast%3DKazumori%26aufirst%3DH.%26aulast%3DKadowaki%26aufirst%3DY.%26aulast%3DIshimura%26aufirst%3DN.%26aulast%3DKinoshita%26aufirst%3DY.%26atitle%3DTherapeutic%2520targeting%2520of%2520toll-like%2520receptors%2520in%2520gastrointestinal%2520inflammation%26jtitle%3DCurr.%2520Pharm.%2520Des.%26date%3D2006%26volume%3D12%26spage%3D4215%26epage%3D4228" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Lewis, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loram, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hutchinson, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maier, S. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rice, K. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watkins, L. R.</span><span> </span><span class="NLM_article-title">(+)-Naloxone, an opioid-inactive toll-like receptor 4 signaling inhibitor, reverses multiple models of chronic neuropathic pain in rats</span> <span class="citation_source-journal">J. Pain</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">498</span><span class="NLM_x">–</span> <span class="NLM_lpage">506</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Fjm401321v&amp;key=10.1016%2Fj.jpain.2012.02.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Fjm401321v&amp;key=22520687" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm401321v&amp;key=1%3ACAS%3A528%3ADC%252BC38XmslyhsLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2012&pages=498-506&author=S.+S.+Lewisauthor=L.+C.+Loramauthor=M.+R.+Hutchinsonauthor=C.+M.+Liauthor=Y.+Zhangauthor=S.+F.+Maierauthor=Y.+Huangauthor=K.+C.+Riceauthor=L.+R.+Watkins&title=%28%2B%29-Naloxone%2C+an+opioid-inactive+toll-like+receptor+4+signaling+inhibitor%2C+reverses+multiple+models+of+chronic+neuropathic+pain+in+rats"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">(+)-Naloxone, an Opioid-Inactive Toll-Like Receptor 4 Signaling Inhibitor, Reverses Multiple Models of Chronic Neuropathic Pain in Rats</span></div><div class="casAuthors">Lewis, Susannah S.; Loram, Lisa C.; Hutchinson, Mark R.; Li, Chien-Ming; Zhang, Yingning; Maier, Steven F.; Huang, Yong; Rice, Kenner C.; Watkins, Linda R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pain</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">498-506</span>CODEN:
                <span class="NLM_cas:coden">JPOAB5</span>;
        ISSN:<span class="NLM_cas:issn">1526-5900</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Previous work demonstrated that both the opioid antagonist (-)-naloxone and the non-opioid (+)-naloxone inhibit toll-like receptor 4 (TLR4) signaling and reverse neuropathic pain expressed shortly after chronic constriction injury.  The present studies reveal that the TLR4 contributes to neuropathic pain in another major model (spinal nerve ligation) and to long established (2-4 mo) neuropathic pain, not just to pain shortly after nerve damage.  Addnl., analyses of plasma levels of (+)-naloxone after s.c. administration indicate that (+)-naloxone has comparable pharmacokinetics to (-)-naloxone with a relatively short half-life.  This finding accounts for the rapid onset and short duration of allodynia reversal produced by s.c. (+)-naloxone.  Given that toll-like receptor 2 (TLR2) has also recently been implicated in neuropathic pain, cell lines transfected with either TLR4 or TLR2, necessary co-signaling mols., and a reporter gene were used to define whether (+)-naloxone effects could be accounted for by actions at TLR2 in addn. to TLR4.  (+)-Naloxone inhibited signaling by TLR4 but not TLR2.  These studies provide evidence for broad involvement of TLR4 in neuropathic pain, both early after nerve damage and months later.  Addnl., they provide further support for the TLR4 inhibitor (+)-naloxone as a novel candidate for the treatment of neuropathic pain.  Perspective: These studies demonstrated that (+)-naloxone, a systemically available, blood-brain barrier permeable, small mol. TLR4 inhibitor can reverse neuropathic pain in rats, even months after nerve injury.  These findings suggest that (+)-naloxone, or similar compds., be considered as a candidate novel, first-in-class treatment for neuropathic pain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoNVO43Bz_AdbVg90H21EOLACvtfcHk0lh0Akc3d0jr8w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XmslyhsLo%253D&md5=302b4b13665ab5f6036de8bca8995437</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1016%2Fj.jpain.2012.02.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jpain.2012.02.005%26sid%3Dliteratum%253Aachs%26aulast%3DLewis%26aufirst%3DS.%2BS.%26aulast%3DLoram%26aufirst%3DL.%2BC.%26aulast%3DHutchinson%26aufirst%3DM.%2BR.%26aulast%3DLi%26aufirst%3DC.%2BM.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DMaier%26aufirst%3DS.%2BF.%26aulast%3DHuang%26aufirst%3DY.%26aulast%3DRice%26aufirst%3DK.%2BC.%26aulast%3DWatkins%26aufirst%3DL.%2BR.%26atitle%3D%2528%252B%2529-Naloxone%252C%2520an%2520opioid-inactive%2520toll-like%2520receptor%25204%2520signaling%2520inhibitor%252C%2520reverses%2520multiple%2520models%2520of%2520chronic%2520neuropathic%2520pain%2520in%2520rats%26jtitle%3DJ.%2520Pain%26date%3D2012%26volume%3D13%26spage%3D498%26epage%3D506" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">O’Neill, L. A.</span><span> </span><span class="NLM_article-title">Therapeutic targeting of Toll-like receptors for inflammatory and infectious diseases</span> <span class="citation_source-journal">Curr. Opin. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">396</span><span class="NLM_x">–</span> <span class="NLM_lpage">403</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Fjm401321v&amp;key=10.1016%2FS1471-4892%2803%2900080-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Fjm401321v&amp;key=12901949" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm401321v&amp;key=1%3ACAS%3A528%3ADC%252BD3sXlvFGju7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2003&pages=396-403&author=L.+A.+O%E2%80%99Neill&title=Therapeutic+targeting+of+Toll-like+receptors+for+inflammatory+and+infectious+diseases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Therapeutic targeting of Toll-like receptors for inflammatory and infectious diseases</span></div><div class="casAuthors">O'Neill, Luke A. J.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Pharmacology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">396-403</span>CODEN:
                <span class="NLM_cas:coden">COPUBK</span>;
        ISSN:<span class="NLM_cas:issn">1471-4892</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A review.  Roles for Toll-like receptors (TLRs) are emerging in conditions such as sepsis syndrome, systemic lupus erythromatosis, rheumatoid arthritis and asthma, suggesting that the selective targeting of TLRs might be useful therapeutically.  TLRs are defined by the presence of extracellular leucine-rich repeats and an intracellular Toll/interleukin-1 receptor domain, and play a role in host defense and inflammation.  Signalling pathways activated by TLRs show remarkable similarity to those activated by the pro-inflammatory cytokine interleukin-1 (the receptor for which also has a Toll/interleukin-1 receptor domain), although adaptor proteins specific for certain TLRs are starting to emerge (e.g. Mal and Trif).  The common signalling pathways used by all members of the TLR superfamily are being targeted, with drugs that block nuclear factor-κB and p38b mitogen-activated protein kinase in clin. development for diseases such as rheumatoid arthritis and psoriasis.  As we learn more about TLR signal transduction, more options are presenting themselves for pharmacol. targeting.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoXDeIEFYRSwrVg90H21EOLACvtfcHk0lh0Akc3d0jr8w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXlvFGju7s%253D&md5=38d89f8c1840a9bf90003364217fe529</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1016%2FS1471-4892%2803%2900080-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1471-4892%252803%252900080-8%26sid%3Dliteratum%253Aachs%26aulast%3DO%25E2%2580%2599Neill%26aufirst%3DL.%2BA.%26atitle%3DTherapeutic%2520targeting%2520of%2520Toll-like%2520receptors%2520for%2520inflammatory%2520and%2520infectious%2520diseases%26jtitle%3DCurr.%2520Opin.%2520Pharmacol.%26date%3D2003%26volume%3D3%26spage%3D396%26epage%3D403" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">O’Neill, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bryant, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doyle, S. L.</span><span> </span><span class="NLM_article-title">Therapeutic targeting of Toll-like receptors for infectious and inflammatory diseases and cancer</span> <span class="citation_source-journal">Pharmacol. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">61</span><span class="NLM_x">, </span> <span class="NLM_fpage">177</span><span class="NLM_x">–</span> <span class="NLM_lpage">197</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2009&pages=177-197&author=L.+A.+O%E2%80%99Neillauthor=C.+E.+Bryantauthor=S.+L.+Doyle&title=Therapeutic+targeting+of+Toll-like+receptors+for+infectious+and+inflammatory+diseases+and+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DO%25E2%2580%2599Neill%26aufirst%3DL.%2BA.%26aulast%3DBryant%26aufirst%3DC.%2BE.%26aulast%3DDoyle%26aufirst%3DS.%2BL.%26atitle%3DTherapeutic%2520targeting%2520of%2520Toll-like%2520receptors%2520for%2520infectious%2520and%2520inflammatory%2520diseases%2520and%2520cancer%26jtitle%3DPharmacol.%2520Rev.%26date%3D2009%26volume%3D61%26spage%3D177%26epage%3D197" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Uematsu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishii, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akira, S.</span><span> </span><span class="NLM_article-title">Therapeutic targetng of Toll-like receptors</span> <span class="citation_source-journal">Drug Discovery Today: Ther. Strategies</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">299</span><span class="NLM_x">–</span> <span class="NLM_lpage">304</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Fjm401321v&amp;key=10.1016%2Fj.ddstr.2004.10.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm401321v&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtFSgurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2004&pages=299-304&author=S.+Uematsuauthor=K.+J.+Ishiiauthor=S.+Akira&title=Therapeutic+targetng+of+Toll-like+receptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Therapeutic targeting of Toll-like receptors</span></div><div class="casAuthors">Uematsu, Satoshi; Ishii, Ken J.; Akira, Shizuo</div><div class="citationInfo"><span class="NLM_cas:title">Drug Discovery Today: Therapeutic Strategies</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">299-304</span>CODEN:
                <span class="NLM_cas:coden">DDTTC6</span>;
        ISSN:<span class="NLM_cas:issn">1740-6773</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Toll-like receptors (TLRs) play a crucial role in innate immune response in mammals.  Individual TLRs recognize microbial components that are conserved among pathogens and activate their signaling pathways.  Each TLR has its own cascade of signaling pathway for exhibiting its specific responses through selective utilization of TIR domain-contg. adaptors.  Increasing evidence for roles of TLRs in various diseases provides us new insights for a basis of new therapies.  In this review, we discuss the possibilities of therapeutics targeting TLRs in various diseases and explain potential problems assocd. with such approaches.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr-cmaR8YLLvbVg90H21EOLACvtfcHk0liu6KfBQ6HDVg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtFSgurk%253D&md5=703f945debf0d475d9bb19532ea28bf4</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1016%2Fj.ddstr.2004.10.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ddstr.2004.10.009%26sid%3Dliteratum%253Aachs%26aulast%3DUematsu%26aufirst%3DS.%26aulast%3DIshii%26aufirst%3DK.%2BJ.%26aulast%3DAkira%26aufirst%3DS.%26atitle%3DTherapeutic%2520targetng%2520of%2520Toll-like%2520receptors%26jtitle%3DDrug%2520Discovery%2520Today%253A%2520Ther.%2520Strategies%26date%3D2004%26volume%3D1%26spage%3D299%26epage%3D304" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Kanzler, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barrat, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hessel, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coffman, R. L.</span><span> </span><span class="NLM_article-title">Therapeutic targeting of innate immunity with Toll-like receptor agonists and antagonists</span> <span class="citation_source-journal">Nat. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">552</span><span class="NLM_x">–</span> <span class="NLM_lpage">559</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Fjm401321v&amp;key=10.1038%2Fnm1589" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Fjm401321v&amp;key=17479101" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Fjm401321v&amp;key=1%3ACAS%3A528%3ADC%252BD2sXkvVOgsrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2007&pages=552-559&author=H.+Kanzlerauthor=F.+J.+Barratauthor=E.+M.+Hesselauthor=R.+L.+Coffman&title=Therapeutic+targeting+of+innate+immunity+with+Toll-like+receptor+agonists+and+antagonists"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Therapeutic targeting of innate immunity with Toll-like receptor agonists and antagonists</span></div><div class="casAuthors">Kanzler, Holger; Barrat, Franck J.; Hessel, Edith M.; Coffman, Robert L.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">552-559</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The identification of the antigen recognition receptors for innate immunity, most notably the Toll-like receptors, has sparked great interest in therapeutic manipulation of the innate immune system.  Toll-like receptor agonists are being developed for the treatment of cancer, allergies and viral infections, and as adjuvants for potent new vaccines to prevent or treat cancer and infectious diseases.  As recognition grows of the role of inappropriate Toll-like receptor stimulation in inflammation and autoimmunity, significant efforts have begun to develop antagonists to Toll-like receptors as well.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqypI4d-NCX7LVg90H21EOLACvtfcHk0liu6KfBQ6HDVg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXkvVOgsrs%253D&md5=5fcd32926d9b24f84ff9fd611dec2175</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1038%2Fnm1589&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm1589%26sid%3Dliteratum%253Aachs%26aulast%3DKanzler%26aufirst%3DH.%26aulast%3DBarrat%26aufirst%3DF.%2BJ.%26aulast%3DHessel%26aufirst%3DE.%2BM.%26aulast%3DCoffman%26aufirst%3DR.%2BL.%26atitle%3DTherapeutic%2520targeting%2520of%2520innate%2520immunity%2520with%2520Toll-like%2520receptor%2520agonists%2520and%2520antagonists%26jtitle%3DNat.%2520Med.%26date%3D2007%26volume%3D13%26spage%3D552%26epage%3D559" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Matsunaga, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsuchimori, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsumoto, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ii, M.</span><span> </span><span class="NLM_article-title">TAK-242 (resatorvid), a small-molecule inhibitor of Toll-like receptor (TLR) 4 signaling, binds selectively to TLR4 and interferes with interactions between TLR4 and its adaptor molecules</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">79</span><span class="NLM_x">, </span> <span class="NLM_fpage">34</span><span class="NLM_x">–</span> <span class="NLM_lpage">41</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=79&publication_year=2011&pages=34-41&author=N.+Matsunagaauthor=N.+Tsuchimoriauthor=T.+Matsumotoauthor=M.+Ii&title=TAK-242+%28resatorvid%29%2C+a+small-molecule+inhibitor+of+Toll-like+receptor+%28TLR%29+4+signaling%2C+binds+selectively+to+TLR4+and+interferes+with+interactions+between+TLR4+and+its+adaptor+molecules"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMatsunaga%26aufirst%3DN.%26aulast%3DTsuchimori%26aufirst%3DN.%26aulast%3DMatsumoto%26aufirst%3DT.%26aulast%3DIi%26aufirst%3DM.%26atitle%3DTAK-242%2520%2528resatorvid%2529%252C%2520a%2520small-molecule%2520inhibitor%2520of%2520Toll-like%2520receptor%2520%2528TLR%2529%25204%2520signaling%252C%2520binds%2520selectively%2520to%2520TLR4%2520and%2520interferes%2520with%2520interactions%2520between%2520TLR4%2520and%2520its%2520adaptor%2520molecules%26jtitle%3DMol.%2520Pharmacol.%26date%3D2011%26volume%3D79%26spage%3D34%26epage%3D41" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Peri, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piazza, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calabrese, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Damore, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cighetti, R.</span><span> </span><span class="NLM_article-title">Exploring the LPS/TLR4 signal pathway with small molecules</span> <span class="citation_source-journal">Biochem. Soc. Trans.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">38</span><span class="NLM_x">, </span> <span class="NLM_fpage">1390</span><span class="NLM_x">–</span> <span class="NLM_lpage">1395</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Fjm401321v&amp;key=10.1042%2FBST0381390" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Fjm401321v&amp;key=20863319" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Fjm401321v&amp;key=1%3ACAS%3A528%3ADC%252BC3cXht1Srt7jM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2010&pages=1390-1395&author=F.+Periauthor=M.+Piazzaauthor=V.+Calabreseauthor=G.+Damoreauthor=R.+Cighetti&title=Exploring+the+LPS%2FTLR4+signal+pathway+with+small+molecules"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Exploring the LPS/TLR4 signal pathway with small molecules</span></div><div class="casAuthors">Peri, Francesco; Piazza, Matteo; Calabrese, Valentina; Damore, Gaetana; Cighetti, Roberto</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Society Transactions</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1390-1395</span>CODEN:
                <span class="NLM_cas:coden">BCSTB5</span>;
        ISSN:<span class="NLM_cas:issn">0300-5127</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">A review.  The identification of the bacterial endotoxin receptors for innate immunity, most notably TLR4 (Toll-like receptor 4), has sparked great interest in therapeutic manipulation of the innate immune system.  In the present mini-review, several natural and synthetic mols. that modulate the TLR4-mediated LPS (lipopolysaccharide) signalling in animals and humans are considered, and their mechanisms of action are discussed.  The process of LPS sensing and signal amplification in humans is based on the sequential action of specific receptors situated in the extracellular side of the innate immunity cells, which bind and transfer LPS to TLR4: LBP (LPS-binding protein), CD14, MD-2 (myeloid differentiation protein 2).  We classified the compds. active on TLR4 pathway depending on the specific mol. targets (LPS, LBP, CD14, MD-2 or TLR4).  Small mols. developed by our group are described that inhibit LPS-stimulated TLR4 activation by selectively targeting the LPS-CD14 interaction.  These compds. have an interesting antiseptic shock, anti-inflammatory and anti-neuropathic pain activity in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqnaiwFrBsLXLVg90H21EOLACvtfcHk0lhWaB8cPf5NeA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXht1Srt7jM&md5=d5ef593c1fed4b262f6bbdb188c8cb6b</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1042%2FBST0381390&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FBST0381390%26sid%3Dliteratum%253Aachs%26aulast%3DPeri%26aufirst%3DF.%26aulast%3DPiazza%26aufirst%3DM.%26aulast%3DCalabrese%26aufirst%3DV.%26aulast%3DDamore%26aufirst%3DG.%26aulast%3DCighetti%26aufirst%3DR.%26atitle%3DExploring%2520the%2520LPS%252FTLR4%2520signal%2520pathway%2520with%2520small%2520molecules%26jtitle%3DBiochem.%2520Soc.%2520Trans.%26date%3D2010%26volume%3D38%26spage%3D1390%26epage%3D1395" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Zhang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yin, H.</span><span> </span><span class="NLM_article-title">Selection, synthesis, and anti-inflammatory evaluation of the arylidene malonate derivatives as TLR4 signaling inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">6073</span><span class="NLM_x">–</span> <span class="NLM_lpage">6079</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2012&pages=6073-6079&author=S.+Zhangauthor=K.+Chengauthor=X.+Wangauthor=H.+Yin&title=Selection%2C+synthesis%2C+and+anti-inflammatory+evaluation+of+the+arylidene+malonate+derivatives+as+TLR4+signaling+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DS.%26aulast%3DCheng%26aufirst%3DK.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DYin%26aufirst%3DH.%26atitle%3DSelection%252C%2520synthesis%252C%2520and%2520anti-inflammatory%2520evaluation%2520of%2520the%2520arylidene%2520malonate%2520derivatives%2520as%2520TLR4%2520signaling%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2012%26volume%3D20%26spage%3D6073%26epage%3D6079" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Nakashima, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oyama, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ito, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Witono, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Darnaedi, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanaka, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murata, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iinuma, M.</span><span> </span><span class="NLM_article-title">Novel quinolinone alkaloids bearing a lignoid moiety and related constituents in the leaves of <i>Melicope denhamii</i></span> <span class="citation_source-journal">Tetrahedron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">68</span><span class="NLM_x">, </span> <span class="NLM_fpage">2421</span><span class="NLM_x">–</span> <span class="NLM_lpage">2428</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2012&pages=2421-2428&author=K.+Nakashimaauthor=M.+Oyamaauthor=T.+Itoauthor=Y.+Akaoauthor=J.+R.+Witonoauthor=D.+Darnaediauthor=T.+Tanakaauthor=J.+Murataauthor=M.+Iinuma&title=Novel+quinolinone+alkaloids+bearing+a+lignoid+moiety+and+related+constituents+in+the+leaves+of+Melicope+denhamii"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNakashima%26aufirst%3DK.%26aulast%3DOyama%26aufirst%3DM.%26aulast%3DIto%26aufirst%3DT.%26aulast%3DAkao%26aufirst%3DY.%26aulast%3DWitono%26aufirst%3DJ.%2BR.%26aulast%3DDarnaedi%26aufirst%3DD.%26aulast%3DTanaka%26aufirst%3DT.%26aulast%3DMurata%26aufirst%3DJ.%26aulast%3DIinuma%26aufirst%3DM.%26atitle%3DNovel%2520quinolinone%2520alkaloids%2520bearing%2520a%2520lignoid%2520moiety%2520and%2520related%2520constituents%2520in%2520the%2520leaves%2520of%2520Melicope%2520denhamii%26jtitle%3DTetrahedron%26date%3D2012%26volume%3D68%26spage%3D2421%26epage%3D2428" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Teague, S. J.</span> Unpublished results.<span class="NLM_x"> </span><span class="NLM_year">2006</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Teague%2C+S.+J.+Unpublished+results.+2006."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dunpublished%26sid%3Dliteratum%253Aachs%26aulast%3DTeague%26aufirst%3DS.%2BJ.%26date%3D2006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Bowman, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grundon, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">James, K. J.</span><span> </span><span class="NLM_article-title">Quinoline alkaloids. Part XVI. 2,2-Dimethylpyranoquinolines from base-catalysed rearrangement of isoprenyl epoxides. Synthesis and biogenesis of flindersine</span> <span class="citation_source-journal">J. Chem. Soc., Perkin Trans. 1</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1973</span><span class="NLM_x">, </span> <span class="NLM_fpage">1055</span><span class="NLM_x">–</span> <span class="NLM_lpage">1059</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1973&pages=1055-1059&author=R.+M.+Bowmanauthor=M.+F.+Grundonauthor=K.+J.+James&title=Quinoline+alkaloids.+Part+XVI.+2%2C2-Dimethylpyranoquinolines+from+base-catalysed+rearrangement+of+isoprenyl+epoxides.+Synthesis+and+biogenesis+of+flindersine"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBowman%26aufirst%3DR.%2BM.%26aulast%3DGrundon%26aufirst%3DM.%2BF.%26aulast%3DJames%26aufirst%3DK.%2BJ.%26atitle%3DQuinoline%2520alkaloids.%2520Part%2520XVI.%25202%252C2-Dimethylpyranoquinolines%2520from%2520base-catalysed%2520rearrangement%2520of%2520isoprenyl%2520epoxides.%2520Synthesis%2520and%2520biogenesis%2520of%2520flindersine%26jtitle%3DJ.%2520Chem.%2520Soc.%252C%2520Perkin%2520Trans.%25201%26date%3D1973%26spage%3D1055%26epage%3D1059" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Jones, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roset, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rossiter, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whitfield, P.</span><span> </span><span class="NLM_article-title">Demethylation of 2,4-dimethoxyquinolines: the synthesis of atanine</span> <span class="citation_source-journal">Org. Biomol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">4380</span><span class="NLM_x">–</span> <span class="NLM_lpage">4383</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2003&pages=4380-4383&author=K.+Jonesauthor=X.+Rosetauthor=S.+Rossiterauthor=P.+Whitfield&title=Demethylation+of+2%2C4-dimethoxyquinolines%3A+the+synthesis+of+atanine"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJones%26aufirst%3DK.%26aulast%3DRoset%26aufirst%3DX.%26aulast%3DRossiter%26aufirst%3DS.%26aulast%3DWhitfield%26aufirst%3DP.%26atitle%3DDemethylation%2520of%25202%252C4-dimethoxyquinolines%253A%2520the%2520synthesis%2520of%2520atanine%26jtitle%3DOrg.%2520Biomol.%2520Chem.%26date%3D2003%26volume%3D1%26spage%3D4380%26epage%3D4383" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Holla, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jenkins, I. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neve, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pouwer, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pham, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teague, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quinn, R. J.</span><span> </span><span class="NLM_article-title">Synthesis of melicodenines C, D and E</span> <span class="citation_source-journal">Tetrahedron Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">7101</span><span class="NLM_x">–</span> <span class="NLM_lpage">7103</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2012&pages=7101-7103&author=H.+Hollaauthor=I.+D.+Jenkinsauthor=J.+E.+Neveauthor=R.+H.+Pouwerauthor=N.+Phamauthor=S.+J.+Teagueauthor=R.+J.+Quinn&title=Synthesis+of+melicodenines+C%2C+D+and+E"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHolla%26aufirst%3DH.%26aulast%3DJenkins%26aufirst%3DI.%2BD.%26aulast%3DNeve%26aufirst%3DJ.%2BE.%26aulast%3DPouwer%26aufirst%3DR.%2BH.%26aulast%3DPham%26aufirst%3DN.%26aulast%3DTeague%26aufirst%3DS.%2BJ.%26aulast%3DQuinn%26aufirst%3DR.%2BJ.%26atitle%3DSynthesis%2520of%2520melicodenines%2520C%252C%2520D%2520and%2520E%26jtitle%3DTetrahedron%2520Lett.%26date%3D2012%26volume%3D53%26spage%3D7101%26epage%3D7103" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Sharma, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joshi, B. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sinha, A. K.</span><span> </span><span class="NLM_article-title">An effective system to synthesize hypolipidemic active alpha-asarone and related methoxylated (E)-arylalkenes</span> <span class="citation_source-journal">Bull. Chem. Soc. Jpn.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">77</span><span class="NLM_x">, </span> <span class="NLM_fpage">2231</span><span class="NLM_x">–</span> <span class="NLM_lpage">2235</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=77&publication_year=2004&pages=2231-2235&author=A.+Sharmaauthor=B.+P.+Joshiauthor=A.+K.+Sinha&title=An+effective+system+to+synthesize+hypolipidemic+active+alpha-asarone+and+related+methoxylated+%28E%29-arylalkenes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSharma%26aufirst%3DA.%26aulast%3DJoshi%26aufirst%3DB.%2BP.%26aulast%3DSinha%26aufirst%3DA.%2BK.%26atitle%3DAn%2520effective%2520system%2520to%2520synthesize%2520hypolipidemic%2520active%2520alpha-asarone%2520and%2520related%2520methoxylated%2520%2528E%2529-arylalkenes%26jtitle%3DBull.%2520Chem.%2520Soc.%2520Jpn.%26date%3D2004%26volume%3D77%26spage%3D2231%26epage%3D2235" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Liu, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jang, Y. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shih, Y. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chu, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yao, C. F.</span><span> </span><span class="NLM_article-title">Novel synthesis of alkenes via triethylborane-induced free-radical reactions of alkyl iodides and beta-nitrostyrenes</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x">, </span> <span class="NLM_fpage">6021</span><span class="NLM_x">–</span> <span class="NLM_lpage">6028</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo010213m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2001&pages=6021-6028&author=J.+T.+Liuauthor=Y.+J.+Jangauthor=Y.+K.+Shihauthor=S.+R.+Huauthor=C.+M.+Chuauthor=C.+F.+Yao&title=Novel+synthesis+of+alkenes+via+triethylborane-induced+free-radical+reactions+of+alkyl+iodides+and+beta-nitrostyrenes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Fjo010213m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo010213m%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DJ.%2BT.%26aulast%3DJang%26aufirst%3DY.%2BJ.%26aulast%3DShih%26aufirst%3DY.%2BK.%26aulast%3DHu%26aufirst%3DS.%2BR.%26aulast%3DChu%26aufirst%3DC.%2BM.%26aulast%3DYao%26aufirst%3DC.%2BF.%26atitle%3DNovel%2520synthesis%2520of%2520alkenes%2520via%2520triethylborane-induced%2520free-radical%2520reactions%2520of%2520alkyl%2520iodides%2520and%2520beta-nitrostyrenes%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2001%26volume%3D66%26spage%3D6021%26epage%3D6028" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Wang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, Y. R.</span><span> </span><span class="NLM_article-title">Efficient synthesis of substituted pyranoquinolinones from 2,4-dihydroxyquinoline: Total synthesis of zanthosimuline, cis-3′,4′-dihydroxy-3′,4′-dihydroflindersine, and orixalone D</span> <span class="citation_source-journal">Synthesis</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_fpage">3044</span><span class="NLM_x">–</span> <span class="NLM_lpage">3050</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Fjm401321v&amp;key=1%3ACAS%3A528%3ADC%252BD2sXht1ynsrnM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2007&pages=3044-3050&author=X.+Wangauthor=Y.+R.+Lee&title=Efficient+synthesis+of+substituted+pyranoquinolinones+from+2%2C4-dihydroxyquinoline%3A+Total+synthesis+of+zanthosimuline%2C+cis-3%E2%80%B2%2C4%E2%80%B2-dihydroxy-3%E2%80%B2%2C4%E2%80%B2-dihydroflindersine%2C+and+orixalone+D"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Efficient synthesis of substituted pyranoquinolinones from 2,4-dihydroxyquinoline: total synthesis of zanthosimuline, cis-3',4'-dihydroxy-3',4'-dihydroflindersine, and orixalone D</span></div><div class="casAuthors">Wang, Xue; Lee, Yong Rok</div><div class="citationInfo"><span class="NLM_cas:title">Synthesis</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume"></span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">3044-3050</span>CODEN:
                <span class="NLM_cas:coden">SYNTBF</span>;
        ISSN:<span class="NLM_cas:issn">0039-7881</span>.
    
            (<span class="NLM_cas:orgname">Georg Thieme Verlag</span>)
        </div><div class="casAbstract">A convenient and efficient synthesis of pyranoquinolinones (e.g. I) was achieved using the ethylenediamine diacetate catalyzed reactions of 2,4-dihydroxyquinoline and a variety of α,β-unsatd. aldehydes in good yield.  The key feature of these reactions is the formal [3+3] cycloaddn.  This new methodol. was applied successfully to the total synthesis of naturally occurring pyranoquinolinone alkaloids, zanthosimuline, cis-3',4'-dihydroxy-3',4'-dihydroflindersine, and orixalone D.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrHn8aODSTDgbVg90H21EOLACvtfcHk0lgD2-s66GanTg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXht1ynsrnM&md5=37e64a12c2467ab129a27da0bb927e18</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DX.%26aulast%3DLee%26aufirst%3DY.%2BR.%26atitle%3DEfficient%2520synthesis%2520of%2520substituted%2520pyranoquinolinones%2520from%25202%252C4-dihydroxyquinoline%253A%2520Total%2520synthesis%2520of%2520zanthosimuline%252C%2520cis-3%25E2%2580%25B2%252C4%25E2%2580%25B2-dihydroxy-3%25E2%2580%25B2%252C4%25E2%2580%25B2-dihydroflindersine%252C%2520and%2520orixalone%2520D%26jtitle%3DSynthesis%26date%3D2007%26spage%3D3044%26epage%3D3050" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i135"><a href="/doi/suppl/10.1021/jm401321v">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_33772"></div></div></div></div></div><hr /></hr><p class="last">Representative NMR data for the 10 most active compounds from the cyclobutane series (compounds <b>1</b>, <b>20</b>, <b>22</b>, <b>26</b>, <b>31</b>, <b>32</b>, <b>34</b>, <b>35</b>, <b>52</b>, and <b>53</b>) and two of the acetal analogues (compounds <b>63</b> and <b>64</b>). Selectivity data for euodenine A, LPS, and the positive controls across the TLR lines. This material is available free of charge via the Internet at <a class="extLink" href="http://pubs.acs.org">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm401321v/suppl_file/jm401321v_si_001.pdf">jm401321v_si_001.pdf (2.52 MB)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm401321v&amp;pbContext=%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2014.57.issue-4%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Barticle%3Aarticle%3A10.1021%2Fjm401321v%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm401321v" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                2MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"67994ea9c9d8329d","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
